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Chapter 1
Introduction
Background
In the early 1980s the Dutch Cancer Society decided to stimulate the development
of expertise in epidemiology, in particular cancer epidemiology, which was at that time
pursued by a few scientists only. The Society put this decision into practice by taking
the two following measures: (a) two-year fellowships were awarded to post-graduate
scientists in order to receive a training in epidemiology and (b) epidemiological
research projects were ranked high in priority for funding by the Society. Without this
policy of the Dutch Cancer Society there would not have been a "Dutch prospective
cohort study on diet and cancer".
The three epidemiologists who initiated the cohort study (P.A.v.d.H, R.A.B.
together with Pieter van 't Veer of the TNO-Toxicology and Nutrition Institute) had
many things in common: all had graduated in human nutrition, were very interested in
epidemiology, were awarded an epidemiology fellowship by the Dutch Cancer Society,
went to the Harvard School of Public Health (Boston, USA) for a formal training in
epidemiology, and, last but not least, were supposed to write each a grant proposal for
a cancer epidemiology project during the second year of their respective fellowships.
Not surprisingly, the potential objectives of the grant proposals concerned the
hypothesized (1) relation between dietary habits and specific tumors, to be investigated
in separate case-control studies. It soon became clear, however, that here was the
opportunity to combine efforts and write a joint grant proposal for a prospective cohort
study in which the association of dietary habits with various types of cancer could be
investigated simultaneously. Although prospective studies are also preferred to case-
control studies in order to avoid biases - in particular information (recall) bias, which
hampers inference from dietary case-control studies -, only very few of such studies on
diet and cancer were being conducted at that time. The scarcity of prospective cohort
studies is caused by the logistic and financial constraints resulting from the large size
required for these studies and by the long follow-up period. The ongoing large-scale
prospective studies on diet and cancer included five American studies: the Adventist
Health Study (34,000 men and women) (2), the New York State Cohort (58,000 men
and women) (3), the Nurses' Health Study (98,000 women) (4), the Canadian Breast
Cancer Screening Study (57,000 women) (5), the Cancer Prevention Study II (1,200,000
men and women) (6) and one Japanese Study (265,000 men and women) (7). The
Japanese study and the Cancer Prevention Study have used very brief questionnaires for
the assessment of dietary habits at baseline, whereas the other studies have used more
extensive methods. A prospective study in the Netherlands among a population
different from that in the other studies, with different lifestyle and dietary habits,
assessed by a more detailed instrument, would contribute substantially to the
interpretation of the results originating from epidemiological diet and cancer studies.
Scope
This thesis describes the methodological and feasibility aspects of the prospective
cohort study on diet and cancer that we have designed and subsequently carried out.
The purpose of this study is to test various existing hypotheses in the field of diet and
cancer. Our initial interest is in cancers of the stomach, colon, rectum, breast and lung
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because of their suspected relationship with diet and because of their relatively high
incidence. The primary goal of the study is to investigate the associations between fats,
vitamins (A, C, carotene), fiber, alcohol, selenium, nitrate, sodium and calcium on the
development of gastric, colorectal, breast and lung tumors (8,9). Besides nutrients we
are also interested in associations with particular foods (e.g., meat, alcoholic beverages)
and dietary patterns. While the scope of this thesis is to describe how the study was
designed and conducted, we also present results on the first etiological analyses to
illustrate what can and what cannot (yet) be done with the data accumulating from the
study. For this purpose, we decided to test some prominent hypotheses. These relate to
the intake of fat and meat and risk of breast and colorectal cancer, and to alcohol
intake and colorectal cancer risk. An illustration of how the cohort study can be used to
investigate whether detection or ascertainment bias can explain particular associations
found in case-control studies is presented with the analysis of cholecystectomy and
colorectal cancer. Finally, we present results regarding selenium status and the risk of
lung, gastrointestinal and breast cancer. This is to illustrate a distinct advantage of a
cohort study, namely that the association with a particular risk factor can be evaluated
for several cancer sites simultaneously.
Design and follow-up
If it were to be a prospective study, we absolutely required it to be a large-scale
study for two reasons: (a) the power should be large enough to detect moderately
increased relative risks (e.g., between 1.5 and 2.0) and to study modification of the
relative risks by other factors and (b) this power should be achieved in a relatively short
follow-up time (i.e. five years) for the most common types of cancers (gastrointestinal,
breast and lung). We considered the short follow-up period important because of the
expected difficulties in raising funds for a study of very long duration and in view of the
risk that hypotheses might be outdated by the end of the study. At the other hand, it
was also very clear that it had to be a relatively low-cost study, since funds in the
Netherlands are limited. We found the potential solution to this apparent paradox by
designing an efficient study. For example, application of the case-cohort approach
(10,11), in which data are processed for cases and a random sample of the cohort only,
would save approximately 90% of the variable processing costs, but lose only a limited
amount of information. The most efficiency-enhancing features, however, were the use
of existing, computerized data bases for cohort recruitment (municipal population
registries) and follow-up (cancer registries). Sampling of potential cohort members from
the population registries, which was permitted for scientific purposes, provided the
opportunity to select the required age group (55-69 year) and receive their - correct -
identifying information in machine-readable form. The elaboration of the study design
is described in Chapter 2.
After a grant had been awarded for a two-year pilot study (1984 and 1985), one of
the major problems we faced was the follow-up by cancer registries. From the beginning
of the 1980s, the cancer registries were in the process of starting up. Although they
were meant to cover the entire country in a few years' time, it was by no means certain
that they would achieve their aim in time. We decided to rule out chance by (a) using
PALGA, a computerized data base of pathology reports, as an additional source from
which cancer cases arising in the cohort could be identified and (b) restricting cohort
recruitment to those areas that were already covered by the cancer registries or
PALGA near the end of 1985. Chapter 3 deals with the method we devised to define
the degree of coverage of each municipality by either a cancer registry or PALGA.
Having decided to recruit the cohort in the municipalities that were sufficiently covered
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by PALGA and/or the cancer registries, the procedure how to actually link a cohort
prospectively to these disease registers still needed to be worked out. Unlike the
situation in, for example, Scandinavian countries where such a linkage can be conducted
using a unique personal identification number, a linkage in the Netherlands had to be
based on other (non-unique) personal identifying information like family name and date
of birth. In collaboration with the regional IK.L cancer registry, we developed a record
linkage protocol which has consequently been adopted by the other cancer registries
and PALGA. Chapter 4 describes the development of the protocol and the
determination of the optimal linkage key.
Assessment of exposure
A prerequisite of a large-scale, low-cost study was, of course, an efficient method to
measure exposure (dietary habits) and potential confounders Guided by the example of
the Nurses' Health Study in the USA, the most sophisticated large-scale prospective
study on several types of exposure including dietary habits and a number of outcomes
including cancer, we decided to use a mailed, self-administered questionnaire. A 'semi-
quantitative food frequency questionnaire' (12) was the only method of dietary
assessment that promised to be both efficient and sufficiently valid. This type of
questionnaire can be viewed as the synthesis of the concepts common among
epidemiologists and those that used to prevail among nutritionists. The classic 'nutrition
school' has long considered the many-day dietary record method and the comprehensive
dietary history interview (13) as the only acceptable methods of individual dietary
assessment, although the need for short-cut, but accurate methods was urgently felt
(14). However, shorter methods were shown to be less accurate in both an absolute and
a relative sense and thus often considered inadequate. Many epidemiologists, in the
early studies on dietary exposure and disease, tried to assess dietary habits by asking a
small number of questions about the consumption of specific foods without knowledge
of the predictive value of those questions with respect to nutrient intake or other
hypotheses of interest (e.g., 7). As a result, etiological epidemiological studies used
either short methods of dubious or unknown validity or an elaborate assessment of
dietary habits, such as the dietary history, which was consequently restricted to relatively
small studies such as case-control studies (e.g., 15). The breakthrough came when
epidemiologists adopted from nutritionists the notion that dietary assessment is a
complicated matter that requires a methodological approach, while nutritionists started
to realize that absolute accuracy of a measurement method is not a prerequisite in
etiological research. A method that is sufficiently accurate in ranking study subjects with
respect to the exposure of interest should be acceptable for epidemiological purposes
(12), that is, when its accuracy can be estimated from a validation study. The (semi-
quantitative) food frequency questionnaires were (and are) developed and validated
according to these acquired insights (e.g., 16-18). Chapter 5 describes how we
developed and validated our food frequency questionnaire according to these principles.
In diet and cancer research, it is important that dietary assessment covers a long
period preceding the clinical diagnosis of cancer (e.g., five to ten years). If dietary
habits were very unstable within individuals, a single assessment would not suffice to
cover such a long period. In Chapter 6 we investigated the stability of the dietary habits
in our cohort over a five-year period. For this purpose, we annually repeated the dietary
questionnaire in random samples from the cohort during the first five years of follow-
up. The repeated measurements also give insight into the questionnaire's test-retest
error, which, together with the results from the validation study, informs us about the
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size, type and possible consequences of the measurement error associated with the food
frequency questionnaire.
An aspect that is related to the quality of the dietary assessment technique is the
presence or absence of an actual exposure contrast between individuals in the study
population. In particular, it has been suggested (19,20) that for several dietary variables,
such as fat intake, Western populations are too homogeneous to reveal associations
with the risk of cancer. On the other hand, conducting a multinational prospective
cohort study in both developed and developing countries simultaneously may pose
severe logistic problems (e.g., exposure assessment, follow-up possibilities,
standardization of methods) and consequently hamper interpretation of the results. We
attempted to enlarge the exposure contrast in our cohort by studying the general
population (as opposed to, for example, certain occupational groups), by recruiting the
cohort from all parts of the Netherlands (as opposed to recruitment in, for example,
one major city or region) and by recruitment of extra subjects with special dietary habits
(vegetarians). The advantages and disadvantages of this approach are described in
Chapter 2.
It has been suggested that the intake of particular nutrients is difficult to measure
(e.g., selenium, of which the content in foods varies considerably, depending on the soil
conditions (21-23)) and that therefore more use should be made of biological markers
of dietary exposure (20,24). What is often overlooked in this recommendation is that
the appropriate choice and use of biomarkers in a large epidemiological study can be
equally difficult. Biomarkers involving serum or urine measurements often reflect short-
term status rather than the etiologically more relevant long-term body status (12). This
would necessitate multiple exposure measurements which may be difficult to accomplish
in large-scale studies. Also, biomarkers that require invasive sampling techniques, such
as blood sampling, may pose logistic and response problems in a healthy population.
Other potential problems involve the requirement of specific transport and storage
conditions. With the usual budgetary constraints this may result in relatively small
cohorts being studied and consequently low power. A promising exception to this at the
start of our cohort study were toenail specimens, which can be collected by participants,
mailed, and stored under normal conditions (12,25). In our pilot study, the mailed
collection of toenail clippings turned out to be feasible in terms of sampling costs, effect
on response rate, transport and storage. We found a correlation of 0.57 between
selenium levels in toenails and erythrocytes, which is also a long-term marker of
selenium status (26). Chapter 7 describes a study on predictors of toenail selenium
levels and the association with dietary selenium intake.
A related study was carried out on the association between dietary nitrate intake
and nitrate levels in urine specimens. This is an illustration of another use of
biomarkers, namely for validating dietary intake measurements, if there is sufficient
reason to assume that the biomarker is more valid than dietary assessment. An
application with regard to nitrate is described in Chapter 8. Because this validation
study was conducted within an earlier cohort study, the relevant questions on nitrate
intake could be incorporated in our baseline questionnaire.
While the assessment of dietary exposure thus forms a challenge in itself, a
retrospective assessment may in addition be prone to information bias in case-control
studies. Dietary habits before the diagnosis of cancer may be recalled in a biased way
since cancer cases may be more aware of their diet than controls, thus influencing
recall, or because dietary habits may be altered due to the disease. For the same
reason, cross-sectional studies are generally considered to be inferior to longitudinal
studies. However, very few data exist to confirm this presumption. In Chapter 9, we
describe a study in which we compared results of a cross-sectional analysis of the
association between meat consumption and cancer with a longitudinal analysis.
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Statistical analysis
A frequently used option to make efficient use of data collected in a cohort study is
to analyze the study with a nested case-control approach. This involves sampling of
control subjects out of the risk set whenever a case occurs. An alternative option is to
use the case-cohort approach, in which a random subcohort is selected after the cohort
baseline measurement, and which is used together with all emerging cases. An
important advantage of this approach is that the subcohort can be used for multiple
endpoints and that exposure data can be processed in advance. However, when we
started the cohort study, there was no standard statistical software available for
analyzing case-cohort studies. The theoretical approach to these analyses was published
in 1988 (27). We developed methods for stratified and multivariate analyses of case-
cohort data. This is described in Chapter 10, where the methods arc illustrated in the
analysis of the smoking-lung cancer association in our cohort.
Results
In Chapters 11-17, results of the first analyses of the cohort study after 3.3 years of
follow-up (September 1986 - December 1989) are presented. As mentioned earlier,
several hypotheses were tested to illustrate applications of the cohort data. These
specific hypotheses were the following:
- The intake of total fat and various types of fat (saturated, monounsaturated and
polyunsaturated fat) is positively associated with the risk of breast cancer.
- The intake of alcohol and alcoholic beverages is positively associated with the risk of
colorectal cancer.
- The consumption of meat and/or fat (from meat) is positively associated with the risk
of colorectal cancer.
- The association between cholecystectomy and colorectal cancer is not attributable to
confounding by dietary habits or to other biases.
- Selenium status, as measured by toenail selenium levels, is inversely associated with
the risk of lung, gastrointestinal and breast cancer.
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Akatraet—In 1986. a prospeclivt cohort Hudy on diet and cancer wai Marled in The
Netherlands The cohort In - 120. 852) of 5$ 69 year old men (48 2%) and women (M 8*4)
originate! from 204 computerized municipal population registries. At baseline, participants
completed a self-administered questionnaire on diet and potential confounding variables In
addition, about 67% of the participants provided tocnail clippings. Cancer follow-up consists
of record linkage to a pathology registry and to cancer registries. The initial interest is in
stomach, colorectal. breast and lung tumors A case-cohort approach is applied, in which
detailed follow-up information of a random subcohort (n = 5000) provides an estimate of the
person-time experience of the cohort Exposure data of the subcohort will he combined with
those of incident cases, yielding exposure-specific incidence rate ratios The intraindividual
variation in determinants is estimated by annually repeated measurements (n = 250) within the
subcohort. The rationale, efficiency aspects and study characteristics are discussed
Diet Neoplasms Epidemiologie methods Biometry Questionnaires Tocnails
INTRODUCTION
The possible role of dietary factors in the eti-
ology of human cancer continues to be a subject
both of research and debate. Various estimates
have been produced on the proportion of cancer
cases attributable to diet and other factors [1-3].
It has been rather difficult, however, to identify
specific elements of the diet as being causative or
preventive. Analytical epidemiological studies
on diet and cancer have been mostly of the
case-control type; their results often seem
to lack consistency, which may be attributed
partly to the potential for selection bias,
and, particularly in dietary studies, recall bias
'Reprint requests should be addressed to: Piet A. van den
Brandt. Department of Epidemiology. University of
Limburg. PO Box 616. 6200 MD Maastricht. The
Netherlands.
[4]. Considering that large-scale randomized
controlled dietary intervention trials are rarely
feasible (because of financial, blinding, com-
pliance and ethical reasons), prospective cohort
studies are often proposed as the alternative
method of choice. At the same time cohort
studies are commonly regarded as prohibitively
expensive, notably studies among the general
population. The costs generally originate from
recruitment of the study population, (baseline)
exposure measurement and follow-up. Thus,
there is a need for cost-efficient prospective
cohort studies [4].
Various ongoing cohort studies on diet
and cancer have been published, with widely
differing characteristics. The following serves
merely as a general description of the character-
istics, supplemented with some examples of
studies, without attempting to be complete.
Reproduced with permission of Pergamon Press
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Most studies are conducted in the general popu-
lation (e.g. [5, 6)) or in a captive (occupational)
subgroup of specific gender (e.g. [7]); other
studies use groups with specific dietary habits
(e.g. [ft 10)). Studies may have been started as
such or have been attached to existing data
collection structures as a census (e.g. (I I)) or to
a screening program (e.g. [12. 13]); others have
made use of existing biological banks, usually
without any dietary assessment (e.g. (14, 15).
Dietary assessment may include a limited (e.g.
(II, I A]) or more extensive questionnaire [7. 17],
with the length usually inversely related to
sample si/c. Still other studies have used a single
24 hr dietary recall [18,19] or cross-check
dietary history interviews [20]. Because of their
characteristics, some studies will yield data on
overall dietary habits, which can hardly be
transluted into nutrient intakes. In addition,
it might he difficult to generalize such results
from studies when conducted in Japan, to
Western i-urnpc or the U.S. Studies that
address the issue of nutrient intake or use
biochemical markers generally take a relatively
long time to yield a large number of cases
because of the small study si/c. Indeed, a combi-
nation of dietary assessment and biological
sampling on a large scale is rare [7], whereas
both sources of information are likely to be
complementary.
Our objective was to design an efficient,
large-scale study among men and women thai
combines extensive dietary assessment with bio-
logical sampling, and that yields a sufficiently
large number of cases within a reasonably short
follow-up period. Efficiency in this respect refers
to selection of the study population and area,
determinant contrasts and their measurement,
biological sampling, follow-up, data processing
and statistical analyses. The cohort study was
started in 1986 and was preceded by a pilot
study in 1984 and 1985 to evaluate the feasibility
of the project and develop the methods to be
used. After presenting the general outline of the
study [21], the various design considerations and
decisions will be discussed in detail.
GENERAL OITLINE OF THE COHORT STUDY
The primary purpose of the study is to
investigate the effects of fats, vitamins, fiber,
alcohol, selenium, nitrate, sodium and calcium
on the development of gastric, colorectal. breast
and lung tumors. Cancer risk associated with
specific dietary patterns will also be evaluated.
These tumor sites chosen because of their
suggested relationship with dietary factors
(e.g. [22, 23]) and their high incidence in The
Netherlands [24].
The study is conducted among 55-69 year old
men and women. Subjects originate from the
general population sampled from municipal
population registries. The pilot study indicated
that a fairly large contrast in dietary intake
exists in this population. To increase the
contrast in the cohort still further, individuals
with special dietary habits (e.g. vegetarians) are
overrepresented. Information on determinants
is obtained by a self-administered questionnaire
and collection of toenail clippings. The 11-page
questionnaire contains 6 pages on food habits,
supplemented with questions on potential con-
founders and other independent risk factors.
These include: smoking and occupational
history, socioeconomic status, history of
selected medical conditions, family history of
cancer, chronic drug use. reproductive history,
obesity and physical activity. The cohort is
constituted by the 120.852 subjects who com-
pleted the baseline questionnaire that was sent
to a total of 340.439 subjects.
Follow-up for cancer incidence will be per-
formed by record linkage to PALGA (a data
base on Dutch pathology reports) and to the
cancer registries. During the first 5 years of
follow-up, approximately 250 cases of stomach
cancer. 450 colon. 300 rectal, 800 breast and
1200 lung cancer cases are expected to arise
from this cohort, taking mortality into account
[25. 26].
A case-cohort approach is applied, by select-
ing a random subcohort (n = 5000) from the
large cohort immediately after identification of
the cohort members. This subcohort is being
followed up for migration and vital status
by contacting the participants and the munici-
palities. As will be discussed, for testing the
primary study hypotheses a subcohort size of
3500 is sufficiently large. Therefore, question-
naires and toenail specimens are initially pro-
cessed only for a random subsample of 3500 out
of the 5000 subcohon members. However, the
person-time experience is also collected for the
remaining 1500 subjects, whose covariate data
will be processed when hypotheses regarding
rare exposures responsible for a small pro-
portion of specific tumors are of interest [27], In
the statistical analyses using the proportional
hazards model [28]. stratification on year of
follow-up will be employed to investigate the
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Fig. I. Design aspects of the prospective cohort study, x. random sample, m. males; f. females.
influence or possible preclinical disease at the
start of the study. The intraindividual variation
in determinants will be estimated by repeating
the questionnaire annually in subsamples
(n = 250 each) of the subcohort. These design
aspects are depicted in Fig. I.
SELECTION OF THE STUDY POPULATION
.4ge a; «Mr»'
Because it has been suggested that diet pre-
dominantly exerts its role on the later stages
rather than the early stages of tumorigenesii
[23. 29], this cohort study is conducted among
elderly people aged 55-69 years at entry. Also,
younger individuals generally show less stable
dietary habits, because they lend to consume
more new foodstuffs [30]. In two longitudinal
Dutch studies, changes in nutrient intake
over a 3 year period have been studied
using interperiod correlation coefficients. The
decrease in correlation among women around
menopause [31] was much smaller than among
adolescents [32]. Although adolescents are
an extreme category in this respect, this com-
parison provides some evidence for higher
stability at older ages.
In the age group well above 70 years, prob-
lems may occur with the dietary assessment, and
there is a tendency for underreporting and
less histological verification of elderly cancer
patients. Finally, a relatively short follow-up (5
years) of a large cohort from the selected age
stratum will yield a sufficient number of cases to
perform meaningful statistical analyses, i.e.
minimally 300 cases per tumor site.
S/re am/
In order to obtain this number of cancer
cases, it was estimated that a cohort size of
150.000 subjects is required [33]. The choice of
the study population is then determined largely
by recruitment efficiency and the required
accuracy of identifying information in view
of the proposed method of follow-up (i.e.
record linkage). In The Netherlands, (computer-
ized) municipal population registries contain
highly accurate identifying information on every
10 Chapter 2
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citizen, and constitute an efficient sampling
frame for the general population. Since a mailed
data collection procedure would be used (with a
lengthy questionnaire), the aim was to start with
an initial sample size of 350,000 subjects in
order to establish a cohort of about 150.000
respondenis
The study area was defined in terms of
municipalities satisfying the following eligibility
criteria: (a) availability of a computcn/ed popu-
lation registry; (b) sufficient cancer follow-up
coverage.
In 1985. 323 out of the 714 municipalities
were computerized; 300 (93%) of (hem agreed
to provide in 1986 a gender-stratified random
sample of specified si/e. equivalent to 40% of
cuch municipal 55 69 years age stratum Cancer
follow-up coverage was determined us follows.
Recently, two sources of incident cancer cases
have become available: PALGA and 9 cancer
registries Since both PALGA and the cancer
registries were nol ycl operating in the entire
country, a list of collaborating hospitals (in
1986) was obtained. Together with data on the
municipal origin of all patients admitted for
cancer to these hospitals (obtained from the
National Health Care Information Center),
expected municipal follow-up coverage degrees
were calculated per tumor site of interest. From
the list of 300 computerized municipalities, 204
were selected with a coverage degree exceeding
75%. yielding a tentative initial sample of
almost 340.000 people. The estimated mean
coverage degree for cases of any of the 5 tumor
sites of initial interest was 93% in this case.
Loss to follow-up due to migration out of the
coverage area (estimated at 1.9% in 5 years) is
taken into account in this estimate. The location
of (he 204 selected municipalities is displayed in
Rg. 2. Municipal samples were selected in
May August 1986, accumulating to 339.733
subjects.
Apart from sampling and follow-up con-
siderations, the expected exposure contrast (and
Fig. 2. The location of the participating municipalities in The Netherlands
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its temporal stability) in the selected study
population needs to be contemplated It has
been suggested that in Western populations the
contrast in exposure may be small when study-
ing individuals within one region or country
[34 36). In our pilot study we have evaluated the
dietary intake in the proposed study population,
which showed a rather large dietary contrast
(e.g. mean ± SD of dietary fat as percent of
calorics was 40.3 + 5.5%). Within western
societies, this variation can be regarded as size-
able. It can be further augmented by extending
the study to other countries with different
dietary habits or by overrepresentation of indi-
viduals with deviant food habits. With the
former approach, problems may arise with
confoundcrs and standardization of dietary
assessment, in view of different eating patterns.
These problems are less serious when the second
approach is used. Therefore, subjects of 55 *9
years and eating meat less than twice a week
were invited to participate by advertisements
and leaflets in life-style magazines and health
food stores located in areas covered by PALGA
or the cancer registries. During the period of
recruitment (April July 1986). about 1000
persons applied; 30% of all applicants were
living outside the covered areas or did not
have the correct age at entry. For some of the
remaining subjects, extra contacts were needed
to obtain complete and correct identifying
information, even though standard application
forms were used. Altogether. 706 eligible
"vegetarians" were recruited in this way.
ASSESSMENT OF DIETARY EXPOSURE
«ƒ </i
Whereas a large interindividual variation
in exposure is desirable and variation within
subjects should preferably be minimal for obser-
vational etiologic studies, it is the ratio of intra-
to-interindividual variation which determines
whether meaningful contrasts in exposure can
be studied. When this ratio is large, substantial
random misclassification will result in attenu-
ated measures of association between exposure
and disease [37]. The variance ratio is in turn
determined by the exposure characteristics of
the study population, combined with the dietary
assessment technique that is being used. In a
transitional study population with rapidly
changing dietary patterns as in Japan [38] and
consequently a large interindividual variation
in food intake, compared to intraindividual
variation, a relatively simple method may
suffice (I I) Compared to the rapid and dramatic
changes in Japan, changes in per capita food
intake in The Netherlands are mink rule |.VJ|.
Our study population will therefore show less
heterogeneity (but also relativcl> stable dietary
habits) In order to minimize misclassilication,
this requires an elaborate dietary assessment
method with a reference period of one ycur,
covering seasonal variations the dietary
history can be used for this purpose, but
the interview method is laborious and imprac-
tical in large-scale studies Therefore, abbre-
viated methods like the (semiquamilalivc) food
frequency questionnaire (SI IQ) have been
developed, which can be self-administered. The
validity and reproducibilily of the SH-'Q have
been studied recently [40 41], Combined with its
feasibility, these results make it the method of
choice for this cohort study furthermore, by
repeating applications of' the method annually
to samples of the cohort, estimates can he
made on the intraindividual variance in annual
intakes. These estimates might also be used
to improve estimates of the rate ratios and
associated confidence intervals [44, 45).
Consfruclion o/ //jp {/teforv furor/an/iairc
A prerequisite for the development was that
the questionnaire should be aimed at measuring
the contrasts in dietary intake that exist in the
cohort and it should be self-administrable. The
construction of the questionnaire is described in
more detail by Bausch-Goldbohm <•/ a/. [46).
Briefly, in 1984 and 1985 detailed dietary history
interviews (covering the preceding year) were
conducted by trained dieticians in a group of
169 subjects (including 20 vegetarians) of similar
age and gender structure as the cohort popu-
lation. After calculation of the intakes of 15
nutrients of interest (related to the hypotheses),
multiple regression analyses were employed
together with residual analysis, to select those
food items that predicted most of the inter-
individual variation in the nutrient intakes of
interest, as measured by the dietary history.
Furthermore, the need for including questions
on portion sizes was also evaluated by this
method. Finally, the remaining list was supple-
mented with some items in order to maintain a
logical (dietary) structure in the questionnaire.
The result was a 6-page dietary questionnaire of
175 food items, that explained the variance in
nutrient intake as measured by the dietary
history, ranging from 86% for vegetable fiber to
12 Chapter 2
290 PITT A VAN DEN BHAKDT CI a/.
100% for alcohol The validity of the final
version, that was used in the cohort, is further
being tested against the dietary record method
and the dietary history method in ongoing
lubstudies.
Oio/c? o/ é;o<7ir*m/ra/
Because of the potential problems associated
with the assessment of food intake, the use of
biochemical markers of dietary exposures has
been proposed as an objective, "hard-evidence"
alternative. Although the use of biological
specimens like plasma seems attractive in that
the biochemical markers address (he nutritional
status more precisely, they nevertheless suffer
from some inherent problems as well The
marker may not properly reflect long term
nutritional status (e.g. [47]); large intra-
individual variations in the marker content may
result in u high ratio of intra-to-interindividual
variation (e.g. serum cholesterol or urinary
•odium) For retrospective ctiologic studies,
various markers may be of less value since the
tumor may have altered the marker level, as has
been shown for plasma Se. vitamin E and retinol
|48 50]. In prospective studies, the collection,
storage und analyses of specimens may be pro-
hibitively expensive, leading to smaller cohorts
with decreased power and an increased risk of
chance findings. A promising exception to this
is (ocnail specimens. These reflect long term
intake of several micronu(rien(s (e.g. selenium
or zinc [51. 52]), and (he specimens can easily
be collected, transported by mail and stored
at room temperature [51]. Given these
characteristics and the study size, we included
the collection of toenail clippings in our study.
BASELINE EXPOSURE MEASUREMENT
ConoWf <>/ four/inr m«*aiuremf«f a/t</ r<"spo/i.«"
In September 1986. the 340.439 selected
subjects were invited by mail to complete the
questionnaire and collect toenail clippings. To
return their completed questionnaire, respon-
dents were offered the choice of using a business
reply number (used by 33% of respondents) or
(preferably) to provide their own stamp (used
by 67%) The acceptability of this approach
had been tested in the pilot [53]. Several large
municipalities had explicitly stated, for reasons
of privacy protection, that the selected subjects
could onk be approached once, without use
of reminders. To elevate the response rate, a
nationwide publicity campaign accompanied
the baseline survey Completed questionnaires
were returned by 120.852 subjects (response rate
35.5%; men 34.5. women 36.6%). An estimated
67% of the respondents also provided toenail
specimens. The first page of the questionnaire
was optically scanned to define the cohort, to
check specific identifying information needed
for future linkage (e.g. date of birth, twinship).
This page also contained questions on the
presence of cancer and other conditions, overall
smoking habits and special food habits (i.e.
vegetarianism, veganism, etc.).
.S'cimr fctsWi'nr rfajrarftrufici o / (Ae roAorf
The cohort is composed of 58,279 men
(48.2%) and 62.573 women (51.8%). To exam-
ine whether the response in our study had
affected the determinant distributions (e.g. did
primarily non- or ex-smokers respond?), an
analysis of response rates was carried out as far
as the available sample data on nonrespondents
permitted. Also, data from the first page of the
questionnaire were used Table I shows the
response rate according to age and degree
of urbanization of municipality of residence.
Table 2 shows the distribution of marital status,
smoking habits and overall frequency of meat
consumption in the total cohort. No data
on these variables are available for (he non-
respondents, but for the first two variables
national large-scale survey data do exist [54. 55].
Furthermore, after the cohort was identified,
a random sample was selected in 1987 to
validate the dietary questionnaire against the
dietary record method, using 9 recording days
evenly distributed over the year 1987 1988.
Available data at this moment permit a com-
parison of the intake of several nutrients of
cohort members with data from a recent
national survey in which a 2-day dietary record
was used [30]. Results for caloric intake and
calorie providing nutrients are presented in
Table I Response rale to baseline measuremeni among men
ami women according to age and degree of urbanization
Response rate (%)
Men Women
Variable lit - 58.279) (n - 62.5731
Age (yr)
55 69 34.6
60 64 35.1
65 69 336
Urbanization of municipalities
Rural 34 5
Semi-urbanized 359
Urbanized 33 9
38.8
36 8
34 1
39.9
39.4
353
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Tabk 2 Distribution of mania! status, smoking habits and overall
frequency of meat consumption among men and vtomen in the total
cohort and in The Netherlands
» l
Variable
Mania! Halt»
Not married
Divorced
Married
Wido*ed
Smoking habits
Never
E>
Currenl
Meal consumption
(freo, per *eek)
0 1
2 j
4 5
6 7
Cohort
3»
36
M 9
J.7
9 3
48 8
41 »
i » :
4 9
24 4
M l
Men(*.l
Mel her land»
6 2 *
43
IS.)
43
40t
SI 0
450
WomeiH*.!
Cohort
14
44
69.9
I7J
5»?
207
201
)6t
77
291
59 8
Nether landi
77»
4 1
t i l
19 4
s.vot
270
200
«Age categor> 55 69 yr |54|
'Smoking habit in 1983. 51 + yr |55|
JNo large-icale reference data available in The Netherlands
Table 3. indicating comparable intake estimates
in the two studies.
These data indicate that the response to the
baseline measurement has not adversely affected
determinant distributions, in the light of etio-
logical analyses. Although of less importance, it
can also be concluded that no large deviations
from representativeness with respect to these
variables are evident.
FOLLOW-UP AND ANALYSIS ISSUES
As mentioned earlier, follow-up for cancer
in this cohort of 120,852 subjects will consist
of record linkage to PALGA and the cancer
registries. As an alternative to a classical cohort
analysis, the covariate histories of incident cases
could also be compared to those of a control
group in a nested case-control study [56. 57).
However, one would then need to wait until
case occurrence for efficient matched sampling
and subsequent standardized questionnaire pro-
cessing for cases and control subjects. To over-
come this problem, we employed a case cohort
(case base) approach, as proposed by Micllincn
[58] and Prentice (59), which offers the possi-
bility of data processing during rather than
after case ascertainment. In this approach, the
denominator information of the rates (i.e. the
accumulated person years of the entire cohort)
is estimated using a subcohort of sufficient si/c,
while cases arc enumerated for the entire cohort
(numerator information).
Determination of the required subcohort si/e
(3500) for testing the primary hypotheses in the
case cohort study was initially based on asymp-
totic relative efficiency comparisons for risk
ratios. Efficiency results regarding rate ratios of
Self and Prentice [60] had not yet been published
at the time the decision on size had to be made.
The asymptotic variances for the logarithm of
the risk ratios estimated from the classical full
cohort design (denoted by VCO) and from
the case-cohort design (VCC) were calculated
Table 3 Mean caloric intake and its contributors among men and women in the cohort,
as calculated from 9-day dietary records, and in The Netherlands (2-day dietary record)
Men Women
Variable
Calonc intake (kcal)
Fat (% energy)
Protein (% energy)
Carbohydrates (% energy)
Alcohol (% energy)
Cohort
In =60)
2408
40.0
141
409
5 0
Netherlands*
(n -431)
2564
41.2
13.7
402
50
Cohort
(<i - 52)
1981
40.7
14.4
42 1
28
Netherlands*
(.1-460)
1946
41 1
14.9
41 2
27
•Ministry of Welfare. Public Health and Culture (30]
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under simplifying assumptions: no competing
risks, negligible loss to follow-up, and for a
tingle dichoiomous exposure variable. With 5
being the ratio of the subcohort size to the
expected number of cases, VCO and VCC were
calculated for a range of values of relative risk
(RR; O.I 10), control exposure probability (a;
2-90%). expected 5-year cumulative incidence
(Cl; 0.2 2%) and .V (I 25) As an example
of a typical situation for a dietary exposure.
Fig. 1 shows a plot of VCC against values
of .V for RR - 2, a - 33%. Cl - 0.2% (female
rectum cancer), Cl - 0.4% (male stomach) and
Cl - 2% (male lung), respectively. This figure
illustrates that the variance estimate (or confi-
dence interval) for the less common cancers will
never be as small as that for lung cancer. The
graph further indicates that for female rectum
cancer the decrease in variance is minimal when
.¥ is increased over 16. while for male stomach
•nd lung cancer this value of 5 is approximately
8 and 2. respectively.
lor the various tumor sites, the relative
efficiency VCO/VCC [27,61] was then consid-
ered. Figure 4 shows VCO/VCC as a function of
RR for a = 33%, Cl = 0.4% and 5 = 1,2,4,8,16
and 25. Figure 4 indicates that .S'-values of 8 or
higher are clearly sufficient over the entire range
of RR-values. Similar results were obtained for
the other tumor sites.
Aller considering the relative efficiencies
under various conditions for various subcohort
si/cs and the added cost of processing additional
questionnaires, we decided to choose a random
subcohort of 3500 subjects. For most tumor
sites, .V-values or more are attained with this
subcohort (e.g. 9 for male stomach and 16 for
<J 002
• -J5X
RR-20
CIOU
— 02
10 IS to
Fig. .V The variance of logRR as u function of the redo
(subcohort cases) for 3 cumulative incidence rates, using
the case cohort method VCC. variance of logRR »ith
the case cohort method. S. ratio of subcohort cases. Cl.
cumulative incidence, a. control exposure probability; RR.
relative nsk
Fig 4 The relative efficiency of the case cohort vs full
cohort analysis as a function of RR. for various subcohon
sizes VCO. variance of logRR with the full cohort method.
VCC. variance of logRR with the case cohort method:
5. ratio of subcohort cases. Cl. cumulative incidence; >.
control exposure probability; RR. relative nsk
female rectum cancer); for male lung and female
breast cancer (he value of 5 would be 1.5 and 2.
respectively. While the associated efficiencies for
the latter tumor sties would be 50 60% for
various combinations of i and RR. it should be
kept in mind that the confidence intervals would
still be much smaller than for less frequent
cancer sites (see Fig. 3).
To check the efficiency of the chosen sub-
cohort size with regard to rate ratios and more
realistic assumptions, parametric relative rate
regression models for case-cohort studies were
formulated. Based on these models, simulation
studies were performed; the results were in
accordance with those concerning the risk ratio.
DISCUSSION
We have started a prospective study on diet
and cancer in a general population cohort of
120.852 men and women, in which determinant
information from questionnaires and from toe-
nail clippings is analyzed together with cancer
incidence, using the case cohort method. Con-
ducting a study among the general population
has the disadvantage of possible incomplete
control for confounding of e.g. occupation as
opposed to cohorts that are restricted in this
sense (e.g. [7]). On the other hand, when these
confounders are measured accurately, it also
provides an opportunity to evaluate their
effect modification (e.g. of occupation). The
choice is usually determined, however, by the
availability of specific population rosters and
the possibilities for follow-up. The presence
of both municipal population registries and
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cancer registries in The Netherlands offered
the opportunity for efficient recruitment and
follow-up of the present cohort.
Another aspect that contributed to the
efficiency was the increase in determinant
contrast in the cohort by the intentional over-
representation of vegetarians, albeit to a small
extern The somewhat disappointing experience
in the recruitment of these individuals illustrates
the inefficiency of obtaining large samples
with accurate data through advertisements,
as opposed to sampling from computerized
population rosters with high quality data,
needed when cancer follow-up is based on
record linkage.
Loss to follow-up is the primary source of
potential selection bias in prospective cohort
studies (provided it is differential across deter-
minant strata [62.63)). Therefore it should be
minimized, like in experimental studies. Hence,
the study area and population in the present
cohort study were chosen in a way to ensure
sufficient follow-up coverage. Recruitment of a
large general population cohort in the way
described, implies an incomplete response to
the baseline measurement. Bias in determinant
distributions due to nonresponse has no serious
implications for ratio estimates, even though
respondents generally show lower mortality or
disease experience during follow-up than non-
respondents (e.g. [64.65]). In studies that
have addressed the issue of nonresponse, odds
ratio estimates were not significantly different
between participants and non-participants,
although both groups exhibited (largely inde-
pendent) differences in determinant distri-
butions and disease experience [65.66]. In fact,
the distribution of risk factors may even become
more favorable for etiologic studies due to
response at baseline. This potentially increased
efficiency is also why intentional overrepresen-
tation of vegetarians was pursued in the present
study, and why in an experimental situation
subjects are allocated equally to determinant
strata. Data on demographic variables, smoking
and dietary habits were presented indicating
that the response did not adversely affect
determinant distributions in the present cohort.
To evaluate whether differential loss to follow-
up occurs, we will compare the determinant
profile of those lost to follow-up with other
participants.
An elderly cohort was selected because di-
etary habits (and their contrasts) are stabilized,
and such a cohort will yield sufficient cases for
meaningful analyses within • reasonable lime
period It can be argued that evaluation of
nutritional determinants of cancer acting early
in life [67] cannot be evaluated with this
approach. Since it has been suggested that
various dietary factors act in later stages of
carcinogenesis and a large-Kale study among a
cohon of eg adolescents would be time-
consuming with the need to consider inter-
mediate (dietary) events also, this potential
drawback was accepted. Together with other
ongoing studies and studies that will investigate
the role of diet in the earlier stages of carcino-
genesis, this study will contribute to a better
understanding of the type, timing and weight of
the influence diet may have on human cancer
development.
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Chapter 3
Estimation of the coverage of municipalities by cancer
registries and PALGA using hospital discharge data*
R. Alexandra Goldbohm", Piet A. van den Brandt, Elisabeth Dorant'.
Abstract
In a large-scale prospective cohort study on diet and cancer, which has been initiated
in September 1986, follow-up for cancer is being conducted through record linkage
with the regional cancer registries (CR) and with PALGA, a data base of pathology
reports. During the first few years of the study, however, neither the CR nor PALGA
operated nation wide. Since the cohort was to be recruited from samples drawn from a
large number of municipal population registries, selection of municipalities according
to the degree in which their inhabitants were "covered" by CR and PALGA would
minimize loss to follow-up.
Hospital discharge data, which include diagnosis, age, sex and residence of each
discharged (or deceased) patient, were used to estimate for each municipality the
proportion of hospitalized patients admitted to those hospitals that were expected to
participate in either the CR or PALGA at the date the cohort study was planned to
start A minimum coverage of 75% was used as criterion for selection of a municipality.
Of the 204 municipalities selected, 188 attained more than 90% coverage; the mean
coverage of the sampled cohort at the start of the study was estimated at 94.3%. The
analysis was repeated several years after the start of the cohort study to assess
retrospectively the actual coverage of the cohort over time. The mean coverage
appeared to increase from 98.5% at the start of the study to 100% in 1988.
* Submitted for publication
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Introduction
In 1986, a large-scale prospective cohort study was initiated in the Netherlands,
which investigates the association between dietary habits and the risk for (stomach,
colorectal, lung and breast) cancer among more than 120,000 men and women aged
55-69. After the baseline administration of a mailed questionnaire in September 1986,
follow-up for cancer was to be accomplished by the nine regional, population-based
cancer registries (IKN, IKO, IKMN, IKA, IKST, IKW, IKR, IKZ and IKL) and
PALGA (Pathologisch Anatomisch Landelijk Geautomatiseerd Archief), a Dutch data
base of pathology reports (1).
The majority of cancer registries functioning in the Netherlands started to register
in a limited number of hospitals in the period between 1982 and 1986 and gradually
extended their registration activities to all hospitals in their own region by 1989 (2).
One registry (IKZ-SOOZ) dates from 1953. In January 1985, the PALGA data base
included 28 of 70 pathology laboratories in the Netherlands, accounting for
approximately 50% of all pathology reports (3). In June 1990, all laboratories had
joined PALGA.
Considering the incomplete coverage of the Netherlands in 1986 as described
above, it was essential for sufficient follow-up to recruit the cohort from geographic
areas in which either one of the cancer registries (CR) or PALGA was operational
from the start of the study. Since it was decided for practical reasons to sample the
cohort from the municipal population registries, the question arose how to determine
the degree of coverage of each Dutch municipality by the CR and PALGA. The
availability of a nation wide data base of hospital discharge data enabled us to answer
that question. This paper describes the methods to estimate the coverage of the
municipalities, the subsequent selection of municipalities for cohort recruitment, and
the actual coverage of the cohort sample as assessed retrospectively from the hospital
discharge data.
Methods
In 1985, during the planning stage of the cohort study, a list of hospitals was
composed that were either participating in one of the registries already or very likely
would do so in 1986. The information concerning participation of hospitals was
obtained from each of the cancer registries. Since most of the pathology laboratories
are connected to and working for one or more hospitals, a list of hospitals linked with
PALGA was also drawn up.
The Dutch Center for Health Care Information (SIG) maintains the National
Medical Registry (LMR), a data base of hospital discharge data (3). The data base
contains (anonymous) data on each patient discharged from or deceased in the hospital.
The following data were relevant to our study: hospital code, diagnosis (ICD-9 code),
sex, age and municipality of residence, and, in case of malignancy, whether it concerned
a first or a repeated admission for that specific diagnosis. For privacy reasons, we could
not obtain the original data. Therefore, we provided the SIG with the two lists of
registering hospitals and received in return the data, aggregated by municipality of
residence and restricted to the age group 55 to 69 and to diagnoses of digestive tract,
lung and breast cancer (ICD-9 codes 151, 153, 154; 162; and 174-175 respectively). For
each municipality, diagnosis and sex, the following data were provided: total number of
discharges in (a) CR hospitals, (b) PALGA hospitals, (c) CR and/or PALGA hospitals
and (d) all hospitals in the country. Similar data for first admission for the disease were
also available.
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From these data we calculated for each municipality the diagnosis- and sex-specific
proportion of patients discharged from "registering" hospitals, i.e. a, b, or c divided by
d. These proportions can be considered as the coverage of a municipality by the
respective registries. The proportion pertaining to coverage by either a CR or PALGA
(c/d) was used as a selection criterion for cohort recruitment. Besides degree of
coverage, also other criteria for eligibility of a municipality for cohort recruitment were
applied. These criteria were: (a) availability of a computerized population registry,
administered by one of nine regional computer centers and (b) permission to draw a
40% sample from the men and women aged 55 to 69 in their population registry. A
higher sampling fraction was thought to jeopardize the participation of municipalities.
Of the 323 (from a total of 714) municipalities that met criterion a, 23 (7%) refused
participation, leaving 300 municipalities eligible for selection according to coverage.
Based on the number of cancer cases to be expected in the cohort study after five years
of follow-up, the required sample size was set at 350,000. The aim of the analysis was to
select municipalities in descending order of coverage until the required sample size was
achieved, taking into account that the average coverage of the sample should not be
lower than 90%. The calculations were performed for all data as well as for those
pertaining to first admission only.
The selection of municipalities for the cohort study was based on the LMR data
base of 1983, the most recent one available in the planning stage of the cohort study.
After the start of the study, the analysis was repeated using the combined LMR data
base of 1987/1988 and hospital lists retrospectively updated according to their actual
registration status on January 1, 1987 and January 1, 1988. The situation at the start of
the study (October 1, 1986) differed from that in 1987 for three hospitals. Coverage of
the municipalities involved was corrected according to these hospitals' contribution to
the total number of hospital beds in the region.
Results
Table 1 displays the number of municipalities and the achievable sample size
according to different cut-off points of anticipated coverage. Complete coverage
appeared to be attained for 219 municipalities, corresponding to a sample size of
256,000. A sample size of 350,000 could be achieved at a cut-off point between 70 and
80%. The ultimately chosen cut-off point of 75% corresponded to a sample size of
342,000 and comprised 249 municipalities. As a result of consolidation of small
municipalities into larger ones during the period between planning and sampling, the
actual sample was drawn from 204 municipalities. The mean anticipated coverage of the
sample amounted to 94.3 %. When it was taken into account that part of the
participants in the cohort study would move to municipalities that were not yet
sufficiently covered, the anticipated coverage decreased to 93.0%.
The coverage of the municipalities participating in the cohort study as determined
from the actual registration situation on January 1, 1987 (three months after the start of
the cohort study) is presented in Figures 1 and 2. Figure 1 shows the coverage by the
CR and PALGA combined, while Figure 2 displays the coverage by the CR alone. The
actual coverage of the cohort appeared to be 99.5%, much higher than the value of
94.3% anticipated before the start of the study. The coverage of three municipalities,
however, did not attain the initial cut-off point of 75%. Neither the CR nor PALGA
attained sufficient coverage alone (88.6% and 82.5%, respectively).
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Table 1. Number of municipalities and sample size according to cut-off point of anticipated coverage by
the cancer registries and PALGA.
Cut-off point (%) Number of municipalities* Sample sizet
No cut-off
70
80
90
100
300
2S1
244
237
219
491000
376000
339000
328000
256000
* 300 of the 714 municipalities were eligible for the analysis.
t Assuming a sampling fraction of 40% (age group 55-69), except for one large municipality, which only
permitted a 20% sample.
Source LMR 1987 1988
Figure 1. Actual awcragc of the cohort municipalities by cancer registries and PALGA, January 1, 1987.
(Blank municipalities are not participating in the study.)
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Coverage
144 H j | •> = 90%
mean: 886%
bource LMH 1987'1SB8
Figure 2. Actual coverage of the cohort municipalities by the cancer registries, January 1,1987. (Blank
municipalities are not participating in the study.)
Table 2 gives the site- and sex-specific coverage on January 1, 1987. No large
differences were detected between any of the cancer sites nor between men and women.
Furthermore, the mean coverage was similar whether all admission data or those
pertaining to first admissions were used.
Table 2. Actual coverage (%) by cancer registries and PA1.GA on January 1, 1987 of the cohort
sampling population specified for cancer site and sex, calculated for all admissions and first
admissions only.
Site
Stomach
Colon
Rectum
Lung
Breast
AU sites (both
ICD code
151
153
154
162
174+175
sexes)
Men
All admissions
99.7
993
99.2
99.1
99.5
First admissions
99.5
99.5
99.2
98.8
99.4
Women
All admissions
993
99.7
100.0
993
994
First admissions
993
99.7
100.0
992
99.5
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Table 3 shows, however, minor differences within municipalities between coverage
degrees calculated from all admissions and those calculated from first admissions only.
Table 3. Classification of cohort municipalities (n = 2O4) according to coverage on January 1, 1987: all
admissions versus first admissions only.
All admissions
First admiaioni 0-74% 75-89% 90%
0-74%
75-89%
2 90%
3
0
0
0
4
192
Figure 3 summarizes the anticipated coverage of the cohort and the development of
the actual coverage from the start of the study up to January 1, 1988, when complete
coverage was reached.
mean
coverage
degree
90 -
200
190
180
number of
municipalities
coverage (%)
I I <75
75-89
>90
expected start 1/87 1/88
at start
Figure 3. Anticipated and actual coverage of the cohort sampling population by the cancer registries and
I'ALCiA.
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Discussion
The value of the presented analysis for the evaluation of the follow-up for cancer in
the cohort study depends on the reliability of the data and the underlying assumptions.
From 1986 onwards, all general and university hospitals in the Netherlands supply
the required registration data to the LMR data base. As for the 1983 data base, a few
hospitals were lacking. Their share in the hospital discharges was 2.5*. An important
hospital that was neither contributing to the 1983 nor to the 1987/1988 data base was
the Daniel den Hoed Hospital, an oncology hospital at Rotterdam. For the missing
hospitals, however, the most crucial data, i.e. the number of admitted patients and their
residence, was known from the Enquête Jaarcijfers Ziekenhuizen (EJZ, 4). The
distribution of diagnoses in the missing general hospitals was estimated from that in
other general hospitals. The diagnoses in the Daniel den Hoed Hospital were assumed
to have the same distribution as those in the Antoni van Leeuwenhoek Hospital, the
oncology hospital in Amsterdam. Thus, the overall error due to missing hospitals in the
LMR data base could not have been very large.
Comparison of the LMR with the EJZ data has shown that the LMR data base is
also virtually complete within each hospital (SIG, personal communication). However,
even if incompleteness were substantial, it would not invalidate the present analysis,
which is based on proportional and not absolute coverage. Some information is
available on the accuracy of the recorded data: the place of residence appeared to be
satisfactory recorded, but the diagnosis was not quite correct in 7% of the cases (5).
Although it should have been recorded whether a patient was admitted for that specific
(malignant) disease for the first time, this item is presumed to be inaccurate, in
particular for university hospitals (SIG, personal communication). The analysis based on
all admissions and that based on first admissions only produced similar results, however.
A substantial change over time in referral patterns, for example as a result of
closing and merging of hospitals, may threaten the representativeness of the data base
for the population in the cohort study. This argument is valid for the 1983 data base,
which was used to estimate coverage in 1986, but not for the 1987/1988 data base,
which referred to exactly the same period as the follow-up of the cohort and which
must actually include the cohort members diagnosed with cancer during these years of
follow-up.
The results of the presented analysis are useful only, if all eligible cases who were
admitted to a hospital affiliated with a cancer registry or PALGA, were really included
in these registries. A study conducted in the IKMN cancer registry, in which the 1986
cancer registry data were compared to the LMR data, has shown that 11% of the cases
were initially missed by the cancer registry (6). In 52% of these missing cases, however,
the diagnosis was not histologically confirmed. The percentage of cases missed was
much lower for cancer of the breast (2.5) and digestive tract (6.8) than for lung cancer
(12.9). These percentages reflect the proportion of cases not confirmed by histologic
examination. From 1986 onwards, LMR is also introduced in most cancer registries as a
check for completeness and as additional source on cancer cases.
Another potential source of loss to follow-up would be imperfect linkage of the
cohort to the records in the CR and PALGA. It has been shown that linkage with the
cancer registries attains a sensitivity of 98% (7). This figure did not include the (now
routinely used) adaptation to the linkage procedure which accounts for frequently
occurring spelling errors in names; true sensitivity is thus likely to be somewhat higher
than 98%.
We conclude from the data presented here that in the cohort study loss to follow-
up is likely to be very small. An opportunity to corroborate this conclusion was
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provided by the subcohort, a random sample of 5000 subjects from the entire cohort
Subcohort members have been followed up for vital status and have reported biennially
whether they had been diagnosed with cancer after the start of the study in 1986. Of
the subjects in the subcohort who reported to have a cancer (145 by the end of 1989)
115 had also been matched independently in the record linkage with the CR and
PALGA. Almost all of the missing cases (29) had reported skin cancer. This can be
explained, since basal cell carcinoma of the skin is not recorded routinely by the CR.
One self-reported case with another cancer type, however, was not matched to a record
in the PALGA data base because of disagreement as to place of residence. After
exclusion of the missed subjects reporting skin cancer, the proportion of cancer cases
retrieved thus amounts to 115/116 = 99% with a 95% lower confidence bound of 96%.
We conclude from all evidence combined that follow-up of the cohort for cancer must
be very complete.
A second conclusion concerns the use of LMR data for this type of problem. These
data provided a quick, efficient and apparently reliable way to solve an important
problem in the planning stage of the cohort study, i.e. how to minimize loss to follow-
up for cancer. Although it will not be necessary to repeat this type of analysis for other
(prospective) epidemiologie studies on cancer, since the CR and PALGA have attained
national coverage, it may be used to check coverage by other local disease registries.
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Development of a Record Linkage
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PIET A VAN DEN BRANDT»". LEO J SCHOUTEN". R ALEXANDRA GOLDBOHMt, ELISABETH
DORANT* AND PERRY M H HUNEN"
Van den Brandt P A (Department of Epidemiology. University of Limburg. PO Box 8)6,6200 MD Maastricht. The Neth
erlands), I J Schouten. R A Goldbohm, E Dorant and P M H Hunen. Development of a record linkage protocol for uae by
the Dutch cancer registry (of epidemiological research /nravnaftone/ .tourna/ o/ fpid»m»o/offy 1990; 19: b&3-6M.
A method has been developed to determine the optimal linkage key for record linkage between the cancer registry and
a large-scale prospective cohort study in the Netherlands. The proposed linkage procedure is a two-stage process In
which the initial computerized linkage using a particular linkage key is followed by visual inspection with additional
information to separate the computer matches into true and false positives. In the determination of the optimal key,
both informativeness and susceptibility to error of personal identifiers were taken into account The performance of
the various keys in the linkage was expressed in terms of sensitivity and predictive value of a reported computer
match. The key. consisting of date of birth, first four characters of the family name and gender was the optimal choice,
with a sensitivity of 98% and an initial predictive value of a computer match of 98%. When additional information on
migration, place of birth and first initial was collected in the second stage, it was possible to eliminate the false posi-
tives from the reported computer matches without loss of true positives. Thus, the sensitivity remained constant
whereas the secondary predictive value of accepted matches was maximized.
In epidemiological research, the use of record linkage
to disease registers for follow-up purposes is increas-
ing.' ' An important aspect of this kind of follow-up is
the development of the linkage procedure. A general
method for (medical) record linkage has been pro-
posed* and then developed further." This method is
based on the calculation of the odds in favour of a cor-
rect match associated with the particular linkage key.
The linkage key is the combination of personal identi-
fiers that is used as matching variable in the computer
linkage. The calculation of the odds can be refined in
various respects to accommodate weights associated
with identifier values and coding (transcription) errors.
However, the method requires detailed prior knowl-
edge about the frequency of specific identifier values in
both files that arc to be matched. Usually investigators
do not have this degree of access to the disease register
to which they want to link, due to confidentiality regu-
lations. The desired frequency distributions can there-
fore not be determined. Also, with manual disease
'Department of Epidemiology. University of Limburg. PO Box 616.
6200 MD. Maastricht. The Netherlands
**1KL-Cancer Registry. Comprehensive Cancer Centre Limburg,
Maastricht. The Netherlands.
'Department of Human Nutrition. TNO-C1VO Toxicology and
Nutrition Institute. Zeist. The Netherlands.
registers, il is generally not feasible to determine these
frequencies."
In either of these instances, one needs to perform
record linkage based on an optimal linkage key. When
a unique personal identification number is being used
throughout in a country such as in Scandinavian
countries, linkage with such a number is appropriate.'
In other situations (which applies to many other
countries) the linkage procedure should be based on a
combination of identifiers serving as a key. The pro-
cedure should then be optimized with respect to the
choice of identifiers in terms of their informativeness
(discriminating power) versus the likelihood that they
contain coding errors. This paper describes the pro-
cedure for determining the optimal linkage key to use
for follow-up of a large general population cohort in
the Netherlands, using cancer registries.
The uniqueness of (combinations of) identifiers has
been studied in the Netherlands." " These studies
were, however, theoretical in the sense that they were
conducted within one dataset and did not take into
account possible coding errors in identifiers that may
lead to false disagreements when two datasets are
actually linked. To take account of both the infor-
mativeness and the susceptibility to error of identifiers,
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we empirically evaluated the usefulness of several keys
in a linkage procedure between Ihc cohort study and
the Regional Cancer Registry Limhuig(IKL-rcgistry).
Ideally, one would like to have an independent source
of diagnosed cancer cases in (he cohort, to check
whether the matched records from the cancer registry
did indeed represent all the truly diagnosed cancer
cases in that cohort There was. however, no 'gold
standard' registry available in the region to which
reporting of cancer patients was unrelated to reporting
of cases to the IKI . registry. Instead, we evaluated Ihc
usefulness ol the keys By linkage with tolerant criteria
and visual inspection of the reported computer
matches, we first detected all existing correct matches
between the cohort and cancer registry. After that,
more strict linkage criteria were applied and the per-
formance of various keys was tested.
METHODS
77i< CVi^ioff
in 1986. a prospective cohort sludy on diet and cancer
began in the Netherlands Ihc cohort (n= 120 852) of
55-69 year old men and women originated from 204
municipal population registries. In view of the size of
the cohort and the method of follow-up (record linkage
to cancer registries), only computerized population
registries were used. Since the identifying information
from (he municipalities was the most accurate infor-
mation available on Dutch citizens, the recruitment
procedure ensured that (his quality was maintained for
the cohort members. At baseline (September 1986).
cohort members completed a questionnaire on diet
and potential confoundcrs " Relevant questions with
respect to record linkage included place of birth, twin-
ship and history of cancer. Data from the K081 cohort
members who live in the area covered by the IKL-
registry were used for the present study.
77if /ACL CUMOT fJrjju/ry
The 1K1. cancer registry is one of the nine Dutch
regional cancer registries: it has been operating since
19K2 in the middle and southern part of the province of
Limhurg In the period 1982-1986, cooperation was
obtained from all hospitals in (he area, resulting in a
picsuniiihl) complete coverage in 19,S(i.'* Tumour data
are abstracted from pathology reports and medical
records and coded according to ICD-Oncology. The
identifying information is read from the patients' iden-
tity card, produced in the hospital when a patient seeks
medical care The cancer registry then converts names
to a Marulaul format (apostrophes and hyphens are
replaced by spaces, the Dutch letter combination 'ij' is
converted into 'y' and a list of allowed prefixes is used).
After conversion, the data are encrypted before stor-
age in the IKL-database Completeness, data consis-
tency and the possibility of duplicate records are
extensively checked by computer programs. The iden-
tifiers available for linkage in the cohort hie and in the
IKI.-registry file arc presented in Table 1.
/?rron/ LinJItagr-
The record linkage between the cohort (n = 8081) and
the IKL-rcgistry was started in November 1988. after
the names of the cohort members had been converted
and encrypted to the cancer registry format Malig-
nancies registered by the IKL until 21 October 1988
(n = 8917) were available for linkage. While for the
actual follow-up of the cohort only incident cases arc of
interest, for the development of the linkage protocol
both incident and prevalent cases were allowed to
match. Prevalent cases were defined as cases diag-
nosed before September 1986 (ie start of the cohort
study).
o//4/V Etit/mj? Corrrrf Wofr/iw
To detect all existing correct matches between Ihc two
files, a computer linkage was carried out with very
tolerant criteria for reporting a match. For this com-
puter linkage, a program was used that had been devel-
oped earlier by the IKL to detect duplicate records in
its registry. It assigns (arbitrary) scores for agreements
on particular identifiers. The tolerance is adjusted by
varying the total score that is needed for a match to be
reported. Table 2 shows the scores that were assigned
to agreements on other identifiers in this linkage exer-
cise. No scores were assigned to agreements on other
identifiers in the computer linkage. The agreement or
iswv /i/r.
Identifier
Dale of h m h
Gender
Family name (enci \p lcd)
Prefix of famih name
Married name (surname of husband.
encrvpled)
FirM inilial
Ptace of hmh
Kesidemi.il postal ctnlc
Percentage availability
Cohort
IUV)
I I »
IUU
IJ
87*
10(1
100"
inu
I K I
registry
100
100
IMI
i :
85*
•42*
*Pcrccnl«([c for women
"Place ofhtrth n available from ihc cohort questionnaires, hut not on
file h can therefore onk he used for additional visual inspection of
reported computer maiche% Percentage availability if hascd on a
random umple of HMX) questionnaires.
tDuc to hospital registration practice in the Netherlands
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disagreement on other identifiers was. however,
measured by the computer but only used for additional
visual evaluation of the computer matches.
To allow reporting of a match even in the case of a
considerable number of coding errors, a low threshold
value for the total score was used Various combi-
nations of identifiers that agreed could therefore lead
lo a match. All matches with identical year of birth or
identical fint four characters of family name (F4)and a
minimum score of 90 were reported The reported
computer matches were then ordered according to
their scores A match was accepted when the computer
indicated agreement on: date of birth (DOB), com-
plete family name (F). first initial (I), gender (G), post-
al code (P4). prefix, and married name (ie a score of
180 and agreement on the latter two identifiers). When
the score was lower or other disagreements were
apparent, a visual inspection of the match was per-
formed using data on the original IKL coding forms.
This was done lo determine whether less than maximal
agreement was due to coding errors or non-availability
of the item in one or both data files, or because it repre-
sented different subjects. Additional information on
migration, birthplace, tumour site and year of diag-
nosis (for prevalent cases) and date of death was also
used for this determination. In this way presumably all
existing correct matches between the two data files
were detected using as much information as possible.
Se7«:rion o/ Oprima/ Lmiajje toy
This number of correct matches was then considered
the maximum number that could be obtained in sub-
sequent linkages using other, less tolerant criteria. In
these linkage exercises, (dis)agreement on identifiers
T A Ü E 2 Srorri /or ayrr^mrn/ /«v idtm/j/ïrr, ,U5r«4 in /Ac rt»mpu/i*r
Score for
Identifier Abbreviation agreement
Related to date of binh (DOB)
Year of binh
Month of binh
Day of birth
Related to name
r-amitv name
First 4 characters of family name*
First initial
Related to address
Postal code (all 4 dipt*)
Postal code (fint 3 dipt* only)
Gender
Y
M
D
F
F4
I
P4
P3
G
20
20
20
60
40
20
M
10
10
"In the Dutch cancer registry, names are first divided into two
segments (F4 and the remaining ctiaraden) which are fhen encrypted
separately
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was assevsed without assigning scores to it. The link-
ages were performed using the uriijiiiii/ datasets (ic
coding errors found alk't ihc extensive linkage
described above were not corrected). For each key. the
number of true and false positives was calculated and
the usefulness of the key was then expressed in the sen-
sitivity (ie proportion of all correct mutches obtained)
and in the positive predictive value (PV4) of n
reported match (ic proportion of reported mutches
that represent correct matches) The optimal key was
defined as the key which shows the best combination of
sensitivity and PV + To miniini/o the numbci nl false
positive matches any further, the initial computci link-
age with the optimal key was followed by 11 second,
manual stage. In this singe, matches were scnurnlcd a»
far as possible into true and false positives by visual
checking, using additional information that was not on
file (eg birthplace and migration data of cohoit mem-
bers). Manual collection and evaluation of these data i»
only feasible when the computer linkage shows a high
initial PV-t-.
RESULTS
DcVrrmi/iafion o/ J4// Corrtr/ AfafWiu
The initial very tolerant linkage between the cohort
and IKL-registry, with a threshold score of 90, resulted
in 8499 computer matches. (In the linkage cohort
members can match to more than one cancer registry
record, especially with (his low threshold; the maxi-
mum number of possible pairs of records is 8081 x
8917 = 72 058 277) Table 3 (second column) shows the
distribution of computer matches according to Iheir
total scores. The maximum score that could be
obtained was 180. Computer matches with scores of
120-180 were visually checked using all available iden-
tifiers, and potential migrations of cases were eval-
uated. All 179 computer matches with scores 160-1 HO
were found to be correct, whereas Ihc nine reported
matches with scores of 140-150 included only one cor-
rect match. In the category with a score of 120-130,
eight correct matches were found out of 185 computer
matches. All eight records represented cases whose
F4-part of the family name had not been converted by
the IKL-rcgistrars according to the standard format (ie
conversion of 'ij' into 'y').
With regard to computer matches with scores of 110
or less, it was anticipated that for a number of matches,
the additional information would be incomplete,
thereby leaving uncertainty about acceptance or rejec-
tion of the match. To overcome this problem, only
matches representing prevalent cancer cases were con-
sidered first, whose diagnoses could be checked against
the self-reported information on the cohort question-
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TA* I I 3 /.in*ujfr 0v/*r™ f/i^foArtrt fn • WW/0 iwirf fnr/K/" rrrn/rv
fff - ffV/7/. d*ti/nr>w/w»i r»/ rrporlrj (rmipurrr maK-fcri «rrordi/tff fa
Score
«0-110
I»M3(>
140-150
160-1*0
Tool
Total
BI26
115
9
179
H499
Number of computer malcho
Fthe poWive»"
8126
177
R
0
O H
True pouuvct*
0
8
1
179
Itw
* A l determined by viiusl impeclKM of compuler iTMIchei.
mire From the computer matches with scores of 90-
110, cases (n - 105V) with clearly distinguishable
cancer Kites (eg. lung, breast, stomach, kidney), diag-
nosed in the year preceding September 1986 and still
•live at baseline were selected from Ihc IKL-regislry.
Visual assessment of the agreement between IKL-reg-
iitry and cohort regarding tumour site and year of diag-
nosis revealed no correct matches in this group. It was
therefore assumed that among the (Ma/ group of
matches with scores of 90-110 no additional correct
matches would be detected. This was based on the
observation that among the category with scores of
120-180, all 94 correct matches representing prevalent
cases with these tumour sites diagnosed in 1985 or 1986
had been self-reported by cohort members. Thus, the
8499 computer matches were separated into 188 true
positives and 8311 false positives.
Following the determination of presumably all correct
matches, linkage with specific keys was conducted on
the original datasets. The following keys were used: all
identifiers together, individual identifiers separately
and identifiers in various combinations. The results arc
presented in Table 4. together with the sensitivity and
PV+ (the denominator used to calculate sensitivity is
188). When all identifiers (listed in Table 1). except
birthplace were used as key in the computer linkage,
only 167 true positives were matched (sensitivity
88.8%), but PV + was 100%. This clearly shows that
the use of many identifiers in a computer linkage yields
a considerable number of false negatives, because of
an increased chance of a coding error in one or more
identifiers. The 21 false negatives occurred because of
errors in the lKL-filc regarding F4 (n = 2), remainder
of F (3), M ( I ) . Y (1). I (9), married name (2), prefix
(3) and P4 ( 1 , ie migration). One false negative was the
result of simultaneous errors in I and in the married
name. Excluding DOB from this key resulted in a sub-
stantial decrease of PV+ with only a minor improve-
ment of sensitivity.
To identify the optimal linkage key while striving for
parsimony, we started with identifiers that have been
indicated in (he literature to be relevant:'" " D O B , For
F4. G. Using DOB as the only identifier in the linkage
key resulted in a very high sensitivity (98.9%), accom-
panied by many false positives (PV+ 3.5%). Using
only F or F4 resulted in many more computer matches,
indicating that the family name is far less informative
than DOB. With F4, an increased sensitivity was noted
compared to F. Combining DOB and F4 resulted in a
PV+ of 94.8% with a sensitivity of 97.9%. The combi-
nation DOB/F4/G showed a high sensitivity (97.9%) as
well as a high PV+ (97.9%). Extending this key with I,
P4 or P3 elevated PV+ further, but reduced sensitivity
at Ihc same time. Moreover, the use of postal codes in
any key is not feasible because their value is time-
dependent (migration is-not assessed continuously for
all cohort members). The keys DOB/G and F4/G are
not attractive options: PV+ is very low, although sensi-
tivity is high (98.9%). The key DOB/F4/G was there-
fore considered optimal, given the combination of its
sensitivity and its PV + . With the use of this key, 188
computer matches were reported. Using additional
information on P4 and birthplace, it was possible to
separate these 188 matches correctly into true and false
positives, and maintaining the same level of sensitivity.
(When place of birth was unknown, agreement on
other identifiers had to exist to accept a match). Also,
TAILE 4 /.inAagr 4* m-ffn //if coAorf fn = &08/J and / V /Af/.-rrg«/ry
(n - fl9/7J.mimfrrro/reported rompuw/Twwnri. fruepojinvrs. /a/se
firgaftves. Mvui»Vi/y and PV+ oMui/irJ ivirn viirioui fcitagr AeyJ.
conjuring o/ a// «femi/iers rogefner, rndividua/ idfnnjfcra sp/MrarWy or
Key
All identifiers
All. except DOB
DOB
F4
F
DOB7C.
DOB/F4
F4/G
DOB/F4/G
DOB/F/G
DOB/C./P4
DOB/G/P3
DOB/F4/G/1
DOB/F4/G/P4
DOB/F4/G/PJ
DOB/F4/G/I/P3
DOB/F7G/I
Matches
167
197
5276
102 070
49 808
2664
194
SO 970
188
184
203
321
175
183
184
174
172
True
positives
167
169
186
186
183
186
184
186
184
181
185
185
175
183
183
174
172
False
negatives
21
19
2
2
5
2
4
2
4
7
3
3
13
5
5
14
16
Sensitivity
(%)
888
89.9
98.9
989
97.3
98.9
97 9
989
97 9
963
98.4
984
93.1
97.3
97.3
92.6
91 5
PV +
('M
100
8S.8
3.5
0.2
0.4
7.0
94.8
04
97 9
98.4
91.1
57.6
100.0
100 0
99.5
100.0
100.0
'Multiple matches possible per cohort member, especially when the
linkage key consists of few identifiers.
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linkage with the key DOB/F4/G resulted in four false
negatives. This was due to misspellings in F4 (n « 2)
and errors in M (month of birth) (I) and Y (year of
birth) (I).
DISCUSSION
We evaluated the usefulness of various keys for record
linkage between two datasets. In general, one would
prefer to use as many identifiers as possible for accu-
rate discrimination between individuals, especially
when very large files arc being used. This does not
imply that one should use all identifiers in a linkage
key, because identifiers may also contain errors The
optimal choice of identifiers to be included in the key
depends on their informativeness versus susceptibility
to error and on the time-dependency of identifier
values. Thus, a record linkage using all identifiers is nol
a very sensitive method, although the predictive value
of such a reported computer match may be maximal.
The sensitivity is increased by using less identifiers in
the key, but this produces more false positive matches.
The problem can be dealt with when the available iden-
tifiers arc used in two steps. Firstly, one uses a rela-
tively small number of accurate identifiers in the initial
computer linkage. Secondly, true and false positives
are separated in a visual check using other information
which is highly informative and accurate, but may
require additional collection. Given the extremely
high specificity values for all reported keys, the optimal
key is then the key with the highest sensitivity given a
reasonably high PV+ (ie a number of false positives
that can reasonably be identified manually).
The key DOB/F4/G behaved optimally in this res-
pea. Extending the number of characters of F beyond
four adds only a small amount of information." Also,
errors tended to occur more towards the end of the
name. The results indicate that the first initial is especi-
ally prone to coding errors. This is partly due to dis-
crepancies between given and (municipal) Christian
names that can exist for Dutch subjects. For example,
frequently occurring given names as 'Hans' or 'Kees'
have Christian names 'Johannes' and 'Cornelis',
respectively. In separating true and false positives,
information on birthplace and (for migration cor-
rected) postal code was very important. Unfortu-
nately, the informative" and accurately recorded"
birthplace is not commonly registered in Dutch
hospitals.
The score values used in the initial determination of
all correct matches are somewhat arbitrary, although
they roughly reflect the informativeness of the items."
However, the score values per Je" are not important in
this respect, as long as one is able to separate matches
correctly. The use of weights in record linkage com-
bined with manual verification has been described
before'*"
Due to coding errors, the key DOB/F4/G was associ-
ated with a false negative rite of 2%. By anticipating
certain potential errors in F4 and DOB. one can poten-
tially increase the sensitivity to some extent. Wi.h
regard to names, various phonetic coding systems have
been developed in England. Canada anil the US to
match variant spellings of names.'""* Such n system
is not available for the Netherlands and it cannot be
applied to the cancer registries because these contain
encrypted names Instead, the data of cohort members
are now systematically sciutimrcd for name types that
can easily be misspelled when the subject is registered
in a hospital. In future linkages, an iidditional (flagged)
record will be used, containing the misspelled version
of the name. When > match occurs on this additional
record, it will be carefully evaluated in the second stage
of the linkage process in order to avoid an increase in
the number of accepted false-positive matches. The
two errors in DOH-ilems were <>( the type Mi I and
Y±l . Analyses of duplicate records in the IKL-rcgislry
indicated that more than half of the coding errors in
DOB-items consisted of two sorts: value 1 1 and ± 10.
Such error patterns can also be anticipated on in future
linkages."
For the cohort study, separate linkages with all
regional cancer registries are planned, in which the
specific regional cohorts will be selected from the large
cohort and linked to the respective registries. In this
way, the prevalence of correct matches in these link-
ages will be comparable to the present study, as will be
PV+.
APPENDIX
DOB = date of birth; D = day of birth; F = family
name (excluding prefix); F4 = first four characters of
family name; G = gender; I = first initial; M = month
of birth; P4 = postal code (all four digits); P3 = postal
code (first three digits only); PV+ = predictive value
of a positive match; Y = year of birth.
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Validation of a dietary questionnaire used in a large-scale
prospective cohort study on diet and cancer*
R. Alexandra Goldbohm'*, Piet A. van den Brandt', Henny A.M. Brants',
Pieter van 't Veer', Monique Al', Ferd Sturmans*. Rudolph J.J. Hcrmus'.
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Abstract
The validity of a self-administered mailed dietary questionnaire (150 food Items), used
in • cohort study on diet and cancer (120,852 men and women, aged 55-69), wat
investigated in a subgroup of the cohort (59 men and 50 women) two years after the
baseline questionnaire was completed. A dietary record, kept over three 3-day periods,
four to five months apart, served as reference method. Pearson correlation coefficients
between nutrient intakes assessed by the record and the questionnaire that was
completed afterwards ranged from 0.40 for vitamin B-l to 0.86 for alcohol Intake, with
correlations for most nutrients between 0.6 and 0.8. Adjustment for energy Intake and
sex did not materially affect these correlations, except the correlation for fat intake,
which changed from 0.72 to 0.52.
To evaluate the representativeness of the study population for the entire cohort, a
comparison was made with the baseline questionnaire of a random sample of the
cohort. Correlation coefficients were only slightly modified when the results were
extrapolated to the cohort at large. Correction of correlation coefficients for
attenuation by day-to-day variance in the record data improved them by 0.07 on
average. It is concluded that the questionnaire is able to rank subjects according to
intake of food groups and nutrients.
* Submitted for publication
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Introduction '
A self-administered dietary questionnaire is often the method of choice in a large-
scale epidemiologie study, such as a prospective cohort study, into dietary habits and
disease. The validity of such a questionnaire is not self-evident, since it is limited with
respect to the foods included and the degree to which portion sizes are quantified.
Moreover, each questionnaire needs to be tuned to the specific dietary habits of the
study population. Validation studies of a number of self-administered dietary
questionnaires have been published (e.g. 1-9).
We developed a self-administered, mailed dietary questionnaire for use in a large-
scale prospective cohort study on dietary habits and cancer in the Netherlands (10). Hie
cohort, consisting of 120,852 men and women aged 55-69, was recruited from the
general population and completed the baseline questionnaire in 1986 (11). The
questionnaire is repeated each year in random samples of the cohort (n = 400) to assess
its rcproducibility and the stability of dietary habits over time.
This paper describes the validity of the dietary questionnaire as compared to a nine-
day diet record. Considering the etiologic purpose of the cohort study, validity of the
questionnaire is primarily defined as its ability to rank study subjects according to
nutrient intake and food (group) consumption. Since the performance of a
questionnaire also depends on the actual study population, the validation study was
conducted within the cohort. Assessment of selection bias, potentially introduced by
incomplete participation in the validation study, was included in the study design.
Materials and methods
Study design
The diet record method was used as reference method, since its errors are assumed
to be independent of the errors in a food-frequency type questionnaire (12). Dietary
intake was recorded over three periods (of three consecutive days each, Figure 1),
representing three seasons in the Netherlands differing with respect to consumption
patterns for (specific) vegetables, fruits and meat (13, 14).
Validation study group:
participants:
non-participants:
Rcproducibility group:
participants:
non-participants:
Time frame:
Ol
Ol
Ol
Ol
Sept
1986
RRR - 3-day record
Q » dietary questionnaire; Ql and Q2 are the baseline
respectively.
S/O » September/October; J/F « January/February; J/J =
RRR RRR
S/O J/F
Sept
1967
and repeated dietary
June/Jury.
RRR 02
O2
J/J
Sept
1988
questionnaires
Figure 1. Design of the validation study of the dietary questionnaire used in the Cohort Study on Diet
and Cancer in the Netherlands, 1987/1988.
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The nine recording days were balanced across the days of the week for each subject and
for the study group as a whole. The diet record was compared to the questionnaire that
was completed approximately three months after the last recording period.
To investigate a possible learning effect of recording of intake, the questionnaire
application coincided with the repeated questionnaire completed annually in the cohort
by participants of the aforementioned reproducibility study (Figure 1). Furthermore, to
assess the representativeness of the validation study group (participants as well as non-
participants) with regard to the cohort, the baseline questionnaires of this group were
compared to those of the 1988 reproducibility study group, which constituted a random
sample of the cohort
Unless specified otherwise, all results pertain to the questionnaire completed by the
study subjects at the end of the year in which recording took place.
Subjects
Since the participants had to be visited at home during each recording period,
recruitment was confined to 12 municipalities, located in an eastern and a western
region of the Netherlands. As far as degree of urbanization was concerned, these
municipalities were representative of the 204 from which the cohort was recruited.
Of a total of 212 randomly selected cohort members (107 men and 105 women),
109 subjects (59 men and 50 women) completed the validation study (51 percent); 92
did not participate from the start, and 11 dropped out during the study. Reasons for
non-participation and drop-out could be attributed to refusal (two thirds) and
unavailability (death, no contact, absence during one or more recording periods, etc.).
Among the non-participants, six subjects were excluded because they did not manage to
keep the record or did not eat at home most of the time and were hence not expected
to keep a good record.
Dietary questionnaire
The purpose of the dietary questionnaire was to assess habitual consumption of
approximately 150 foods during the past year. The foods included in the questionnaire
were originally selected according to their contribution to the between-person variance
of the intake of energy and of the following nutrients: protein (vegetable as well as
animal), fat (saturated, monounsaturated and poryunsaturated), cholesterol,
carbohydrates (mono- and disaccharides, polysaccharides), dietary fiber (of cereal as
well as vegetable and fruit origin), alcohol, calcium, vitamin A, B-carotene and vitamin
C (10). The contribution to the variance was calculated from a data set previously
collected by means of a dietary history method in a population of men and women of
the same age category as the cohort.
For each item, the questionnaire asked for frequency of use on a scale of seven
frequency categories: never/less than once per month, once per month, 2-3 times per
month, once per week, 2-3 times per week, 4-5 times per week, 6-7 times per week. The
number of servings per consumption frequency was asked in natural (e.g. apple, slice of
bread) or household units (e.g. glass, spoon). For cooked vegetables and meat, the
typical individual serving size in grams was asked. For several items, the frequency
categories were replaced with the number of serving units taken daily (coffee, tea,
bread), weekly (eggs, onions, tomatoes) or monthly (mushrooms, sweet peppers).
Ouestions on vegetables were specified with respect to season (summer and winter).
Margarine used on bread and cooking fats and oils were specified as to type and brand
in open questions. An open-ended question also asked to list any foods eaten regularly
(once a week or more) but not included in the questionnaire.
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Questionnaires were double-keyed and automatically coded by the data-entry
program. Data were checked for completeness, consistency, range, and other response
errors and corrected whenever feasible by means of an SPSS computer program, which
had been developed using the data from the first 3000 cohort questionnaires entered
and from an earlier small validation study (15). The resulting program ensures identical
cleaning procedures for all questionnaires.
To determine the completeness and the quality of the questionnaires, they were
evaluated by means of the number of blank items and by means of an error index,
which was calculated as the sum of the scores of 15 variables that indicated each the
presence of a specific response error (see footnote to Table 4). Visual inspection of the
cohort questionnaires had revealed that part of the subjects had consistently skipped
items that they never ate, instead of checking the frequency category "never/less than
once per month". Questionnaires were considered unacceptabry incomplete when either:
(a) more than 60 items (out of 150) were left blank and less than 35 items were eaten
at least once a month; or (b) one or more item blocks (i.e. groupings of items in the
questionnaire, e.g. beverages) were left blank. According to these criteria 6.0 percent of
the cohort (6.5 and 5.5 percent for men and women respectively), among whom 1
percent had mistakenly skipped a page, has to be excluded from etiologic analyses
relating dietary habits to cancer. In addition, 1.0 percent of the cohort members were
excluded because the error index of their questionnaires exceeded 10. This criterion was
based on the subjective verdict of inconsistency after visual inspection of the
questionnaires.
Diet records
The diet records were collected and coded by nine (student) dietitians (three for
each recording period), who were trained and supervised by one experienced dietitian
(H.A.M.B.), who also checked the coding of each record. The participants were asked
to write down all foods and beverages taken and to specify type and brand. The amount
had to be specified in their own household measures (glass, etc.) and/or weight as
purchased. We did not use a weighed record method since, in our experience with
untrained subjects, it is liable to mistakes. Moreover, it has been found that weighing
could influence eating habits (16).
One day before the beginning of the recording period, the participant was
instructed at home by the dietitian and received the diary, including written instructions
and examples. The day after the last recording day, the same dietitian checked the diary
with the subject and, if necessary, with the subject's partner. During the same visit, the
dietitian measured the capacity of the household utensils (glasses, cups, etc.) specified
in the diary and weighed the amount of butter or margarine used on bread and the
amount of sugar used in tea and coffee. For the second and third recording periods, the
instruction visit, but not the check visit, was skipped and diaries were mailed to those
participants who appeared to have properly understood the record-keeping procedure.
Calculation of intake of nutrients and food groups
Mean individual nutrient intake per day was calculated from the record as the
average of the nine recording days. Questionnaire data were converted to mean dairy
intake by multiplying consumption frequency, number of serving units and weight of a
unit (either standard or individual). The weight of a standard serving was either derived
from pilot study data or from common Dutch household measures. If the number of
serving units was omitted, the median number found among other questionnaires was
taken instead. Since the serving sizes of potatoes and other bulk foods, such as rice and
pasta, appeared to be proportionally related within subjects, the substituted number of
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serving units for these bulk foods was derived from the serving size of potatoes for the
same subject. Season was taken into account when applicable.
Record and questionnaire data (mean dairy item intake) were both converted to
nutrient intake using the computerized Dutch food composition table (17). Although
validation of supplement use was included in the study design, nutrient intake through
supplements is not taken into account in this paper. Results indicated that vitamin
supplements (A, C or multivitamin supplements) were used by 3 to 9 percent of the
validation study population and correctly reported by 67 percent of the users; calcium
supplements were correctly reported by 53 percent of tie fifteen (14 percent) users
(Dorant et al., submitted for publication).
The items in the questionnaire were also aggregated into 27 food groups according
to their shared properties and origin (e.g. bread, vegetables). For each food group mean
dairy weight consumed was calculated. The purpose of classification was to evaluate the
validity of the questionnaire with respect to food group-related properties other than
the nutrients studied and to facilitate interpretation of the strengths and limitations of
the questionnaire.
Data analysis
Nutrient intakes calculated from the record and the questionnaire were
log,-transformed to improve their distribution towards normality. Results were,
however, similar for untransformed data. An alcohol intake of 0 gram per day was
replaced with 0.1 gram per day before transformation. Energy-adjusted nutrient intakes
were calculated as residuals from regression of each log, (nutrient) on log, (energy) and
sex (12). Pearson correlation coefficients between record and questionnaire were
calculated for unadjusted and adjusted nutrient intakes.
Furthermore, men and women were divided into quintiles according to nutrient
intake (unadjusted and energy-adjusted) assessed by the questionnaire. For each
quintile, the corresponding mean (untransformed) nutrient intake as assessed from the
record was calculated (12). For this procedure, energy-adjusted residuals, to which
mean nutrient intake was added, were calculated from untransformed energy and
nutrient intakes.
For the comparison regarding the 27 food groups, most of which had a skewed
distribution, a Spearman correlation coefficient was used. The specific food items within
each food group were not analyzed individually, because estimation of their usual
consumption frequency on the basis of a nine-day record was expected to be imprecise.
Analysis of variance was applied to both the number of blank items and the error
index of the baseline questionnaire (log,-transformed), assessing the effects of group
(validation study group versus reproducibility study group) and participation status for
the repeated questionnaire (participants versus non-participants). The presence of a
learning effect with respect to the number of blank items and the error index (repeated
versus baseline questionnaire) was investigated in both study groups with a paired t-test.
To account for possible differences in the error index among the validation
subgroup and the cohort, Pearson correlation coefficients were adjusted to the
distribution of the error index in the baseline questionnaires of the reproducibility
sample. Calculations were performed using the error index dichotomized at the highest
tertile (scores five and over) in the cohort. Regression analyses of nutrient intake
assessed by record on that assessed by questionnaire were conducted within each of the
two groups that differed with respect to error index. In the usual formula for a squared
correlation coefficient the residual sum of squares in the numerator was replaced with
the residual sum of squares within both groups together with the sum of squares of
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regression over both groups. Thus, correlation coefficients can be calculated according
to:
2
ssj / SSY
In this formula, i denotes the group, df the degrees of freedom, RMS the residual mean
square of regression within group i, SS the sum of squares of the regression over groups
and SSY the variance of the dependent variable (i.e. nutrient intake assessed by
record). The actual adjustment for the error index was conducted by substituting the
degrees of freedom in both groups for those derived from the distribution of the error
index in the reproducibility sample.
Finally, because day-to-day variation will still have influenced the observed mean
individual intake based on nine days (18), correlation coefficients were adjusted for this
source of variation according to Beaton et al. (19) with 95 percent confidence intervals
according to Rosner and Willett (20). For this purpose, the ratios of within-subject to
between-subject variance of nutrient intake were calculated from the nine recording
days, ignoring day-of-the-week and period effects.
Results
Out of a total of 109 questionnaires completed by the validation study subjects, 2
(1.8 percent) were incomplete according to the formal criteria, leaving 107
questionnaires (59 from men and 48 from women) for analysis. The corresponding
percentage for the reproducibility study group was 4.7. No questionnaires needed to be
excluded for an error index exceeding 10.
Table 1 presents the mean daily nutrient intake for both dietary methods as well as
unadjusted and adjusted (for energy and sex) Pearson correlation coefficients. Data for
men and women were pooled since none of the correlations differed significantly
between men and women. For most nutrients mean intake according to the
questionnaire was lower than according to the record; only for poryunsaturated fat,
dietary fiber, niacin and vitamin C the questionnaire gave a higher intake. On average,
the questionnaire covered 91 percent of the record intake. Unadjusted correlation
coefficients ranged from 0.40 (95 percent confidence interval (CI) 0.22-0.54) for vitamin
B-l to 0.86 (CI 0.80-0.90) for alcohol, with a median of 0.69.
The only substantial (though statistically non-significant) differences in correlations
between men and women were found for dietary fiber (0.79 and 0.63 respectively),
vitamin A (0.58 and 0.46) and vitamin B-2 (0.66 and 0.55). For fiber the sex difference
was attributable to the higher range in intake of bread for men, for vitamin B-2 one
woman had an outlying residual that was responsible for the lower correlation.
Correlation coefficients adjusted for energy intake and sex ranged from 0.33 (CI
0.15-0.49) for vitamin B-l to 0.86 (CI 0.80-0.90) for alcohol, with a median of 0.67.
Spearman correlation coefficients, calculated from untransformed nutrient intakes, are
included in Table 1 for the purpose of comparison. They were slightly lower than the
corresponding Pearson correlation coefficients.
To assess the relation between record and questionnaire data for different reference
periods, the baseline questionnaire was also compared to the record (Table 1). Energy-
and sex-adjusted correlation coefficients for the baseline questionnaire ranged from 0.25
(CI 0.06-0.43) for vitamin A to 0.85 (CI 0.79-0.89) for alcohol, with a median of 0.64.
No systematic differences were found between the baseline and repeated questionnaires
with respect to absolute intake of energy and nutrients (data not shown).
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Table 1. Mean daily energy and nutrient intake as assessed by 9-day record and by the questionnaire,
and Pearson correlation coefficients* between the two methods (59 men, 48 women): Cohort
Study on Diet and Cancer in the Netherlands, 1987/1988.
Nutrient Record Questionnaire Record with
questionnaire
Record with
baseline
questionnaire
Mean SD Mean (%)t SD Unadjusted r Adjusted) r Adjusted* r
Energy (kcal)
Total protein (g)
Vegetable protein (g)
Animal protein (g)
Total fat (g)
Saturated (S) fat (g)
Polyunsaluralcd (P) fat (g)
P/S ratio
Cholesterol (nig)
Total carbohydrates (g)
Momv/disaccharides (g)
Poh/saccharidcs (g)
Dietary fiber (g)
Alcohol (g)
All participants
Alcohol users only§
Water (g) |
Calcium (nig)
Phosphorus (mg)
Potassium (mg)
Vitamin A (mg eq. 1)
Vitamin B-l (mg)
Vitamin B-2 (mg)
Vitamin B-6 (ug)
Niacin (mg)
Vitamin C (mg)
Iron (mg)
Protein, % of energy intake
Fat, % of energy intake
Carbohydrates, % of energy
intake
2219
773
243
53.1
100.2
422
17.0
0.42
330
227.5
111.9
115.6
25.7
13.2
16.3
2281
1076
1545
3654
0.95
1.13
1.69
1447
13.3
96.7
12.8
14.2
40.3
41.3
445
152
6.0
14.0
27.1
123
7.1
0.19
99
512
32.6
32.4
6.8
14.7
14.8
508
332
345
637
0.32
0.24
0.46
294
4.3
42.4
2.7
23
5.0
53
1898
68.6
24.6
44.0
823
32.4
17.8
038
243
200.8
923
108.3
273
10.7
13.3
2140
908
1402
3551
0.87
1.09
1.47
1416
13.6
104.4
12.4
14.7
38.7
42.4
( 86)
( 88)
(100)
( 83)
( 82)
( 76)
(105)
( 74)
( 88)
( 83)
(94)
(106)
(81)
(86)
( 94)
( 84)
(91)
( 97)
(92)
( 96)
( 87)
( 98)
(102)
(108)
( 97)
477
13.9
72
10.7
263
10.9
9.1
0.28
76
57.9
37.0
34.1
7.7
12.1
12.1
484
268
317
695
0.29
0.25
038
322
3.9
39.4
2.7
2.4
5.6
5.9
0.74
0.61
0.77
0.61
0.72
0.73
0.73
0.76
0.66
0.77
0.78
0.83
0.74
0.86
0.78
0.73
0.60
0.66
0.66
0.52
0.40
0.62
0.67
0.62
038
038
0.67
0.57
0.72
(0.70)
(034)
(0.73)
(034)
(0.69)
(0.73)
(0.70)
(0.79)
(0.71)
(0.72)
(0.76)
(0.76)
(0.68)
(0.89)
(0.85)
(0.73)
(0.55)
(0.58)
(0.63)
(0.49)
(0.42)
(0.58)
(0.65)
(0.61)
(032)
(0.61)
(0.62)
(036)
(0.68)
039
0.68
0.64
032
038
0.75
0.76
0.62
0.71
0.79
0.79
0.74
0.86
0.76
0.75
0.62
0.69
0.71
0.48
0.33
0.67
0.67
0.61
035
033
039
032
0.71
(032)
(0.67)
(038)
(0.50)
(0.53)
(0.73)
(0.77)
(0.65)
(0.65)
(0.77)
(0.75)
(0.68)
(0.88)
(0.82)
(0.74)
(034)
(0.67)
(0.67)
(0.44)
(037)
(0.62)
(0.62)
(0.64)
(031)
(034)
(038)
(030)
(0.68)
0.61
0.71
0.69
0.47
039
0.63
0.66
0.64
0.71
0.68
0.79
0.70
0.85
0.74
0.67
0.62
0.60
0.62
0.25
0.57
0.72
0.61
0.67
0.42
0.48
0.61
0.47
0.71
* Based on log.-transformed values. In parenthesis: Spearman correlation coefficients for untransformed
data.
t % of record mean,
t Adjusted for energy intake and sex.
S n = 86, based on alcohol users according to questionnaire.
I Includes water in beverages and foods.
1 mg equivalents: retinol (mg) + B-carotene (mg)/6.
Table 2 shows the intake of food groups and the correlation between the two
methods. As for the nutrients, the questionnaire generally resulted in lower intakes than
the record; exceptions were vegetables, citrus fruits, bread and added fats. On average,
the mean of the intakes of all food groups as assessed by questionnaire accounted for
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85 percent of the record assessment. The Spearman correlation coefficients ranged from
0.38 for vegetables to 0.89 for alcoholic beverages, with a median of 0.60.
Table 2. Mean daily intake of food groups (g)' as assessed by 9-day record and by the questionnaire,
including correlation coefficients (59 men, 48 women): Cohort Study on Diet and Cancer in
the Netherlands, 1987/1988.
Food group
Potatoes
Rice
Vegetables
Fruits
Citrus fruit*
Other fruiu
Bread
Milk and milk products
Cheese
Eggi
Meat
Meal products
Fish
Other sandwich fillingt
Added fats
Added sugar
Cakes, cookies
Soup
Non-alcoholic beverages
Alcoholic beverages
Record
Mean
162
19
160
207
67
140
134
363
33
20
99
20
19
15
45
19
51
72
1131
139
SD
83
36
83
107
59
81
54
220
20
13
38
16
23
12
21
22
30
70
420
222
Questionnaire
Mean (%)t
136 ( 84)
17 ( 88)
189 (118)
189 ( 91)
72 (107)
117 ( 84)
159 (119)
311 ( 86)
21 ( 6 4 )
15 ( 75)
97 ( 98)
12 ( 57)
11 ( 58)
11 ( 71)
47 (103)
16 ( 82)
28 ( 56)
67 ( 94)
1102 ( 97)
99 ( 7 1 )
SD
73
30
69
114
70
91
70
192
15
10
36
11
12
11
25
22
23
87
383
138
Spearman's r
0.74
039
038
0.60
0.68
0.60
0.80
0.60
0.61
0.61
0.46
0.54
0.53
0.68
0.57
0.84
0.65
0.54
0.63
0.89
* Food groups with mean intake less than 10 g per day are not listed in this table: pulses, cereals, mixed
dishes, nuts, snacks, candy and soy products,
t % of record mean.
$ Including peanut butter, jam and other sweet fillings.
Table 3 visualizes the actual level of and the heterogeneity in nutrient intake that
could be discriminated by quintiles derived from the questionnaire. Energy adjustment
decreased the range for some nutrients, and for some nutrients the results suggest non-
linear relationships. For example, the questionnaire was not able to separate the two
highest quintiles of vitamin C intake, but could nevertheless discriminate a twofold
range. The anomaly in the two highest quintiles of vitamin C intake was likely to be
attributed to subjects consuming fresh orange juice who checked both the item on
(pressed) oranges and that on orange juice.
Table 4 shows the mean number of blank items and the mean error index of the
questionnaire according to study group and participation. The validation group had a
lower number of blank items and a slightly lower mean error index at baseline than the
reproducibility group. Furthermore, among both study groups, the baseline
questionnaires of the participants had significantly less blank items and response errors
than those of the non-participants; in both study groups combined, the mean number of
blank items for participants was 18.6 versus 22.3 for non-participants, while the mean
error index was 3.2 and 3.8 respectively. There was no evidence for an interaction effect
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between participation status and study group. Compared to the baseline questionnaire,
the mean error index of the repeated questionnaire was not significantly lowered,
indicating the absence of a learning effect attributable to recording of intake. The
number of blank items, however, was significantly lower for the repeated questionnaire,
particularly in the reproducibility group.
Table 3. Mean nutrient intake assessed by 9-day record according to quinlilc categoric* of nutrient
intake assessed by questionnaire (59 men, 48 women): Cohort Study on Diet and Cancer in
the Netherlands, 1987/1988.
Nutrient
Energy (kcal)
Men
Women
Protein (g)
Men
Women
Total fat (g)
Men
Women
Polyunsaturated fat (g)
Men
Women
Cholesterol (mg)
Men
Women
Mono-, disaccharides (g)
Men
Women
Potysaccharides (g)
Men
Women
Dietary fiber (g)
Men
Women
Alcohol (g)
Men
Women
Calcium (nig)
Men
Women
Vitamin A (mg eq.)t
Men
Women
Vitamin C (mg)
Men
Women
Fat, % of energy intake
Men
Women
Unadjusted
Oi
1981
1636
78
58
84
71
12
10
253
219
75
77
94
77
20
19
1
0
874
756
0.76
0.76
59
75
34
38
0 :
2318
2047
74
71
97
87
15
14
284
287
103
103
111
100
24
23
6
3
1065
1026
0.97
0.81
81
102
40
39
0,
2395
1826
83
71
109
89
20
13
343
285
126
101
127
99
26
26
14
4
1012
983
0.89
0.90
87
101
39
39
2511
2168
83
76
113
93
21
18
414
338
124
115
139
116
29
24
27
11
1084
1146
1.03
0.87
103
138
43
43
0,
2840
2274
99
76
138
HI
26
20
455
3%
155
138
169
112
37
27
36
24
1481
1297
1.32
1.16
94
141
44
45
Adjusted for
0,
80
60
100
85
12
11
272
257
82
88
99
87
20
20
1
1
934
799
0.87
0.75
53
75
38
38
0.
75
69
104
84
17
10
318
272
103
98
116
95
24
23
7
3
925
945
0.86
0.87
86
93
37
40
energy*
0.
82
72
108
91
19
15
343
308
122
102
127
100
25
24
14
4
1192
1015
0.97
0.93
92
108
39
40
0.
88
73
111
93
22
17
352
335
128
116
144
102
29
24
28
12
1018
1106
1.07
0.93
100
139
42
42
0,
93
78
117
99
23
21
465
351
147
130
154
118
37
29
35
24
1463
1332
1.21
1.02
93
142
43
44
* Adjusted intakes for record and questionnaire nutrients were calculated as residuals from regression
analyses of nutrient on energy intake, to which mean nutrient intake was added,
t mg equivalents: retinol (mg) + B-carotene (mg)/6.
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Table 4. Mean number of blank items and mean error index* of baseline questionnaire and (repeated)
questionnaire by study group and participation status: Cohort Study on Diet and Cancer in the
Netherlands, 1987/1988.
Study group/
participation status
ADiubjccts(n-199)t
Participants (n-104)
Nun participant» (n-95)
All subject» (n-373)t
I'arlicipunts (n-281)
Non-parlicipant.1 (n-92)
Number of blank
Baseline
Mean SD
Validation study j
18.1
163
20.01
25.8
25.5
26.2
items
Repeated
Mean
group
14.5}
Kcproducibility study group
20.8
19.4
25.1*
27.5
26.2
30.7
15.7J
SD
23.9
24.2
Error index
Baseline
Mean
33
3.0
3.5$
3.4
3.2
4.1*
SD
23
1.9
2.6
2.4
2.4
2.4
Repeated
Mean
2.9
3.5
SD
1.9
2.2
* Error index is the sum of 15 scores each representing an inconsistency or other response error in the
completed questionnaire (0 = no error, 1 = moderate error, 2 = serious error). Since the value of 2
was not assigned for 7 out of 15 variables, the maximum score that could theoretically be attained was
23; actually, the highest score encountered in the cohort was 14. The error index did not include the
number of blank items. Its exact composition is available on request.
t Data refer to accepted questionnaires.
t Significant difference (p<0.05, log.-transformed data) between participants and non-participants, both
study groups combined. There was no evidence for an interaction effect between participation status
and study group.
§ Significant difference (p=0.001, paired t-test) between baseline and repeated questionnaire, both study
groups combined.
Table 5 shows some implications of the validation study results for the cohort as a
whole. The Pearson correlation coefficients for intake of the major nutrients, adjusted
for energy and sex as presented in Table 1, were adjusted for the distribution of the
error index in the questionnaires of the cohort, i.e. the baseline questionnaires of the
random reproducibility sample. Based on the dichotomized error index, 21 percent of
the questionnaires of the validation study participants appeared to fall within the high
error group, compared to 32 percent of the baseline questionnaires of the random
reproducibility sample. The anticipated decrease in correlation coefficients was small
and appeared to be mainly restricted to cholesterol and vitamin C.
There was no need to adjust for the difference in number of blank items between
the two groups, since it resulted in minor (less than 1 percent), non-significant
differences in nutrient intake, which was considered as a measure of underreporting.
The attenuation of the correlation coefficients due to the relatively low number of
nine recording days is demonstrated by the effect of correction for day-to-day variation
in the record data (Table 5). Although the 95 percent confidence intervals became
somewhat wider, correlation coefficients increased on average by 0.07. Due to their
relatively large day-to-day variation, the effects of de-attenuation were most pronounced
for cholesterol and vitamins A and C.
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Table 5. Pearson correlation coefficients between nine-day diet record and questionnaire for nutrient
intake (adjusted for energy and sex), after correction for error index of the questionnaire and
day-to-day variation in tbc record (59 men and 48 women): Cohort Study on Diet and Cancer
in the Netherlands. 1987/1988.
Nutrient
Protein
Total fat
Poh/unsaturated fat
Cholesterol
Mono- .disaccharides
Porysaccharidcs
Dietary fiber
Alcohol
Calcium
Vitamin A
Vitamin C
Mean
Correlation
betwceil record
and questionnaire*
r
0.59
0.52
0.7S
0.62
0.79
0.79
0.74
046
0.62
0.48
0.55
0.66
(95% CI)
(0.45-0.70)
(0J7-O.65)
(0.65-0.82)
(0.49-0.72)
(0.71-0.85)
(0.71-0.85)
(0.64-0.82)
(0.80-0.90)
(0.49-0.72)
(032-0.61)
(0.40-0.67)
Adjusted
for error
indcxt
r
038
0.49
0.76
0.56
0.80
0.80
0.73
0.83
0.62
0.52
0.50
0.65
Adjusted
index and
variation
r*
0.64
033
0.80
0.67
0.83
0.84
0.79
0.86
0.66
0.76
0.58
0.72
for error
day-to-day
(95% CI)I
(0.48-0.75)
(OJ6-0.67)
(0.70-0.87)
(0.48-0.80)
(0.75-0.89)
(0.75-0.89)
(0.670.87)
(0.79-0.91)
(0.51-0.76)
(0.41-0.91)
(0.39-0.72)
* Derived from Table 1.
t Sec methods section (data analysis) for adjustment procedure.
t According to Beaton et al. (19).
§ According to Rosner and Willett (20).
Discussion
We have validated a self-administered dietary questionnaire for use in a large-scale
prospective cohort study on diet and cancer in the Netherlands. A number of
parameters are available to evaluate the validity of an instrument or method relative to
another method (e.g. 12). We have chosen two of them: the (Pearson and Spearman)
correlation coefficient and the distribution of mean nutrient intakes assessed by the
record according to quintile categories of intake assessed by the questionnaire.
Although the use of a correlation coefficient for validation purposes in general is
criticized by some (21), it has some attractive properties relevant to the etiologic
purpose of the cohort study: the correlation coefficient reflects the questionnaire's
capacity to rank subjects according to exposure (more important than absolute
agreement), taking into account the true variation in exposure in the population studied
(12). Thus, it is an adequate measure of the performance of the questionnaire in the
cohort population to which it is actually applied. Furthermore, it facilitates comparison
with other validation studies of self-administered dietary questionnaires.
Compared to a number of other self-administered questionnaires developed for a
similar purpose (Table 6), our questionnaire, comprising approximately 150 food items,
is comprehensive. This is mainly due to our requirement to rank subjects with respect
to both nutrient and energy intake. In our study, the Pearson correlation coefficients,
for unadjusted as well as sex- and energy-adjusted intakes, were generally higher than
for questionnaires with fewer items, but similar to the Finnish questionnaire with 276
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items (4). Inspection of Table 6 may lead to the tentative conclusion that the validity of
a questionnaire is proportional to its length, although not all questionnaires match this
rule (5,9). Of course, also other properties of the questionnaire, such as lay-out, data
editing procedures (22) and characteristics of the population (dietary pattern, range in
intake, motivation and ability to complete the questionnaire (22)) influence the validity
of the questionnaire.
Table 6. Comparison of validation studies of self-administered questionnaires using the diet record as
reference method with respect to the intake of some nutrients important in diet and cancer
ltudics (Pearson correlation coefficients).
I-'irat author
Reference
Year
Sex of subjects
Number of items
Energy
lal
Unadjusted
I'juTgy-adjuslcdt
I'olyuiisaturaled fat
Unadjusted
linergy-adjusledi
Fiber
Unadjusted
Hnergy-adjustedt
Calcium
Unadjusted
1'jiergy-adjustcdt
Vitamin A
Unadjusted
1'jicrgy-adjustcdi
Vitamin C
Unadjusted
Hnergy-adjustedJ
Wilktl
2
1983
F
61
t
0J9
0.53
0.40
0.48
0.46
0.58
0.26
0.36
0.63
0.66
Willed
3
1987
M + F'
116
037
0.57
039
0.50
0.28
0.37
0.65
0.42
0.57
0.62
0.70
0.34
0.49
Pit linen
5
1988
M
44
0.43
0.42
0.47
0.68
0.77
0.67
0.61
0.38
0.36
0.40
033
Pie linen
4
1988
M
276
039
0.60
032
0.73
0.76
0.70
0.73
0.62
0.66
0.51
0.49
039
0.60
Bkx*
7
1990
I
94
031
0.60
0.48
0.56
0.47
036
TJWineUnd
8
1991
M + F*
92
0.32
0.41
0.58
0.41
0.46
0.34
0.46
0.38
035
0.27
0.36
0.55
038
Rimm
9
1992
M
131
0.40
032
0.61
0.33
0.29
0.49
0.64
0.52
033
035
0.41
0.64
0.68
Thk tludy
M + F*
150
0.69
0.69
032
0.71
0.75
0.74
0.74
0.60
0.62
033
0.48
034
035
* Studies with both sexes arc adjusted for sex (study 8 based on mean for men and women); study 3 also
adjusted for age because of the large age range of the study population (20-54 years),
t I'niply entries; no data published.
I Adjusted for energy and sex, if applicable; study 3 also adjusted for age.
The correlation coefficients for food groups appeared to be somewhat lower than
those for nutrients. Differences in coding of foods between the two methods are partly
responsible for this: many of the record data were coded as ingredients from recipes or
mixed dishes as opposed to the questionnaire data, which were coded as food product.
Consequently, the division between food groups was not always clear, resulting in lower
correlations. For some food groups, such as vegetables, the relatively low correlation
(0.38) was due to a lack of variation in consumption frequency combined with, in our
experience, imprecise estimation of portion size. We have evidence, however, that
correlations for specific vegetables will be higher due to larger variation in consumption
frequency (15).
The general underestimation by our questionnaire of absolute mean nutrient intake
is more pronounced than for other questionnaires (2-5,7,9). Underreporting, caused by
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an incomplete list of foods and items erroneously left blank, counteracts the effect of
overreporting caused by long lists of the same sort of items (22). In this study,
ovcrreporting due to long enumerations was likely to have occurred for vegetables,
citrus fruits and meat. The consumption frequencies for specific meat types, however,
were adjusted to the reported weekly frequency of meat consumption, because the
adjustment appeared to increase correlation coefficients for the meat types (15). The
overreporting of bread may be due to occasional substitution of bread for other foods,
such as crackers.
Like in other studies (2,4,5,9), comparison of the baseline questionnaire with the
dietary record revealed that it performed almost as well as the repeated questionnaire,
which was actually to be validated. It shows that synchronization of the period of
reference for the diet record and the questionnaire was not very important, which is
indicative of stable dietary habits over time. This result is reassuring when it it
considered that a single measurement has to characterize a subject's long-term dietary
intake to link it to cancer risk. It may also indicate the absence of a training effect of
the diet record keeping which has been suggested by some.
A criticism of validation studies is that the participants are highly motivated and
will do better than the population in which the method has been applied at large. This
is a particular problem when response to the validation study is relatively low such as
for this and other study populations that were not selected for high motivation from the
very start (9,23). Indeed, the percentage of questionnaires rejected for incompleteness
was 6.0 for the baseline questionnaires of the cohort and 4.7 and 1.8 for the
questionnaires repeated in the reproducibility study and the validation study
respectively, whereas the number of blank items in accepted questionnaires was also
lower for the participants. Similarly, subjects who were willing to participate in the
validation study or the reproducibility study had less errors in their baseline
questionnaires already. Apparently, subjects who have more problems with the
questionnaire or have completed it somewhat carelessly, are less inclined to participate
for a second time, in particular in a demanding method like a diet record.
Lack of comparability of the study groups with respect to completeness of the
questionnaires is largely solved by exclusion of incomplete questionnaires from all
analyses according to identical criteria. Moreover, the difference regarding the number
of blank items within accepted questionnaires did not result in differential
underreporting. Adjustment for the impact of the difference between the two groups in
the error index, which is conceptually more directly related to the questionnaire's
performance than, for example, nutrient intake and level of education, has shown that
selection of the validation study group did not appear to influence the generalizability
of the results to the cohort at large.
The adjustment for intraindividual variation in nutrient intake as determined by the
record shows that some of the observed correlation coefficients were attenuated by the
relatively small number of nine recording days. Vitamins A and C have both relatively
low observed correlations. However, the low correlation of vitamin A apparently has
been caused by the high day-to-day variation in the record data, while vitamin C
assessment depends more on questionnaire performance as was also suggested by the
quintile analysis.
In conclusion, we have shown that the questionnaire is able to rank subjects
adequately according to intake of the food groups and nutrients investigated. Although
the validation study group differed from the cohort with respect to completeness and
quality of their questionnaires, this appeared to be no major threat to the
generalizability of the validation study's results to the cohort
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Chapter 6
Reproducibility of a food frequency questionnaire and
stability of dietary habits determined from five annually
repeated measurements*
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Abstract
The reproducibility of a ISO-item food frequency questionnaire (FFQ), which has been
used to assess dietary habits in a cohort study on diet and cancer among 120,000
subjects, was determined from five annually repeated questionnaire administrations in
independent random samples from the cohort. Pearson correlation coefficients between
the baseline and the repeated measurement of nutrient intake were calculated for each
time interval, i.e. ranging from one to five years. Linear regression of the correlation
coefficients on time interval provided estimates of the test-retest correlation of the FFQ
(intercept of the regression line) and of the decline in correlation over time (slope).
The test-retest correlation averaged over all nutrients was 0.66. The average decline in
correlation amounted to 0.07 after five years, indicating that the potential of the FFQ
measurement to rank subjects according to nutrient intake is maintained relatively
well over time. It Is concluded that a single baseline measurement of the FFQ is a good
indicator of nutrient intake over a period of at least five years.
Submitted for publication
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Introduction
Food frequency questionnaires are often the method of choice for assessing dietary
habits in large-scale epidemiological studies, such as a prospective cohort study. It is
generally recognized, however, that it has to be validated against a standard reference
method of dietary assessment, such as a diet record (1,2). It is furthermore considered
desirable to assess the reproducibility of the instniment by repeating the questionnaire
administration, although such information is much less needed in the presence of data
from a validation study. In the latter situation repeated measurements are mainly useful
to assess changes in dietary habits over time (1,2).
Most studies on reproducibility of food frequency questionnaires or dietary histories
have repeated the measurement once (3-7) or, occasionally, twice (8). From these
studies, it is difficult to deduce whether the imperfect reproducibility is caused by the
measurement error of the instrument, changes in dietary habits between the
administrations, or both. A further complicating problem is that part of the
measurement error may not be random, but correlated between two measurements by
the same instrument resulting in spuriously high reproducibility. This happens when an
error associated with the questionnaire recurs systematically for a subject (9).
We evaluated the reproducibility of a self-administered food frequency
questionnaire (FFQ) that has been used for baseline assessment of exposure in a large
prospective cohort study on diet and cancer (10). The questionnaire has been validated
against a 9-day diet record (Goldbohm et al., submitted for publication). While the
validation study provided insight into the measurement error of the questionnaire, we
also wished to know how well one measurement was able to characterize the long-term
dietary habits of the participants in the cohort study. Therefore, we repeated the
questionnaire administration annually during the first five years of follow-up in random
independent samples of the cohort. The relatively large number of repetitions allows us
to separate the effect of changes in dietary habits over time from the (pure) test-retest
error of the questionnaire. This type of information is relevant for the interpretation (or
correction for attenuation) of the associations between dietary habits as assessed by the
FFQ and the outcome, i.e. the risk of cancer.
A second purpose of this study was to combine the results from the validation and
the reproducibility study to elucidate to what extent the measurement error is
correlated between two repeated measurements. Although this information is less
relevant to the interpretation of the diet-cancer relation, it may provide more insight
into the composition of the measurement error associated with a food frequency
questionnaire, and thus open ways to improve methods in future studies.
Subjects and methods
Subjects and design
The prospective cohort study on diet and cancer has been initiated in the
Netherlands in September 1986. The cohort included 58,279 men and 62,573 women
aged 55-69 at the start of the study. At baseline, the cohort members completed a
mailed, self-administered questionnaire, which included the food frequency
questionnaire. A subcohort of 3500 subjects, randomly sampled from the cohort after
baseline measurement, was followed up for vital status biennially by means of short
mailed questionnaires. The subjects for the reproducibility study were randomly
sampled from the subcohort and comprised five independent samples of 400 subjects
(200 men and 200 women), one for each year in which the food frequency
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questionnaire was repeated. The repeated questionnaires were mailed in the same
month (September) as the baseline questionnaire in each following year (1987 to 1991).
Food frequency questionnaire
The dietary questionnaire and its processing have been described in detail by
Goldbohm et al. (submitted for publication). The questionnaire's most important
characteristics are summarized here. It assessed habitual consumption of 150 food items
during the past year. Respondents could choose one of seven frequency categories
ranging from never/less than once per month to 6-7 times per week. The number of
servings per consumption frequency was asked in natural or household units (e.g.,
glass). Questions on vegetables were specified with respect to season (summer and
winter). Margarine used on bread and cooking fats and oils were specified as to type
and brand in open questions. An open-ended question also asked to list any foods eaten
regularly (at least once a week) but not included in the questionnaire. The repeated
questionnaires included an additional question on the changes in dietary habits
perceived by the respondent since the baseline administration.
Questionnaires were double-keyed and checked for completeness, consistency, range
and other response errors. In the subcohort, 7.0 percent of the baseline questionnaires
were considered unacceptable according to formal criteria for incompleteness or
inconsistency (Goldbohm et a!., submitted for publication). Nutrient intake was
calculated using the computerized Dutch food composition table (11).
Data analysis
Participants of the reproducibility study were excluded from data analysis when
their baseline or repeated questionnaire was considered unacceptable for reasons
described above. Nutrient intakes were log-transformed to improve their distribution
towards normality. An alcohol intake of 0 gram per day was replaced with 0.1 gram
before transformation. Energy adjustment of nutrient intakes was done by means of
regression analysis according to Willett and Stampfer (12).
The analyses referred to the intake of a number of nutrients considered relevant for
diet and cancer studies (see Results). Pearson correlation coefficients were calculated
between the baseline and each repeated measurement. The five resulting data points
(correlation coefficients), i.e. one for each time interval, were regressed on time interval
since baseline. The slope of the resulting regression line is an indicator of the
intraindividual difference in change in nutrient intake over time, while the intercept (r,,)
provides an estimate of the reproducibility of the measurement as if no time had
elapsed between these measurements (13). For comparison of the measurement error
between subgroups of the study population, we calculated the standard deviations of the
differences between baseline and repeated measurements.
Finally, the variance of nutrient intakes as assessed by the FFQ was divided into
between-subject and within-subject variance. The latter is to be considered as error
variance of the FFQ. The ratio of within- to between-subject variance of the FFQ was
estimated from the Pearson correlation coefficient between the FFQ and reference
method used in the validation study (9-day diet record), adjusted for the within-subject
(day-to-day) variation in the diet record (14). Subsequently, the error (within-subject)
variance of the FFQ was divided into random and correlated error variance (14). The
error correlated between two FFQ measurements was calculated from the data of the
validation and the reproducibility study combined. First, the expected (in the absence of
correlated error) test-retest correlation was calculated from the validation study as the
square of the correlation coefficient between FFQ and record, corrected for day-to-day
variation in the record. Then, the expected correlation was subtracted from the
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correlation observed in the reproducibility study; the resulting difference represents the
proportion of correlated error variance of the total variance observed by the FFQ.
Results
Table 1 shows the response to the repeated questionnaire administrations after
correcting the samples for uneligible subjects (i.e. deceased and moved to an unknown
address). The overall response during the five years was 82%. Neither a trend with
increasing time interval nor relevant differences between men and women were
detected. After exclusion of subjects with unacceptable (i.e. incomplete or inconsistent)
baseline and/or repeated questionnaires, 74.9% of the eligible subjects remained for
data analysis. Among the responders, the mean percentage of unacceptable baseline
questionnaires was 5.3%. The proportion of responders with acceptable baseline, but
unacceptable repeated questionnaires increased from 1.5% in 1987 to 5.6% in 1991.
Table 1. KcqioiMC to the annually repeated questionnaire administrations.
Men Women
Year Higible' Responden Acceptcdt Kligible' Responders Acceptedt
n (%) n (%) n n (%) n (%)
1987
1968
1989
1990
1991
193
186
190
178
183
160
155
154
140
158
(83)
(83)
(81)
(79)
(86)
152
138
141
130
142
(79)
(74)
(74)
(73)
(78)
200
186
192
191
187
174
143
154
153
155
(87)
(77)
(80)
(80)
(83)
166
131
144
133
136
(83)
(70)
(75)
(70)
(73)
Total 930 767 (83) 703 (76) 956 779 (82) 710 (74)
* Sample sizes at baseline: 200; deceased subjects and subjects with unknown address were considered
ineligible,
t Incomplete and inconsistent questionnaires excluded.
Table 2 presents descriptive data on nutrient intake in the study population as
assessed by the baseline FFQ. Evaluation of the mean nutrient intakes over time
revealed very weak trends, which were compatible with differences between age groups,
i.e. among both sexes there was a tendency to decrease energy and energy-adjusted fat
intake (with the exception of poh/unsaturated fat), which was compensated with protein
(men) or carbohydrates (women).
The separation of the intraindividual change over time from the reproducibility of
the FFQ is illustrated in Figure 1 for calcium intake in women. The mean correlation
coefficient over five time intervals is 0.63. Linear regression of the interval-specific
correlation coefficients on time interval resulted in a regression line that had a slightly
negative slope and its intercept (rg) at 0.69. The slope indicates a decline in the
correlation coefficient of 0.02 per year.
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Table 2. Mean and standard deviation of nutrient intake as assessed by the bMeline FKQ and trend (%
of baseline mean in five years)* for men and women. ' >
Nutrient
Energy (kcal)
Protein (g)
Animal
Vegetable
Fat(g)
Saturated
Monounsaturated
Potyunsalurated
Cholesterol (mg)
Carbohydrates (g)
Mono/disaccharides
Polysaccharides
Alcohol (g)
Dietary fiber (g)
Vitamin A (mg eq)t
B-carotene (mg eq)t
Retinol (mg)
Vitamin C (mg)
Calcium (mg)
Selenium (|ig)
Men (n
Mean
2134
75.0
47.6
28.0
«.7
36.4
34.9
19.5
275
222.7
101.2
120.7
14.7
28.8
1.02
0.41
0.61
98.9
937
61.1
-703)
SD
470
16.5
133
83
27.4
11.4
11.1
9.5
88
62.4
41.4
36.1
15.4
8.7
0.41
0.22
0.34
41.4
317
15.9
Trend (%)
- 4
3
5
0
- 1
- 3
- 3
6
- 5
0
- 1
0
1
- 2
- 7
0
- 12
- 6
7
1
Women
Mean
1670
65.3
43.7
22.0
73.6
293
27.6
14.9
234
176.5
84.0
923
5.4
25.1
0.89
0.42
0.47
107.6
895
53.6
(n-710)
SD
395
153
12.8
63
23.6
9.9
9.6
73
71
475
32.0
25.6
83
7.1
038
0.23
0.27
45.1
312
14.9
1>end (%)
- 1
- 2
- 2
- 2
- 3
- 5
- 5
8
- 10
2
3
2
23
- 5
- 19
- 12
- 26
- 1
0
- 5
* Trend: regression coefficient of the (energy-adjusted) difference between baseline and repeated
measurement regressed on time interval (5 years), expressed as % of the baseline mean. A negative
value denotes a decreasing trend.
t retinol equivalents: B-carotenc(mg)/6 4- retinol(mg).
r
i.on
0.8-
0.6-
0.2-
• 0 626
• lop* • - 0.
Tim* Interval Cy«
Figure 1. Example of the regression of the Pearson correlation coefficients between two measurements
of the FFQ on time interval between the measurements. This example pertains to calcium
intake in women.
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Table 3. Mean Pearson correlation coefficients (r^) between paired measurements of nutrient intake by
I-TQ and parameters of their regression on time interval.
Nutrient
Energy
Protein
Animal
Vegetable
Fat
Saturated
Monounnaluratcd
Polyunsaturalcd
Cholesterol
Carbohydrates
Mono/disaccharidcs
Polysaccharides
Alcohol
Dieliiry fiber
Vitamin A
U-carotcnc
Ketinol
Vitamin C
Calcium
Selenium
Unadjusted
048
0J7
OJ55
046
043
044
0.64
044
046
0.71
0.6«
0.68
0.85
048
Oil
055
0.46
0.62
059
0J8
043
0.57
034
0.70
058
0.62
0.64
0.60
0.61
0.72
0.70
0.74
0.90
0.71
0.48
0.52
0.50
0.67
0.67
0.63
Res.SDt
Men
0.056
0.041
0.108
0.050
0.097
0.074
0.081
0.099
0.071
0.044
0.057
0.079
0.044
0.047
0.065
0.037
0.061
0.042
0.075
0.058
Energy-
0.52
0.54
0.63
0.58
0.62
0.60
0.64
0.66
0.70
0.63
0.67
0.85
0.69
0.49
0.54
0.43
0.63
0.59
0.57
adjusted
.
0.61
0.61
0.65
0.56
0.69
0.65
0.63
0.62
0.72
0.72
0.72
0.89
0.78
0.54
032
0.57
0.69
0.73
0.64
Res.SDt
-
0.036
0.092
0.076
0.104
0.099
0.096
0.065
0.073
0.044
0.054
0.044
0.046
0.034
0.077
0.029
0.085
0.042
0.088
0.143
Meant 0.635 0.649 0.619 0.674
Women
Energy
Protein
Animal
Vegetable
Fat
Saturated
Monounsaturated
Polyunsaluralcd
Cholesterol
Carbohydrates
Mono/disaccharides
Polysaccharides
Alcohol
Dietary fiber
Vitamin A
I)-carotene
Ketinol
Vitamin C
Calcium
Selenium
Meant
0.64
041
0.60
041
056
039
057
035
0.6S
0.67
0.65
0.65
0.84
0.66
052
058
0.47
0.64
0.63
055
0.617
0.66
0.63
0.65
0.64
0.60
0.68
0.60
0.62
0.73
0.67
0.68
0.68
0.87
0.69
0.66
0.69
0.56
0.71
0.69
0.46
0.663
0.081
0.064
0.054
0.088
0.115
0.056
0.104
0.095
0.041
0.040
0.065
0.050
0.010
0.064
0.061
0.084
0.102
0.062
0.034
0.057
-
0.61
059
059
0.48
056
058
0.54
0.61
0.61
0.59
0.61
0.84
0.67
0.49
0.57
0.40
0.64
0.63
054
0597
-
0.64
0.64
0.68
0.43
0.62
0.61
0.65
0.72
0.57
0.66
0.62
0.87
0.76
0.67
0.71
0.43
0.73
0.63
0.42
0.650
-
0.059
0.049
0.070
0.071
0.040
0.048
0.066
0.066
0.041
0.050
0.033
0.019
0.067
0.033
0.081
0.085
0.056
0.075
0.077
Intercept of the linear regression line: estimate of r (test-retest) from which the effect of change over
time has been removed.
Residual standard deviation for regression of r on time interval.
The following nutrients were included in the calculation of the averages: energy, animal and vegetable
protein, saturated, monounsaluralcd and polyunsaturated fat, cholesterol, mono/disaccharides,
polysaccharides, alcohol, dietary fiber, 0-carotenc, retinol, vitamin C, calcium and selenium.
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Table 3 summarizes the mean correlation coefficients and the regression results for
all nutrient intakes. For most nutrients a negative slope was observed, but none of them
significantly differed from zero. The decrease in correlation averaged across nutrients
ranged from 0.005 to 0.018 per year. The intercept was on average ca. 0.05 higher than
the mean correlation, with the exception of the unadjusted intake in men, which
showed a smaller difference. The residual standard deviation of the regression ranged
from 0.01 (alcohol) to 0.14 (selenium). For most nutrients, it agreed well with the
standard error of the mean of the correlation coefficients (0.07), indicating that the fit
of the regression lines is according to expectation.
Overall, 13% of the men and 17% of the women reported to have changed their
dietary habits between the two measurements. These proportions did not increase with
increasing time interval. The measurement error of nutrient intakes (expressed as a
percentage of mean intake) is displayed in Table 4 for all subjects as well as for thoae
who reported a change in their dietary habits after baseline measurement. The
measurement error, which in this table also includes the intraindividual change in
dietary habits between two measurements, was consistently higher for the subjects who
reported to have changed habits. Adjustment for energy intake consistently decreased
the measurement error. The measurement errors were very similar for men and women
(data not shown), with the exception of intake of energy and fats, which was ca. 15%
higher for women than for men. Adjustment for energy intake strongly reduced these
differences.
Table 4. Pooled measurement error (%) of nutrient intakes assessed by 1'T'Q for all subjects and
subjects who reported to have changed their dietary habits after baseline.
Nutrient
Energy
Protein
Animal
Vegetable
Fat
Saturated
Monounsaturatcd
Poh/unsaturaled
Cholesterol
Carbohydrates
Mono/disaccharides
Poh/saccharides
Alcohol
Dietary fiber
Vitamin A
6-carotene
Retinol
Vitamin C
Calcium
Selenium
Unadjusted
All
133
14.8
20.0
16.7
19.9
20.7
21.0
32.0
19.9
14.9
23.1
163
77-4
16.6
26D
32,9
373
25.6
21.7
18JO
Changed
14.2
15.9
23.0
173
22.1
23.8
24.5
354
24.7
174
29.1
18.7
84.9
17.0
272
31.7
402
27.7
25.7
232
Lnergy
All
10.4
162
124
10.9
13JO
124
27.1
16.7
93
193
122
75.9
13.7
22.9
324
323
24.5
18.9
153
-adjusted
Changed
11.6
17.9
13.1
14.7
173
164
31.6
20.9
11.1
242
14.7
833
143
244
314
362
263
224
204
Table 5 shows for a limited number of nutrients the results of the partitioning of
variance as measured by the FFQ. The ratio of within- to between-subject variance of
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the nutrient intakes was less than 1, with the exception of the higher ratio for intake of
protein, calcium and vitamin C. Adjustment for energy intake did not substantially
change the relative size of the variance components, except for fat intake for which the
relative contribution to between-subject variance decreased. The nutrients that showed
the highest correlated error were, again, protein, calcium, vitamin C and energy-
adjusted fat.
Table 5. Component» of variance (%) of nutrient intake as assessed by FFQ (unadjusted and energy-
adjusted).
Nutrient
F-nergy
Protein
Fat
I'olyuiiMiluratcd fat
Cholesterol
Mono/disaccharidcs
Polysaccharidcs
Dietary fiber
Alcohol
Calcium
Vitamin A
Vitamin C
Between-
subject
S3
38
54
56
58
64
72
64
78
40
40
39
Within-subject
Total
47
62
46
44
42
36
28
36
22
60
60
61
Random
33
40
39
39
31
31
29
30
12
32
42
31
Correlated
14
22
7
5
11
5
- 1
6
10
28
18
30
Between-
subject
37
32
62
55
68
68
65
80
43
49
40
Within
Total
63
68
38
45
32
32
35
20
57
51
60
-subject
Random
38
44
35
33
31
33
23
12
32
40
29
Correlated
25
24
3
12
1
- 1
12
8
25
11
31
Discussion
We have evaluated the stability of dietary habits over time among participants of
the Dutch cohort study on diet and cancer. Mean intakes changed very little. The
correlations between two measurements decreased slightly over time, indicating a minor
change in the capacity of the baseline (FFQ) measurement to rank subjects within the
distribution of nutrient intake.
A matter of potential concern in the interpretation of the results is the
representativeness of the participants of the study, in particular those with acceptable
questionnaires, relative to the entire cohort. Although response remained high during
the study period, the proportion of unacceptable questionnaires increased somewhat
with time. This is compatible with the cross-sectionnally observed association between
age and proportion of unacceptable questionnaires. As people grow older, they
experience apparently more trouble in completing the questionnaire, most likely due to
sickness, poor sight or shorter memory. We may thus have included in the
reproducibility study subjects who perform better on average than the cohort at large.
However, since the percentage of questionnaires that had to be excluded in addition to
those already excluded from the baseline measurement in the complete sample is small
(3.2%), the effect on generalizibility of the study results to the cohort at large is not
likely to be serious.
Our data also provided evidence that subjects who consciously changed their dietary
habits have consistently larger measurement errors than those who did not report a
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change. These results are consistent with the assumption that the decreased correlation
over time is to be attributed to intraindividual change in dietary habits and have also
been observed by others (15,16). It is not immediately clear why the proportion of
subjects who reported a change did not increase with time. The most plausible
explanations are that they may have forgotten any changes in the more distant past (i.e.
more than a year ago), as is consistent with the literature (17-22), or that reported
changes may have been temporary. The latter explanation does not fit the data.
To describe the reproducibility of the FFQ and the intraindividual stability of
nutrient intake over time, we used the Pearson product-moment correlation coefficient.
This statistic depends on both the within-subject measurement error of the instrument
and the variation of the measured variable in the population. It therefore adequately
describes the ability of the FFQ to discriminate between exposure levels within the
study population (2). Furthermore, the straightforward statistical properties of the
Pearson correlation coefficient facilitate calculation of statistics such as the (pure) test-
re test error and the intraindividual change over time, as was done in the present
analysis. Finally, the Pearson r (or the related regression coefficient) may be used to
correct for attenuation present in associations between nutrient intake as assessed by
FFQ and outcome (9,23,24). For other commonly used statistics, such as percentage
agreement, (weighted) kappa (20) and the intraclass correlation coefficient (3,4,6-8), it
has been shown empirically that they are related to the Pearson r (25). Indeed, in
reproducibility studies of diet assessment the intraclass and the Pearson correlation
coefficient appeared to be very similar (3,4,6). In our study, the intraclass correlation
coefficient would be less useful as it also depends on temporal trends in mean intake.
Repeated measurements are relevant since they give information on how well the
classification of subjects is maintained over time. This is of particular importance in diet
and cancer studies, in which the relevant dietary exposure is presumed to extend over
many more years than just the one addressed by the FFQ. Potential alternative
approaches to this problem include recall over a longer reference period than one year
or a more distant past, but, unfortunately, such approaches tend to be influenced
considerably by current habits (17-22). Another, costly approach, which has been used
in some prospective studies (26), is to repeat the FFQ administration regularly in the
entire cohort. Our results substantiate the initial idea that a single FFQ administration
is not only relevant to the dietary habits in the previous year, but may extend to a much
longer period. The average decline in correlation after five years amounted to 0.07.
Assuming that the same trends in correlation apply to the five years preceding the
baseline measurement, we may have been able to quantify the measurement error of
the single FFQ measurement with respect to the dietary habits over a ten-year period.
Extrapolation of the decrease in correlation beyond the five year period may be
considered speculative, but is in line with the literature, which has reported correlation
coefficients of 0.30 to 0.40 for dietary assessments 11 to 25 years apart (17,22).
It is not very useful to compare the reproducibility of our FFQ to those reported
for other FFQs, since reproducibility is determined in different ways and FFQs may
have a varying degree of correlated error. One study, however, assessed the
reproducibility of an extensive cross-check dietary history method in the same way as we
did, also using 5 repeated measurements (13,27). In that study higher test-retest
correlations were found. For example, for calcium intake a fy of 0.83 was found,
indicating a smaller measurement error than observed for our FFQ (under the
assumption that the proportion of correlated error is similar for both methods). The
slope of the regression line, however, was smaller for the FFQ.
In addition to the assessment of reproducibility of the FFQ and the stability of
dietary habits, the data from this study, combined with those from the validation study,
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provided a good opportunity to learn more about the measurement error of the FFQ.
Although there appears to be interest in this subject, published data are scarce (14).
The method proposed by Beaton (14) to estimate components of variance is attractive,
but it relies on a number of assumptions. Since we cannot be sure that the assumptions
have been met, the results have to be considered as rough indicators rather than as
exact data. For example, one of the assumptions, i.e. the reference (record) method
measures true usual intake, may not hold for all nutrients as is made plausible by
Hunter et al.(28). Another assumption, required for the calculation of correlated error,
is that there is no change in dietary habits between two FFQ measurements. We have
met this assumption by using the intercept (rg) from the regression of correlations on
time interval, instead of the mean r. The results indicate that nutrient intakes as
assessed by FFQ have a ratio of within- to between-subject variance of less than 1, with
the exception of protein, calcium and vitamin C. These are also the nutrients with the
largest proportion of correlated error (>20%). These results appear to be more
favorable for our FFQ than those presented by Wu et al.(29), who have found larger
within- to between-subject variance ratios. For our FFQ, energy adjustment did not
seriously affect the performance of the questionnaire, nor the composition of the
variance. Fat intake appeared to be the only unfavorable exception to this finding.
Although the measurement error appeared to decrease substantially after energy
adjustment, it did not outweigh the effect of decrease in true between-subject variance.
Repeated measurements in subgroups of the study population are advocated by
many authors (23,24,30,31) to correct relative risk estimates for attenuation. The
assumption that errors are independent is often made explicitly (24,32). Our data
suggest that errors may be correlated between two measurements, although their
relative size is small. Beaton (14) has also given some examples of nutrient intakes
assessed by FFQ that have larger correlated errors. In particular (short) questionnaires
that are missing food items contributing substantially to the nutrient intake of part of
the subjects are likely to result in high reproducibility combined with low validity (9,33).
Relying on the reproducibility of the FFQ alone, which may be inflated by the
reproducibility of the error, might therefore result in underestimation of the attenuation
present in the data. For this reason, Walker and Blettner (23) have suggested to
consider the reproducibility of a method as an estimate of the upper limit of the
correlation of that method with a presumed underlying "true" value.
In conclusion, we have demonstrated that a single FFQ measurement characterizes
dietary habits for a period of at least five years, and perhaps even for a decade.
Furthermore, the ratio of within- to between-subject variance of the FFQ and the
relative size of the error repeated between measurements do not seem to be as large
for most nutrients as has been suggested for FFQs in general.
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Abstract
Potential predictors of toenail selenium levels were studied in 1211 men and 1248
women aged 55-69 years. These subjects were randomly selected cohort members
without prevalent cancer (other than skin) participating in a prospective study on diet
and cancer in the Netherlands. Information on the considered potential predictors
(gender, age, smoking, intake of dietary selenium and alcohol, Quetelet Index) was
collected together with toenail specimens in 1986. The average toenail selenium
concentration was significantly (p<0.001) lower In men than In women: 0.547 ± 0.126
ug/g (mean ± SD) and 0.575 ± 0.109 ug/g, respectively. The gender difference
remained significant after adjustment for the other variables In multiple regression
analyses. Age was not associated with toenail selenium levels In men nor women. An
inverse association was observed with current smoking but not with past smoking. The
average toenail selenium values for male current smokers were 0.513 ± 0.106 jig/g
(mean ± SD) versus 0.571 ± 0.133 ug/g for male never- or ex-smokers (p<0.001). For
women these values were 0.548 ± 0.101 and 0.581 ± 0.109 ug/g, respectively (p<0.001).
Dietary selenium intake was positively associated with toenail selenium levels in
multivariate analyses (p<0.001), but the association was weak (partial r = 0.09).
Alcohol intake and Quetelet index were no significant independent predictors of toenail
selenium. The observed associations had similar directions in both genders but were
stronger in men.
* Accepted by Cancer Epidemiology, Biomarkers & Prevention
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Introduction
Several reports on the association between low tissue selenium levels and the risk of
cancer and cardiovascular disease (1-4) have increased the interest in the role of
selenium in disease-etiology during the past decade. Estimation of dietary selenium
intake in epidemiologie studies is considered unreliable since the selenium content of
foods may vary considerably between varieties of the same type of food, depending on
the soil where the food was grown (S). Therefore, epidemiologie studies on the relation
between selenium and chronic diseases often rely on biologic markers of selenium
status. Especially in relation to such diseases with long latency periods as cancer, these
markers should preferably reflect the long-term selenium status. Available markers
include selenium levels in whole blood, serum, erythrocytes, urine, hair and nails and
glutathionc pcroxidase activity (5-7). Of these, urinary and serum selenium levels reflect
short-term changes in dietary selenium intake (8,9), and it has been found that serum
selenium levels may be influenced by the presence of (preclinical) disease (10). Long-
term markers of selenium status include hair, erythrocytes and nails (8,11), while whole
blood appears to take an intermediate position in this respect between erythrocytes and
plasma (12,13).
In large-scale epidemiologie studies among thousands of subjects, markers such as
erythrocytes requiring invasive sampling and specific transport and storage conditions
are less attractive options. Hair and fingernails may be contaminated by selenium-
containing anti-dandruff shampoos (14,15) or environmental contamination in general
and may therefore be less useful, in spite of the observed correlation between hair and
blood selenium levels (3). Toenails are less prone to contamination problems in
populations wearing shoes and because their surface-to-volume ratio is smaller; their
usefulness as biomarker has been investigated in the last decade. Because toenails have
different lengths with corresponding age differences, toenails clipped from all toes at a
single time provide a time-integrated measure of selenium intake over several months
(6). Higher toenail selenium levels have been observed in subjects living in seleniferous
areas as South-Dakota compared to residents of Boston or New Zealand with low
selenium levels in the soil (11). Longnecker et al. (17) observed correlation coefficients
of 0.91 and 0.89 for selenium levels in toenails with those in whole blood and serum,
respectively, among residents of South-Dakota and Wyoming. Also, elevated selenium
levels were found in toenails of subjects consuming dietary selenium supplements (16).
In a recent study in South-Dakota in a population with widely varying selenium intakes,
strong correlations were observed between selenium intake measurements from
duplicate meal portions and selenium levels in toenails, as well as serum and whole
blood (18).
The observations on the potential value and sensitivity of toenail selenium
concentrations combined with feasibility considerations have stimulated the collection of
toenail clippings in epidemiologie studies (19-21). We have started a prospective cohort
study on diet and cancer among men and women, that includes toenail clippings as a
biologic marker of selenium status (22). Before analyzing the relationship between
selenium and the risk of cancer it is important to identify potential determinants of
toenail selenium levels in men and women, that may act as confounders in subsequent
analyses of selenium and cancer risk. Hunter et al. (16) recently concluded that
smoking, age and use of selenium supplements were predictive of toenail selenium
levels among US nurses, while alcohol and dietary selenium intake were not. Swanson
et al., however, did not observe a relationship with age in men and women (18). The
purpose of our study was to examine whether associations between toenail selenium and
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age, smoking, alcohol, Quetelet index and selenium intake in the Netherlands do exist
in women and to evaluate whether these relationships would also hold for men.
Materials and methods
Subjects
The study population is derived from an ongoing prospective cohort study on diet
and cancer that was started in September 1986. The cohort (n= 120,852) of 55-69 year
old men (48.2 percent) and women (51.8 percent) originates from 204 municipal
population registries. At baseline, the cohort members completed a self-administered
questionnaire on diet and potential confounding variables and also provided toenail
clippings. For efficiency reasons a case-cohort approach is being used for the analysis of
the cohort study (22), requiring processing of questionnaires and toenail clippings of a
random subcohort (n = 3500) and incident cancer cases only. For the present study on
potential predictors of toenail selenium we have used data of the subcohort only.
Prevalent cancer cases other than skin tumours were excluded from this group, leaving
3346 subjects (1630 men, 1716 women). Of these, toenail clippings had been provided
by 1247 men (76.5 percent) and 1322 women (77.0 percent). Problems with the
detection of toenail selenium (interference by other elements such as calcium) occurred
in 16 of these 2569 samples. An additional 94 specimens were excluded because the
specimen weighed less than 10 mg, which would yield unreliable selenium
measurements. Thus, toenail selenium data on 2459 subjects (1211 men, 1248 women)
were available for analysis.
Potential predictors of toenail selenium
The considered potential predictors of toenail selenium were: gender, age, smoking
habits (type of tobacco and amount smoked), alcohol consumption, Quetelet index,
dietary selenium intake as calculated from food consumption and intake of selenium
supplements. Information on the predictors other than gender and age was obtained
from the baseline questionnaire. The food questionnaire has recently been validated
(Goldbohm et al., unpublished manuscript). The dietary selenium intake was estimated
by multiplying the average dairy intake of foods with their selenium content. We used
data on the selenium content of Dutch foods which were collected for an earlier case-
control study on diet and breast cancer (21). Of the dietary questionnaires, about 7
percent could not be used for nutrient intake calculation because of missing or
inconsistent data.
Determination of toenail selenium levels
The toenail selenium analyses were carried out by the Interfaculty Reactor Institute
(IRI) at Delft University, the Netherlands. Toenails were first cleared by scratching off
any debris with a quartz knife. After ultrasonic cleaning with acetone for 15 minutes,
distilled water for 10 minutes and acetone for 15 minutes respectively, the specimens
were freeze-dried during 15 hours to eliminate any humidity variations between runs.
The selenium content of the toenails was measured by instrumental neutron activation
analysis of the metastable-selenium-77 isotope. The specimens were irradiated for 17
seconds in a thermal flux of 1.2x10" neutrons. s'.cm*. After a decay time of 20 seconds,
gamma radiation of ™"Se was measured for 60 seconds. The accuracy of the method
was checked by analysis of a certified Bovine liver standard (Standard Reference
Material 1577a of the US National Bureau of Standards). For 26 determinations, a
mean value (± SD) of 0.70 ± 0.04 ng/g selenium was observed against a certified value
of 0.71 ± 0.04 ng/g. The precision of the method was evaluated by duplicate selenium
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measurements of specimens from 27 randomly selected subjects; the coefficient of
variation was 6.6 percent.
Data analyses
Because of some skewness to the right, data on toenail selenium concentrations and
dietary selenium intake were normalized with a log.-transformation. Selenium intake
data were adjusted for energy intake by the residual method (23). The relationship
between toenail selenium and its potential predictors was tested in bivariate and
multivariate analyses. Analyses were carried out for men and women separately, and
afterwards combined, if appropriate. First, mean toenail selenium concentrations in the
various strata of the potential predictors were compared using a t-test. To investigate
the influence of various potential predictors simultaneously, multiple regression analysis
was employed with toenail selenium as the dependent variable and the potential
predictors as independent variables. Two-sided p-values are reported throughout.
Results
Before excluding toenail specimens with weights below 10 mg, the specimen weights
ranged from 1.25 to 280.59 mg in men and from 1.50 to 442.31 mg in women. With the
aforementioned exclusion, the average weight of the toenail specimens was 91.0 ± 57.2
mg (mean ± SD) in men and 70.2 ± 47.4 mg in women. In table 1 the mean selenium
levels in toenails of men and women are presented separately. Overall, men were found
to have significantly (p<0.001) lower mean selenium levels in toenails than women:
0.547 ± 0.126 ^g/g versus 0.575 ± 0.109 ug/g, respectively.
Table 1 also shows the associations between toenail selenium and the considered
potential predictors of toenail selenium levels for each gender. In the age range studied
(55-69 years) no association between toenail selenium level and age existed in men, nor
in women. Smoking, on the other hand, showed a strong relationship with toenail
selenium, especially among men. Current cigarette smokers have significantly (p<0.001)
lower toenail selenium levels than persons who never smoked and the selenium levels in
men decrease with increasing amounts smoked. This relationship does not hold for
women, where subjects smoking 10-19 cigarettes/day have the lowest toenail selenium
concentrations. The Spearman rank correlation coefficient between (untransformed)
toenail selenium and number of cigarettes smoked in the combined group of current
smokers and never-smokers was -0.29 for men (p<0.001) and -0.13 for women
(p<0.001). Men who only smoke cigars or pipe also have significantly lower toenail
selenium levels than never-smokers. The corresponding Spearman correlation
coefficient for these 155 subjects was -0.20 (p<0.014) in this case. Ex-smokers of
cigarettes have somewhat lower selenium levels than never-smokers but this difference
is not significant in men nor in women. When current smokers were contrasted with
never or ex-smokers, the average toenail selenium values for male current smokers were
0.513 ± 0.106 ug/g versus 0.571 ± 0.133 ug/g for male never or ex-smokers (p<0.001).
For women these values were 0.548 ± 0.101 versus 0.581 ± 0.109 ug/g, respectively
(p<0.001).
Alcohol intake does not show a consistent relationship with toenail selenium
concentration. Subjects drinking more than 30 g alcohol/day have lower selenium levels
than non-drinkers (not statistically significant in men nor women). However, males
drinking 5-14 g alcohol/day show somewhat higher toenail selenium levels than males
drinking 1-4 g alcohol daily. Women drinking 1-4 g alcohol/day even show somewhat
higher selenium levels than non-drinkers, but the levels decrease with higher alcohol
consumption.
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Table 1. Toenail selenium levels (|ig/g) according to various characteristics among 1211 men and 1248
women in the Netherlands, 1986.
Characteristic
All subjects
Age (yrs)
55-59
60-64
65-69
Smoking status
Never
Only cigar/pipe
Ex-cigarette
Current cigarette
1- 9/day
10-19/day
2 20/day
Alcohol intake (g/day)
0
1- 4
5-14
15-29
a 30
Quetelet index (kg/m')
< 20
20-24
25-29
£ 30
Dietary Se (pg/day), quintiles
(energy-adjusted)
1 (S 47.5)
2 (> 47.5-S 533)
3 (> 533-s 59.1)
4 (> 59.1-S 66.7)
5 (> 66.7)
Men
n*
1211
467
426
318
119
46
636
57
147
152
170
235
314
261
159
35
579
513
47
253
227
216
232
220
Mean ± SD
0.547 ± 0.126
0.544 ± 0.113
0-548 ± 0.148
0.551 ± 0.112
0.576 ± 0.105
0.535 ±0.113
0.568 ± 0.136
0.518 ± 0.097
0-508 ± 0.094
0.497 ± 0.081
0.565 ±0.193
0.543 ± 0.090
0.556 ±0.126
0.538 ± 0.120
0.538 ± 0.0%
0.516 ± 0.106
0.550 ± 0.140
0.545 ± 0.104
0.551 ± 0.086
0.529 ± 0.095
0.548 ± 0.169
0.543 ±0.126
0.561 ± 0.119
0.562 ± 0.116
p valuct
-t0.791
0304
.
0.021
0313
< 0.001
< 0.001
< 0.001
.
0.271
0.776
0.072
0.134
0.150
-t
0.733
0.558
-
0.167
0.282
0.001
0.001
Women
n*
1248
474
429
345
744
250
77
93
65
366
404
209
103
45
57
591
444
109
213
235
243
237
250
Mean
0.575
0.575
0.570
0.580
0.583
0.577
0.566
0.537
0.551
0.573
0.580
0.572
0.570
0.557
0.558
0.571
0.584
0.570
0.550
0.581
0.585
0.575
0.577
±SD
±0.109
± 0.109
±0.104
± 0.114
± 0.112
± 0.101
± 0.087
±0.112
±0.096
±0.113
±0.114
±0.100
±0.106
± 0.082
± 0.137
±0.113
± 0.101
±0.093
±0.097
±0.106
± 0.129
±0.104
±0.0%
p valuet
-*
0.573
0.626
0.557
0.247
0.001
0.030
-
0.438
0.908
0.821
0.403
0345
-t
0.014
0.751
-
0.002
0.002
0.015
0.006
* Due to missing questionnaire data, numbers may not add up to 1211 and 1248, respectively,
t T-tesl between strata, based on In-transformed toenail selenium level*.
I Reference category.
Subjects with a Quetelet index less than 20 kg/m* exhibit lower toenail selenium
levels in men and women than in the referent category 20-25 kg/m*, although the
differences are not significant. Although women with a Quetelet index between 25-29
have significantly increased toenail selenium levels compared to the referent category,
the levels are decreased again in the obese women (QI 230 kg/m*). In men the toenail
selenium levels are comparable in the upper three Quetelet index categories.
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Selenium supplement use was not reported by any of the subjects studied; therefore
its relationship with toenail selenium was not evaluated. Since the estimated selenium
intake was positively correlated with total energy intake (r=0.58), the relationship
between toenail selenium and dietary selenium was evaluated after adjusting the latter
for energy intake. After dividing the energy-adjusted selenium intake into quintiles (for
men and women combined) there was a positive trend with toenail selenium levels. For
men, the mean toenail selenium levels in the upper two quintiles of intake were
significantly higher than in the lowest quintile. For women, the mean toenail selenium
levels in the second and third quintile were also significantly higher than in the bottom
quintile but the levels in the upper two quintiles were somewhat lower than in the
second and third quintile. The Spearman correlation coefficient between toenail
selenium and energy-adjusted dietary selenium intake was 0.11 (p<0.001).
To investigate whether the lower toenail selenium levels in smokers might possibly
be due to a decreased intake of selenium we also calculated the average energy-
adjusted selenium intake according to smoking habits and tested the differences in both
men and women (table 2). The results in table 2 indicate that male current smokers
indeed consume less selenium per day (after adjustment for energy intake) than those
who never smoked; the difference increases with increasing amount smoked and is
significant for those smoking 20 cigarettes/day or more. In women, no significant
differences were observed although heavy smokers consume less selenium. Table 2 also
shows the mean energy-adjusted selenium intake values in men and women without
regard to smoking status. The mean selenium intake in men is significantly lower
(p=0.003) than in women: 57.0 ± 12.7 /xg/day and 58.7 ± 14.0 ^g/day, respectively.
Table 2. Mean (± SD) daily energy-adjusted intake of selenium (/xg) in men and women separately
according to smoking status.
Smoking status
All subjects
Never smoked
Only cigar/pipe
Ex-cigarette
Current cigarette
1-9/day
10-19/day
20+/day
Men
n
1148
113
43
613
54
138
142
Mean ± SD
57.0 ± 12.7
58.1 ± 12.9
58.6 ± 15.0
58.0 ± 12.6
56.8 ±11.8
55.9 ± 13.2
543 ± 12.2
p value*
- t
0.874
0.972
0.586
0.150
0.014
Women
n
1178
701
240
73
90
62
Mean ± SD
58.7 ± 14.0
58.4 ± 14.0
60.0 ± 13.2
60.4 + 17.1
58.1 ± 13.8
55.3 ± 143
p value*
- t
0.096
0.458
0.788
0.065
* T-lcst based on In-transTormcd toenail selenium values,
t Reference category.
The results of both bivariate regression and multiple regression analyses, where the
effects of several predictors are controlled simultaneously, are shown in table 3.
Because the previous analyses in both genders had not revealed any large differences
between men and women in the associations with potential predictors, the regression
analyses were carried out for the combined group. The multivariate analysis yielded a
significant effect of gender while no effect of age was observed. The negative
association between smoking on toenail selenium levels remained significant in the
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regression model although not for subjects who only smoke cigars or pipe. Also, the
energy-adjusted selenium intake showed an independent positive association with
toenail selenium levels in this population. The partial correlation coefficient between
the two variables was 0.09, indicating a weak relationship. Although the effect is in the
anticipated direction, the significance of it (p<0.001) is merely the result of the large
number of individuals studied. The observed regression coefficient of 0.082 for the log,-
transformed values in the multivariate model implies, for example, a 4 percent increase
in toenail selenium level when the median of the top quintile of selenium intake (73.8
/ig/day) is contrasted with the median of the bottom quintile of intake (43.3 iig/day).
Alcohol intake and Quetelet index were no significant predictors of toenail selenium in
this model. Together, the independent predictors gender, smoking habits and selenium
intake explained 7 percent of the variance in toenail selenium levels in this population.
Regression analyses conducted for men and women separately (results not shown
here) revealed similar directions of the associations with smoking and selenium intake
in both genders, although the associations were somewhat stronger in men.
Table 3. Predictors of toenail selenium levels (jig/g. In-transformed) in bivarialc and multiple regression
analysis in 2459 men and women, ihc Netherlands, 1986.
Intercept
Gender (M=0, F=l)
Age (10 years)
Smoking habits*
Only cigar/pipe
1- 9 cigts/day
10-19 cigts/day
2 20 cigts/day
Alcohol intake (g/day)t
< 15
a 15
Quetelet index (5 kg/m')
Selenium intake (In u.g/day)
(energy-adjusted)
Btvariate
B
0.051
0.005
-0.074
-0.053
-0.109
-0.116
-0.007
-0.041
0.015
0.101
regression
se(B)
0.008
0.009
0.029
0.017
0.013
0.014
0.010
0.012
0.006
0.018
p value
< 0.001
0.571
0.011
0.002
< 0.001
< 0.001
0.493
< 0.001
0.020
< 0.001
Multiple
B
-0.858
0.034
-0.010
-0.043
-0.043
-0.106
-0.093
-0.006
-0.011
0.001
0.082
regression
sc(fl)
0.009
0.010
0.030
0.017
0.014
0.014
0.010
0.012
0.007
0.018
R' = 0.07; adjusted
p value
< 0.001
0.308
0.151
0.013
< 0.001
< 0.001
0.532
0.343
0.870
< 0.001
R' - 0.07
* Dummy variables (coded as 0,1) were introduced for the smoking categories, with never- or ex-smokers
as baseline category,
t Dummy variables were introduced for the drinking categories, with nondrinkers as baseline category.
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Discussion
The average toenail selenium values that we observed among women (0.58 ug/g)
are somewhat lower than other recent estimates (0.65 ng/g) from the Netherlands (21),
but the estimates of selenium intake in both studies were virtually similar, using the
same food tables. The difference in toenail levels might be due to differences in analytic
conditions, used in different nuclear research reactors. Among US nurses toenail
selenium levels around 0.80 ng/g were observed (16), whereas substantially higher
values (averaging 1.17 ug/g) were found among residents of a seleniferous area in
South-Dakota (18). Similar values were found by Morris et al. (11) who also observed
an average value of 0.26 jig/g for residents of New Zealand. In Greece values around
0.54 ug/g have been observed in fingernails (24). The fact that men have lower toenail
•elenium levels than women was also observed by Swanson et al. (18). Other studies did
not show a clear gender difference regarding fingernail (24), whole blood or plasma
selenium levels (25). However, Lloyd et al. (25) did find significantly lower selenium
values in erythrocytcs among men.
Age was not a predictor of toenail selenium in our study. Various investigators have
found an inverse association between selenium status parameters and age (16,25,26) but
this observation is not consistent (18,24,27). In the study of Dickson and Tomlinson
(26), the inverse association between serum selenium and age was restricted to subjects
under 55 years of age, while Lloyd et aJ. (25) onry observed lower JeveJs in persons 56
years or older, and Bratakos et al. (24) noted an inverse trend only in subjects 40 years
or older. The absence of an age effect in our study may also be due to the limited age
range in our cohort population (55-69 years).
Smoking was an independent predictor of lowered toenail selenium levels in both
men and women. In general, a negative dose-response relationship existed with the
amount smoked, as was observed earlier in women (16). Swanson et al. (18) also
observed a strong negative association of smoking with toenail selenium levels, but not
with serum or whole blood selenium. Negative relationships with smoking have been
observed for whole blood and serum selenium (28). Lloyd et al. (25) found significantly
decreased levels of selenium in whole blood, plasma and erythrocytes among smoking
men, but for smoking women only in plasma for those who drank alcohol dairy. This is
in accordance with our observation that the smoking effect is more pronounced in men
than in women. It is unclear whether smoking induces increased selenium utilization
(e.g. as active site of glutathione peroxidase) or influences selenium incorporation in
nail keratin. Our data indicate that current smokers have lower energy-adjusted
selenium intakes compared to never-smokers, but in the multiple regression analysis
smoking remained an independent predictor. Swanson et al. (18) also observed
significantly lower selenium intakes among smokers although no adjustment was made
for energy intake. We also compared selenium intakes of smokers and nonsmokers
without adjustment for energy intake; the unadjusted intakes in ex- or in current
smokers were not significantly lower than in those who never smoked.
Our estimates of selenium intake are substantially lower than the intakes measured
by Swanson et al. (18) among South-Dakota residents (174 ug/day) using the duplicate
portion technique. These investigators observed a very strong independent effect of
dietary selenium on toenail selenium levels. Our intake estimates are also lower than
the intakes estimated by Hunter et al. (16) with a questionnaire among US nurses. The
estimation of dietary selenium intake based on questionnaires or interviews is difficult
because of large variations in selenium contents within varieties of the same food,
depending on soil conditions. When a single selenium food table is used, the estimation
problem is likely to aggravate if a study is conducted in a country as the US as opposed
Predictors of loc ruil selenium in men and women 67
to the Netherlands (16). Although we observed a positive association between selenium
intake and toenail levels, in contrast to Hunter et al. (16), the partial correlation
coefficient between dietary and toenail selenium was still only 0.09 in our study,
indicating a weak positive relationship which reached only significance due to the large
numbers of subjects studied. We could not evaluate the influence of dietary methionine
on the toenail selenium levels (which was recently found to be a mediating factor in the
deposition of selenium in nails of rats (29)), because information on methionine intake
was not available.
Although in bivariate regression analysis of men and women combined, subjects
drinking 15 g of alcohol or more per day showed significantly lower toenail selenium
levels, alcohol intake was not an independent predictor of toenail selenium in
multivariate analyses with smoking in the model. Earlier studies have revealed
decreased serum selenium levels among alcoholics (30,31). The absence of an alcohol
effect in the dose range we have studied is in agreement with other studies using
toenail selenium (16), or whole blood or erythrocyte selenium (25). With regard to
plasma selenium, Lloyd et al. (25) observed decreased levels in non-smoking men who
were dairy drinkers compared to non- and weekend drinkers, but not in women.
In bivariate analyses there was an indication that Quetelet index is positively
associated with toenail selenium levels, but it was no independent predictor in multiple
regression analyses. Swanson et al. (18) suggested that controlling for differences in
lean body mass instead of weight (or relative weight) would diminish the effect of
gender on toenail selenium levels, because of the storage of selenium in muscle tissue
(32,33). This adjustment is difficult in practice, however, because data on lean body
mass are typically unavailable. The present result does not support a need to control for
Quetelet index as a confounder in studies on selenium and obesity-associated diseases.
In conclusion, smoking was the most important predictor of toenail selenium levels
in both men and women. The inverse relationship with smoking appeared to be
stronger in men than in women. Gender itself was also an independent predictor of
toenail selenium, with men showing lower values than women. Dietary selenium intake
(excluding supplements) showed a significantly weak positive association with toenail
selenium levels, despite the well-known lack of reliability of questionnaire-based
assessment of selenium intake (5). Age, alcohol intake and Quetelet index were no
independent predictors of toenail selenium levels. In any epidemiologie analysis relating
toenail selenium to risk of smoking associated diseases, adjustment for smoking habits
is indicated.
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Assessment of Dietary Nitrate Intake
by a Self-Administered
Questionnaire and by Overnight
Urinary Measurement
PIET A VAN DEN BRANDT.' WALTER C WILLETT" AND STEVEN R TANNENBAUMf
Van den Brandt P A (Department of Epidemiology. University of Limburg Maastricht. The Netherlands) Willen W C and
Tannenbaum S R Assessment of dietary nitrate intake by a self administered questionnaire and by overnight urinary
measurement /nfemervona' Joorn»/ of fp'devmo/o^y. 1989. I I : 852-857.
The relationship between dietary intake and urinary excretion of nitrate was investigated among 36 male and 24
female graduate students in Boston The dietary assessment method consisted of a self administered semi quantitative
food frequency questionnaire currently used for large scale epidemiological studies Calculated mean daily nitrate
intake was 1 83 mmolfor men and 2.96 mmol for women; broccoli and green leafy vegetables accounted for 60S of the
total Urinary measurements involved two overnight specimens with a mean col lection timeof approximately 13 hours
The ratio of intra-tointer individual variance in urinary nitrate excretion llambda) was 1.87 The simple correlation
coefficient between intake and excretion of nitrate was found to be 0.20; after correction for the within .person variation
by using lambda, the correlation coefficient was 0.28. Adjustment for gender, age and Quetelet's Index in multiple
regression analyses resulted in a partial correlation coefficient between nitrate inteke and excretion of 0 37 |p - 0.0061
Correction for within person variation in urinary excretion increased this partial correlation coefficient between intake
and excretion to 0.59 (95% Cl = 0 03 to 0.87) These data suggest that a self administered questionnaire may provide
useful information on usual nitrate intake, and indicate the need to pursue this possibility further.
Increasing interest in relationships between long-term When possible, the use of biochemical measure-
dietary intake and the occurrence of chronic disease has ments to validate dietary questionnaires is appealing
stimulated the development and evaluation of methods since the sources of error should be largely indepcn-
to measure dietary factors among large groups of indivi- dent. In a previous study' we evaluated the capacity of
duals. Methods based on questionnaires' or bio- our semi-quantitative food frequency questionnaire to
chemical measurements may both be useful. depending measure vitamin E and carotenoid intake using plasma
on the parameter being assessed and on the practical levels of these nutrients for comparison However, the
constraints imposed by the particular study design. For use of biochemical measures for this purpose is fre-
any method it will be important to evaluate the quently limited because many are insensitive to dietary
reproducibility and validity of the measurement. Since intake over much of the dose-response range, or are
long-term intake is important in most epidemiological highly variable from day to day. Urinary nitrate has
hypotheses, interview or biochemical parameters that been proposed as an estimate of the dietary nitrate
reflect intake over a short period (such as a single day) intake, after the observation that 65-70% of ingested
may be of limited use. even though highly accurate for nitrate is excreted in the urine during the following 24
that short interval.' hours and less than 1 % in faeces.'
Nitrate has been hypothesized to play a role in the
~ 77 I ! T T aetiology of certain gastrointestinal cancers, notably
• Department ol Epidemiology. University of Umburg. Maastricht. * ' * . '
The Netherlands gastnecancer.'"* Nitrate may be converted into nitrite in
' * Departments of Epuiemioiog> and Nutrition Harvard School of foods, in the stomach" and in the oral canty ." ' " nitrate
Public Health and Chanmng Laboratory and Bripham and Women s and nitnte can react with secondary amines or amides to
Ho*pn.i. Boston USA , „ ^ N-nilroso compounds." '- The relation of nitrate
' Department of Applied Biological Sciences. Massachusetts Inui- , . , . . .
tuie of Technology, tambndgc. ISA ' " " • "= *"*> cancer risk has been investigated in various
Repnm requests Dr Wiiktt. channmg Uboraion. isoLongwood epidemiological s t u d i e s . " " Attention has also been
Avenue. Boston, M A o:il5 USA given to the cancer risk associated with nitrate in drink-
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ing waier because of the increasing use of nitrogenous
fertilizers. "In none of these studies wasevidence found
to support a positive association.
We therefore assessed the within-person variability
of timed overnight urinary nitrate excretion measure-
ments and the influence of demographic and other
factors on these levels. We then used these urinary
measures to evaluate questionnaire estimates of nitrate
intake. Finally, we evaluated the effects of within-per-
son variation and other variables on the association
between questionnaire estimates of intake and urinary
measurement.
MATERIALS AND METHODS
In April 1984 we invited a random sample of the student
population of the Harvard School of Public Health to
participate in this study. The sample consisted mainly of
North American and European students, but also
included four Japanese students Sixty-one students
agreed to participate, but two failed to complete all
procedures. Hence, our analyses are based on 59 sub-
jects consisting of 35 males and 24 females, age 30.3 (1
SD ± 4.5) and 28.9 (± 6.5) years respectively. Subjects
were unaware of the fact that the investigation con-
cerned the consumption and excretion of nitrate, since
that might have interfered with their intake. The pro-
cedures used in this study were approved by the Com-
mittee on the Use of Human Subjects at the Harvard
School of Public Health, and all individuals signed an
informed consent form.
Participants were asked to collect timed, overnight
urine specimens on two occasions, separated by two
weeks. To impose minimal inconvenience on the sub-
jects, they were asked to start the urine collection after
they had arrived at home in the evening and to continue
until the next morning, recording the exact time of start-
ing and stopping. We appreciated that the overnight
specimens would be less optimal than full 24-hour col-
lections: however, we wished to evaluate a method that
might be feasible on a much larger scale. In this way
unne samples covering a penod of approximately 13
hours were obtained. The dietary questionnaire was
completed at the time the first unne specimen was
obtained.
Dirtury
The semi-quantitative food frequency questionnaire
we employed is a questionnaire that is being used in a
variety of epidemiological studies. Earlier versions of
this form were validated previously with respect to the
intake of carotene, retinol. and vitamin E' as well as
other nutrients.' The current self-administered ques-
tionnaire consists of 120 specified foods: the participant
is asked how often, on average, a specified quantity of
each food was consumed over the past year. Nine
responses are possible, ranging from never to six or
more times a day.
As described elsewhere, nutrient scores were com-
puted by summing the products of the frequency and
nutrient composition of the specified serving size for
each food.' Food composition values for nitrate were
derived from a report of the National Research Council
on the health effects of nitrate.' and a compilation by
White." For some food items the nitrate content was
derived by extrapolation, since published data were not
available. Nitrate from drinking water was not included
in our calculation; however, the concentration of this
ion in the Boston municipal water supply is less than five
parts per million. Assuming an average intake of one
litre of water per day. the intake from this source would
be less than 0.05 mmol/24 hours (which is less than 2%
of intake from food sources).
C/rine Co//ecrion
Timed overnight urine specimens were collected in two
litre plastic bottles containing 50 ml of 3% HC1 solution
as a bacteriostatic agent. On the morning that the col-
lection was completed, four 10 ml aliquots of urine were
taken and immediately frozen at -20°C for chemical
analysis. At both collection periodssubjects were asked
about any infections they might have had at that time,
since this might influence the nitrate content of the urine
(D A Wagner, personal communication).
Urinary nitrate concentrations were determined via
reduction with a high-pressure cadmium column as
described by Green rt a/." Creatinine concentration
was measured by flame photometry.
Statistical analyses were carried out using the BMDP
statistical package.* Urinary values were expressed as
excretion rates per hour; in the analyses comparing die-
tary and urinary values, the mean of the excretion rates
for the two collection periods was used as the dependent
variable. Highly skewed vanables were logarithmically
transformed to meet normality assumptions. Dietary
intake and excretion values were tested for gender-
specific differences using Student's t-test.
Analysis of variance was performed on the two
repeated urinary measurements per person to examine
the components of variability in nitrate excretion as
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described by Beaton. -In this way estimates of the imer-
individual ( v ) and intra-individual variance (s»') were
computed. The intra-individual variance is composed
of the biological intra-indivtdual variation (which may
be largely due to daily variation in diet) as well as
random measurement errors in the urinary values. The
ratio of the intra-individual to the inter-individual vari-
ance components (lambda) provides an indication of
the reproducibility of the urinary excretion values.
Lambda can also be used to determine the degree of
attenuation in the estimated correlation or regression
coefficient describing the relationship between the die-
tary and urinary variables that is due to within-person
variation. Conversely, these coefficients can be cor-
rected for within-person variation by using lambda. In
this application, the corrected correlation coëfficiënt
can be thought of as the correlation that would describe
the relationship between the questionnaire measure-
ment and an infinite number of urine specimens per
subject. The relationship between the true and
observed coefficient is as follows.- •'
r, = r„ TfT+l/k)
where r„ = observed correlation coefficient
r, = true correlation coefficient
k = number of measurements per person
X. = ratio of within-person variance to between-
person variance.
Confidence intervals for the corrected correlation
coefficient were also computed."
We first computed simple correlation coefficients to
compare nitrate intake and urinary output. In the final
analyses we utilized multiple regression to assess the
influence of several predictors of the urinary excretion
rate simultaneously. Statistical significance is expressed
as two-sided p-values throughout the text.
RESULTS
Genera/ Dncripfion
The daily intake of nitrate as estimated by the question-
naire was lower in males (1.83 ± 0.79 mmol) than in
TABLE 1 O
59 mr/i ofuf (mean t / 5D/. Da/f wvrr roftrcrrd in Sosfon.
I'M rfunitg /«M
Variable
Time of collection (hr»>
Nitrate (mmol'hn
(»unolhr/kg)
Crealminc (m^hr)
(mghrkg)
Men
(n =
130 3
U 08 :
1.15 3
67 6 3
0 98 i
35)
• 2.3
k 0 04
: u 67
t 9 4
t 0 10
Women
(n =
125 3
005 3
OKI 3
42.8 .
0 7 8
24)
• 1 8
t 0.02
t 0.42
t 9.2
• 0 17
p-valuc
<0 001
0.011
<0 001
<0 001
females (2.96 ± 2.05 mmol); however, this difference
did not reach statistical significance. Broccoli, spinach,
other greens and lettuce accounted for ftCV of the calcu-
lated nitrate intake among the 59 subjects, each of these
items was reported more frequently by women.
The excretion rate of nitrate was found to be higher
among men than among women (see Table 1). Thus,
men were estimated to have a lower intake of nitrate,
although their excretion was higher, whether expressed
as mmoLhr or umol/hr/kg. If we assume that overnight
urine samples are representative of 24-hour excretion,
then the proportion of ingested nitrate that would be
excreted was 1.04 in males and only 0.37 in fcmulev
Estimates of the within-perxon and betwecn-pcrson
variances, as well as the ratio of these two variance
components, are given in Table 2. The variance ratio for
nitrate is 1.87. while that for crealimne is 0.36.
Jtr/afioruAip DrrHrrn /ma&r u/id £>rrrri»n o/
The Pearson correlation coefficient between nitrate
intake and excretion per hour was 0.20 (p > 0.05),
Although this simple correlation was not statistically
significant, it has not been corrected for variables that
might influence (ie confound) the relationship between
intake and excretion rate. In Table 3 Pearson moment
correlation coefficients are reported between potential
confounders and the excretion rate.
As noted above, men had a higher excretion rate than
women. Quetelet's Index (weight/height') and age
were positively correlated with nitrate excretion.
Caloric intake, as well as the intake of most mac-
ronutrients (not presented), did not appear to be
strongly related to the excretion rate. Subsequent
regression analyses were earned out with and without
adjustment for calonc intake. Since the results were not
materially different and nitrate-rich foods in general
contain few calorics, caloric intake was left out of the
regression model presented. We did not find an effect of
reported infection on the measurement of nitrate
excretion.
Adjusting the relationship between intake and excre-
tion for these potentially confounding variable»
resulted in higher partial correlation coefficients in
some instances (Table 4). Allowing for gender or
Quetelet's Index changed the partial correlation coeffi-
cient between intake and excretion of nitrate
substantially.
Multiple regression analysis was performed to con-
trol for the effects of several predictors simultaneously.
The results of both univariate regression and multiple
regression analyses for nitrate are shown in Table 5.
Only nitrate intake, gender and Ouetelet's Index were
significantly associated with nitrate excretion in the
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multiple regression model. Inclusion of age did nol
affect the estimated regression coefficients, nor R- The
partial correlation coefficient between nitrate intake
and excretion after controlling for Quetelet s Index,
gender and age was 0.37 Since men reported a lower
nitrate intake, but were observed to have a higher
excretion of the ion. we also tested for possible interac-
tion between gender and nitrate intake; no evidence
was found for a statistically significant interaction.
As suggested by Beaton <•( <J/-' and Liu rr a/-' we used
the ratio of within-to-bctwcen-person variance to
adjust the corrclutioncoefficient between nitrate intake
and excretion. Utilizing the observed simple correla-
tion coefficient from Table 4. and the values for lambda
from Table 2, the corrected coefficient adjusted for
within-person variation was 0.28 (95% confidence
interval (CI) = -0.09. 0.58). This simple correlation,
however, does not reflect the effects of variables that
would normally be controlled in any epidemiological
analysis, such as age and sex. or that influenced the
relation between intake and excretion in this data set.
such as Ouetelet's Index. We therefore also calculated
the value of lambda for nitrate excretion after adjusting
each individual level for the variables in Table 5
(adjusted levels were computed as the residuals of the
excretion values regressed on the predictor variables).
Asexpected. the value of lambda increased from 1.87 to
3.13 since sources of inter-individual variation were
removed while the intra-individual variation remained
unchanged. This adjusted value of lambda was then
used to correct the partial correlation from Table 5.
which represents the correlation between the adjusted
excretion and intake levels. Although the correlation
coefficient increased substantially with this correction
(0.59). the associated 95*7 confide nee interval was wide
(0.03, 0.87).
DISCUSSION
In this population of graduate students, we observed a
moderately high within-person variability in the over-
night unnarv excretion of nitrate. The intra-to-inter
individual variance ratio (lambda) for nitrate excretion
was found to bc 1ST Although this is less than the
lambda-value reported for sodium of 3.20.-' the intra-
individual variation in nitrate excretion remains con-
siderable. The use of a single overnight specimen will
therefore be of limited utility for characterizing an indi-
vidual's long-term intake or excretion of this ion.
although it may be useful for comparing populations. In
simple bivanate analyses, nitrate intake based on a self-
admimstered dietary questionnaire was only weakly
correlated with excretion measured by the average of
two overnight urine samples. However, adjustment for
additional variables in multiple regression analysis
increased the association between intake and excre-
tion, and further correction for within-person vari-
ability in urinary excretion suggested that the
questionnaire may actually provide reasonable discrim-
ination of individual intakes of nitrate.
The predictive value of overnight unne specimens
was studied, among others, by Watson and Langford.-*
who compared excretion rates in specimens collected
overnight and dunng the full 24 hours. They reported
correlations for sodium and potassium excretion
between the overnight and 24-hour excretion rates of
0.76 and 0.73 respectively. While in their experiment
the mean duration of overnight collection was only 7.9
hours, in our study this was almost 13 hours. Our speci-
mens would therefore be expected to be more repre-
sentative of the 24-hour period. Bartholomew and Hill*
showed that urinary nitrate reaches its maximum 4-6
hours after an oral nitrate load, and returns to the base-
line value within 18 hours. This suggests that overnight
specimens may be useful in the case of nitrate, also
considering the usual consumption time of foods rich in
nitrate. In our analysis, we computed the excretion rate
per hour and used this as our criterion variable to com-
pare with intake.
Few estimates have been made of the nitrate intake of
individuals. The estimates so far have generally been
based on population averages. White" estimated daily
nitrate intake as 1.19mmol/day in the US: per capita
intakes for European countries vary mostly between
111 and 2.51 mmolday,-* while Japanese per capita
estimates amount to 4.52 mmol/day* In two recent
British studies individual nitrate intake was estimated
TAILE 3 /Varjtwi (wrrtfllion ror^ririro frerwwt un/iarv mrrofr
«crrno/i / « r ü andpovnna/pirdicloT in 5S*men and »offlw. Bojron.
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by a food frequency questionnaire" and a diet record.-'
Forman « a/" estimated daily nitrate intake to be
1.89 mmol in areas at low risk for gastnc cancer and
1.19 mmol in high risk areas. Using 48-hour dietary
records. Chilvers c/ af" estimated this intake to be 1.78
± 1.25 mmol among 404 adults (177 men. 227 women).
No differences according to gender were reported. We
noted lower intakes in males, although this difference
was not significant. Chilvers <•( a/, also measured unnary
nitrate output and found mean 24-hour excretion levels
of 1.94 ± 1.21 mmol, which was slightly higher than
their intake (one urine specimen was collected per sub-
ject). In our study using two urine collections of
approximately 13 hours we estimated excretion rates to
be 0.08 (± 0.04)mmol/hr in men and 0.05 (±
0.02) mmol/hr in women, respectively. If our overnight
excretion rates would be representative for the daily
output, our corresponding 24-hour excretion levels
would be 1.90 ± 1.06 mmol for men and 1.08 ±
0.59 mmol for women.
The percentage of ingested nitrate that was excreted
into the urine estimated by our methods differed sub-
stantially between males and females. The reasons for
this are not clear, but include the possibilities of dif-
ferential reporting of intake by gender, and chance,
particularly since the questionnaire asked about usual
intake of foods over the past year and the urines repre-
sented only two days. While differences in metabolism
of nitrate between men and women cannot be excluded,
we have little reason to suspect they might exist. It is also
possible, of course, that the questionnaire under-
estimates intake for males However, in earlier valida-
tion studies on beta-carotene intake'-' the same
questionnaire was able to discriminate between men
and women adequately In that study women were
shown to have both higher plasma levels and higher
dietary intake of carotene than men.
Overall, assuming that our urine measurements
reflected the entire 24-hour intake we found the propor-
tion of ingested nitrate that was excreted to be 77% in
men and women combined. Excreted nitrate represents
the combination of exogenous intake and endogenous
synthesis corrected for metabolic losses." "The appar-
ent recovery from urine of ingested nitrate will be influ-
enced by the relative proportion of these two inputs.
Assuming that endogenous synthesis is relatively con-
stant for an individual, higher ingested amounts of
nitrate will lead to lower apparent recovery in urine if
the endogenous component is not accounted in this
balance."" "The 77% recovery, however, is in agree-
ment with the estimates made for recovery of "NO,,
where approximately half the metabolic losses appear
to be due to the action of the gastrointestinal flora."
Despite the substantial variation in nitrate excretion
within a person, a reasonable correlation between
intake and excretion was observed after adjustment for
gender and Quetelet's Index.
Caloric intake was not correlated with nitrate excre-
tion rate. This might be expected since foods rich in
nitrate generally contain few calories (eg vegetables).
The absence of any age effect on excretion was expected
since the population was relatively homogeneous with
respect to age. This group of public health students was
also unusual with regard to the Ouetelet's Index: males
had a higher index than females, contrary to what is
generally found. However, no one was grossly obese.
This had no adverse effects on the study, since the effect
TABLE 5 PITrfinon o/ nirrarr « c w i o n fmmo///irl. foffanrAmira//v f . id 59 iwn artrf HW»WI WWnjf w JÏOTfcwi rfurtn
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of these variables could be controlled for in multiple
regression analyses.
In conclusion, our data suggest that a simple selt-
admimstered questionnaire may provide useful infor-
mation on usual nitrate intake. However, these findings
should be replicated among larger and more diverse
population», since the performance of the question-
naire and the between-person variation in dietary
sources of nitrate may be different in other demo-
graphic groups The performance may also be different
when subjects arc living in areas where the nitrate con-
tent of drinking water is elevated; questions on water
consumption will have to be added in that case.
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Chapter 9
Brig/" Refrorts
Cross-sectional versus Longitudinal Investigations of the
Diet-Cancer Relation
Piet A. van den Brandt,' R. Alexandra Goldbohm,* A. Jeanne M. van Loon,' and Frans J.
Within a prospective cohort study on diet and cancer, information was collected on cancer prevalence and baseline meat
consumption. A nested case-control study on meat and cancer was conducted with 656 prevalent colorectal cases, 1,894 brcu.it
cancer cases, and 4,701 controls. When analyzed cruss-sectionally, prevalence odds ratios for eating meat rarely versus reuularly
were 2.06 for female colorectal and 1.75 for breast cancer. In the longitudinal analysis, cases who started consuming meat rarely
•rter diagnosis were excluded, resulting in odds ratios t>f 0.51 for female colorectal and 1.17 for breast ctmtcr. These opposite
findings highlight the problem of cross-sectional designs. (Epidemiology 1990; 1:402-404)
Keywords: diet, epidemiologie methods, biometry, questionnaires, colorectal cancer, breast cancer
A prerequisite for etiologic inference is that exposure
precedes disease; cross-sectional designs are considered
inferior for studying etiology. In observational studies on
diet and cancer etiology, exposure may he measured
with biological specimens or by dietary assessment. Such
studies are presumed to be longitudinal, although some-
times observed exposure levels may have been influ-
enced by (preclinical) disease. Changes in various serum
nutrient levels owing to tumor growth have been de-
scribed (1-6). Case-control studies aimed at dietary in-
take may also be partly cross-sectional, even though
they are conducted with incident cases. Interviewing
cases about their prediagnostic diet usually occurs within
some months after diagnosis. The recall of past dietary
habits is influenced by current habits (7-10); when cur-
rent habits of cancer patients have been influenced by
(preclinical) disease, the study may contain a cross-
sectional element.
Little is known about the magnitude of this problem
because the necessary data are often not available. In an
extreme approach to this issue, we have investigated
how odds ratios might be affected when a true cross-
sectional study is actually conducted. Our study exam-
ined the relation between meat consumption and colo-
rectal and breast cancer, which has been reported in
various studies (11-19).
Deportment of Epidemiology, Umverairy of Limburg, P.O. Box 616,
620O MD Maastricht, The Netherlands. 'Epidemiology Section,
TNO-C1VO Toxicology and Nutrition Institute, Zeist. The Nether-
lands. Address repnnr requests to Piet A. van den Bnndt.
TVus work was supported in pan by the Dutch Cancer Society.
C 1990 Epidemiology Resources Inc.
Methods
We used an ongoing prospective cohort study on diet
and cancer. The cohort comprises 120,852 men and
women aged 55-69 years. At baseline (1986), cohort
members completed a questionnaire on dietary habit»
and potential confounders. Analysis will involve a case-
cohort approach for which purpose a random subcohort
(n = 5,000) has been selected. Thus, complete ques-
tionnaires will be processed only for subcohort members
and incident cancer cases from the cohort (21). One
questionnaire page has, however, been processed for ev-
ery cohort member to identify all participants and to
measure several key variables important for future anal-
yses. Among other questions, this page contained ques-
tions on the lifetime prevalence of cancer (with infor-
mation on site and year of diagnosis) and the frequency
of meat consumption. Subjects who ate little or no meat
at baseline (0-1 day/week) were also asked to state the
year in which they started this habit. The cohort in-
cluded 656 colorectal and 1,894 self-reported prevalent
breast cancer patients.
The relation between meat consumption frequency
and the prevalence of both colorectal and breast cancer
was analyzed in a nested case-control manner using the
prevalent cases of both sites; the control group was
formed by the 4,701 subjects without cancer from the
mentioned subcohort of 5,000 subjects. First, the "cross-
sectional" association between meat consumption fre-
quency and cancer prevalence, both at baseline, wat
determined while controlling for age (5-year group*) in
a stratified analysis. This analysis was followed by a
"longitudinal" analysis in which the timing of exposure
and disease was also taken into account. Analyses were
earned out for men and women separately. Because it
402
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TABLE 1 • Prevalence Odd» Ratio» between Frequency of Meal Consumption and Cancer in Crou-xctiocul Analyae*
Tumor Site
Colorecwl
BNK
Sex
m
f
f
Meat Consumption
(dayt/week)
0-1
2-4
5-7t
0-1
1-4
5-7»
0-1
2-4
5-7*
CMO
12
32
282
19
54
248
92
364
1,409
Control»
45
246
1.565
73
380
1.945
73
380
1,945
OR„„ (95% CD'
1.89 (0.98-3.63)
0.89 (0.61-1.32)
1.00
2.08(1.23-3.52)
1.13 (0.82-1.55)
1.00
1.75 (1.27-2.39)
1.32 (1.13-1.55)
1.00
t lUfcranu cattfory.
« u known for cohort memhen who consumed meat less
than twice a week in what year they started doing so, we
were ahle to determine for the prevalent cases with this
habit whether it indeed had preceded cancer diagnosis.
The longitudinal analysis was confined to those cases
who already consumed meat rarely before diagnosis.
Controls who consumed meat rarely were excluded ac-
cordingly when they had started this after the earliest
year of cancer diagnosis of the cases in their respective
age-sex stratum. It was considered unlikely that cases
would start eating meat more often after their diagnosis;
therefore, the exposure category 5-7 days/week meat
consumption is assumed to be constant over time. Be-
cause the stability of the category 2-4 days/week meat
consumption is unclear in this respect, it is omitted from
the analysis. Confidence intervals for Mantel-Haenszel
odds ratios were calculated using the formula of Robins
et al (22).
Results
The cross-sectional analysis, in which timing of expo-
sure and disease was ignored, revealed a positive associ-
ation between infrequent meat consumption and cancer
prevalence in both sexes (Table 1).
For the ensuing longitudinal analysis, it was found
that only 12% of the 31 colorectal and 26% of the 92
breast cancer cases who consumed meat 0-1 Jays/week
at baseline exhibited similar behavior before diagnosis.
Since all these cases were female, we were unable to
determine which male controls were to be excluded in
the stratified analysis. Consequently, longitudinal odds
ratio estimates could not be calculated tor men. For
women, the longitudinal analysis now shows an inverse
association between infrequent meat intake and colon
cancer, while there is essentially no association with
breast cancer (Table 2).
Discussion
The results of the cross-sectional and longitudinal anal-
ysis are in contrast with each other, especially for colon
cancer. The odds ratios from the longitudinal analysis
for female colorectal and breast cancer (0.51 and 1.17,
respectively) are within the range ot values round in
other studies (14,17-19) based on incident cases. To
investigate whether dietary habits change because of the
presence of cancer and what effect this might have on
odds ratio estimates, one would ideally conduct a pro-
spective cohort study with baseline dietary assessment
and then interview incident cases again after diagnosis
about their current and prediagnostic diets. Our results
are limited because we had to use prevalent cases for this
analysis.
The use of prevalent cases in a longitudinal analysis is
problematic when the exposure also acts as a prognostic
factor (23). For breast cancer, a high fat intake was
found to be weakly associated with a worse prognosis
(24). If, for breast and colorectal cancer, a high meat
intake were also related to a declined prognosis, it would
imply that prevalent cases eating meat rarely are over-
represented. Under these circumstances, the observed
longitudinal odds ratios would be biased towards a pos-
itive association, which cannot explain the low odds
ratio for colorectal cancer.
The estimates might also be confounded, for example,
by fat intake and reproductive variables; such confound-
ing, however, did not explain the relation in various
other studies (14,17,19). This possibility will be inves-
tigated in detail in the prospective part of the cohort
study that incorporates incident rather than prevalent
cases (21). Moreover, the type of meat and portion sue
will also be considered then, since the complete dietary
questionnaire is ot a semiquantitative nature.
Because prevalent cases are not ideal for studying the
Epidemiology September 1990, Volume 1 Number 5 403
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TABLE 2.
Tumor Site
Colorectal
Breast
Prevalence Odds
Sex
ft
f
Rarioa between Frequency
Meat Consumption
(dayi/week)
0-1
5-7*
0-1
5-7*
of Meat Consumption and Cancer
Cat»
3
248
19
1.409
Controls
49
1.945
24
1.945
In Longitudinal Analyses
ov«<mc.r
0.51(0.16-1.63)
1.00
1.17(0.63-2.17)
1.00
' Adjusted for age.
t No estimates for men available (see text).
t Reference category
etiologic role of this type of exposure, no great impor-
tance should be attached to the absolute values of the
odds ratios reported here. Nevertheless, this analysis in-
dicates that, for colon cancer, the direction of the as-
sociation might be reversed when cross-sectional instead
of longitudinal analyses are performed. For breast can-
cer, the positive association largely disappeared when a
longitudinal analysis was done. These data indicate that
the presence of cancer may result in a change of dietary
habits, and they confirm the limitations of truly cross-
sectional studies for etiologic inference. As mentioned
earlier, data in some studies with a presumably longitu-
dinal design may to some extent be cross-sectional. We
believe that the quantification of this problem and its
implications for bias warrant further study.
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Chapter 10
Stratified and simple regression methods for the analysis
of case-cohort studies*
Alexander Voiovics', Piet A. van den Brandt*.
Abstract
Case-cohort and nested case-control sampling methods have recently been introduced
as a means of reducing cost in large cohort studies. The asymptotic distribution theory
results for relative rate estimation based on Cox type partial or pseudolikelihoods for
case-cohort and nested case-control studies have been accounted for. However, many
researchers use elementary (stratified) methods for a first or primary summarization
of the most important evidence on exposure-disease or dose-response relationships, I.e.
the classical Mantel-Haenszel analyses, trend tests and tests for heterogeneity of
relative rates, which can be followed by exponential failure time regression methods on
grouped and individual data to model relationships between several factors and
response. In this paper we present the adaptations needed to use these methods with
case-cohort designs, illustrating their use with data from a recent case-cohort study on
the relationship between diet, life-style and cancer.
Submitted for publication
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1 Introduction
The germs of the ideas of nested case-control and case-cohort sampling from a cohort
can be found scattered through the statistical and epidemiological literature of the 60's
and 70's. In the failure time context Thomas (1) appears to have first comprehensively
formulated the nested case-control approach while Prentice (2) proposed the case-
cohort design as a more efficient solution, in some situations, to sampling cohort
subjects than the nested case-control sampling design.
The general approach to nested case-control sampling involves the selection of a
random sample without replacement of subjects at risk but without disease (control
subjects) at each distinct failure time (every time a case is observed). Selected controls
remain eligible for control selection at other failure times. The control selection
procedures at distinct failure times are statistically independent. Relative rate
estimation can be based on a Cox type partial likelihood approach. Curiously this
approach has only recently been theoretically justified by Goldstein and Langholz (3).
When studying a range of disease endpoints this design can pose logistical and
administrative problems as a different random sample of controls has to be selected
each time a specific endpoint is observed. Furthermore, collecting and processing of
covariatc information on controls can only start at the time of the first failure and all
covariate information will only be available at the end of the study period.
The case-cohort design avoids these problems by selecting a subcohort randomly from
the entire cohort which then provides a comparison group at each disease occurrence
time, i.e. those subjects in the subcohort still at risk for the disease under study at a
given failure time function as controls for the occurring failure whether that failure
occurs 'inside' or 'outside' the subcohort. This design allows the comparison group to
be selected in advance of cohort follow-up, a distinct advantage since the subcohort can
then be used, for example, to monitor the achievement of intervention goals and the
collection and processing of covariate information for all controls (the subcohort
members) can be started immediately on inception.
Also, in contrast to the control sample in the time-matched nested case-control design,
the subcohort provides a natural comparison group for a range of disease endpoints.
Prentice (4) provided heuristic justification for relative rate regression analysis based on
a pseudolikelihood approach. Full theoretical justification for the proposed methods
was presented by Self and Prentice (5). Readers interested in further methodological
details regarding the above and other similar designs can consult various references
(2,4-11).
We will concentrate here on procedures for the analyses of case-cohort studies. The
organization of this paper is as follows: §2 presents a heuristic introduction, §3 presents
necessary preliminary calculations and notation, §4 contains the adaptations for the
elementary (stratified) methods, §5 contains the adaptations for exponential failure time
regression, §6 contains an illustration of the procedures in a case-cohort analysis of
smoking and lung cancer. In §7 we discuss the procedures and the two approaches:
'blow-up' and 'shrink'. All formulas that will be presented were programmed in GLIM-
code; these macros are available upon request.
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2 Heuristic introduction to case-cohort analyses
The elementary analysis of cohort studies and Poisson regression for grouped data are
comprehensively described in Breslow and Day (12), chapters 2, 3, 4 and 5, to which we
refer for standard formulas and practice. 'Poisson' regression for individual data is
described in Aitkin et al. (13), chapter 6.
The results of a cohort and case-cohort study with only two exposure groups can be
summarized as in table 1, a and b.
Table 1. Summarized results of a cohort and case-cohort study involving a dichotomous exposure.
a. Cohort study b. Case-Cohort
Exposure Observed Person years Observed Person years
failures failures
Failures Censored Total Failures Censored Total
1 ««1 «di 'ci ' i «*, tj, t„, I,
2 d> to U u d, U t_i I,
The notation t^ , t„, t^ in table 1 indicates person years for failures, for censored
individuals and for censored individuals in the subcohort only, respectively. Censoring is
due for example to ending of follow-up, withdrawals or competing causes of failure.
Assuming a constant failure rate during the study period the failure rate A., for exposure
group i in the cohort study can be estimated as i, = d/t,, the number of observed cases
divided by the total person years of exposure in group i, i = 1,2. The relative rate f of
exposure 2 versus exposure 1 can be estimated as • = ÜyÜ., = djt/ditj. It will be
intuitively clear that the analogous statistic djij/d,ij in the case-cohort set-up should in
general not be used to estimate the relative rate. The person years of the failures is the
same in both studies but the person years of the censored individuals in the case-cohort
study is a random sample from the censoring times in the cohort study. If the sampling
fraction is p = m/n with m denoting subcohort and n cohort size, we can expect that
t^ « pt^ . Thus djti/djtj « dj(t,,, + pt,.,)/d,(t,,2+pte2) and this will in general not be close
to djt,/d,tj.
Two solutions present themselves:
a. 'Blow-up' the person years of the censored individuals in the case-cohort study by a
factor p~\ that is to say use t^+p"'t^ •> tj instead of I,.
Using the 'blow-up' method we estimate f by
b. 'Shrink' the person years of the failures by a factor p, i.e. use
ptdi+tid instead of !<. The same effect could of course be accomplished by using
only the total person years of subcohort members, namely t,j = t^+t^ where t^ is
the observed person years for failures in the subcohort only: t^  «• pt,. Using the
'shrink' method we estimate f by ^ = ^
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It is important to note that the 'blow-up' method gives direct estimates of the exposure
specific failure rates, namely A.," = d/(t,,,+ p~'t^) « A.;. With the 'shrink' method we
cannot use the analogous estimator for the exposure specific rates because
d/t,, «- P 'd/t, = p 'X,. The obvious corrected estimator for A; is pd/t,j. We shall also
say that the 'shrink' method estimates blown-up exposure specific rates u^  = p"'Xj with
estimators jii, = d/t,,; to estimate the A, we have to 'shrink' jij by the sampling fraction:
Confidence intervals for f are usually calculated using estimated asymptotic variances
of log f. Concentrating for the moment on the 'shrink' approach we have:
log •* - log{djt.,/d,U
- log<djt,/d,tj} + <log(t»-log(t^/m)}-{log(t,/n)-log(t,,/m)}
- log f + D*. say.
This equality illustrates 2 things.
Firstly, if a suitably normalized version of D* converges in distribution to a
nondcgcncratc random variable, then as was to be expected, f* will be an inefficient
estimate of f compared to f, having a larger asymptotic variance (AV): namely
AV(log •") = AV(log t ) + AV(D*). (It can be shown that * and D* are asymptotically
independent).
Secondly, given the n individual failure times constituting the t,, i=l,2, the variance of
D" is due to random sampling of m failure times from the finite population of cohort
failure times and in estimating the variance of log f* this extra finite sampling
variability will have to be accounted for. This means that 'naive' estimators for
AV(log ijr") calculated analogously to the estimator for AV(log +) will underestimate
the true AV and should not be used. Analogous reasoning can be used to show
comparable results for i>".
In the classical situation where a Poisson distribution is assumed for the number of
failures in each cell of a table determined by stratum and exposure group combinations
or an exponential distribution is assumed for the individual failure times (see Breslow
and Day (12)), it can be shown that the Mantel-Haenszel test, the test for trend and the
test for heterogeneity of relative risk are asymptotic approximations of finite sample
uniformly most powerful unbiased tests. The Mantel-Haenszel estimator (which can be
derived as a weighted combination of stratum specific relative risks, as the first iteration
of the maximum likelihood estimator or via an estimating function approach), is a
consistent estimator of the relative rate. Even though it is not generally mentioned, the
classical set up can accommodate multiple 'failures' per individual. If it is suspected that
the failure rate does not remain constant during the study period, or to accommodate
time dependent exposure, the time axis can also be stratified, assuming a constant
failure rate on each stratum. In the classical set up censoring not due to ending of
follow-up must, just as failure, be a very rare phenomenon to justify the Poisson
assumption.
In adapting the simple methods for case-cohort sampling we will at the same time
assume a more general set up than in the classical situation, namely: a piecewise
constant failure rate, possible recurrent events (multiple 'failures') per individual,
independent censoring and possible left-truncation. The assumption of independent
censoring roughly means that at any time t the survival experience in the future is not
statistically altered (from what it would have been without censoring) by censoring and
survival experience in the past. This is the most general assumption possible with
respect to censoring (14). Left truncation, in the simple form of only including subjects
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conditionally on being alive (not having failed) at a certain given calendar time or age,
is quite common to cohort studies. These assumptions should guarantee applicability of
the methods and reliability of the analysis results for most types of cohort studies
whatever being the dynamics driving the process (subject of course to the accuracy of
the asymptotic approximations). Under these conditions the adapted Mantel-Haenszel
estimator remains a consistent estimator. However the tests have only 'large sample',
i.e. asymptotic optimality. Full details concerning all results are presented by Volovics
(15).
3 Organization of the data
In the classical set up, calculation of the above-mentioned elementary statistics and
regression analyses are based on a tabulation of observed failures d^ and person years
t^  by stratum (j=l,2,..,J) and exposure group (k=l,2,..,K) (e.g. table 3.4 in Breslow and
Day (12)). The J strata might be determined by one factor such as age or by an
amalgamation of two or more variables such as for example age and sex. The K
exposure classes can also result from the amalgamation of two or more exposure
variables.
In the case-cohort set up a similar table can be made substituting for cohort person
years t^ either 'blow-up' person years t ^ + p ~ ' t ^ or 'shrink' (subcohort) person years
V = djk+W' k°th of which we shall simply denote by t^ too. Such a table contains
sufficient information to calculate the Mantel-Haenszel estimator and the chi-square
heterogeneity tests. To calculate standard errors, the Mantel-Haenszel test and the
trend tests, however, some further quantities are needed, namely a stratum-exposure
specific (cell-specific) variance for which we have two possible estimates: vl^ or v2^.
Given cell-specific rates, 0^ say, vl^ (or v2^) is an estimate of the asymptotic variance
of the cell-specific 'residual': d^ — 9^t^ (observed minus 'expected' failures). The vl^ (or
v2^) are needed because all statistics discussed in this paper are functions of these cell-
specific 'residuals' so that their asymptotic variances are also functions of these cell-
specific variances (see appendix for more details). In the classical set-up v2^ = ê^t^,
where 9^ is the maximum likelihood estimate of 0^. All these quantities are
summarized in table 2 where again, just as with the t^, we have used one symbol
(vl^, v2^) to denote quantities that are calculated differently depending on whether a
'blow-up' or 'shrink' approach is used. We shall comment on a possible choice in the
discussion, d^ always stands for the total number of observed stratum-exposure specific
failures, whichever approach is used.
To indicate how the table entries are calculated we present formulas for a basic study
design with simultaneous entry of all cohort members at the starting date, a constant
hazard rate for the duration of the study period, one type of nonrecurrent failure and
no time dependent exposure. Amendations to the formulas on departure from this basic
design are essentially self evident; details are presented by Volovics (IS). The total
number of individuals in the case-cohort study itself is n = m + the (random) number
of subjects failing, for the failure type under study, outside the subcohort.
For each individual i in the case-cohort study u,,, x*. s, and d, are indicator variables
defined as follows: u,, = 1 if subject i is in stratum j and 0 otherwise, x* = 1 if subject i
is in exposure group k and 0 otherwise, s, = 1 if subject i has been selected for the
subcohort and 0 otherwise and d,= l indicates if subject i has failed while d, = 0
indicates if subject i was censored. The reference exposure category will always be
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coded 1; thus x,, = 1 indicates that subject i is in the reference exposure group. For
each individual i in the case-cohort study t, is the person years of observation.
The classical elementary methods all assume an underlying relative or multiplicative
rate model, i.e. 0^ = A.^, where A., = 0,, ( f , = l ) is the rate for individuals in the
baseline or nonexposed category ( k = l ) in stratum j . ^ will denote a Mantel-Haenszel
or maximum likelihood estimate of the relative rate of failing in exposure group k as
against failing in the reference exposure group 1; thus »), = 1 always. A, (= &V,) denotes
a maximum^ likelihood estimate of the stratum j specific failure rate for the reference
exposure category. B or S attached to the formula number will indicate whether the
'blow-up' or 'shrink' version is being presented. The cell-specific number of failures
(dp), person years (t^) and variance estimates (vl^ and v2^) are calculated as follows:
Table 2. Summarization by stratum and exposure level of basic quantities needed for the elementary
statistical analysis of casc-cobort studies assuming either a 'blow-up' or 'shrink' approach.
Stratum Exposure Failures Person years Variance 1 Variance2
1 1 d,, I,, vl„ v2„
2 d,j I,, vl,j v2„
1 dj, t„
2 d^ ta
K
1 dj, t„ vlj, v2j,
2 d,2 t„ vl„ v2„
( 3 2 B) t ^ - f u ^ [d,*p-» (i-dj) s j t
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(3.2 S)
(3.3 B)
(3-3 S)
(3.4 B)
(3-4 S)
The estimates ^ and A., in formulas 3.3 B, 3.3 S, 3.4 B and 3.4 S will be specified below
when needed. In the following 2 paragraphs all formulas are expressed in terms of the
quantities d ,^ t^  and v^ where v^ stands for either vl^ or v2^ depending on which cell-
specific variance estimate is used. For the 'blow-up' and 'shrink' approach the quantities
3.2 B, 3.3 B (or 3.4 B) and 3.2 S, 3.3 S (or 3.4 S) are to be used, respectively.
4 Case-cohort adaptations for elementary (stratified) methods
4.1 The Mantel-Haenszel estimator
Given table 2 and a fixed exposure group k the Mantel-Haenszel estimator ^ for the
relative rate tk °f failure in exposure group k with respect to failure in the reference
exposure group is just the well known formula:
(••1) t > - *
with relevant quantities from table 2 plugged in. The asymptotic variance of the
logarithm of f ^ can be estimated by
(4.2)
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where ^ is the above Mantel-Haenszel statistic, ^ = (dj, + d^)/(tj, + • ^ and
naturally these same ^ and i, are used to calculate v-, and v .^
If we plug in the classical estimates v2,, = ijt,, and v2^ = •k^,V ^>*" formula 4.2
reduces to the classical estimate of AV(log^).
If we substitute v2^ for the v ,^ formula 4.2 can be expanded as
v^« -2 j Ü—Is + (1-p) i l i — j Ü—If
with 'blow-up' q
or 'shrink' <ïjk'E
The reader will recognize the classical estimator of the asymptotic variance of the
logarithm of the Mantel-Haenszel estimator in the first term. We have written this
formula as a sum of two terms to illustrate again that plugging the relevant quantities
from table 2 into the classical formula would give an underestimate of the asymptotic
variance even though the second term will in general be small; see the example in §6.
4.2 The Mantel-Haenszel test
We will present the Mantel-Haenszel test for the hypothesis 1^=1 for a given exposure
category k with respect to the reference category 1 in the one degree of freedom chi-
square form: NUM^/DEN^ with
j
l=i
(4-3) HUM,
Use A., = (dj, + d,J/(t,, + t,j) and ^ = 1 to calculate 4.3 and v,, and v^ in (4.4). If we plug
in the classical estimates for v2^ and v2^ then (4.4) reduces to the classical variance
estimator.
4.3 Trend tests
Trend tests are usually presented in their one degree of freedom chi-square form,
namely: N U M V D E N . For the test for trend in the stratum specific rate ratios given a
certain exposure category k we have:
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= V
and
(4.6)
where the z^  are quantitative variables representing the level of a stratum defining
variable, for example the age level in age stratum j. Here Ü, and ^ arc maximum
likelihood estimators under the null hypothesis of no trend: A., = (d,, + d^)/(tj,+ ^t^) and
ft can be obtained as the iterative solution to the equation:
•> t T ^ H t
Pi ^n Tk^ jk pi
or by fitting a regression model (§5).
See Breslow and Day (12, pages 110 and 111) on using the Mantel-Haenszel estimator
instead of the maximum likelihood estimator. (The Mantel-Haenszel estimator is the
first step iteration of the maximum likelihood estimator obtained by substituting 1 for
f i on the right hand side of the above equation in i|r J.
The test for trend in relative rates with increasing exposure has:
k - l
and
Here, in (4.7) and the calculation of the v^ in (4.8), we take f t = l and
k - l k - l
the maximum likelihood estimator of the stratum specific failure rate under the null
hypothesis of no trend across exposure. The x^  are quantitative variables representing
exposure levels. Again plugging in the classical v2^ in (4.6) and (4.8) results in the
classical variance formulas.
4.4 Tests for heterogeneity of relative rates
To test for a general difference among the rate ratios in the J strata or to test the
global null hypothesis that failure rates for none of the K exposure classes differ (that is
•k=l for k=l,2...,K) the usual chi-square tests can be used. The classical chi-square
tests remain chi-square with the usual degrees of freedom on substituting the relevant
case-cohort quantities from table 2 in the formulas.
To test for a general difference among the rate ratios in the J strata we can use:
(4.9) ,2 - V (dji-Xjtji)' ^ (djfc-+fc*jtjfc)*.
1 r e l l" ^ *• f 1- * A i t-
Pi Xjtjj ^^Ajt.j,
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where ft and A., = (d,,+d^)/(tj, + ^ ^ are the same maximum likelihood estimators used
in formulas (4.5) and (4.6).
To test the global null hypothesis that f t = l , k=l,2,...,K we can use:
with •>= land
Both statistics have asymptotic chi-square distributions with J-l and K-1 degrees of
freedom, respectively.
However, the test (4.10) for the null hypothesis ^ = 1 , k«l,2,...,K is conservative
compared to the score test for the same hypothesis (see ref. 12, page 114). The formula
for the score test is, using notation as in Breslow and Day (12):
(4.11) xi-i=<O-E)*M-MO-E)
and this statistic has an asymptotic chi-square distribution with K-1 degrees of freedom.
O is a K-1 dimensional vector (Oj, Oj, ..., O*)* with components
i* . k - 2 . 3 K
E is a K-1 dimensional vector (E,, E„ ..., E*)^ with
* j t j k , k = 2 , 3 K
M is a (K-1) by (K-1) dimensional matrix that can be represented as a sum of J (K-1)
by (K-1) dimensional matrices
- 1
Each matrix M, has diagonal elements v^Vj-v^/Vj (with k=2,3,...,K) and off diagonal
elements - v ^ v ^ (with 2^k^K and 2s lsK) , with Vj=S v^ where the summation is
over k from 1 to K.
The Et and the v^ are calculated using ^ = 1 and
- l
Plugging in the classical v2^ again gives the classical formula for M.
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5 Regression methods for grouped and individual case-cohort data
In §4 we presented case-cohort set-up adaptations of the well known elementary
statistical methods. These methods presumed a summarization of the data in a two-
dimensional table with J rows, the strata, and K columns, the exposure classes. Each
cell of such a table contains the basic data: the failure counts d^ and the case-cohort
equivalents of the person years denominators t^ . The stratification variables will in
general be nuisance factors known to have an effect on the baseline rates but with only
secondary importance. The real problem is to describe the effects of the exposure
variables, and their possible modification by the effects of the stratification variables, in
explicit detail.
Regression analyses offers a more versatile approach than these elementary methods
and is easily initiated by adding to the basic data (d ,^ t^ ) in each cell of the table a p-
dimensional row vector x^  = (x,i,, ... x,^ ) of regression variables. These may represent
either qualitative or quantitative coding of degree, intensity and/or duration of possibly
different exposure variables, nuisance (stratification) variables and interactions among
exposure variables and/or interactions between exposure and nuisance variables. The
goal of the regression analysis is to try to disentangle the separate effects of exposure
and nuisance variables, the x,,. ... x^ , on these rates by introducing different
parametrizations to represent possible effects. A number of structures have been
proposed for the rates of which the additive (excess) and multiplicative (relative) rate
models are the most common.
We shall here concentrate on the multiplicative rate model as this seems to be the
model that is by far the most frequently used. The multiplicative model implies that the
cell-specific rate
is an exponential relative rate function exp(x,u/3, + ...+x,,^?p) times a baseline rate
*o = exp(B„) where x,„ stands for (l,x,k„ x^, ..., x , ^ .
Other structures are discussed by Volovics (15).
Given a data matrix as above, regression analysis can be based on a 'pseudo partial-
likelihood' function. For example, for the 'blow-up' approach:
L ( P ) = L ( P O , P I Pp) = n
where A.^=exp(x^) and the d^ and t^  are taken from table 2.
The expression is a pseudolikelihood because it does not represent the 'likelihood' of
the data given the sampling design (it does exhibit properties more or less similar to
those of a proper likelihood function) and it is a partial likelihood because it does not
contain a factor describing the conditional distribution of censoring or the distribution
Using the formal resemblance of the pseudolikelihood to a likelihood for a Poisson
process, any software package with facilities for Poisson regression can be used to
estimate 6 and to test hypotheses with respect to B (likelihood ratio, score or Wald
tests). However, as will be clear from the presentation of the elementary methods
above, the estimate of the asymptotic covariance matrix of the estimator for B will have
90 Chapter 10
to be adapted to account for case-cohort sampling. To calculate the case-cohort
adapted estimate of the asymptotic covariance matrix we need quantities v^ (analogous
to the v^ specified in table 2) using formulas (3.3) or (3.4) but with i^ = exp(Xj/6),
C the maximum likelihood estimate of 6, substituted instead of the I, and ^ from the
elementary analyses situation. This means that after estimating 6 from the grouped data
we would have to go back to the data on the individual level to adjust the covariance
estimates or to prepare in advance a table containing other (and more) quantities than
the V;t. This does not seem very practicable and we will therefore only present
exponential failure time regression analysis for data on the individual level. (Grouped
data analyses can then easily be accomplished by defining dummy variables or scores for
levels of strata or levels of exposure variables).
The analyses are based on a pseudo partial-likelihood function for the individual data
with individuals denoted by i (i=l,2,...,n), which we present separately for the 'shrink'
and 'blow-up' approaches:
L ( p ) - fi u?'
(5.1 S) i-i
(5.1 B) L ( P > - f i (A^e•*''•>*'(e•*'"•*•>'"'"-*'»
i-l
with d;, t, and s, as in §2, u.j=p~'Aj, Aj=exp(x^/3).
When using the 'shrink' likelihood one should keep in mind that given
A, = exp(/3„+X|i/3, + ...+Xip/3p) this approach always estimates
u,j=p~'A,j = exp(«o+Xj^?| + ...+x^p) with a„ = B„—logp: the baseline failure rate exp(/J<,)
is 'blown-up' to p~'exp(/3„) = exp(a„). The relative rates exp(XjjBj), however, are
correctly estimated, see the heuristic argument in §2.
Any software package with facilities for exponential failure time regression or, in some
cases, Poisson regression or nonlinear regression, can be used to get a maximum
likelihood estimate /) of B and thus an estimate A., of X; (13). Likelihood ratio tests for
hypothesis about B or B components are also easily calculated. For confidence intervals
or for Wald or score tests, however, the case-cohort adapted estimates of the covariance
matrix of 6 will be needed. Software with macro or programming facilities and matrix
operations will be needed for this. GAUSS, GLIM, S, and SAS with IML for example,
are excellent. Let X stand for the n by (p+1) data matrix with rows Xj=(l, Xj,, .., x^ ,).
Let C stand for the covariance matrix of /) estimated by the regression program. Then
the estimate of the case-cohort adjusted covariance matrix can be written as CAC where
the matrix A is estimated differently depending on which approach, 'shrink' or 'blow-
up', is used. We will denote these estimates A^  and AR. Again just as in §3 we present
two estimates of A* and A,,, namely:
(5.2S)
(5.2 B) A l , » x
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(5-3 S)
(53B) ^ 2 B = X
where the notation Diag(w,) stands for an n by n matrix with w,, Wj, ..., w, on the
diagonal and the off-diagonal elements equal to 0. The matrices Al and A2 contain the
equivalents, in the context of regression based on individual subjects, of the vl^ and v2^
introduced in §3. The vl^ and v2^ can in principle be calculated through Al and A2
after defining relevant likelihood functions based on stratum-exposure specific rates and
using a data matrix X containing variables to define strata and exposure.
If it is suspected that the failure rate is not approximately constant for the study
duration it is advisable to fit a piecewise exponential distribution to the failure times.
This is achieved by choosing a set of time points a,<aj<...<aL_, with 0=8o<a, and
aL_,<a, = oo or a, =T with T the maximal possible observation time for any individual
under study. In each interval (a,.,, a,] we model an individual hazard function A.,(t) as a
constant A.,,. Given a multiplicative rate model as used above, this means defining a
piecewise constant baseline failure rate common to all subjects i.e. A.o, = exp(/j„) on
, , , ,
Then we have as individual failure rate A.>, = A.^  exp(x//J) = exp(/3o<+*//?)• Note that
the 'shrink' approach estimates a blown up baseline failure rate on each interval
a,_,<t2ïa„ namely n«=P~'expOw) = exp(/3„-logp) = exp(a„)-
If we consider failure for each interval (a,.,, a,] separately, then the i-th subject
experiences a sequence of censorings at a,, a^ ,... until final censoring or failure at t,
defined to fall in the L-th interval, so that a^-i^Sa^.
Define for every subject a sequence of failure indicators d,,, d,j, ..., d,^  with d,,=0 for
ls€<Lj and d,,^=l or 0 depending on whether i failed or was censored at tj and a
sequence of failure (exposure) times tj,, t^ , ..., t^ with t,,=a,-a,_, for l s£<L, and
t*u=t,-au-i-
When the 'blow-up' approach is being used it is easiest to blow-up failure times of
censored individuals (d,=0) beforehand, i.e. to use p"'t, instead of t,. Then L, is defined
by a^_,<p"'t,<a,^. The d,, and t,, for such individuals are adapted accordingly.
Then the pseudolikelihood functions (5.1 S) and (5.1 B) become:
(5.4 S) up) -fi ïi
ii ii-i i-i
i(5.4 B) UP) = H i  (A e'*"'")'"<e"*"*''")"'*"'
i-l 1-1
The pseudolikelihood for the 'blow-up' approach (5.4 B) is written without an exponent
p~' in the second factor here (compare (5.1 B)) because the t,, are defined using p'tj.
To fit such piecewise exponential models, the data matrix has to be augmented to
contain L, rows for each individual i (see Aitkin et al. (13), section 6.22). This means
that the total number of data matrix rows equals L
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If L; and n, are at all large this might pose problems for some software packages and
machines, and also the computation time might become prohibitive. When fitting the
regression model based on (5.4 S) or (5.4 B) we treat each row of the augmented data
matrix as an independent subject and proceed as if fitting the models (5.1 S) or (5.1 B).
The necessary adaptations of the covariance matrix estimates for case-cohort studies are
easily obtained with formulas (5.2 S) to (5.3 B), replacing X by the augmented data
matrix of size L by (p+ 1) and d,, t,, X,, |I, by d,,, t,,, A.,,, (1,,. For further details on fitting
pieccwise exponential distribution models and also on fitting time-dependent covariates
(which follows the same procedures) see Aitkin et al. (13), sections 6.15, 6.16, 6.17 and
6.22.
6 Illustrative analysis
The data for this illustration come from a prospective cohort study on diet, life-style
and cancer that was started in the Netherlands in 1986. The cohort included 58,279
men and 62,573 women aged 55-69 years at the start of the study. At baseline, cohort
members completed a self-administered questionnaire on dietary habits, potential
confoundcrs and other independent risk factors for cancer such as smoking habits,
occupation and education. Following the case-cohort approach, a subcohort of 3,500
subjects was randomly sampled from the cohort after the baseline exposure
measurement. The subcohort has been followed up biennially for vital status
information in order to estimate the accumulated persontime in the cohort (16).
Incident cancer cases occurring in the cohort have been identified by record linkage to
cancer registries and a pathology register (17). This illustrative analysis pertains to the
lung cancer incidence in the recently completed 3.3 year follow-up period. In this
period a total of 617 cases of lung cancer were detected in the total cohort of 120,852
subjects. After excluding incident cases with in situ carcinoma, cases whose diagnosis
was not microscopically confirmed and cases who reported a history of cancer other
than skin cancer in the baseline questionnaire, 552 incident cases of lung cancer were
available for analysis. After excluding prevalent cancer cases other than skin cancer
from the subcohort of 3500 as well, 3346 subjects remained in this group.
For this illustration, the relationship between smoking habits (categorized as
never/ex/current smokers) and lung cancer risk was analyzed with the proposed methods
of case-cohort analysis. To be concise, we only present results here on relative rate
estimation, confidence intervals, Mantel-Haenszel tests and test for trend in relative
rates across exposure categories. In the stratified analysis, we stratified for gender and
age (in three five-year categories). This was followed by relative rate regression analysis
using the individual data, while adjusting for gender and age (again in 3 categories for
reasons of comparability with the stratified analysis). All analyses were conducted using
the 'shrink' method and the 'blow-up' method of estimating the person years. Table 3
shows the basic quantities that were computed for the stratified smoking-lung cancer
analyses. In this table (with the same format as table 2), the quantities for the 'shrink'
and 'blow-up' method have been specified.
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TaMe 3. Grouped data
Stratum
Ü)
1 (55-69 y, men)
2 (55-59 y. women)
3 (60-64 y. men)
4 (6044 y, women)
5 (65-69 y, men)
6 (65-69 y, women)
for stratified
Eipoiure*
00
1 Never
2Ex
3 Current
1 Never
2 Ex
3 Current
1 Never
2 Hi
3 Current
1 Never
2 B
3 Current
1 Never
2Ex
3 Current
1 Never
2 L i
3 Current
analysis of c
Failure*
«1»)
0
32
87
0
3
16
1
51
119
6
4
12
6
63
124
7
4
10
MC-cohort
Shrink n
Person
yean
(V
209
925
873
1092
490
545
167
854
787
1151
338
392
136
722
556
1083
269
217
study on
method
Vahana
am
35.08
113.61
0.00
3.02
17.10
1.02
60J5
174.26
6.09
4.27
13.66
6.87
8157
213.96
7.15
4.34
12.03
smoking and lung cancer.
Ett Varianee2t
c y
000
33J3
111.43
0.00
1.91
14.56
1.02
58J2
17314
6.10
5.52
15.77
6.84
84.72
218.57
7.14
5.65
13.59
Blow-up method
Person
yean
7227
31920
30195
37710
16925
18846
5765
29564
27154
39692
11678
13562
4705
25028
19092
37420
9279
7504
Variance I t
(vl»)
am
3513
113.17
am
3.02
17.05
1.02
59.99
174.05
6.10
4.26
13.61
6.84
S I M
215.38
7.14
4.33
11.96
Variance^
000
33.32
111.31
0.00
1.91
14.56
1.02
58.46
172.87
6.10
5J2
15.78
6.84
84.56
218.51
7.14
5.64
13.60
*) Smoking categories.
t) Cell specific variances used for Ibe estimation of the variance of the Manlelllaenszel relative rale.
In table 4 (panel A), the results of the stratified analyses are shown for both the shrink
and the blow-up approach. As expected, the relationship between smoking and lung
cancer is very strong. Compared to never-smokers, the Mantel-Haenszel relative rate
estimates for ex-smokers and for current smokers are 3.77 and 10.79, respectively, using
the shrink method. The RR estimates obtained with the blow-up method are virtually
identical.
The 95% confidence intervals shown are constructed using the first variance estimates
(formula 4.2, using vl^). The first and second estimate of var(logRR„„) were very close
to each other: for the contrast between ex- and never smokers the two estimates of
var(logRR^H) were 0.0876 and 0.0889, respectively, while for the contrast between
current and never smokers these variances estimates were 0.0849 and 0.0831,
respectively (using the shrink method). Both relative rate estimates were significantly
different from 1: the Mantel-Haenszel x*-test values were 28.60 and 109.38 for the
respective contrasts in smoking habits (ex vs. never; current vs. never smoking). The x*-
test for trend was also highly significant. The variance estimates and x'-test values were
again similar when using the blow-up method instead of the shrink method.
Table 4 (panel B) also shows the results of the relative rate regression analysis with the
individual data. When an exponential distribution of failure times is assumed (i.e., a
constant hazard), the association between smoking status and lung cancer is estimated
essentially similar to the stratified analyses. (Again, the presented confidence intervals
are based on the first variance estimate (formula 5.2).)
Table 4. Result* of stratified analysis and relative rate regression analysis for case-cobort study on smoking and lung cancer.
Method No. of Shrink method
cases in
cohort
Person
years
subcohort
RR (95% CI) Test for trend
(p-value)
Blow-op mehod
Person RR (95% CI)
years
cohort
Test for trend
x' (p-valuc)
A. Stratified analysis
Never smoked
Ex-smoker
Current smoker
20
157
370
3838
3597
3369
1.00
3.77
10.79
(2.11- 6.74)
(6.10-19.11)
132516 1.00
200.57 (<0.001) 124392 3.77 (2.11- 6.73)
116356 10.81 (6.11-19.11)
201.92 (<0.001)
B. RR regression using individual data
Bl. Exponential model
Never smoked 20 3838
Ex-smoker 157 3597
Current smoker 370 3369
B2. Piecewise exponential model
Never smoked 20 3838
Ex-smoker 157 3597
Current smoker 370 3369
1.00
3.65 (1.74- 7.67)
9.79 (4.70-20.41)
1.00
3.64 (1.84- 7.20)
9.75 (5.00-19.01)
132516 1.00
216.18 (<O001) 124392 3.64 (1.72- 7.70)
116356 9.79 (4.65-20.63)
132516 1.00
216.14 (<0.001) 124392 3.63 (1.74- 7.59)
116356 9.78 (4.70-20.33)
217.21 (<0J»l)
217.21 (<0.001)
Analysis of case-cohort studies 95
It should be mentioned that we compare here the Mantel-Haenszel relative rate of the
stratified analysis with the maximum likelihood estimate of the regression analysis. Also,
the tests for trend are results from the score test and the likelihood ratio test,
respectively. As an aside, when unconnected variance estimates would have been used,
the 95% confidence intervals would have been more narrow, with limits (2.25, 5.93) and
(6.12, 15.66) for the respective exposure contrasts (with the shrink method). Again,
there is no difference in relative rate estimates, confidence intervals and trend tests
between the shrink and blow-up approach. When a piecewise exponential distribution is
assumed (with constant hazards per year of follow-up in the 3.3 year period), the results
are similar to the situation where an exponential distribution is assumed. Thus, the
assumption of a constant hazard during the 3.3 years of follow-up is justified.
In conclusion, the strong positive dose-response relationship between smoking and lung
cancer is reproduced in this case-cohort analysis. With two covariates in the model, the
stratified analysis and the regression analyses yield essentially similar results. The
advantage of the relative rate regression model using individual data is that it can easily
be extended to more covariates.
7 Discussion
Given the availability of GLIM-macros, the described case-cohort analysis methods
(which are adaptations of the standard tools of epidemiologie practice) arc easy to use.
We have chosen to analyze as an example data on the relationship between smoking
and lung cancer to demonstrate that these methods reproduce results close to the
relatively stable relative risks of lung cancer known for smoking exposure. Ideally this
illustration should have been complemented by simulation studies or by a comparison
of the results of a case-cohort analysis with those from a classical analysis of an original,
full cohort study, but we have not yet had the opportunity to attempt these time-
consuming activities.
There seems to be no clear reason for choosing between the 'shrink' and the 'blow-up'
approach. In the various exposure-disease relationships analyzed so far in our cohort
study on diet and cancer, the results of the 'shrink' approach and the 'blow-up'
approach are very close. It seems slightly more natural to use only subcohort person
years instead of the (crudely) estimated cohort person years but this subjective
preference is not reflected in the performance of the methods. With respect to the two
possible variance estimators for the asymptotic variances of the statistics (those based
on the vlj), (Al) and those based on the v2^ (A2)), the following can be mentioned.
Both variance estimators are consistent estimates of the same parameters and thus
asymptotically equivalent. We can only judge the small sample behavior on the basis of
the various exposure-disease relationships analyzed so far; the variance estimates based
on the v2,k (A2) appear to be somewhat more variable than those based on the vl^
(Al). Furthermore the agreement between the two methods is less than that between
the 'shrink' and the 'blow-up' approach. On the basis of results obtained so far we
suggest using variance estimates based on the vl^ (Al), but a definite conclusion will
have to await the results of simulation studies.
In the illustration we showed that the assumption of a constant hazard in the 3.3 years
of follow-up was justified, after comparing it with results from the piecewise exponential
model with a year-specific hazard. We used the years of follow-up as outpoints for the
piecewise modelling; a further refinement of the outpoints is possible, eventually
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resulting in cutpoints defined by the individual failure times. The use of such cutpoints
would result in estimates that are close to the estimates obtained by fitting a Cox
proportional hazards model (Aitkin et al. (13), sections 6.15 and 6.16). With a size of
the case-cohort study that we are conducting, the use of these detailed cutpoints would
computationally be very burdensome, however.
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Appendix
Proofs of all results mentioned in this paper can be obtained by applying the results of
Borgan (18) and Self and Prentice (5). Here we only sketch the ideas behind the
proofs, full details and formulations of necessary assumptions and conditions can be
found in Volovics (15). Given a cohort study comprising n individuals, J strata and K
exposure classes we have denoted the stratum-exposure specific failures and person
years with d^ and t^. When a case-cohort study is derived from this cohort based on a
sample of m of the n cohort members we shall denote both 'shrink' and 'blow-up'
stratum-exposure specific person years by t^. For the 'shrink' approach i^ = Xs,t, and
for the 'blow-up' approach t^ = X[d,tj+(l-d,)p.~'s,tj] where the summation is over all
individuals i in the stratum-exposure combination (j,k) and we here write p„ for the
sampling fraction m/n. Write 0^ for the stratum-exposure specific rates.
From a multivariate version of the martingale central limit theorem (e.g., ref. 19,
appendix I) it follows easily and under rather mild regularity conditions, that the
random vector with components n"^(d^-ö^t^ converges in distribution to a vector with
components which are independent and normally distributed with means zero and
variances 0 ^ , where it is assumed that n ' t ^ converges in probability to r^>0 (in short
notation: n ' t ^ — > p r,k). Writing 9^ for the maximum likelihood estimates of 0^ based
on a cohort study, it follows from the results of Borgan (18) that the random vector
with components n^(§^-0) converges in distribution to a vector with components which
are again independently and normally distributed with means zero and variances 0 , ^ .
If we parametrize 0,j as 0,i=A.,+k or 0,k=exp(a,+^) it again follows from Borgan (18)
that the vector with cohort study maximum likelihood estimates (A.,,....A.;,^,...,%,<) or
(a, a,,^,...J|() converges in distribution to a vector with a multivariate normal
distribution with mean vector 0 and a certain covariance matrix £.
The maximum likelihood estimators are in all cases consistent estimators of their
parameters. Returning for the moment to the rates 0^ we have for the 'shrink' approach
that
n (n
If it is additionally assumed that p„ --> p>0 and that rrT'l^ ~>p r^ and given some
further regularity conditions, then we have upon combining the martingale central limit
theorem and the results of Self and Prentice (5, proposition 1) that the vector with
components n~'''(d,j-p„~'0^t^) converges in distribution to a vector with components
which are independently and normally distributed with means zero and variances
0 ^ + p " ' ( l - p ) 0 . ^ a ^ where p~'(l-p)a* is the asymptotic variance of n^(n"'t^-m"'l^):
(1) ( n - ^ ( d j , - p ^ , t ^ ) ) -->„ N<0, ( 6 j , r , ^ p - ' ( l - p ) e j ^ ) )
The variances 0,kr,t+p~'(l-p)0^a^ can be consistently estimated by the quantities v2 .^
It can also be shown that, given the necessary conditions,
(2) lim ^ - p."
whence foDows that the variances
the vl^, the empirical 'covariances'
can be consistently estimated by
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Again combining Borgan (18) and Self and Prentice (5) we have also:
0 ) ( n ^ ( ^ - P ^ ) ) - - > , N ( 0 , ( P
pljk
where ji^ is the consistent case-cohort maximum likelihood estimator of p . " ' ^ .
Results like (3) can also be shown for the case-cohort maximum likelihood estimates
(A. A.J,^2.--.^K) ° ' (ÓTp--.aj,^ 2<'••^ K)< again using Borgan (18) and Self and Prentice (5).
The 'blow-up' approach can be treated analogously and we shall not repeat the results
here, see Volovics (15).
Now, for example, for the case-cohort Mantel-Haenszel estimator f (in the situation of
2 exposure classes denoted 1 and 2) we have ('shrink' approach):
from which, using the results with respect to the (d^-O^i^) above, it can be shown that
"*(•"""•) converges to a normally distributed variable with mean zero and a certain
variance which can be estimated by formula (4.2) and that i> is a consistent estimator of
f. As the Mantel-Haenszel test (4.3), the two trend tests (4.5) and (4.7) and the
heterogeneity chi-square test (4.11) can be expanded likewise, the convergence results
with respect to these statistics follow analogously. The 2 trend tests and the chi-square
test (4.11) can also be obtained as score tests given a relevant case-cohort likelihood
function and then the convergence results and the relevant variance estimator can also
be obtained from the pseudolikelihood function results mentioned below. The
asymptotics of the two remaining chi-square tests (4.9 and 4.10) can also be established
by expressing these tests as functions of the (d^—ö^t^) and following reasoning as in
Lehmann (20, chapter 7).
Given pseudolikelihoods like (5.1 S) or (5.1 B) where A.j=exp(x^/3) it is only a slight
generalization of the foregoing to show, again combining Borgan (18) and Self and
Prentice (5) results that the case-cohort maximum likelihood estimator # is a consistent
estimator of ^ and that n''(/)-/3) is asymptotically normally distributed with mean vector
0 and a covariance matrix S which can be consistently estimated by CAC as specified in
§5. The two estimators 5.2.1a versus 5.2.1b for example, for the same asymptotic
covariance X can be explained by reasoning like that given above with respect to
formulas 1 and 2. The estimator 5.2.1b can also be derived using an estimating function
theory approach. Standard asymptotic theory can be used to justify Wald, score,
likelihood ratio tests and confidence intervals.
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A prospective cohort study on dietary fat and the risk of
postmenopausal breast cancer*
Piet A. van den Brandt', Pieter van 't Veer^, R. Alexandra Goldbohm''*,
Elisabeth Dorant', Alexander Volovics\ Rudolph J.J. Hermus^, Ferd Sturmans'.
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Abstract
In 1986 a prospective cohort study on diet and cancer was started In the Netherlands
among 62,573 women aged 55-69 years. Baseline information on diet and other risk
factors was collected with a questionnaire. Cancer incidence was measured by record
linkage with cancer registries and a pathology register. A case-cohort approach was
used, in which the accumulated persontime in the cohort was estimated by follow-up of
a randomly selected subcohort (n= 1,812). After 3.3 years of follow-up, 471 incident
breast cancer cases were available for analysis. Questionnaire data of these cases and
the 1,716 female subcohort members without a history of cancer other than skin cancer
were analyzed. In a multivariate analysis, controlling for traditional risk factors, the
relative rates (RR) for breast cancer in increasing quintiles of energy-adjusted total fat
intake were: 1.00, 1.00, 1.34, 1.22, 1.08 (p-trend=0J2). For saturated fat there was
some evidence for a weak positive association when quintiles were used (RR In
quintiles 1-5: 1.00, 1.22, 1.22, 1.38, 1.39; p-trend=0.049). The 95% confidence interval
(CI) for the top quintile was 0.94-2.06, however, and when saturated fat was used as a
continuous variable, the effect was no longer significant (p=0.20). Relative rate
estimates for the highest versus lowest quintiles of monounsaturated fat,
polyunsaturated fat and cholesterol intake were 0.75 (95% CI: 0.50-1.12), 0.95 (95% CI:
0.64-1.40) and 1.09 (95% CI: 0.74-1.61), respectively, with no evidence for significant
trends. This prospective study does not support a major role of dietary fat In the
etiology of postmenopausal breast cancer.
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Introduction
One of the hypotheses on diet and cancer that has attracted considerable attention
of investigators and public health officials relates to the role of dietary fat in the
development of breast cancer. This is largely based on evidence from ecological studies
relating per capita fat consumption (particularly animal fat) to breast cancer incidence
or mortality in different countries (1-5) and on early laboratory experiments (6,7). Also,
migrant studies have suggested a positive relationship (8,9). Analytic epidemiologie
studies in humans have been far less conclusive, however.
After an early case control study suggested a positive association between dietary
fat and breast cancer incidence (10), subsequent case-control studies have yielded
conflicting results regarding the consumption of animal products or various types of fat
and their association with breast cancer risk (11-38). In a recent combined analysis of
12 case-control studies, it was concluded that a significantly positive association existed
between breast cancer risk and total, saturated or monounsaturated fat intake in
postmcnopausal women (39). However, there was considerable heterogeneity between
the 12 studies regarding the individual estimates. Although no association was found
with fat intake for premcnopausal breast cancer in that analysis (39), a recent case-
control study (28) nevertheless reported only significant associations with fat intake
among premenopausal women.
In contrast to the abundance of case-control studies, relatively few prospective
cohort studies have been published to date on fat or animal products and breast cancer
risk (40-48). Whereas two studies reported a positive association with meat intake
(40,47), this was not confirmed in four other studies (41-43,45). The prospective studies
which used intake estimates of total fat, various types of fat and energy intake have
resulted in a weakly negative (44), weakly positive (46,48) or no significant association
(43) with breast cancer risk. With the exception of the studies by Willett et al. (43) and
Howe et al. (46), the mentioned cohort studies are limited by the small number of cases
and/or the absence of information on habitual intake of energy, total fat and types of
fat. Thus, the evidence from cohort studies of sufficient size with a comprehensive
assessment of habitual dietary intake is still very scarce. We have conducted a
prospective cohort study in the Netherlands among postmenopausal women to evaluate
the association between the habitual intake of fat, various types of fat and the incidence
of breast cancer.
Materials and methods
The cohort
In September 1986, a prospective cohort study on diet and cancer of the breast,
colon, rectum, stomach and lung has been initiated in the Netherlands. The cohort
included 58,279 men and 62,573 women aged 55-69 years at the start of the study. The
study population originated from 204 municipal population registries throughout the
country. At baseline, cohort members completed a mailed self-administered
questionnaire on dietary habits and other potential risk factors for cancer such as
smoking habits, job history, education, reproductive history, medical history, and family
history of cancer. The study design has been described in detail elsewhere (49). For
data processing and analysis the case-cohort approach (50) is used: the cases are
enumerated for the entire cohort (numerator information of incidence rates), while the
accumulated person years of the entire cohort are estimated using a subcohort sample
(providing the denominator information).
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Following this approach, a random subcohort of 3,500 subjects (1688 men, 1812
women) was sampled from the cohort after the baseline exposure measurement. The
subcohort has been followed up for vital status information in order to estimate the
accumulated persontime in the cohort. This involved personal mailings and (for
nonrespondents) additional contacts with municipal population registries, rendering a
complete follow-up: after 3.3 years of follow-up there were no subcohort members lost
to follow-up.
Cancer follow-up
Follow-up for incident cancer consisted of computerized record linkage with all
nine regional cancer registries in the Netherlands and with PALGA, the Dutch national
data base of pathology reports. The method of record linkage has been published
previously (51). Record linkage has been conducted annually with PALGA and the
cancer registries. The lag time between diagnosis of cancer and definitive registration in
the cancer registries is usually less than three months, but may occasionally extend to
1.5 years. Considering this lag time, the linkage performed in 1991 thus accounted for
presumably all cancers diagnosed until the end of 1989. The analysis in this report is
restricted to the cancer incidence in the period from September 17, 1986 (cohort
baseline measurement) until December 31, 1989, i.e. a follow-up period of 3.3 years.
In this period a total of 1882 cases of breast, colorectal, stomach or lung cancer
were detected in the cohort of 120,852 subjects. This observed number of cases was
compared with the number of cases that would be expected on the basis of cancer
incidence rates, while taking mortality (52) into account. For this purpose, age- and
gender-specific cancer incidence rates for breast, colon, rectum, stomach and lung were
obtained from the regional cancer registries for the period 1987-89 (for one registry
rates of 1983-87 were used). The expected number of cases of the mentioned tumor
sites in the 3.3 years of follow-up was estimated at 1971, thus yielding an observed-to-
expected ratio of 0.95, with a 95% confidence interval of (0.91, 1.00) using Byar's
approximation (53). Evidence of good coverage of the cohort by the cancer registries
and PALGA is also available from another, independent source. Age- and gender-
specific data on hospital admissions for cancer (obtained from the National Health
Care Information Center) were used to calculate for each municipality the degree of
coverage by the cancer registries and PALGA. The results indicated that the mean
coverage degree of the municipalities in which the cohort was recruited increased from
98.5% at the start of the study to 99.5% at the beginning of 1987 and 100% at the
beginning of 1988 (54). A high degree of coverage was to be expected, because the 204
municipalities participating in the cohort study were purposely selected on the basis of
the estimated coverage degree (49).
Population for breast cancer analysis
Among the 1882 cases, there were 553 female breast cancer cases. After excluding
incident cases with in situ carcinoma and women who reported a history of cancer other
than skin cancer in the baseline questionnaire, 471 microscopically confirmed incident
cases of breast cancer were available for data entry and analysis. After excluding
prevalent cancer cases other than skin cancer from the female subcohort of 1812 as
well, 1716 subjects remained in this group. The questionnaire data of the subcohort
members and of the cancer cases were key-entered twice and processed in a manner
blinded with respect to case/subcohort status to avoid bias in coding and interpretation
of the data. The evaluation of the associations between breast cancer and traditional,
nondietary risk factors was based on the data of the aforementioned 471 cases and 1716
subcohort members. Regarding the dietary part of the questionnaires, about 7% could
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not be used for nutrient intake calculation because of missing or inconsistent dietary
data (see also next paragraph). The analyses of dietary associations with breast cancer
are therefore based on data of 437 breast cancer cases and 1598 subcohort members.
The dietary questionnaire
Usual diet was assessed at baseline with a semi-quantitative food frequency
questionnaire (150 items) specifically designed for, and pretested among men and
women of the cohort age range (55). The principal nutrients of interest in the design of
the questionnaire were: energy, protein (vegetable, animal), fat (saturated, mono- and
polyunsaturated), cholesterol, carbohydrates (mono- and disaccharides,
poh/saccharides), dietary fiber, alcohol, calcium, vitamin A, B-carotene and vitamin C.
Because subjects tended to skip questions on items they did not consume,
questionnaires were considered incomplete when either: (a) more than 60 items were
left blank a/u/ less than 35 items were eaten at least once a month; or (b) one or more
item blocks (groupings of items, e.g. beverages) were left blank. More details are given
in a separate report (Goldbohm et al , submitted for publication). Mean individual
nutrient intakes per day are computed using the Dutch food table of 1986 (56) by
cumulating the multiplied frequencies and portion sizes of all food items with their
tabulated nutrient contents. The validity of the questionnaire was studied in 1987-88 by
comparing it to a nine-day dietary record method among 109 cohort members (59 men,
50 women). Pearson correlation coefficients between the dietary record and the
questionnaire varied from 0.40 for vitamin Bl to 0.86 for alcohol intake, with a median
of 0.69. After adjustment for energy intake and gender by the residual method (57),
correlation coefficients ranged from 0.33 for vitamin Bl to 0.86 for alcohol (median
r=0.67). Crude and energy-gender-adjusted (in parentheses) correlation coefficients
were 0.74 for energy intake, 0.72 (0.52) for total fat, 0.73 (0.58) for saturated fat, 0.73
(0.75) for polyunsaturated fat and 0.66 (0.62) for cholesterol. Correlation coefficients
were comparable in men and women.
Data analysis
Relationships between dietary fat intake and potential confounders for breast
cancer were investigated by computing age- and energy-adjusted (57) intakes of fat and
various types of fat among the female subcohort members and comparing the mean
intakes in the various categories of the confounders with analysis of variance. Two-sided
p-values are used throughout this report.
Although a theoretical approach for analyzing case-cohort studies based on Cox's
partial likelihood has been published (58), no standard software was available for
computing correct variance estimates for the relative rates and for significance testing.
Our analyses are based on the assumption that survival times were exponentially
distributed in the current follow-up period, which was confirmed after considering log-
log plots of the cumulative survival distribution against the logarithm of the survival
time. We developed methods for stratified and multivariate case-cohort analyses,
allowing for the additional variance introduced by the subcohort sampling. The analyses
were programmed and carried out with the GLIM statistical package (59) (specific
programs are available upon request). Specifically, the analysis methods concern
computation of Mantel-Haenszel estimators of the relative rate together with corrected
estimates of confidence intervals, Mantel-Haenszel test statistics and tests for trend in
the stratified analyses. In the stratified analyses presented in this report, we evaluated
the influence of the various risk factors and dietary fat on breast cancer, after
stratification on age in three 5-year categories. Fat intake values were adjusted for
energy intake by the residual method (57) and categorized as quintiles, according to the
distribution in the subcohort.
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In the multivariate analysis, relative rates for quintiles of fat intake were computed,
adjusted for other covariates in the model. Confidence intervals for relative rates were
computed using corrected variance-covariance estimates. Tests for trend were based on
likelihood ratio tests, with scores of 1-5 assigned to the increasing quintiles, as in the
stratified analyses.
Analyses were also conducted after excluding cases that occurred in the first year of
follow-up. The results were essentially similar; thus only results regarding the complete
follow-up period are presented.
Results
Details on the observed exposure distribution are given in the appendix-table where
quintile boundaries and medians within quintiles of dairy energy and fat intake are
presented for the 1598 female subcohort members with complete dietary questionnaires.
The unadjusted median dairy intake of total fat ranged from 47.0 g in the lowest
quintile to 104.8 g in the highest quintile. After adjustment for energy intake these
medians were 61.0 and 85.5 g/day, respectively. Likewise, a reduction of variation in
intake estimates of the other fats and cholesterol occurred after adjustment for energy
intake. In this population energy intake was strongly associated with various fats; the
Pearson correlation coefficients between energy and fat intake were 0.89 for total fat,
0.81 for saturated fat, 0.84 for monounsaturated fat, 0.59 for polyunsaturated fal and
0.59 for cholesterol intake, respectively. Expressed as percentage of energy intake, the
median energy contribution of total fat ranged from 32.1% in the lowest quintile to
46.2% in the highest quintile. For saturated fat, these values were 12.1%) and 19.9%;,
respectively.
Table 1 shows the age-adjusted mean intake of energy and the mean intake of fats,
adjusted for age and energy intake, among the 1598 subcohort members. The average
mean dairy intake was 1689 ± 409 kcal for energy (mean ± SD), 74.2 ± 10.5 g for total
fat, 29.7 ± 5.7 g for saturated fat, 27.6 ± 5.2 g for monounsaturated fat, 15.3 ± 6.2 g
for polyunsaturated fat and 235 ± 60 mg for cholesterol. The table also shows the mean
intake values according to the categories of various traditional nondietary confounders.
Energy intake was significantly positively associated with age at first birth (p<0.05), age
at menopause (p<0.01) and use of oral contraceptives (p<0.05). Significantly negative
associations existed between energy intake, an artificially induced menopause (p<0.01)
and Quetelet index (p<0.01). Total fat and monounsaturated fat intake were
significantly associated with a history of benign breast disease (p<0.05). Whereas
saturated fat intake showed no significant associations with any of the other risk factors,
both monounsaturated and polyunsaturated fat intake were significantly inversely
associated with highest attained level of education (p<0.05). Cholesterol intake was
significantly associated with age at first birth (p<0.05), parity (p<0.05) and Quetelet
index (p<0.001). Overall, the differences in intake between the various categories of the
mentioned confounding factors were relatively small.
In table 2 the results of the stratified analyses for nondietary established and
potential risk factors for breast cancer are shown, after stratification by age in 5-year
categories. In this table the observed person years in the subcohort are shown, together
with the number of incident cases in each stratum. To illustrate the principle of the
case-cohort approach, the breast cancer incidence rate in the cohort can be estimated
after inflating the person years in the subcohort with the inverse of the subcohort
sampling fraction, i.e., 62573/1812. For example, the estimated crude breast cancer
incidence rate in women without a history of benign breast disease would be
411/(5150x62573/1812) or 231 per 100,000 person years.
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Table 1. Mean daily intake of energy (age-adjusted) and fats (age- and energy-adjusted), according to
various characteristics, in female subcohort members with complete dietary data (n = 1598).
Mean dairy intake
Characteristic n* Age-adj. Age- and energy-adjusted
Kncrgy
(kcal)
Total Saturated Mono-unsat.
fat (g) fat (g) fat (g)
Poryunsat. Cholesterol
fat (g) (mg)
15.3 235Total 1598 1689 74.2 29.7 27.6
Hcnigfi breast disease t t
No 1476 1690 74.4 29.8 27.7
Yc« 122 1672 72.2 28.9 26.6
Maternal brcantca
No 1548 1691 74.2 29.7 27.6
Ye» 50 1611 743 30.0 27.8
Brcaslca in iuler(s)
N o 1515 1687 74.2 29.8 27.6
Y« 83 1719 74.5 29.5 27.9
Purity
Nulliparou» 275 1697 74.8 30.2 273
1 129 1702 74.5 29.7 27.4
2 347 1658 73.8 29.9 27 J
23 823 1699 74.1 29 J 27.8
Age at first birth (yrs) t
1719 23 1416 733 293 26.8
20-24 342 1673 74.2 29.7 27.7
25-29 653 1699 743 29.7 27.8
i 30 292 1707 73.7 29.5 27.6
Nulliparous 275 1697 74.8 30.2 273
Age at menarche (yrs)
S 12 401 1671 74.2 29.8 27.4
13 736 1689 74.0 29.7 27.5
a: 14 442 1709 74.5 29.6 28.0
Age at menopause (yrs) t
s 44 232 1609 75.0 30.0 28.1
45-49 479 1676 74.4 29.6 27.7
50-54 673 1724 73.6 29.8 27.4
a 55 117 1730 74.2 29.7 27.4
Artificial menopause t
No 1304 1702 74.1 29.7 27.5
Yes 251 1621 74.8 29.8 28.2
Use of oral contraceptives t
Never 1180 1676 743 29.8 27.6
F.vcr 394 1735 74.0 29.6 27.6
Highest level of education t
Low 902 1675 74.5 29.6 27.9
Medium 550 1704 747 29.9 273
High 135 1721 72-5 30.1 26.9
Current cigarette smoking
No 1266 1694 743 29.8 27.6
Yes 332 1669 73.9 29.6 27.7
Ouctelet index (kgW) t
S 22 412 1724 73.7 29.9 273
23-24 436 1723 74.5 29.8 27.6
25-26 308 1656 74.1 29.4 27.5
i27 395 1630 74.8 29.8 28.2
* Due to missing questionnaire data on non-dietary factors, numbers may not add up to 1598 subjects
t p-value (Analysis of variance comparing means) < 0.05; I p-value < 0.01; § p-value < 0.001
153
152
153
14.9
15.2
153
15.5
16.0
14.8
152
153
153
15.2
15.1
15.5
15.4
15.1
15.4
153
15.6
14.8
153
15.2
15.2
15.2
153
t
15.4
153
13.8
153
15.0
14.8
15.4
15.6
153
236
231
235
230
236
223
t
227
231
239
237
t
242
239
239
230
227
239
233
236
240
231
234
251
234
240
234
240
234
235
240
235
237
§
227
232
232
251
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Table 2. Mantel-Haenszel
age (3 categories)
Characteristic
Benign breast disease
No
Yes
Maternal breastcancer
No
Yes
Breastca in sister(s)
No
Yes
Parity
Nulliparous
1
2
2 3
Age at first birth (yrs)
17-19
20-24
25-29
2 30
Nulliparous
Age at mcnarche (yrs)
2 12
13
2 14
Age at menopause (yrs)
S 44
4549
50-54
a 55
Artificial menopause
No
Yes
Use of oral contraceptives
Never
Ever
Highest level of education
Low
Medium
High
Current cigarette smoking
No
Yes
Quetelet index (kg/m*)
S 22
23-24
25-26
i 27
relative rate
No. of
cases
from
cohort*
411
60
443
28
434
37
107
47
105
203
5
95
158
102
107
140
204
118
54
116
212
49
376
73
348
105
281
146
37
376
94
125
124
88
111
of breast cancer
Person years of
observation in
subcohortt
5150
415
5392
173
5269
296
960
454
1223
2&33
95
1198
2237
1016
960
1387
2536
1559
826
1650
2304
394
4474
887
4111
1343
3198
1824
450
4410
1146
1414
1483
1085
1381
according
1.00*
1.91
1.00*
2.03
l.OOt
1.48
1.00$
0.94
0.78
0.64
0.47
0.74
0.64
0.91
l.OOt
l.OOt
0.80
0.77
l.OOt
1.08
1.43
1.89
1.00t
0.98
l.OOt
1.00
l.OOt
0.91
0.95
l.OOt
0.99
root
0.94
0.91
0.90
to various characteristics, stratified by
(95% CI)
(U7-2.66)
(1.26-3.24)
(0.98-2.21)
(0.63-1.40)
(0.57-1.06)
(0.49-0.84)
(0.18-1.24)
(0.53-1.01)
(0.48-0.85)
(0.66-1.24)
(0.63-1.02)
(0.58-1.01)
(0.76-1.55)
(1.03-2.00)
(1.22-2.93)
(0.74-1.31)
(0.77-1.30)
(0.73-1.15)
(0.64-1.39)
(0.76-1.27)
(0.71-1.24)
(0.67-1.24)
(0.67-1.20)
Test for trend
X* (p-vtlue)
11.02 (<0.001)
2.12 (0.15)
(parous only)
331 (0.07)
11.46 (<0.001)
0.40 (0.53)
0.60 (0.44)
* Due to missing questionnaire data, the number of cases may be less than 471.
t The number of person years in the total cohort can be estimated by multiplying the subcohort person
years by 62573/1812 (i.e., the inverse of the sampling fraction),
t Reference category.
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As can be seen from table 2, the effects of the established risk factors are in the
anticipated direction. Elevated risks were found for women with a history of benign
breast disease (Mantel-Haenszel relative rate, RR = 1.91; p<0.001), history of breast
cancer in mother (RR = 2.03; p=0.01) and history of breast cancer among one or more
sisters (RR = 1.48; p = 0.08). Age at first birth was positively associated with the risk of
breast cancer, although the test for trend among parous women only was not significant
(p=0.15). When nulliparous were included, the test for trend became highly significant
(X^ = 8.38, p = 0.004). Parity showed a significantly negative association with breast
cancer risk (test for trend: p<0.001). Age at menarche was negatively associated with
breast cancer risk, although not significantly (p-trend=0.07), whereas age at menopause
was significantly associated with an elevated risk of breast cancer (p<0.001). No
significant associations were observed with artificial menopause (induced by hormones
or surgical) (RR=0.99; p=0.93), use of oral contraceptives (RR=1.00; p=0.99), level of
education (p-trend=0.53), current cigarette smoking (RR=0.99; p=0.91) or Quetelet
index (p-trend = 0.44).
Table 3 shows the observed Mantel-Haenszel relative rates for breast cancer
according to quintiles of energy and energy-adjusted fat intake, after stratification by
age. No significant associations were found with energy intake or energy-adjusted intake
of total fat, saturated fat, monounsaturated or poryunsaturated fat nor cholesterol.
Whereas the relative rate estimates for saturated fat were above the null-value, those
for monounsaturatcd fat and poh/unsaturated fat were generally somewhat below the
null-value. None of the tests for trend was significant, however. With regard to energy
.inlfthr, Asun' .(«v .<\ns' .ihsilartfiw»! «sssf.ruial^ .tip j*ss«r.ifttip.p m" £taf.*xsd Xh? jamr
picture emerged for fat intake quintiles that were not adjusted for energy intake or
when fat intake was expressed as percentage energy contribution (results not shown).
The associations between the risk of breast cancer and fat intake were further
evaluated in a multivariate model with adjustment for age, history of benign breast
disease, maternal breast cancer, breast cancer in sister(s), age at menarche, age at
menopause, oral contraceptive use, parity, age at first birth, Quetelet index, education,
habitual alcohol use and current cigarette smoking. The results are presented in table 4.
As anticipated from the earlier associations in table 1, this adjustment did not alter the
relative rate estimates appreciably. For total fat, the relative rate of breast cancer
increased to 1.34 and 1.29 in the third and fourth quintile of intake, respectively, but
decreased to 1.08 in the fifth quintile. The test for trend was not significant, nor were
any of the quintile-specific relative rates significantly different from unity. When energy-
adjusted total fat intake was entered as a continuous variable in the model, the relative
rate associated with an increase of 25.5 g/day (i.e., the difference in energy-adjusted
median intake between the fifth and first quintile) was 1.08 (95% CI: 0.82-1.44). For
saturated fat, a positive association with the risk of breast cancer was observed in the
multivariate analysis, with relative rate estimates of 1.22, 1.22, 1.38 and 1.39 for the
second to fifth quintile. respectively (p-trend=0.049). None of quintile estimates was
significantly different from the null value, however. When saturated fat was entered as a
continuous variable in the model, no significant association was observed (p=0.20). The
relative rate of breast cancer for an increased intake of 14.3 g saturated fat per day
(difference in medians between fifth and first quintile) was 1.18 (95% CI: 0.89-1.59).
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Table 3. Mantel-Haenszel relative rale of breast cancer according to quintiks of coergy intake and of
energy-adjusted fat intake, stratified by age (3 categories).
Characteristic
Energy (quintiks)
1 (low)
2
3
4
5 (high)
Total fat
1
2
3
4
5
Saturated fat
1
2
3
4
5
Monounsaturated fat
1
2
3
4
5
Pohyunsaturated fat
1
2
3
4
5
Cholesterol
1
2
3
4
5
No. of
cases
from
cohort'
83
83
98
92
81
88
75
95
95
84
76
84
81
97
99
95
91
98
82
71
97
83
89
84
84
90
88
84
80
95
Person years of
observation in
subcohort
1032
1035
1046
1040
1034
1038
1034
1036
1040
1040
1039
1036
1042
1037
1033
1034
1042
1036
1035
1040
1031
1041
1040
1033
1042
1037
1042
1040
1032
1036
RRMH
l.OOt
0.99
1.17
1.11
0.99
1.00t
0.84
1.08
1.07
0.95
l.OOt
1.14
1.07
1.32
1.29
1.00t
0.94
1.05
0.85
0.75
l.OOt
0.84
0.92
0.87
0.85
1.00t
0.98
0.91
0.87
1.04
(95% CI)
(0.71-1.40)
(0.84-1.63)
(0.79-1.55)
(0.70-1.39)
(0.59-1.18)
(0.78-1.51)
(0.77-1.49)
(0.68-1.34)
(0.80-1.62)
(0.75-1.52)
(0.93-1.86)
(0.92-1.81)
(0.68-1.31)
(0.76-1.45)
(0.61-1.19)
(0.53-1.05)
(0.60-1.18)
(0.66-1.28)
(0.62-1.22)
(0.61-1.19)
(0.70-1.37)
(0.65-1.28)
(0.62-1.23)
(0.75-1.44)
Test
x*
0.06
0.10
2.91
3.00
0.47
0.00
for trend
(p-valuc)
(0.81)
(0.75)
(0.09)
(0.08)
(0.49)
(0.99)
* There were 437 cases with complete dietary data,
t Reference category.
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Table 4. Relative rate of breast cancer according to quintiles of energy-adjusted fat intake in
mullivariatc analysis.
Nutrient RR* (95% CI) Test for trend
(p-value)
Total fat, qumtiles
1 (low)
2
3
4
5 (high)
Saturated fat
1
2
4
S
Monounsaturatcd fat
1
2
3
4
5
Polyunsnturalcd fat
1
2
3
4
5
Cholesterol
1
2
3
4
5
1-OOt
1.00
134
119
1.08
1.00t
1.22
122
138
139
1.00t
1.03
1.00
0.99
0.75
1.00t
0.91
0.90
1.09
0.95
1.00t
0.84
0.85
0.85
1.09
(0.67-1.49)
(0.91-1.97)
(0.88-1.91)
(0.73-1.59)
(0.81-1.84)
(0.82-1.84)
(0.92-2.06)
(0.94-2.06)
(0.71-1.51)
(0.69-1.46)
(0.67-1.46)
(0.50-1.12)
(0.62-1.34)
(0.61-1.32)
(0.75-1.59)
(0.64-1.40)
(0.57-1.24)
(0.57-1.26)
(0.57-1.27)
(0.74-1.61)
1.00 (032)
3.87 (0.049)
253 (0.13)
0.04 (0.85)
0.29 (0-59)
• Relative rale after adjustment for: age, history of benign breast disease, maternal breast cancer, breast
enncer in sistcr(s), age at menarche, age al menopause, oral contraceptive use, parity, age at first birth,
Quclclct index, education, alcohol use, current cigarette smoking.
t Reference category.
Monounsaturated fat intake was not associated with the risk of breast cancer in the
nuiltivariate analysis; the relative rates for increasing quintiles were 1.00, 1.03, 1.00, 0.99
and 0.75 (p-trend=0.13). Polyunsaturated fat and cholesterol intake also did not show
any association with breast cancer risk; the relative rates for the highest quintile
compared to the lowest were 0.95 and 1.09, respectively. When fat intake was expressed
as percentage contribution to energy intake, no significant trends were observed in the
multivariate analyses. For example, for total fat the relative rates in increasing quintiles
of consumption were 1.00. 1.09, 1.51, 1.22 and 1.02 (p-trend=0.734), with the medians
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of these quintiles corresponding to 32.1, 36.6, 39.3, 42.1 and 46.2 energy-%,
respectively. For saturated fat the relative rates were estimated as 1.00, 0.98, 0.99, 1.21
and 1.24 (p-trend = 0.093). In addition, when a fat decomposition model was used (60),
again no significant effect of saturated fat intake was noted (results of latter analyses
not shown).
Discussion
We found no evidence for an elevated risk of breast cancer with increasing intake
of total fat, when adjusted for energy intake. For saturated fat, a weak positive trend
with risk of breast cancer was observed, with increases in relative rate up to 1.39 for
those in the highest intake quintile. However, none of the relative rates in the higher
quintiles of saturated fat intake was significantly different from unity. An association
would have been more likely if the positive trend was also significant when saturated fat
was entered as a continuous variable. This, however, was not the case. For
poh/unsaturated fat and cholesterol intake, essentially no evidence for a relationship was
found. Monounsaturated fat intake was, if anything, negatively associated with breast
cancer risk, but not significantly.
Before discussing these results in relation to other studies on dietary fat and breast
cancer, we will first describe the strengths and limitations of this study. These refer to
the source of the population and the selected age range, homogeneity of dietary fat
intake, misclassification of exposure, selection and confounding bias and the length of
follow-up. This study was carried out in a large sample of the general population of
women aged 55-69 years at baseline, which yields a sufficient number of cases to study
etiologic relationships (61). A potential disadvantage of this approach is that potential
effects of diet early in life cannot be studied. However, most laboratory experiments
have suggested an effect of dietary fat on the promotional phase of breast cancer (e.g.,
62), and recent case-control studies (25, 32) and a cohort study (45) indicated no strong
associations between fat intake during childhood or adolescence and breast cancer risk.
Also, most epidemiologie studies on diet and breast cancer with positive results indicate
an effect on postmenopausal rather than premenopausal breast cancer (39).
Although the Netherlands is known for its high per capita fat intake (63), etiologic
studies might be hampered when the population is relatively homogeneous regarding
dietary fat intake. In our cohort, the unadjusted total fat intake varied from a median
of 47 g/day (or, 32% of total energy) in the lowest quintile to 105 g/day (46 cnergy-%)
in the highest quintile according to our questionnaire data. The questionnaire data may
have overestimated the variability that actually existed in our cohort. In this respect, the
medians of the lowest and highest quintiles of intake according to the 9-day record
method in our validation study were 34 and 46 energy-%, respectively. It may be that
fat intake needs to be reduced more substantially to exert an effect, although a true
reduction of habitual fat intake below 30 energy-% may prove to be very difficult to
achieve in free-living Western populations. Also, epidemiological studies that included
subjects with observed fat intakes as low as 20% of total energy or less (21,27) have
produced negative findings with respect to breast cancer risk. Results from studies
among southern-European populations in Greece and Italy with presumably more
heterogeneity in the diet than the Netherlands were inconsistent (13,23,33).
An issue that is related to the observed range of exposure is the misclassification of
exposure that is inherent in dietary epidemiological studies. For our study we used a
semiquantitative food frequency questionnaire, which was designed to capture the
etiologically interesting variation in intake between individuals. Our validation study
indicated a reasonably good validity, which is partly explained by the large number of
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included food items. Most dietary assessment methods in the diet and breast cancer
studies were not validated and included considerably less items, sometimes as few as 10
or less (e.g., 31,33,36,40). This also limits the possibility to adjust for energy intake,
which is of importance considering the often strong correlation between fat and energy
intake (64) and the recent laboratory evidence suggesting that energy intake rather than
fat may be implicated as a determinant of breast cancer (65-67).
Selection bias due to loss to follow-up is unlikely in our study considering the 100%
complete follow-up of person years and the high completeness of cancer follow-up.
Also, there are no reasons to assume that there is insufficient control of confounding in
our analysis. We measured and controlled for the established risk factors of breast
cancer. Moreover, the relative risk estimates were not materially affected by controlling
for these factors because of the weak associations with fat intake.
A potential drawback of the study is the still limited length of follow-up, i.e. 3.3
years. When we excluded cases occurring during the first year of follow-up, the
conclusions about the effect of fat were not different from those based on the total
group of cases. Although it cannot be excluded that a stronger effect of fat will become
apparent when a longer follow-up period will be available, other cohort studies
employing longer follow-up periods do not provide a clear indication for this possibility.
Knckt ct al. (46) observed a borderline significantly positive association with
monounsaturated fat after 20 years of follow-up, but in another cohort study with 21
years of follow-up no significantly elevated risks were found (42). Other cohort studies
with five to ten years of follow-up mostly produced no significant associations with fat
or meat intake (40,44,45,48,68). In future analyses we will evaluate whether the
estimated association between dietary fat and breast cancer will change with a longer
follow-up period.
A review of the published case-control studies on dietary fat and breast cancer
reveals that the results vary substantially. Of the case-control studies that measured fat
intake, eight showed a significant positive association between intake of total fat or a
particular type of fat and breast cancer risk (10-17). In 12 other case-control studies no
(significant positive) association was reported (18-29). In a number of case-control
studies only the intake of some specific fat-containing foods such as meat or dairy
produce was measured, but the results were also inconsistent. Significant positive
associations were found with meat intake in six studies (18,26,28,31-33) with intake of
dairy produce in five studies (13,18,31,34,35), whereas no (significant positive)
associations with meat intake were detected in seven studies (13,16,34-38) and with
dairy produce in two studies (32,38).
In prospective cohort studies, the potential problem of biased recall of past food
intake (inherent in case-control studies) is avoided. Hirayama found a positive
relationship with meat consumption in Japan, but there were only 14 cases in the
exposed group (daily meat consumption) and no significance testing was described (40).
The cohort studies among US nurses (64) and among special exposure groups such as
Seventh Day Adventists (42,45) and nuns eating little or no meat (41) were negative
with regard to meat and breast cancer risk. Vatten et al. (47) recently reported an
increased risk associated with the consumption of meat at hot meals. However, there
was no control in the analysis for various reproductive factors, nor for energy intake.
We did also analyze the relationship between meat intake and breast cancer in our
cohort study and found the rate ratio of breast cancer for women consuming meat 0-1
days/week relative to those consuming meat 5-7 days/week to be 1.23 (95% CI: 0.63-
2.37), with no evidence for a trend. Only four prospective cohort studies have used
dietary assessment methods that permitted calculation of energy intake (43,44,46,48).
Jones et al. (44) found significantly negative associations between total and saturated
fat intake and breast cancer risk, but this was based on 24-hr dietary recall data which
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may not adequately represent an individuals' habitual intake. Knekt et al. (46) reported
positive associations with energy-adjusted intake of fats but the trend was only
significant for monounsaturated fat. Even after a follow-up of 20 years, the number of
incident cases was small, however. Willett et al. (43) and Howe et al. (48) have reported
results from large cohorts of women in the US and Canada, respectively. Willett et al.
observed no effects of high fat or cholesterol intake on breast cancer risk after four (43)
and eight years of follow-up (68). Howe et al. reported slightly elevated relative risks of
1.2-1.3 in the highest quartile of intake for total fat and monounsaturated fat, with
marginally significant tests for trend (48). However, the relative risk estimates in highest
category were not significantly different from unity, similarly to what we observed in
our study regarding saturated fat.
In conclusion, we found no significant association between total fat intake and
postmenopausal breast cancer risk. There was some evidence for a weak positive
relationship with saturated fat intake but not with the other types of fat or cholesterol.
The significance of the association with saturated fat depended on the model
specification and was inconsistent. We cannot exclude that a longer follow-up period
may yield positive findings, but the current study does not indicate that fat intake is
strongly related to breast cancer risk. If dietary fat is etiologically relevant, our study
suggests it is accountable to saturated fat.
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Appcndix-lable. Percentile values of dairy intake of energy and fat (quintile boundaries plus medians
within quintile») in female subcohort members with complete dietary data (n=1598).
Variable
Fvncrgy (kcal)
Total fat (g)
Unadjusted
Ivncrgy-adjustcd
Saturated fat (g)
Unadjusted
Hncrgy-adjuslcd
Monnunaat. fat (g)
Unadjusted
I'inergy-adjustcd
Poryunnat. fat (g)
Unadjusted
Energy-adjusted
Cholesterol (nig)
Unadjusted
lincrgy-adjusted
Percentile value
10%
1215
47.0
61.0
18.4
23.0
17.1
21.8
6.8
8.1
150
163
20%
1347
54.5
66.1
21.5
25.1
20.2
23.7
8.7
10.2
177
188
30%
1455
60.4
69.1
23.9
26.6
22.3
25.0
10.3
11.6
194
204
40%
1540
66.6
71.8
26.3
27.9
243
11.7
12.8
211
219
50%
1651
71.9
74.1
28.6
29.2
26.4
27.4
13.7
14J
228
232
60%
1751
77.9
76.7
30.9
30.5
28.4
28.6
15.9
15.8
246
246
70%
1862
84.0
78.9
33.6
32.2
31.0
29.8
187
17.8
265
261
80%
2006
92.4
82.0
37.5
34.1
34.4
3 U
21.1
20.2
290
282
90%
2220
104.8
86.5
42.9
37.4
39.7
33.8
26.0
23.5
333
306
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Chapter 12
Prospective study on alcohol consumption and the risk of
cancer of the colon and rectum*
R. Alexandra Goldbohm'*, Piet A. van den Brandt*,
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Abstract
The association between alcohol consumption and cancer of the colon and rectum was
investigated in a prospective cohort study, conducted in the Netherlands from 1986
onwards among 120,852 men and women, aged 55-69. During 3 J yean of follow-up,
312 and 166 cases of colon and rectal cancer had accumulated respectively. After
exclusion of cases diagnosed in the first year of follow-up, the analysis was based on
217 incident cases of colon cancer (107 men and 110 women) and 113 cases of rectal
cancer (75 men and 38 women). For colon cancer, no association with Intake of alcohol
nor with the consumption of beer and wine could be demonstrated; for liquor a
significant (p=0.042) decreasing risk with Increasing consumption was observed. For
rectal cancer in men, positive trends were observed for alcohol intake (p=0.041), beer
(p=0.050) and liquor (p=0.056). Multivariate models including alcohol intake and one
beverage type at a time showed that the increased risk was mainly restricted to
consumption of beer (RR (yes/no): 1.94, 95% confidence interval: 1.09-3.47). Results for
rectal cancer in women were consistent with those in men, but data were too scarce to
provide stable estimates. It is concluded that only consumption of beer appeared to
increase risk of rectal cancer, but not colon cancer. It is speculated whether the high
nitrosamine content of beer in the past has caused the Increased risk.
' Submitted for publication
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Introduction
The consumption of large amounts of alcohol has definitely been shown to increase
the risk for cancer of the upper digestive tract (oral cavity, pharynx, esophagus). For
cancer of the lower intestinal tract, i.e. colon and rectum, substantial evidence has
accumulated from epidemiological studies that alcohol consumption has only a weak
effect on risk, if any. A recently published meta-analysis, performed on presumably all
27 epidemiologie studies regarding colorectal cancer that quantified alcohol
consumption, demonstrated a relative risk (RR) of only 1.10 (95% confidence interval
(CI) 1.04-1.14) for subjects taking two drinks per day (equivalent to 24 g of ethanol)
compared to abstainers; the association in follow-up studies, however, was stronger
(RR = 1.32, CI 1.16-1.51) than that in case-control studies (RR = 1.07, CI 1.02-1.12)(1).
In the meta-analysis, no difference in RR between men and women was observed, nor
between tumor sites (colon or rectum). When type of alcoholic beverage was evaluated
(in 8 of the 27 studies), consumption of beer had the largest relative risk (1.26, CI
1.13-1.41) as compared to wine (RR=1.11, CI 0.91-1.36) or liquor (RR = 1.13, CI
0.99-1.29). Nevertheless, a number of studies have convincingly shown a higher relative
risk for rectal cancer than for colon cancer (2-7). It is furthermore intriguing that in
some studies beer drinking is clearly associated with an increased relative risk of rectal
cancer, (2,3,5,6,8,9) while in other studies it is not (4,10,11). It has been suggested that
the higher risk associated with beer drinking has been caused by contamination of many
types of beer with nitrosamines in the past (12).
These results prompted us to investigate the relation between consumption of
alcoholic beverages and the risk of colon and rectal cancer in the Dutch prospective
cohort study on diet and cancer (13). In this study among 120,000 men and women,
which started in 1986, detailed information has been collected on dietary habits
including drinking habits by means of a self-administered questionnaire.
Subjects and methods
The cohort
The prospective cohort study on diet and cancer has been initiated in the
Netherlands in September 1986. The cohort included 58,279 men and 62,573 women
aged 55-69 at the start of the study. The study population originated from 204
municipal population registries throughout the country. At baseline, the cohort
members completed a mailed, self-administered questionnaire on dietary habits and
other risk factors for cancer. For data processing and analysis the case-cohort approach
was used: the cases were enumerated for the entire cohort, while the person years at
risk accumulated in the cohort were estimated from a random sample (subcohort). This
subcohort of 3500 subjects (1688 men, 1812 women) was sampled from the cohort after
the baseline measurement and was followed up for vital status over 3.3 years. The study
design has been described in detail elsewhere (13).
Follow-up for cancer
Follow-up for incident cancer was established by computerized record linkage with
all nine regional cancer registries in the Netherlands and with PALGA, the Dutch
national data base of pathology reports. The method of record linkage has been
published previously (14). The present analysis is restricted to cancer incidence in the
period from September 1986 (baseline measurement) to December 1989, i.e. a follow-
up period of 3.3 years. In this period, completeness of follow-up of the cohort through
linkage with the cancer registries and PALGA together was estimated to be very high
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(15). After excluding subjects who reported a history of cancer other than skin cancer
in the baseline questionnaire, a total of 478 incident cases with microscopically
confirmed primary adenocarcinoma of the colon (157 men, 155 women) and rectum
(101 men, 65 women) were identified.
Questionnaire
A self-administered questionnaire was used at baseline to collect data on dietary
habits, precursors and other (possible) risk factors for colon, rectal and other cancers.
The dietary section of the questionnaire concentrated on habitual consumption of food
and beverages during the year preceding the start of the study and included 150 food
items. Use of alcoholic beverages was addressed by six items: (a) beer, (b) red wine, (c)
white wine, (d) sherry and other fortified wines, (e) liqueur (containing 16% ethanol)
and (f) (Dutch) gin, brandy, whiskey. Together, these items presumably covered all
types of alcoholic beverages consumed. For each item, the questionnaire included seven
frequency categories (never/less than once per month, once per month, 2-3 times per
month, once per week, 2-3 times per week, 4-5 times per week, 6-7 times per week) and
the number of glasses per consumption frequency.
The questionnaire has been validated against a 9-day diet record (16). The
Spearman correlation coefficient between mean dairy ethanol intake assessed by the
questionnaire and that estimated from the 9-day record was 0.89 for all subjects and
0.85 for users of alcoholic beverages; the absolute amount of ethanol reported in the
questionnaire by users of alcoholic beverages was, on average, 86% of that reported in
the record.
Data analysis
Questionnaire data were processed for all 478 incident colorectal cases in the
cohort and for all subcohort members. After excluding prevalent cancer cases other
than skin cancer from the subcohort, 3346 subjects (1630 men and 1716 women)
remained in this group. The questionnaire data were key-entered twice and processed in
a manner blinded with respect to case/subcohort status in order to minimize observer
bias in coding and interpretation of the data. Alcohol data were considered incomplete
when all questions on consumption frequency of alcoholic beverages were left blank
and two other questions on alcohol consumption did not indicate that the subject was
an abstainer. These two questions concerned alcohol intake during the past week and
five years ago. The analysis is based on 3170 subcohort members (94.7%) and 461 cases
(96.4%) for whom the data on alcohol consumption were considered complete. An
additional 4.3 % of the subjects produced incomplete or inconsistent dietary data,
according to criteria described by Goldbohm et al (16). For these subjects, a dummy
variable was included in the models adjusting for dietary factors.
For each alcoholic beverage item, the number of glasses taken per week was
calculated by multiplying the frequency per week by the number of glasses per
frequency. Four items from the questionnaire, i.e. red wine, white wine, sherry and
liqueur, were combined in this and subsequent analyses, since these items were
substantially correlated and separate treatment would eventually result in scarcity of
data. Mean dairy ethanol and nutrient intakes were calculated using the computerized
Dutch food composition table (17). Energy adjustment of nutrient intakes was done
according to Willett and Stampfer (18). The Quetelet Index (kg/m*) was used as a
measure of obesity.
Data were analysed using the case-cohort approach, (19) assuming exponentially
distributed survival times in the follow-up period. Since standard software was not
available for this type of analysis, specific programs were developed to account for the
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additional variance introduced by sampling from the cohort instead of using the entire
cohort (20). The following variables were considered as potential confounders: age,
large-bowel cancer in first-degree relatives, smoking, Quetelet index, level of education,
previous gallbladder surgery, intake of energy and energy-adjusted intake of fat, meat
protein, dietary fiber, vitamin C and calcium. Subclinical symptoms of large bowel
cancer may influence dietary habits before diagnosis. Therefore, we excluded cases
diagnosed in the first year of follow-up after assessing the impact of exclusion on the
risk estimates.
Results
Table 1. Drinking habits among subcohort and cases of colon and rectal cancer.
Men Women
Drinking habit
Toul '
Ahmainers
User» of alcoholic beverages:
I'lhimol (g/iiay)
0.1- 4.9
5.0-14.9
15.0-29.9
a 30.0
Hccr (glasses/week)
No beer
< 1.1
1.1-4.9
i 5.0
Wine (glasscs/wcck)i
No wine
< 1.2
1.2-4.9
a 5.0
liquor (glasses/week)
No liquor
S 2.0
2.1-7.4
2 7.5
Subcohort
n
1591
246
325
441
358
221
435
344
229
337
554
251
271
268
435
311
285
313
PTt
5114
782
1043
1418
1167
704
1396
1107
746
1083
1777
806
879
867
1402
1005
924
998
Colon
n
153
27
30
30
39
27
45
26
19
36
42
22
24
38
38
32
26
29
Rectum
n
%
14
24
17
23
18
24
23
15
20
38
15
15
14
24
17
16
25
Subcohort
n
1579
513
582
286
142
56
921
91
25
28
58
353
323
327
855
102
65
42
m
5144
1667
1907
933
458
179
3005
297
79
92
188
1158
1056
1059
2789
335
209
137
Colon
n
146
56
42
25
16
7
75
7
4
4
9
24
22
35
77
6
2
5
Rectum
n
57
19
21
9
5
3
30
6
1
1
3
11
10
14
35
1
1
1
Total number of subjects for whom information on drinking habits was available.
PT: IVrson-lime-al-risk (year) in the subcohort: multiplying PT by the inverse of the subcohort
sampling fraction (M>029=34.533) gives the estimated pcrson-lime-al-risk in the cohort, which may be
used to calculate incidence density rates.
Aiming male wine drinkers, 63% drank red wine, 59% white wine, 48% sherry and 16% liqueur;
among female wine drinkers, the corresponding percentages were 47, 54, 51 and 38 respectively.
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Table 1 displays the drinking habits in the study population. Of the men in the
subcohort, 85% drank alcoholic beverages at least once a month. Consumption of beer,
wine and liquor was about equally distributed. Liquor was consumed in larger amounts
than beer or wine. In contrast, 689r of the women reported drinking of alcoholic
beverages, mainly wine. Their intake of alcohol (mean 8.5, SD 10.6 g/day) was also
much lower than that of male alcohol consumers (mean 17.1, SD 16.6 g/day).
Table 2 shows that the three types of alcoholic beverage were uncorrelated. The
correlation of the beverage type with ethanol intake indicates their relative importance
in men (liquor) and women (wine). Since alcohol provides energy, alcohol and energy
intake are modestly correlated (r=0.14). The very low correlation with energy derived
from other sources indicates that alcohol is merely added to the diet without affecting
energy intake from other sources.
Table 2. Associations between ethanol intake, consumption of specific alcoholic beverages and energy
in the subcohorl (Pearson (Rp) and Spearman (Rs) correlation coefficients).
Men (n=1591)
Hlhanol
Beer
Wine
Liquor
Energy
Energy excl. ethanol
Women (n= 1579)
Ethanol
Beer
Wine
Liquor
Energy
Energy excl. ethanol
Ethanol
Rp
1.00
0.51
0.50
0.73
0.15
-0.07
1.00
0.24
0.84
0.57
0.14
-0.02
Rs
( 0.52)
( 0.41)
( 0.69)
( 0.14)
(-0.05)
( 033)
( 0.90)
( 0.43)
( 0.14)
( 0.02)
Beer
Rp
1.00
0.01
0.02
0.13
0.02
1.00
0.05
0.04
0.03
-0.01
Rs
( 0.08)
( 0.16)
( 017)
( 0.08)
( 0.20)
( 0.16)
( 0.09)
( 0.03)
Wine
Rp
1.00
0.04
0.07
-0.04
1.00
0.07
0.14
0.07
Rs
( 0.07)
( 0.06)
(-0.01)
( 0.16)
( 0.14)
( 0.04)
liquor
Rp
1.00
0.07
-0.09
1.00
0.05
-0.04
Rs
( 0.09)
(-0.05)
( 0.10)
( 0.02)
Table 3 presents mean alcohol intake in the subcohort according to several
characteristics that are considered to be confounding variables for the relationship
between alcohol intake and colorectal cancer. Smoking and education were strongly,
positively related to alcohol intake. The Quetelet index was positively related to alcohol
intake in men only; in women a weak inverse association was found. Alcohol intake was
relatively constant across quintiles of absolute fat intake, but decreased with increasing
level of energy-adjusted fat intake (data not shown), because alcohol contributes to
energy intake. Dietary fiber was negatively associated with alcohol intake. The intake of
protein from meat increased with alcohol consumption, which relation persisted after
adjustment for energy intake.
Table 4 shows the relative rates (RR) for all cases of cancer of the colon and
rectum according to alcohol consumption and for those cases diagnosed after one year
of follow-up.
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Table 3. Mean ethanol intake (g/day), adjusted for age, according to baseline characteristics of men and
women in the subcohort*.
Characteristic
Age (year)
55-59
60-64
65-69
Smoking
Never
lix-smokcri
Current cigarette smoker
< 10/day
10-19/day
2 20/day
Quclclcl index (kg/ni')
S 22
23-24
25-26
fc 27
Gallbluddcr surgery
No
YM
Level of education
I.OW
Medium
nigh
Fat intake
Ouintilc 1
Quinlile 2
Quintilc 3
Ouinlilc 4
Ouinlilc 5
Meat protein intake
Ouinlilc 1
Ouinlilc 2
Ouinlilc 3
Ouinlilc 4
Ouinlilc 5
Dietary fiber intake
Ouinlilc 1
Quintilc 2
Ouinlilc 3
Ouinlilc 4
Ouinlilc 5
Men
n
575
526
407
146
825
83
265
189
298
475
394
287
1440
68
702
525
271
303
300
302
300
303
299
302
302
302
303
305
2 %
309
301
297
Mean
14.8t
15.2t
13.4t
7.9
15.1
16.2
16.7
21.6
13.1
16.9
15.1
16.8
15.7
13.5
13.3
16.3
20.2
16.4
14.0
16.1
16.7
14.6
11.8
13.8
14.9
18.4
18.9
18.1
16J
16.2
14.0
13.1
SD
16.9
17.5
14.9
10.5
14.9
15.6
18.7
21.5
15.3
18.4
15.2
16.8
16.7
12.9
14.1
18.6
17.6
183
14.1
16.0
18.4
15.8
14.1
14.1
16.1
16.0
20.7
18.5
16.4
18.6
14.4
13.9
Women
n
589
515
415
890
308
103
134
84
398
420
289
368
1316
203
839
537
135
2%
308
304
303
308
307
306
298
304
304
297
308
308
305
301
Mean
63t
5.6t
5.2t
3.6
8.7
8.9
7.6
14.1
6.9
6.5
5.2
5.1
6.1
5.2
4.4
7.5
9.8
5.5
6.0
5.2
5.6
7.4
3.9
4.5
6.7
7 3
7.4
6.8
7.1
6.1
4.8
4.8
SD
103
93
8.8
6.6
10.9
11.5
10.6
16.0
9.8
9.8
9.0
9.7
9.7
8.4
7.7
10.9
12.2
10.5
9.0
8.4
9.2
10.4
7.5
72
102
10.8
10.9
11.0
10.7
8.7
8.1
8.8
* Subjects with complete dietary data (1508 men and 1519 women); numbers may not add up to these
figures due to missing values for non-dietary variables,
t I'thanol intake not adjusted for age.
$ I ix-smokcrs include current smokers of pipe and cigars. /
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Table 4. Age-adjusted relative rate of colon and rectal cancer classified according to ethanol intake
among all cases and after exclusion of cases diagnosed in the first year of follow-up.
I rvel of ethanol
intake (g/day)
Men total
Abstainers
0.1- 4.9
5.0-14.9
15.0-29.9
2 30.0
p-valuc for trend
Women total
Abstainers
0.1- 4.9
5.0-14.9
15.0-29.9
a 30.0
p-valuc for tread
Men total
Abstainers
0.1- 4.9
5.0-14.9
15.0-29.9
2 30.0
p-value for trend
Women total
Abstainers
0.1- 4.9
5.0-14.9
15.0-29.9
a 30.0
p-value for trend
All cases
n
153
27
30
30
39
27
0.413
146
56
42
25
16
7
0.754
105
14
24
17
23
27
0.479
57
19
21
9
5
3
0.781
RR
1.00
0.91
0.67
1.02
1.20
1.00
0.67
0.81
1.07
131
1.00
136
0.71
1.14
1.51
1.00
0.99
0.86
0.99
1.71
95% CI
COLON
0J2-1.57
039-1.15
0.61-112
0.68-2.12
0.45-1.00
0.50-1.29
0.61-1.86
0.60-2.87
RECIUM
0.69-2.67
0.35-1.46
0.58-2.26
0.74-3.09
0.54-1.82
039-1.87
038-2.61
0.52-5.68
First year
D
107
23
21
20
26
17
0.771
110
45
31
16
13
5
0.938
75
8
16
12
22
17
0.021
38
13
13
6
4
2
0.685
excluded
RR
1.00
0.76
033
0.81
0.91
1.00
0.62
0.64
1.09
1.22
1.00
1.58
0.87
1.90
2.49
1.00
0.90
0.84
1.17
1.74
95% CI
0.41-1.42
0.29-1.00
0.45-1.45
0.47-1.76
039-0.97
0361.14
0.59-2.03
0.48-3.09
0.70-3.61
037-2.80
0.86-4.19
1.10-5.66
0.42-1.93
032-2.20
038-3.59
039-7.76
Among men, the estimated relative rates in cases diagnosed after more than one
year of follow-up were clearly different from those in all cases, although among colon
cancer cases relatively more heavy drinkers and less abstainers were diagnosed in the
first year of follow-up, whereas among rectal cancer cases an opposite trend was
detected. Further exclusion of cases diagnosed in the second year of follow-up did not
change the estimates anymore. Among women, no effect of exclusion of cases
diagnosed in the first year was seen. For subsequent analyses, we excluded male as well
as female cases diagnosed in the first year of follow-up.
Tables 5 and 6 present the relative rates of colon and rectal cancer for ethanol
intake and the three types of alcoholic beverage after adjustment for confounding.
Familial history of large-bowel cancer, vitamin C and calcium were not included in the
models since they did not affect the estimates for alcohol. The estimated RR's were
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quite similar for men and women, justifying pooling of the data of both sexes. For colon
cancer no enhancing effect of alcohol of any type was evident. Notable are the U-
shaped dose-effect relations for ethanol intake and all beverage types except liquor,
which showed a significant (p = 0.042) negative association. The risk of rectal cancer, on
the contrary, appeared to be enhanced by alcohol consumption and, most consistently,
by beer consumption.
Table 5. Relative rate of colon cancer* according to drinking habits, adjusted for confounderst.
Drinking habit»
Atataincrst
iJhiwiol(RAlay)
0.1- 4.9
5.0-14.9
15.0-29.9
a 30.0
p-valuc for trend
Beer (glasses/week)
No beer
< 1.1
1.1- 4.9
& 5.0
p-vuluc for trend
Wine (glasses/week)
No wine
< 1.2
1.2- 4.9
2 5.0
p-valuc for trend
Liquor (glasses/week)
No liquor
£ 2.0
2.1- 7.4
i 7.5
p-valuc for trend
Men
n
22
20
19
24
16
0.767
33
12
12
22
0.450
27
14
15
13
0.746
26
19
18
16
0.114
RR
1.00
0.72
0.52
0.79
0.94
0.84
0.39
0.66
0.88
0.60
0.65
0.63
1.05
0.76
0.69
0.72
0.56
Women
n
41
31
15
12
5
0.756
51
121
0.464
6
18
16
23
0.160
53
101
0.090
RR
1.00
0.69
0.61
1.01
1.29
0.68
1.071
1.41
0.64
0.63
0.81
0.75
0.581
Both sexes
n
63
51
34
36
21
0.787
84
17
16
25
0.592
33
32
31
46
0.464
79
25
19
19
0.042
RR§
1.00
0.70
0.58
0.89
1.09
0.74
0.46
0.83
0.94
0.70
0.65
0.63
0.%
0.76
0.73
0.61
0.62
95% CI
0.47-1.06
0.37-0.93
0.49-1.60
033-3.59
0.52-1.05
0.25-0.83
0.44-1.56
0.41-2.14
0.41-1.20
0.42-1.02
0.40-0.99
0.57-1.59
0.54-1.08
0.43-1.22
0J5-1.08
0.30-1.28
* Cases diagnosed in first year of follow-up excluded; number of cases may not add up to those in Table
4 duo to missing values for non-dietary variables,
t Adjusted for age, smoking, Quctclct index, history of gallbladder surgery, level of education, intake of
energy and energy-adjusted intake of fat, meat protein and dietary fiber.
t Reference category.
§ Also adjusted for sex.
I All three quantitative levels combined.
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Table 6. Relative rate
Drinking habits
Abstainers}
Ethanol(g/day)
0.1- 4.9
5.0-14.9
15.0-29.9
2 30.0
p-value for trend
Beer (glasses/week)
No beer
£ 1.1
1.1- 4.9
it 5.0
p-valuc for trend
Wine (glasses/week)
No wine
< U
1.2- 4.9
2 5.0
p-value for trend
Liquor (glasscs/wcck)
No liquor
£ 2.0
2.1- 7.4
2 7.5
p-valuc for trend
of recul cancer*
Men
n
7
16
12
21
17
0.041
15
19
13
19
0.050
30
13
9
14
0.972
19
13
11
23
0.056
according
RR
1.00
1.91
1.08
2.14
2.83
1.26
2.03
2.17
2.04
2.10
1.93
1.13
1.70
1.65
1.60
1.35
2.67
to drinking habits.
Women
n
12
10
5
4
2
0.965
15
61
0.594
2
5
4
10
0.964
RR
1.00
0.83
0.71
0.97
U l
0.71
1.911
1.56
0.63
0.56
1.29
1
adjusted for confoundcrst.
Both sexes
n
19
26
17
15
19
0.091
30
23
14
20
0.044
32
18
13
24
1.000
RR|
1.00
1.22
0.84
1.51
1.95
0.91
1.81
1.88
1.66
1.59
1.18
0.79
1.38
9 5 * CI
0.63-135
0.43-1.64
0.713.21
0.40-9.64
0.50-1.65
0.91-3.58
0.84-4.13
0.57-4.80
0.83-3.04
0.62-2.24
0J8-1.63
0.66-2.89
1
0.68-4.00
0.61-4.19
0.50-3.60
0.95-7.52
* Cases diagnosed in first year of follow-up excluded; number of cases may not add up to those in Table
4 due to missing values for non-dietary variables,
t Adjusted for age, smoking, Quetelet index, history of gallbladder surgery, level of education, intake of
energy and energy-adjusted intake of fat, meat protein and dietary fiber.
t Reference category.
S Also adjusted for sex.
I All three quantitative levels combined.
1 Insufficient data for liquor consumption in women; confidence intervals based on estimates for men
only.
From the analysis presented in Table 7, which included ethanol intake as well as
one type of beverage in the model, it was evident that beer was the only beverage for
which risk was significantly increased (RR = 1.94, CI 1.09-3.47).
The estimated RR's of colon and rectal cancer for red, white and fortified wines
were comparable to those for all wine. The results with respect to alcohol consumption
were similar for subjects with and without a history of large-bowel cancer in first-degree
relatives.
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Table 7. Relative rate estimates for colon and rectal cancer (men and women combined) in multivariate
models including ethanol intake and type of alcoholic beverage*.
Variable
(•thanol(g/day)
0
O.I- 4.9
5. 0-14.9
15.0-29.9
2 30.0
p-value for trend
'type (yci/no)
p-valuc
l'.lhHn«l(g/day)
()
0.1- 4.9
5.0-14.9
15.0-29.9
2 30.0
p-value for trend
lypc (yes/no)
p-value
Beer
RR
IX»
0.72
0.61
0.95
1.17
0.893
0.86
0.466
1.00
1.01
0.61
1.04
1.31
0.525
1.94
0.012
95% CI
0.48-1.09
0.38-1.00
0.50-1.81
033-4.13
0J7-1.31
0.51-1.98
0.29-1.30
0.43-2.53
0.23-3.47
1.09-3.47
Wine
RR 95% CI
COLON
1.00
0.67 039-1.16
0.56 031-1.02
0.85 0.42-1.75
1.05 0.28-3.89
0.677
1.06 0.67-1.67
0.7%
RF.CTUM
1.00
1.60 0.77-3.33
1.10 0.51-2.41
1.96 0.82-4.69
2.62 0.49-13.9
0.031
0.69 0.41-1.16
0.149
Liquor
RR
1.00
0.74
0.65
1.04
131
0.620
0.76
0.173
1.00
1.26
0.90
1.66
2.16
0.066
0.87
0.578
95% CI
0.49-1.12
0.40-1.08
0.52-2.09
035-4.94
0.49-1.18
0.66-2.42
0.44-1.87
0.66-4.15
036-12.8
0.50-1.50
* The models included all covariatcs that were also included in the models in Tables 5 and 6, the
categorical variable ethanol intake and one type of alcoholic beverage (yes/no).
Discussion
We have presented evidence that supports a positive relationship between alcohol
consumption and rectal cancer but not colon cancer. For rectal cancer, the positive
association was most pronounced among men and referred to alcohol intake and beer
consumption, both showing a significant trend. Liquor consumption showed a
significantly increased risk in the highest consumption category, i.e. one or more drinks
per day. Multivariate analysis, however, revealed that beer was the only beverage type
that accounted for the increased risk. The results for women were compatible with
those for men, although the data were too scarce to draw definite conclusions with
respect to women specifically. For colon cancer, the U-shaped relation with amount of
alcohol consumed was very clear in men as well as women. The lowest relative rate
(RR=0.58) was observed for consumption of 5-15 g of ethanol per day. For types of
alcoholic beverage the U -shape seemed to hold as well, except for liquor which showed
a significantly negative trend (p=0.042).
Misclassification of alcohol consumers as abstainers can easily occur in self-
administered food frequency questionnaires since some subjects not only tend to skip
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items they do not consume (16.21), but possibly also items found difficult to answer.
We have minimized such misclassification by coding subjects who skipped the alcohol
items as abstainer only when this was consistent with other information on alcohol
consumption. Although the consequence of this choice may have been that the subjects
with missing alcohol data (2.4% of the men and 8.0% of the women) comprise a
relatively high proportion of actual abstainers, resulting in an underestimation of the
proportion of abstainers among the subjects included in the analysis, this is not likely to
affect the risk estimate among abstainers.
We did not try to assess lifetime alcohol consumption, which may be a more
relevant measure of exposure in the etiology of cancer than alcohol consumption during
the past year. Annually repeated administration of the questionnaire over five years,
however, has demonstrated that the correlations between the baseline and repeated
measurements of alcohol intake remained virtually stable with increasing interval
between the measurements (22). Moreover, it is well known from methodological
studies on nutrient intake that retrospective assessment of diet in the distant past is
strongly influenced by cuirent diet (23-25).
We decided, mainly on biological grounds, to exclude from the analysis all cases
diagnosed in the first year after completion of the baseline questionnaire. Exclusion
appeared to have effect on the distribution of alcohol intake among men only;
furthermore, the effect of exclusion was dissimilar for colon and rectal cancer. We do
not have a ready explanation for these differences.
Drinking habits are strongly related to dietary habits and other lifestyle
characteristics. The strong association between smoking and alcohol consumption is a
very common finding. The association between alcohol and Quetelet index, which was
shown to be positive in our male population just as in another Dutch population (26), is
not found in all populations (27), e.g. in the USA in which almost no association has
been demonstrated (28). In women, the slightly negative association corresponded with
that reported in the USA (28). Level of education is strongly and positively related to
alcohol intake. This association may be restricted to older age groups (29). The absence
of a relation with fat intake and a negative relation with fiber intake has also been
reported for other populations (30). A positive association of alcohol with protein from
meat has also been shown (30). The finding that energy from alcohol did not substitute
but is merely added to energy from other sources is consistent with many other studies
(27). All characteristics described, including history of gallbladder surgery (31), were
determinants of either colon or rectal cancer or both. Because of their strong
associations with alcohol intake, we included them in all multivariate analyses. The
results of the multivariate analysis showed, however, that the estimates of the relative
rates for alcohol consumption were only slightly confounded. It is therefore unlikely
that residual confounding due to potential inaccurate measurement of these
confounders explains the association found between alcohol intake and rectal cancer.
We cannot entirely exclude, of course, the possibility that another, unevaluated
confounder is involved in this relation.
The consistent U-shaped dose-effect relation for alcohol intake and colon cancer
may be considered to result from the choice of abstainers as reference category. The
group of abstainers may comprise subjects with "deviant" characteristics and an
increased risk for (colon) cancer. Nevertheless, we had a number of reasons to choose
abstainers as sole reference instead of, for example, abstainers and very light drinkers
combined. First, from the dose-response curves presented, the effect of the choice of a
different reference group can be interpolated. This is not true if a combined reference
group is used. Second, it is unlikely that the much larger, culturally determined,
proportion of female abstainers comprised a similar proportion of "deviant" subjects as
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male abstainers. We nevertheless observed the same U-shaped relationship for women.
Third, combining abstainers with the group having an intake of less than 5 gram
ethanol per day would still show a U-shaped curve, since the lowest risk is associated
with a consumption between S and IS g of ethanol daily, corresponding to
approximately one glass. U-shaped curves have also been reported in other studies. A
case-control study in France (6) found the lowest RR of colon cancer for an alcohol
intake of 10-15.5 ml per day in women; in men, for whom not any association was
observed, alcohol intake was much higher. Stemmermann et al. (5) observed in a
prospective study among Japanese in Hawaii the lowest risk at a slightly lower level of
alcohol consumption. The monotonie significantly decreasing relative rate for colon
cancer for increasing liquor consumption has not been reported in other studies.
Unlike the results of the meta-analysis (1), which averaged the results over all
studies included, our study showed a clearly increased risk for rectal cancer, whereas
the risk of colon cancer tended to be reduced at moderate alcohol consumption levels.
This result is in line with other studies reporting a higher risk for rectal than for colon
cancer. Some of these studies were included in the meta-analysis (3,4,32), while others
have been published later (6,7). Beer consumption is also implicated in an increased
risk for rectal cancer in a substantial number of studies (2,3,5,6,8,9). Cohort studies
among brewery workers have provided evidence of an increased risk of rectal cancer
among beer drinkers in Ireland (33) and Sweden (34), but not in Denmark (10).
Correlation studies have also supported the relation between beer consumption and
rectal cancer (25,36). The study by Potter et al. (36) furthermore presented evidence
thnt the sex ratio of rectal cancer mortality is higher than unity in beer drinking
countries in contrast to countries where beer consumption is low. We have calculated
from our data (Table 7) the number of cases attributable to beer drinking (37). The
high proportion of male (57%) compared to female (9%) beer drinkers appeared to
explain part of the difference in incidence of rectal cancer between men and women. In
men, 25 of the 73 cases were attributable to beer consumption, and in women only 3
out of 33.
The mechanism for the effect of alcohol on the development of colorectal cancer is
not clear. Contrary to the upper digestive tract, which has direct contact with the
ingested alcohol, the influence on the lower digestive tract must be indirect. One of the
most plausible explanations is the effect of alcohol on liver enzymes, demonstrated in
rats, which results in decreased "first-pass clearance" of carcinogens, in particular
nitrosamines (38). Other explanations include the effect of ethanol on cell proliferation
of rectal mucosa, possibly caused by the ethanol metabolite acetaldehyde (38). It may
be that the consumption of alcohol increases risk due to a combined action of ethanol
and contaminants in alcoholic beverages. This may also explain the differences between
results of epidemiological studies.
It has been shown that beer in the Netherlands used to be contaminated with a
relatively large amount (mean 1.2 u,g/kg) of N-nitrosodimethylamine (NDMA) (39).
Beer accounted for 90 % of NDMA intake of beer drinkers, whose intake of NDMA
was ten times higher than that of non-beer drinkers. The contamination of beer with
NDMA, which was caused by direct heating of the malt through gas-firing, was
discovered in 1978. Subsequent changes in de production process of malt since 1979
decreased the contamination with NDMA to low levels (40). From other countries (e.g.
Germany, New Zealand. USA) high NDMA levels in beer have also been reported (41,
42). If contamination of beer with nitrosamines has caused the increased risk for rectal
cancer, we would expect a decrease in relative risk associated with beer drinking over
time. It is likely that we have observed in our study, conducted eight to ten years after
the change in beer production, a relative risk that is still influenced by beer
consumption before 1979. Unfortunately, no data are available from earlier studies in
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the Netherlands. A direct proof of the role of nitrosamine contamination of beer in the
development of rectal cancer in man may come from future studies in this country; we
would expect the relative risk associated with the consumption of beer adjusted for
alcohol to reduce.
If beer consumption is causal to the development of rectal cancer, we would expect
an increasing risk with increasing dose. Such a dose-response relation, however, was not
evident from our data. It is plausible to presume that the quantitative assessment is
likely to refer more to the recent than to the distant past (i.e. more than ten years
before baseline). If it is true that beer consumption did not entail a higher risk during
the eight years immediately preceding baseline assessment, then the assessment may not
have been sufficiently related to the quantitative intake of beer before that period,
resulting in the absence of a dose-response relation.
In conclusion, alcohol consumption did not increase risk for colon cancer; light to
moderate intake, i.e. less than two drinks per day, even implied a significantly decreased
risk, which held for all types of alcoholic beverages. Risk of rectal cancer, on the
contrary, is clearly increased for moderate to heavy alcohol consumption (more than 30
gram per day). The enhancing effect appeared to be mainly attributable to the
consumption of beer. Light to moderate consumption of alcoholic beverages docs not
appear to be harmful with respect to overall risk of colorectal cancer, but rather tends
to reduce risk. If the increased risk of rectal cancer by beer was caused by its high
content of nitrosamines in the past, then this problem has been solved already. The
data do not permit a conclusion about the risk of very heavy drinkers, since this
category was insufficiently represented in the cohort.
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Abstract
The association between the consumption of meat and cancer of the colon was
investigated in a prospective cohort study on diet and cancer, which Is being conducted
in the Netherlands since 1986 among 120,852 men and women, aged 55-69. The
analysis was based on 215 incident cases of colon cancer (105 men and 110 women)
accumulated In 3.3 years of follow-up, excluding cases diagnosed in the first year of
follow-up. No trends in relative rates were detected for intake of energy and energy-
adjusted intake of fats, protein, fat from meat and protein from meat. Consumption of
(fresh) meat, beef, pork, minced meat, chicken and fish was not associated with risk of
colon cancer either. Meat products, however, were shown to increase risk in men and
women (RR 1.17 per 15 g/day, 95% confidence interval 1.03-1.33).
Submitted for publication
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Introduction
A number of articles have reviewed the epidemiologie evidence for an association
between dietary habits and the risk of colon cancer (1-4). Although consensus as to a
protective effect of dietary fiber seems to develop, debate remains about the relation
between meat consumption and/or fat intake and colon cancer. In case-control studies,
positive associations with meat consumption or with fat intake have been found
frequently, but the majority of the studies conducted yielded non-significant results
(5,6). Few results are available from prospective studies, which may carry more weight
than case-control studies in assessing the relation between diet and cancer since they
are presumed not to be biased by recall of past dietary habits after the cancer has been
diagnosed. All but two prospective studies were conducted in the USA. Bjelke (7)
found an increased relative risk for processed meat only (Norway, 65 cases). Hirayama
(8) observed an increased risk of colon cancer with frequency of meat consumption in
the group with infrequent vegetable consumption among a cohort of 265,000 men and
women in Japan. Phillips and Snowdon (9) did not find a clear gradient in risk for
frequency of meat and poultry consumption in a population of Seventh Day Adventists
(139 cases), which included a large proportion of vegetarians. A prospective study
among Hawaiian Japanese men (102 cases, 10) found a negative association with fiber
intake, but no association with meat and fat consumption. A more recent analysis of
those data, including more cases (182), showed a negative tendency for the association
with fat intake (II). A publication on the Nurses' Health Study, a prospective study
among female nurses, snowed an increased risk of colon cancer (150 cases) for the
consumption of meat, in particular beef, pork and lamb, and also for the intake of fat,
in particular saturated and monounsaturated fat (12). Quite surprisingly, the association
between animal protein and the risk of colon cancer was found to be slightly inverse in
this study. A comparable prospective study among middle-aged women, using a similar,
although extended, dietary questionnaire, did not find an association of colon cancer
(158 cases) with fat nor with fiber intake (13). In the large Cancer Prevention Study II
(1150 fatal cases) no association with meat consumption or fat intake was observed
(14).
We have studied the relation between meat consumption and the risk of colon
cancer in a prospective cohort study on diet and cancer that was initiated in the
Netherlands in 1986. Apart from meat consumption, we also included fat and protein in
the analysis to obtain better insight into the origin of a possibly increased risk.
Consumption of fish was included since it may substitute meat consumption.
Subjects and methods
The cohort
The prospective cohort study on diet and cancer has been initiated in the
Netherlands in September 1986. The cohort included 58,279 men and 62,573 women
aged 55-69 at the start of the study. The study population originated from 204
municipal population registries throughout the country. At baseline, the cohort
members completed a mailed, self-administered questionnaire on dietary habits and
other risk factors for cancer. For data processing and analysis the case-cohort approach
was used: the cases were enumerated for the entire cohort while the person years at
risk accumulating in the cohort were estimated from a random sample (subcohort). This
subcohort of 3500 subjects (1688 men, 1812 women) was sampled from the cohort after
baseline measurement and was followed up for vital status over 3.3 years. The study
design has been described in detail elsewhere (15).
Meal and colon cancer 131
Follow-up for cancer
Follow-up for incident cancer was established by computerized record linkage with
all nine regional cancer registries in the Netherlands and with PAI.GA, the Dutch
national data base of pathology reports. The method of record linkage has been
published previously (16). The present analysis is restricted to cancer incidence in the
period from September 1986 (baseline measurement) to December 1989, i.e. a follow-
up period of 3.3 years. In this period, completeness of follow-up of the cohort through
linkage with the cancer registries and PALGA was estimated to be 95% (17). After
excluding subjects who reported a history of cancer other than skin cancer in the
baseline questionnaire, a total of 312 incident cases with microscopically confirmed
primary adenocarcinoma of the colon (i.e. cecum through sigmoid colon) were
identified (157 men and 155 women).
Questionnaire
The self-administered questionnaire has been described in more detail elsewhere
(17). For the present analysis, characteristics of interest are summarized below. The
dietary section of the questionnaire, a 150-item semi-quantitative food frequency
questionnaire, concentrated on habitual intake of food and beverages during the year
preceding the start of the study. The questionnaire contained 14 items on the
consumption of meat with the hot meal (mainly fresh meat, including chicken), 5 items
on the consumption of meat products, which are used as sandwich filling, and 3 items
on fish consumption. As for the serving sizes, a question was included on the quantity
of (fresh) meat usually purchased (per person, per meal). For meat products, the
number of sandwiches filled with a product was asked. For chicken and fish standard
serving sizes were used.
Dairy mean nutrient intakes were calculated using the computerized Dutch food
composition table (18). Energy adjustment of nutrient intakes was done by regression
analysis according to Willett and Stampfer (19). The questionnaire was validated against
a 9-day diet record (Goldbohm et al., submitted for publication). The Pearson
correlation coefficients between the mean dairy intakes of energy, protein, fat, and fiber
as assessed by the questionnaire and those estimated from the 9-day record were 0.70,
0.61, 0.72 and 0.74 respectively; the corresponding energy- and sex-adjusted correlation
coefficients were 0.59, 0.52 and 0.74. The Spearman correlation coefficients for meat,
meat products and fish were 0.46, 0.54 and 0.53 respectively.
Data analysis
Questionnaire data of all 312 cases and the subcohort were key-entered twice and
processed in a manner blinded with respect to case/cohort status in order to minimize
observer bias in coding and interpretation of the data. After excluding prevalent cancer
cases other than skin cancer from the subcohort, 3346 subjects (1630 men and 1716
women) remained in this group. Furthermore, subjects with incomplete or inconsistent
dietary data, according to criteria described by van den Brandt et al. (17), were
excluded (7.0%). Eventually, 150 male and 143 female colon cancer cases and 1525
male and 1598 female subcohort members were included in the analysis.
Fats and types of fat, protein as well as animal fat and animal protein (the latter
two excluding fat and protein from dairy sources and margarine) were separately
evaluated. Furthermore, dairy mean consumption of the following food groups was
included in the analysis: beef, pork, minced meat (mixed beef and pork), meat products
(i.e. raw and cooked cured meat products and sausages), chicken and fish. Some of
these food groups resulted from collapsing several items from the questionnaire.
Variables were initially included as quintile categorical variables, except fish and meat
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products, which were classified into a non-user and three user categories (0-10, 10-20,
£20 g/day). Specific types of meat and meat products were only included as continuous
variables in models that compared overall consumption with that decomposed in types.
Age, dietary fiber intake and Quetelet index (kg/m*) were considered as potential
confounders.
Data were analysed using the case-cohort approach (20), assuming exponentially
distributed survival times in the follow-up period. Since standard software was not
available for this type of analysis, specific programs were developed to account for the
additional variance introduced by sampling from the cohort instead of using the entire
cohort (17). Since subclinical symptoms of large-bowel cancer may influence dietary
habits before diagnosis, we excluded cases in the first year of follow-up after assessing
the mean intake of cases diagnosed in different follow-up years.
Results
Table 1 presents mean daily intake of the variables most relevant to this analysis for
subcohort and cases categorized according to year of diagnosis. Among men, energy
intake was lower in cases diagnosed in the first year of follow-up, but energy-adjusted
fat intake remained fairly constant. Among women, no appreciable difference in
absolute intake was detected, but energy-adjusted intake of fat and protein appeared to
be lower in the cases diagnosed in the first year of follow-up. None of these differences,
however, reached statistical significance. Subsequent analyses excluded cases diagnosed
in the first year.
Table 1. Hncrgy, fat and protein intake in the subcohort and colon cancer cases according to year of
diagnosis.
Nutrient
lïnergy (kcal)*
Subcohort
Cases
Fat (g)t
Subcohort
Cases
Protein (g)t
Subeohort
Cases
Meat fat (g)tt
Subcohort
Cases
Meat protein (g)tt
Subcohort
Cases
Year of diagnosis
1
2
£ 3
.
1
2
a 3
.
1
2
£ 3
.
1
2
2 3
.
1
2
2 3
Men
n
1519
45
46
59
1519
45
46
59
1519
45
46
59
1519
45
46
59
1519
45
46
59
Mean
2159
1930
2194
2072
93.7
93.0
933
94.9
75.4
72.1
75.7
74.0
19.9
20.1
20.1
20.4
28.0
28.9
27.5
27.7
SD
509
419
435
436
14.4
15.2
12J
13.0
11.4
10.2
8.6
9.6
8.4
6.6
8.6
8.6
9.6
9.5
8.2
103
Women
n
1592
33
38
72
1592
33
38
72
1592
33
38
72
1592
33
38
72
1592
33
38
72
Mean
1688
1723
1592
1673
74.2
71.6
72.8
75.5
65.7
643
66.2
65.5
15.8
14.0
15.0
15.4
24.0
21.7
24.0
23.5
SD
409
516
390
378
10.5
8.6
10.7
113
10.6
9.0
10.6
12.0
7.2
6.5
8.1
8.1
9.0
8.5
8.6
9.1
Age-adjusted; t Age- and energy-adjusted; t Meat fat and protein: animal fat and protein excluding
dairy sources and margarine.
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Table 2. Sex-adjusted Pearson correlation coefficients between meat types and intake of energy and
energy-adjusted fats, protein and dietary fiber in the subcohorl
Nutrient
Energy
Fal
Saturated
Monounsaturatcd
Poryunsaturated
Protein
Meat fat
Meat protein
Dietary fiber
Fresh
Total
(UI
0.21
0.15
033
-0.03
0.46
0.67
0.84
-0.18
meat
Beef
0.09
0.03
0.08
0.05
-0.08
024
0.15
039
-0.05
Pork
0.13
0.19
0.11
028
0.01
024
0.59
0.53
-0.17
Minced*
0.05
0.15
0.14
0.21
-0.03
0.18
0.44
0.27
-0.06
Chicken
0.03
OX»
-0.06
0.03
0.06
020
-0.08
0.28
0.01
lish
0.10
-0.06
-0.10
-0.06
0.05
022
-0.07
031
0.01
Meat products
032
0.03
0.01
0.08
0.02
022
0.40
038
-0.05
* Composed of beef and pork
Table 2 gives the Pearson correlation coefficients for meats with energy intake and
energy-adjusted intakes of fats, protein and dietary fiber. Meat consumption was not
strongly correlated with energy intake. The relatively high correlation of meat products
with energy could be explained by the association of bread consumption with energy.
Consumption of pork appeared to contribute most to the intake of fat, in particular
monounsaturated fat. The consumption of meat and meat products was positively
associated (r: 0.14), whereas meat and fish consumption were not related. Consumption
of chicken correlated negatively with other types of meat (r: -0.05 to -0.13).
Table 3 displays the relative rates (RR) of colon cancer for energy intake and
energy-adjusted intakes of fats and protein. None of the variables showed any evidence
of a (positive or negative) trend across quintiles of intake. For fat and protein derived
from meat no trend was detected either (Table 4). In Table 4, the pooled estimates for
men and women, which were also adjusted for dietary fiber intake, did not show any
association with risk either.
Table 5 shows the relative rates for the consumption of meat (including chicken),
meat products and fish. These data were adjusted for energy intake by including energy
in the multivariate model. The results for meat were consistent with those from Table
4, i.e. no evidence of a trend. Similar results were seen for frequency of meat
consumption. The RRs were 0.65, 0.56, 0.78, and 0.81 for consumption frequencies of
3/4, 5, 6 and 7 days per week respectively, relative to the reference group using meat on
0-2 days per week. Consumption of meat products, however, showed a (non-significant)
positive trend in men (p=0.06) and women (p=0.10).
For fish consumption a weakly negative, but not significant association with colon
cancer occurrence was observed. Pooled results for men and women in the table were
also adjusted for dietary fiber intake, which had a small effect on the estimates. As was
to be expected, only meat products showed a significant (p=0.017) positive trend. When
fitted as a continuous variable, this resulted in a RR of 1.17 (95% Cl 1.03-1.33) for an
increment of 15 g (equivalent to one sandwich filling) of mean dairy consumption of
meat products. Introduction of fat from meat into the models for meat and meat
products did not have any effect on the estimates for meat, but strengthened the
association between meat products and colon cancer (p=0.007). Addition of the
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Quetelet index, which was positively associated with meat consumption, to the models
did not change the estimates.
Table 3. Age-adjusted relative rates (RK) for quintiles of energy and energy-adjusted nutrient intakes.
Nutricn
quintile
Energy
1
2
3
4
5
p-valuc
1
2
3
4
5
p-valuc
t Men
Median'
(kcal)
1510
1836
2096
2364
2791
for trend
76
87
94
100
111
for trend
Saturated fat (g)
1
2
3
4
5
p-value
28
32
36
40
47
for trend
nt 1
23 1
<R
.00
21 0.92
13 1
24 1
.02
.09
14 0.72
20 1
22 1
0.624
.00
.14
18 0.87
23 1
22
21
.11
.10
0.793
.00
17 0.79
27 ] .13
20 0.90
20 0.90
Monounsaturatcd fat (g)
1
2
3
4
5
p-valuc
27
32
35
38
43
for trend
Polyunsaturatcd fat
1
2
3
4
5
p-valuc
Protein
1
2
3
4
5
p-value
II
15
18
23
31
for trend
(g)
61
69
75
81
90
for trend
21 1
0.882
.00
18 0.91
21 .03
20 0.94
15
(g)
16
20
26
19
24
19
24
25
15
.26
0.453
.00
.20
.63
.17
.49
0.297
.00
36
37
.53
12 0.67
0353
95% CI
-
030-1.70
036-1.86
0.60-1.98
036-1.45
0.61-2.13
0.45-1.67
0.60-2.07
0.59-2.07
-
0.41-1.52
0.68-2.23
0.47-1.69
0.47-1.70
0.47-1.75
035-1.93
0.50-1.77
0.69-131
0.61-2.37
0.86-3.11
039-2.32
0.77-186
0.72-156
0.74-155
0.82-187
032-1.43
Women
Median'
1163
1435
1626
1848
2200
61
69
74
79
87
23
27
29
32
37
22
25
27
30
33
8
12
14
18
24
53
60
65
70
79
nt
25
21
31
15
18
24
19
17
22
28
21
23
18
17
31
20
25
24
23
18
21
20
24
19
26
23
20
18
15
24
RR
1.00
0.85
1.22
0.62
0.75
0.233
1.00
0.79
0.72
0.91
1.13
0315
1.00
1.10
0.85
0.79
136
0311
1.00
1.19
1.15
1.10
0.88
0.628
1.00
0.99
1.20
0.99
1.29
0.415
1.00
0.88
0.80
1.09
1.05
0.634
95% CI
-
0.47-135
0.70-2.12
032-1.20
0.40-1.41
0.42-1.47
038-1.36
030-1.67
0.64-100
-
039-2.02
0.45-1.63
0.41-133
0.77-2.42
-
0.65-2.19
0.62-114
0.59-105
0.45-1.69
-
033-1.86
0.65-120
032-1.91
0.71-135
0.47-1.63
0.42-130
0.61-1.96
038-1.89
Both sexes
RRt
1.00
0.88
1.12
0.84
0.74
0.236
1.00
0.90
0.74
0.94
1.07
0.684
1.00
0.88
0.97
0.77
1.07
0.914
1.00
0.98
1.01
0.91
1.00
0.882
1.00
1.04
135
1.04
138
0.186
1.00
1.10
1.05
1.28
0.90
0.953
95% CI
-
0.67-1.14
0.87-1.46
0.54-131
039-139
0.57-1.41
0.46-1.18
0.60-1.46
0.70-1.64
0.56-1.40
0.62-1.52
0.48-1.23
0.69-1.66
0.62-133
0.64-139
038-1.44
0.63-137
0.65-1.67
0.86-2.13
0.64-1.69
0.88-2.16
0.70-1.71
0.67-1.65
0.82-2.00
037-1.42
* Median of energy or nutrient intake in the quintile.
t Number of colon cancer cases in the quintile.
t RR also adjusted for sex and dietary' fiber intake.
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Table 4. Age-adjusted relative rates (RR) for quintiles of energy-adjusted intake of fat and protein
derived from meat.
Nutrient Men
quintOe
Meat
1
2
3
4
5
Median
fat(g)
10
16
19
23
31
p-valuc for trend
Meat
1
2
3
4
5
protein (g)
17
23
27
32
41
p-valuc for trend
n
24
18
20
17
26
21
26
18
20
20
RR
1.00
0.75
0.86
0.73
1.13
0.724
1.00
1.18
0.87
0.94
1.00
0.714
95% CI
0.40-1.42
0.46-1.59
0J8-1.38
0.63-2.02
0.65-2.15
0.45-1.67
0.50-1.77
0-52-1.90
Women
Median
7
12
15
19
25
13
20
24
28
35
n
24
29
13
22
22
20
24
22
19
25
RR
1.00
1.22
0.56
0.90
0.94
95% CI
0.70-2.15
0.28-1.12
0.49-1.64
0.52-1.72
0.474
1.00
1.21
1.05
0.94
1.24
0.65-2.24
0.56-1.97
0.49-1.79
0.68-2.29
0.769
Both;
RR*
1.00
0.95
0.66
0.76
0.98
mes
9 5 * CI
0.62-1.45
0.42-1.05
0.49-1.19
0.64-1.49
0.668
1.00
1.16
0.91
0.90
1.07
0.75-1.78
0.58-1.44
0.57-1.42
0.69-1.67
0.792
* RR also adjusted for sex and dietary fiber intake.
Table 5. Relative rates (RR) for meat, meat products and fish consumption.
Food
group
Men
Median
Meat (g)$
j
2
3
4
5
p-value
54
84
101
123
158
for trend
Meat products (g)
0
0-10
10-20
S 20
p-value
Fish(g)
0
0-10
10-20
a 20
p-value
for trend
for trend
n
20
22
30
18
15
9
30
29
37
34
28
11
32
RR*
1.00
1.09
1.62
0.98
0.87
0.704
1.00
1.25
1.45
1.84
0.061
1.00
0.84
0.41
0.73
0.093
95% CI
_
0.58-2.04
0.89-2.93
0.51-1.91
0.43-1.77
0.59-2.70
0.67-3.12
0.85-3.95
0.50-1.42
021-0.83
0.44-1.21
Women
Median
43
72
91
107
145
n
24
19
26
22
19
14
44
30
22
36
25
22
27
RR*
1.00
0.83
1.03
1.05
0.88
0.969
1.00
1.22
1.48
1.66
0.097
1.00
1.14
1.14
0.87
0.635
95% CI
0.44-1.56
0.58-1.84
0.57-1.93
0.45-1.69
0.66-2.26
0.77-2.87
0.82-3.35
0.67-1.94
0.66-1.97
0.52-1.45
Both i
RRt
1.00
0.92
1.24
0.98
0.84
KXCS
95% CI
0.59-1.44
0.81-1.90
0.62-1.55
0.51-1.37
0.618
1.00
1.23
1.43
1.72
0.76-1.98
0.87-2.35
1.03-2.87
0.017
1.00
1.00
0.74
0.81
0.68-1.47
0.48-1.15
0.56-1.17
0.139
* Age (year) and energy included in model as continuous variables.
t RR also adjusted for sex and dietary fiber intake.
t Including all types of meat (except meat products) and chicken.
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The results of a further subdivision of meat and meat products are shown in Table
6, which displays the RRs for an increment in consumption of IS g/day. For (fresh)
meat, none of the results for types of meat deviated from those for total meat. For
meat products, however, "other meat products", which mainly represented sausages,
appeared to contribute most to the elevated RR.
Table 6. Mean, standard deviation and age- and energy-adjusted relative rate for types of meat and
meat products, fitted as continuous variables.
'lypc (g/day)
All (fresh) meat
Beef
Pork
Minced meatt
Liver
Chicken
Other meal
All meal product!
Hum
HiK'ont
1 onii meat products 1
Cooked liver
Other meat productsU
Model'
>
b
b
b
b
b
b
c
d
d
d
d
d
Mean
99
25
38
18
2
14
3
14
4
1
3
1
5
SD
42
22
30
17
4
16
6
16
7
4
S
2
8
RRt
0.98
0.96
0.99
0.91
0.90
1.03
0.99
1.17
1.04
1.25
1.14
0.15
1.27
95% CI
0.93-1.03
0.87-1.06
0.92-1.06
0.80-1.04
0.54-1.48
0.90-1.17
0.66-1.47
1.03-1.33
0.78-1.39
0.84-1.88
0.82-1.61
0.02-1.12
1.04-1.55
• Models were fitted for: (a) total (fresh) meat; (b) (fresh) meat decomposed in types; (c) total meal
products; (d) meat products decomposed in types; all models were adjusted for sex, age and energy.
l.R-X^ for the (combined) meat terms: 0.99, 3.33, 5.77, 11.13 for models a to d respectively.
t KR per increment of 15g/day, equivalent to one standard sandwich filling.
t Composed of beef and pork.
§ Raw cured belly and dried backs.
I Raw cured smoked beef, lean cooked ham, lean cooked pork.
H Mainly sausages.
Discussion
We have presented evidence from a prospective study that the consumption of
meat, fat from meat or protein from meat is not associated with an increased risk for
colon cancer. The consumption of meat products, in contrast, appears to be consistently
and positively related to risk for colon cancer.
After excluding the cases diagnosed in the first year of follow-up, this study
included 215 colon cancer cases, indicating that it had reasonable but not very large
power. We have thus to take into consideration that existing associations may not have
been detected only because of insufficient power. Furthermore, the validity of the FFQ
with respect to fat intake and consumption of meat and meat products was not very
high. For (energy-adjusted) fat intake and meat consumption, this was mainly caused by
the relatively small variation in intake in the population. For consumption of meat
products, which varied much more in the population studied, the relatively low validity
may be attributable to underreporting which may have varied among subjects
(Goldbohm et al.submittcd). Taking into account these limitations, there appears
nevertheless to be a considerable difference in risk for colon cancer in this population
between meat (and fat) consumption on the one hand and meat products on the other,
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the latter showing a consistently increasing risk with increasing consumption in men as
well as women. The consumption of (fresh) meat and specific types of meat (beef, pork,
minced meat and chicken), in contrast, does not display any trends in risk, whereas the
highest quintile is lower than unity most of the time.
We also have to consider the possibility that the results can be explained by
confounding by dietary or other determinants of colon cancer. However, we have
adjusted for intake of dietary fiber and Quetelet index, which resulted in virtually
unchanged relative rate estimates. Other nutrients were no or only weak determinants
of colon cancer. Smoking and alcohol consumption have also shown to be hardly
related to colon cancer in this data set (Goldbohm et al., submitted for publication).
Comparing our results with findings of others, we may conclude that those for
(fresh) meat are in agreement with the substantial number of epidemiologie studies
showing no association (7,9,10,14,21-27). The consumption of meat products or
processed meat has been investigated in a smaller number of studies
(7,9,12,14,21,22,25-34). Most of these studies, however, did not find an increased risk
for (types of) processed meat, with exception of Bjelke (18), Young et al. (27) (for
lunchmeat only), Willett et al.( 12) and Thun et al.( 14). This does not necessarily mean
that our finding for meat products is a chance finding. Meat products differ from fresh
meat in that they have been processed, i.e. cured after the addition of preservatives
(salt, nitrite, smoke) and other additives (phosphate, glutamate, ascorbic acid). In the
Dutch population, (fresh) meat, usually beef, pork, minced meat or chicken, or fish are
part of the hot meal, which is taken once per day and further includes vegetables and
(usually) potatoes. Meat products, on the other hand, may or may not constitute part of
the sandwich meals, which are taken by most people twice dairy. It may be that in this
population the circumstances in which meat products are eaten - as sandwich without
vegetables and often without fruits in the same meal - are important determinants for
the risk. Unfortunately, we do not yet have a sufficient number of cases to explore
these possibilities.
The conflicting results between studies regarding meat consumption and colon
cancer risk may be attributable to a number of sources. First, the validity of the dietary
questionnaire may have been insufficient in some studies. This is in particular critical
when the variability in the study population with respect to meat consumption and fat
intake is small. Second, the age of study population differed between studies. Available
evidence suggests that associations may be stronger at younger ages (7). This may be
one of the explanations for the positive result in the Nurses' Health Study, which is
based on a relatively young cohort (12). Third, risk of colon cancer may depend on the
method of preparation of the meat (products), which is likely to differ between
populations. Gerhardsson de Verdier et al.(32) observed an increased risk for subjects
who preferred meat with a heavily browned surface. There appears, however, to be no
clear relationship between risk and the temperature at which meat is prepared
(27,32,35). We did not inform about methods of meat preparation in our study, but in
this country it is usually panfried or stewed. Last but not least, one of the most
plausible explanations is the population level of and variability in the consumption of
other foods, such as (specific) vegetables, which may modify the effects of meat
consumption (8,36,37). Large studies are required, however, to study effect modification
in a relatively homogeneous population.
We conclude from the data presented here that our prospective study does not
support the hypothesis that a higher consumption of (fresh) meat increases the risk of
colon cancer within the range of meat consumption and fat intake prevailing in the
population studied. Consumption of meat products, on the other hand, appears to be
associated with an increased risk for colon cancer in this population. These results
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warrant further analysis, in particular in combination with other foods and nutrients,
when the number of cases has accrued.
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Chapter 14
Cholecystectomy and colorectal cancer: evidence from a
cohort study on diet and cancer*
R. Alexandra Goldbohm'-*, Piet A. van den Brandt*. Pieter van 't Veer',
Elisabeth Dorant*, Ferd Sturmans\ Rudolph J.J. Hermus'.
Abstract
The association between cholecystectomy and subsequent risk for colorectal carcinoma
was investigated in a prospective cohort study on diet and cancer, which Is being
conducted in the Netherlands from 1986 onwards among 120,852 men and women,
aged 55-69. After a follow-up period of 3.3 years, 478 incident cases of colorectal cancer
(258 men and 220 women) were identified in the cohort, 64 of whom reported at
baseline to have undergone previous gallbladder surgery (21 men and 43 women). After
adjustment for age and familial history of large bowel cancer, the relative rate (RR) for
colorectal cancer in cholecystectomized subjects compared to non-cholecystectomlzed
subjects was 1.81 in men (p=0.02) and 1.47 in women (p=0.05). Additional adjustment
for parity, Quetelet index, alcohol intake and other dietary variables resulted In an RR
of 1.78 in men and 1.51 in women. In women, the highest RR was detected in the right
colon (RR=1.89), whereas in men, no specific segment of the large bowel accounted
specifically for the increased relative rate. In both men and women, the rate appeared
to increase from approximately six years after cholecystectomy onward. According to
the TNM stage of the disease, patients who had undergone cholecystectomy were not
detected at an earlier stage than the other patients. It is concluded that in this study
the positive association between colorectal cancer and cholecystectomy cannot be
explained by detection bias or ascertainment bias and is not confounded by risk factors
for gallstone disease or dietary factors.
' Accepted in shortened form in the International Journal of Cancer
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Introduction
Over the last decade, many studies have been published on the association between
cholecystectomy and colorectal cancer. Many of these, often small, studies have
reported a positive association. The possibly increased risk for colorectal cancer after
removal of the gallbladder is often explained by the higher turnover of bile acids;
bacterial degradation then increases the proportion of secondary bile acids (mainly
deoxycholic acid) in the bile and thus in the large intestine (1). It has also been shown
that the mitotic index of the colonic mucosa, as indicator of cell proliferation, increases
after cholecystectomy (2).
Among the studies with a reasonable number of cases (e.g., more than 30 cancer
cases with cholecystectomy), the case-control studies by Vernick and Kuiler (3),
Moorehead et al. (4), Lee S.S. et al. (5) and Berkel et al. (6) and the follow-up studies
by Linos et al. (7) in the USA and Nielsen et al. (8) in Iceland reported a positive
association. The last study found the increased risk in men only, as in the autopsy study
by Breuer et al. (9) on gallstones and colorectal cancer. Many of the former studies
found the highest risk for right-sided colon cancer (3,4,6,7), sometimes restricted to
women only. Some groups compared right-sided with left-sided colon cancer cases
(3,10-13). All but Abrams et al. (12) found an increased relative risk (RR) for right-
sided colon cancer, varying from 1.5 to 2.4. However, a number of large studies
reported no association at all (14-16); even a negative association has been reported
from a large follow-up study in Sweden (17). Trying to explain the findings, some
(15,18) have suggested that the positive association may be due to an artifact such as
"medical attention" or "detection" bias: people seeking medical care for gallstone
disease, who are more likely to undergo a cholecystectomy, may also tend to visit a
doctor earlier for symptoms of colorectal cancer. Consequently, cancer in patients who
underwent cholecystectomy would then be diagnosed at an earlier stage compared to
those in other patients and might therefore artifactually increase relative risk.
Another explanation may be "ascertainment" bias, which is introduced when
ascertainment of previous cholecystectomy is more thorough for cases than for controls.
For example, this may happen when hospital records are used to determine whether
study subjects have undergone gallbladder surgery: it is conceivable that colorectal
cancer patients, during their extensive diagnostic work-up and surgery, are more likely
to have cholecystectomy recorded, if they ever had it, than control subjects with other
diseases such as breast or lung cancer. However, this explanation may not be very
plausible for studies comparing right-sided with left-sided colon cancer. Further
explanations for the inconsistent findings include confounding or effect modification by
other risk factors for colorectal cancer, such as diet. Most of the published studies
controlled for age and sex only, presumably because other data were not available. The
very few studies that controlled for dietary factors (19, 20) were very small.
We have conducted a prospective cohort study among more than 120,000 middle-
aged men and women with the primary purpose to evaluate the relation between diet
and cancer (21). Risk factors for gallstone disease and colorectal cancer as well as the
prevalence and age at which cholecystectomy took place were assessed. The availability
of this information, together with data on the TNM stage, present for a large part of
the colorectal cancers diagnosed, provided the opportunity to assess whether the
suggested biases may have had any effect on the association.
Cbokcystectomy and coktrecul cancer 143
Subjects and methods
The cohort
The prospective cohort study on diet and cancer has been initiated in the
Netherlands in September 1986. The cohort included 58,279 men and 62,573 women
aged 55-69 at the start of the study. The study population originated from 204
municipal population registries throughout the country. At baseline, the cohort
members completed a mailed, self-administered questionnaire on dietary habits and
other risk factors for cancer. For data processing and analysis the case-cohort approach
was used: the cases were enumerated for the entire cohort, while the person years at
risk accumulated in the cohort were estimated from a random sample (subcohort). A
subcohort of 3500 subjects (1688 men, 1812 women) was sampled from the cohort after
baseline measurement and was followed up for vital status over 3.3 years. The study
design has been described in detail elsewhere (21).
Follow-up for cancer
Follow-up for incident cancer was established by computerized record linkage with
all nine regional cancer registries in the Netherlands and with PALGA, the Dutch
national data base of pathology reports. The method of record linkage has been
published previously (22). The present analysis is restricted to cancer incidence in the
period from September 1986 (baseline measurement) to December 1989, i.e. a follow-
up period of 3.3 years. In this period, completeness of follow-up (i.e. ratio between
number of observed and number of expected cases) of the cohort through linkage with
the cancer registries and PALGA together is estimated to be 95% (23). After excluding
subjects who reported a history of cancer other than skin cancer in the baseline
questionnaire, a total of 478 incident cases with microscopically confirmed primary
colorectal adenocarcinoma were identified (258 men and 220 women). Colorectal
cancer was classified according to site as follows. Right colon: cecum through transverse
colon (ICD-Oncology codes: 153.0, 153.1, 153.4, 153.5, 153.6); left colon: splenic flexure
through sigmoid colon (ICD-Oncology codes: 153.2, 153.3, 153.7); rectum: rectosigmoid
and rectum (ICD-Oncology codes: 154.0 and 154.1).
To investigate whether detection bias played a role in the association between
cholecystectomy and colorectal cancer, the anatomical extent of the primary tumor (T),
as assessed according to the criteria of the TNM classification, was used to compare
cancer patients who had undergone cholecystectomy with those who had not. The TNM
stage was available for 258 cases, all originating from the cancer registries (from four of
the nine registries for cases diagnosed in 1989 only). The PALGA registry, the source
for 19% of all colorectal cases, did not include data on stage of disease.
Questionnaire
A self-administered questionnaire was used at baseline to collect data on dietary
habits, and (possible) risk factors for colon, rectum and other cancers. The dietary part
of the questionnaire, concentrating on habitual food intake during the year preceding
the start of the study, includes 150 food items and has been validated against a 9-day
diet record. Other factors relevant to the association between cholecystectomy and
colorectal cancer concern: lifetime history of smoking habits, anthropometry (height
and weight), reproductive history (for women only) and familial history of cancer. To
study the association between colorectal cancer and the prevalence of (symptomatic)
gallstone disease as well as cholecystectomy, the following two questions were included
in the questionnaire: (a) "Has a doctor ever diagnosed gallstones, and at what age?" and
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(b) "Did you ever had gallbladder surgery, and at what age?". The applicable age was
recorded in five-year age categories.
Data analysis
Questionnaire data were processed for all 478 incident colorectal cases in the
cohort and for all subcohort members. After excluding prevalent cancer cases other
than skin cancer from the subcohort, 3346 subjects (1630 men and 1716 women)
remained in this group. The questionnaire data were key-entered twice and processed in
a manner blinded with respect to case/cohort status in order to minimize observer bias
in coding and interpretation of the data. Mean dairy nutrient intake was calculated from
the dietary questionnaire using the computerized Dutch food composition table (24).
Energy adjustment of nutrient intakes was done according to Willett and Stampfer (25).
Approximately 7 % of the subjects were excluded for the analyses including dietary
variables, because of incomplete or inconsistent dietary data. Quetelet index (kg/m*),
was used as measure of obesity. Data were analysed using the case-cohort approach
(26), assuming exponentially distributed survival times in the follow-up period. Since
standard software was not available for this type of analysis, specific programs were
developed to account for the additional variance introduced by sampling from the
cohort instead of using the entire cohort (23).
Apart from the known risk factors for gallstone disease (age, Quetelet index, parity
and possibly alcohol intake), the following variables were evaluated for confounding:
large bowel cancer in first-degree relatives, smoking, level of education, intake of
energy and energy-adjusted intake of fat, protein from meat, dietary fiber, vitamin C
and calcium. To evaluate the effect of the time interval between cholecystectomy and
diagnosis of colorectal cancer on relative rates, we calculated the interval between age
at cholecystectomy, which was taken at the mid-point of the reported five-year age
category, and age at start of the cohort study. Age at start of the study was chosen as
end-point of the interval (instead of age at diagnosis of cancer) since the follow-up
period was short and this end-point was the only strictly comparable end-point available
for both cases and subcohort. The calculated intervals were divided into four categories
each containing an approximately equal number of cholecystectomy subjects in the
entire data set.
Results
Table 1 presents the self-reported prevalences of ever diagnosed gallstones and of
cholecystectomy categorized by age and sex in the subcohort. Restricting the subcohort
to subjects with complete dietary questionnaires did not change these prevalence
figures. The prevalence of cholecystectomy in women (13.3%) was approximately three
times higher than that in men (4.7%). Although the prevalence of reported gallstones
was, as expected, higher than that of cholecystectomy, the agreement between the two
was very high: 78.5% of the subjects who reported gallstones (72.8 and 80.7 for men
and women, respectively), also reported cholecystectomy, while 87.5% of the
cholecystectomized subjects reported to have had gallstones.
Table 2 shows data on the cross-sectional association between cholecystectomy and
established risk factors for gallstone disease. In women a non-significant positive
association is seen for the Quetelet index. Alcohol intake was negatively associated with
cholecystectomy in both men and women. Nulliparous women reported significantly less
cholecystectomies than parous women (8.4% and 14.5% respectively; p<0.01), but the
prevalence of cholecystectomy did not increase further with parity. Adjustment for age
did not change these associations.
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Table 1. Prevalence of gallstones and cholecystectomy (%) by age at baseline and sex in the complete
subcobort (n=35OO).
Men (n=1688)
Gallstones
Cholecystectomy
Women (n = 1812)
Gallstones
Cbolecysteclomy
Age category
55-59
3.5
U
12.4
103
60-64
6.4
5.4
15.7
15.0
65-69
8.0
«J
164
15.2
Ibttl
5.7
4.7
14.7
133
Table 2. Association between prevalence of cholecystcctomy and risk factors for gallstone disease in
3346 subcohort members free of cancer.
Quetelct index (kg/m*)
S 22
23-24
25-26
a 27
p-valuc for trend
Alcohol consumption (g/day)
no
£ 4
5-14
15-29
a 30
p-value for trend
Parity
0
1
2
a 3
p-value for trend
Men (n»
Not
304
480
396
310
230
309
427
340
211
1630)*
Vest
17
22
17
17
0.92
16
16
14
18
10
039
% yes
S3
43
4.1
5.2
6.5
4.9
4.1
5.0
4.5
Women
Not
385
396
289
358
430
512
247
126
52
274
117
320
749
(n-1716)'
Yest
51
60
44
69
0.06
83
70
39
16
4
0.04
25
21
55
125
0.03
%yc§
11.7
13.2
13.2
16.2
16.2
12.0
13.6
11.3
7.1
8.4
15.2
14.7
143
* Numbers may not add up to 1630 and 1716 respectively, due to missing values for some of tbe
variables.
t No: no cbolecystectomy reported; yes: cholecystectomy reported.
Table 3 shows the results of the prospective cohort analysis, i.e. the relative rates
(RR) for colorectal cancer by cholecystectomy status, adjusted for risk factors for
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gallstone disease from Table 2 as well as for other dietary confounders. Both men and
women with cholecystectomy had an increased rate for colorectal cancer (RR = 1.81,
p=0.023 and RR = 1.47, p=0.052, respectively). Adjustment for the confounding
variables affected estimated relative rates only slightly. For women, adjustment for
confounding by parity, Quetelet index and alcohol intake increased the estimated
relative rate to 1.55 (data not shown). The slight increase was virtually cancelled out by
further adjustment for dietary variables (RR = 1.51). Inclusion in the multivariate
models of smoking, level of education and intake of vitamin C and calcium did not
change the estimates. In women, the relative rate after cholecystectomy appeared to be
highest for the right colon (RR = 1.89); other sites showed less and non-significantly
increased relative rates. In men, no specific subsite accounted for the increased risk.
Table 3. Adjusted relative rate of colorectal cancer in cholccystectomized subjects compared to non-
cholccyslcctomizcd subjects, according to sex and subsite.
Men
AUcaaea
Right colon
Left colon
Rectum
Women
All cases
Right colon
I eft colon
Rectum
Number of
of cases
231 (19)»
61 ( 5)
68 ( 6)
88 (7 )
177 (34)
62 (14)
51 ( 9)
48 (10)
RRt
1.81
1.74
1.96
1.80
1.47
1.69
1.33
1.62
95% Cl
1.06-3.08
0.70-4.32
0.89-4.45
0.80-4.05
0.99-2.19
0.93-3.08
0.63-2.81
0.81-3.24
RRt
1.78
1.66
2.22
1.70
1.51
1.89
125
1.55
95% CI
1.03-3.08
0.61-4.52
0.90-5.46
0.73-3.94
1.02-2.23
1.04-3.42
0.60-2.59
0.73-3.27
* In parenthesis: number of cases with cholecystectomy. Number of cases less than total number in the
study due to missing values for several variables used for adjustment. In 30 cases (14 men and 16
women), virtually all originating from the PA1.GA registry, subsite is unknown.
t Reference category: no cholecystectomy. Adjusted for age (year) and large-bowel cancer in first-degree
relatives.
t Reference category: no cholecystectomy. Adjusted for age (year), large-bowel cancer in first-degree
relatives, Quetelet index, parity (women only), intake of energy, alcohol and energy-adjusted intakes of
fat (men only), meat protein (men only) and dietary fiber.
Table 4 shows the relative rates of colorectal cancer classified by interval between
cholecystectomy and start of the study. In both men and women, a significant trend
with increasing length of the interval was detected; the increased rates appeared to be
limited to the intervals greater than six years.
Table 5 presents data on the pathological stage of the primary tumor in the cancer
cases according to cholecystectomy status. Neither men nor women with
cholecystectomy showed a trend towards earlier stage of disease at diagnosis. In women
an inverse trend could be detected.
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Tabie 4. Relative rate of colorectal cancer classified by lime interval between cholecystectomy and the
start of the study.
Time interval Number of cases* Men Women Both sexes
Men
212
4
6
7
2
Women
143
5
8
9
11
RRt
1.00
1.12
1.99
3.66
1.12
«Rt
.00
.19
.82
1.56
1.66
RRt
1.00
1.19
1.83
1.91
1.66
95% CI
0.60-2.36
1.02-3.29
1.08-3.36
0.91-3.02
No cholecystectomy
0- 6 years
7-13 years
14-23 years
2 24 yean
p-trend 0.044 0.030 0.001
* For 1 female colorectal cancer case age at cholccystcctomy was unknown.
t Adjusted for age (year), large bowel cancer in first-degree relatives, Quctclcl index, parity (women
only), intake of energy, alcohol and energy-adjusted intakes of fat (men only), meat protein (men only)
and dietary fiber,
t The pooled estimate for both sexes was adjusted for sex, age, large bowel cancer in first-degree
relatives, Quetclcl index and alcohol intake.
Table 5. Number of incident cases of colorectal cancer classified by cholecystectomy status and sex, and
according to the final pathology stage (TNM) of the disease.
TNM stage
Total number of cases
TNM available
T1+T2
T3+T4
TXt
Men
No»
n
235
122
54
64
4
%
100.0
443
52J
33
Yes'
n
21
11
5
6
0
%
100.0
453
543
0
Women
No»
n
177
103
41
60
2
%
100.0
39.8
583
1.9
Yes*
n
43
28
7
21
0
%
100.0
25.0
75.0
0
* No: no cholecystectomy reported; yes: cholecystectomy reported.
t Stage of primary tumor not assessable.
Discussion
Our findings are supportive of a positive association between cholecystectomy and
colorectal cancer. Considering the prospective nature of our study - all participants
recorded gallbladder surgery irrespective of the later occurrence of cancer - , it is
unlikely that ascertainment bias explains these findings. It is also unlikely that detection
bias plays a major role, since we have shown that cholecystectomized colorectal cancer
patients were diagnosed with equally advanced cancers as patients who did not have
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previous cholecystectomy; in women even an inverse trend could be observed. Although
the data on TNM classification were not available for all cases, there is no reason to
expect different findings in a complete data set, since the availability of TNM depended
on source and year of registration and is thus likely to have influenced the results at
random.
A criticism on the study might be the method used to determine presence of
cholecystectomy by self-reporting without any check. The data themselves, however,
appear to refute this. First, the prevalence of cholecystectomy measured in the
subcohort agreed very well with that found in a recent survey in the south of the
Netherlands, in which subjects were interviewed and cholecystectomy diagnoses were
verified by either hospital records or ultrasound examination (27). The prevalences for
men in that survey (n = 182) were 2.5 and 5.8% in the age groups 50 to 59 and 60 to 69
respectively. For women (n = 215) the corresponding figures were 13.1 and 14.1%.
Cholecystectomy rates are very similar throughout the country, as was shown by autopsy
studies in six cities (28). Furthermore, in the subcohort restricted to subjects with
complete dietary questionnaires the same prevalences were found, indicating that
subjects with incomplete (dietary) questionnaires, who also might have skipped the
question on gallbladder surgery, did not underreport cholecystectomy. Finally,
established risk factors for gallstone disease investigated in this study, i.e. age, sex,
parity (29) and Quetelet index (30), were all found to be associated with
cholecystectomy in the anticipated direction. Also alcohol consumption, which has often
been shown to be inversely related to gallstone disease (30), was negatively associated
with cholecystectomy in our data although, of course, this may have been a
consequence rather than a cause of gallstones and thus cholecystectomy. We therefore
conclude that underreporting of previous cholecystectomy is not likely to have been
substantial. There might have been subjects who falsely reported gallbladder surgery.
Although in self-reporting this is probably less likely to happen than false-negative
reporting, under- and overreporting acting together will lead to misclassification that is
presumably non-differential with respect to prospectively recorded disease status. In
that case we would have observed a lower relative risk than the true one (31).
Underreporting alone does not change the estimated relative risk.
Adjustment for confounding by risk factors for gallstone disease and by dietary
factors did not strongly influence the estimated relative rates. It is unlikely, therefore,
that in this study the positive association between cholecystectomy and colorectal cancer
has been confounded by any of the factors investigated. This also suggests that gallstone
disease is not the (sole) underlying causal link between cholecystectomy and colorectal
cancer, as proposed by some (32). Unfortunately, no prospective study so far (including
ours) comprised enough subjects with unoperated gallstone disease to evaluate this
directly. Moreover, parity and obesity, important risk factors for gallstones in women,
were found to be slightly inversely associated with colorectal cancer. Although we
cannot exclude that other factors could explain the positive association (e.g. physical
activity), the investigated more obvious factors do not appear to be important in this
respect. This conclusion does not imply that the (lack of an) association reported in
other studies is not influenced by confounding, because this depends on the distribution
of potential confounders in a population. Non-adjustment for parity is likely to have
underestimated the relative risk for women in other studies, since parity is a risk factor
for gallstone disease, but has been found protective against colorectal cancer in a
number of populations (33) including our population. However, the degree of
underestimation of the relative risk by not adjusting for parity is difficult to assess and
is likely to differ from one study to another. The role of parity in the relation between
cholecystectomy and colorectal cancer also suggests that cholecystectomy rather than
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shared risk factors for gallstone disease and colorectal cancer causes (at least part of)
the increased risk.
If the association between cholecystectomy and colorectal cancer were causal, one
would expect the relative risk to start increasing some years after removal of the
gallbladder. This is precisely what is suggested by our data on the time interval between
age at cholecystectomy and age at the start of the study, although the number of cases
in each interval category is too small to draw definite conclusions about the strength of
the associations in separate intervals. Neither is it possible to determine exactly the
length of the interval after which the relative rate starts to depart from unity, since the
starting point of each individual interval was defined as the mid-point of a five-year age
category and the end-point preceded the diagnosis of cancer by three years at most.
This implies that the true individual interval was within the range of the calculated
interval minus two and plus five years. Few other studies have presented data on the
association within interval categories. Four of seven studies show a relative risk close to
one in the first years after cholecystectomy (3,5,8,15). Even the large study by Friedman
et al.(15), which did not find an overall relative risk different from unity, shows
evidence for an increased relative risk from five years after cholecystectomy onward.
Spitz et al. (12), who used left-sided colon cancer cases as controls for right-sided colon
cancer cases, did not observe a risk gradient with time interval. Kune et al. (16) and
Berkel et al. (6) reported a highly increased risk in the first few years directly following
cholecystectomy, which may be attributed to confounding of symptoms of (right-sided)
colon cancer with those of gallstone disease (16).
In men, we found an increased relative rate for all subsites; in women, the relative
rate appeared to be highest for the right side of the colon. This result in women is in
accordance with many other studies (3-7,10,16,34). We require, however, more cases to
draw more definite conclusions with respect to subsite.
In conclusion, our study corroborates the evidence for a positive relationship
between cholecystectomy and colorectal cancer, unlikely to be attributable to many
well-known methodological biases. The data also provide support for the possibility that
cholecystectomy is the causal factor rather than (predisposition for) gallstone disease.
An intact gallbladder empties only after a (fat-containing) meal, whereas after
cholecystectomy bile from the bile duct trickles continuously into the gut. The increased
risk after cholecystectomy may be attributed to the difference in composition and
content between bile from the gallbladder and that from the bile duct, but also to the
increased time that the gut is exposed to bile. The latter possibility is consistent with
observations that meal frequency and thus a more frequent exposure of the gut to bile
also increases risk for colorectal cancer (35-37).
The results warrant further study into differences between subsites and into
potential modification of the effect by dietary factors when, after more years of follow-
up, a sufficient number of cases will have been accrued.
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A prospective cohort study on selenium status and the
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Abstract
Selenium may be anticarcinogenlc because of its role In the cellular defense system
against oxidative stress. The association between toenail selenium (a marker of long-
term selenium status) and lung cancer was investigated In a cohort study on diet and
cancer, that started in 1986 among 120,852 Dutch men and women aged 55-69 years.
After 3.3 years of follow-up, 550 microscopically confirmed incident cases with lung
carcinoma were detected. Toenail selenium data were available for 370 lung cancer
cases and 2459 members of a randomly selected subcohort. After controlling for age,
gender, smoking and education, the relative rate of lung cancer for subjects in the
highest compared to the lowest quintile of toenail selenium was 0.50 (95% confidence
interval 0.30-0.81), with a significant inverse trend across quintiles (p=0.006). The
protective effect of selenium was concentrated in subjects with a relatively low dietary
intake of beta-carotene or vitamin C. The relative rate in the highest compared to the
lowest quintile of selenium was 0.45 in the low beta-carotene group (95% confidence
interval 0.22-0.92; trend-p=0.028) and 0.36 in the low vitamin C group (95% confidence
interval 0.17-0.75; trend-p<0.001). This study supports an inverse association between
selenium status and lung cancer and suggests a modification of the effect of selenium
by the antioxidants beta-carotene and vitamin C.
Submitted for publication
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Introduction
It has been suggested that selenium has anticarcinogenic potential through its role
as component of glutathione peroxidase, an enzyme that is part of the cellular defense
system against oxidative damage (1). Animal studies have indicated that selenium
compounds may have an inhibitory effect on carcinogenesis in various experimental
models, although not all of these studies show a reduced tumour incidence (2). In
humans, ecological studies have shown an inverse association between cancer mortality
rates and selenium concentrations in forage crops and serum (2,3). Among other
tumours, this inverse relationship was found for lung cancer. Since smoking induces
oxidative stress (4,5), studying a smoking-related cancer such as lung cancer provides an
opportunity to investigate the postulated anticarcinogenic effect of selenium.
Analytic epidemiological studies on selenium and cancer frequently use biological
markers of selenium status such as serum or toenail selenium levels, because estimation
of dietary selenium intake is considered unreliable (6). Although there are a number of
case-control studies that have shown that cases have lower serum selenium levels than
control subjects (2), these findings are difficult to interpret because serum levels might
be reduced due to a lower intake or sequestration of selenium by tumour cells (7,8).
Prospective studies, in which this problem can be avoided, have yielded varying results
regarding scrum selenium levels and cancer risk (8). Due to their limited size, the
majority of these prospective studies was confined to analysis of all tumour sites
combined. A potential limitation of the serum studies is the large intraindividual
variation in serum selenium levels (6). There is evidence that toenail selenium levels
represent the selenium status over several months (9,10) and that the levels reflect
differences in selenium intake (11,12). Toenail clippings have been used recently as a
long-term biomarker of selenium status in various prospective studies (13,14), but none
of these studies dealt with lung cancer. The purpose of our study was to investigate the
relationship between prediagnostic toenail selenium levels and lung cancer risk in a
large-scale prospective cohort study in the Netherlands. Apart from the overall
association, we evaluated associations for specific types of lung carcinoma, considering
the evidence that etiological factors may differ between types (15,16). In view of the
suggested possible gender-specific effect of selenium (17), analyses were also conducted
for men and women separately. The potential effect modification by the antioxidant
vitamins beta-carotene and vitamin C, as well as retinol was also investigated.
Materials and methods
The cohort characteristics and the method of cancer follow-up have been described
before (18,19). Briefly, the cohort study started in 1986 when 58,279 Dutch men and
62,573 women aged 55-69 years were enrolled in the cohort. At baseline, cohort
members completed a self-administered questionnaire on usual dietary intake and
potential confounders and also provided toenail clippings. Following the case-cohort
approach for analysis of the data, a subcohort of 3,500 subjects (1688 men, 1812
women) was randomly sampled from the cohort after the baseline exposure
measurement. The subcohort has been followed up biennially for vital status
information in order to estimate the accumulated person time in the cohort. Incident
cancer cases occurring in the cohort have been identified by record linkage to cancer
registries and a pathology register. The analysis in this report is restricted to the cancer
incidence in the recently completed 3.3 year follow-up period from September 1986 to
December 1989. The completeness of cancer follow-up was estimated to be 95% (20).
In these 3.3 years of follow-up, a total of 617 lung cancer cases were detected (542
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men, 75 women). After excluding cases who reported a history of cancer other than
skin cancer in the baseline questionnaire (n=53), cases with in situ carcinoma (n» l )
and cases without a microscopically confirmed diagnosis (n=l l ) , 552 incident cases
remained available for analysis. Because we were interested in the association of toenail
selenium with the various types of lung carcinoma, cases with a sarcoma (n=l) or
unspecified morphology (n=l) were also excluded, leaving 550 cases with lung
carcinoma (488 men, 62 women). After excluding prevalent cancer cases other than skin
cancer from the subcohort of 3500 as well, 3346 subjects (1630 men, 1716 women)
remained in this group. Toenail clippings had been provided by 384 lung cancer cases
and 2569 subcohort members. Problems with the detection of toenail selenium
(interference by other elements such as calcium) occurred in 1 and 16 of these 384 and
2569 specimens, respectively. In addition, 13 and 94 specimens were excluded from the
case and subcohort groups, respectively, because the specimens weighed less than 10
mg, which would yield unreliable selenium measurements. Thus, toenail selenium data
on 370 lung cancer cases (335 men, 35 women), and 2459 subcohort members (1211
men, 1248 women) were available for analysis.
Determination of toenail selenium levels
The toenail selenium analyses were carried out by the Interfaculty Reactor Institute
(IRI) at Delft University, the Netherlands. Each analytical batch contained toenail
specimens of cases and subcohort members, and specimens were analyzed in a manner
blinded with respect to case/subcohort status. Toenails were first cleared by scratching
off any debris with a quartz knife. After ultrasonic cleaning with acetone for 15
minutes, distilled water for 10 minutes and acetone for 15 minutes, respectively, the
specimens were freeze-dried during 15 hours to eliminate any humidity variations
between runs. The selenium content of the toenails was measured by instrumental
neutron activation analysis of the metastable-selenium-77 isotope. The specimens were
irradiated for 17 seconds in a thermal flux of 1.2xio'* neutrons, s'.cm"*. After a decay
time of 20 seconds, gamma radiation of "™Se was measured for 60 seconds. The
accuracy of the method was checked by analysis of a certified Bovine liver standard
(Standard Reference Material 1577a of the US National Bureau of Standards). For 26
determinations, a mean value (± SD) of 0.70 ± 0.04 ug/g selenium was observed
against a certified value of 0.71 ± 0.04 ug/g. The precision of the method was evaluated
by duplicate selenium measurements of specimens from 27 randomly selected subjects;
the coefficient of variation was 6.6 percent.
Data analysis
The distribution of various potential confounders known to be associated with lung
cancer (gender, age, smoking habits and level of education) in the case and subcohort
group were compared as well as the mean toenail selenium levels. The highest attained
level of education was classified as follows: primary school only; lower level vocational
education (in addition to primary school); secondary school or medium level vocational
education; university or higher level vocational education. After categorization of the
cases according to histological type of lung carcinoma (squamous cell carcinoma, small
cell carcinoma, adenocarcinoma, large cell and other types of carcinoma) or according
to the year of follow-up in which the diagnosis was made, the mean toenail selenium
concentrations of the case groups were also compared with each other.
Next, case-cohort analyses (21) were conducted, based on the assumption that
survival times were exponentially distributed in this follow-up period. For these
analyses, toenail selenium levels were categorized into quartiles or quintiles (depending
on the available number of cases) according to the distribution in the subcohort. In the
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gender-age-stratified analyses, we computed Mantel-Haenszel relative rates of lung
cancer for each of the quantiles, 95% confidence intervals, and tests for trend in the
relative rates (which were corrected for the additional variance introduced by the
subcohort sampling). In the multivariate case-cohort analyses, relative rates (with
corrected 95% confidence intervals) of lung cancer were computed after adjustment for
the effects of gender, age, smoking (expressed as packyears for past and current
smokers) and highest level of education. The age and smoking variables were entered as
continuous variables. Tests for trend were computed based on likelihood ratio tests with
scores of 1-5 assigned to increasing quintiles of toenail selenium, as in the stratified
analysis. Apart from analyses for the total group, analyses were also conducted for men
and women separately and for each histological type of lung carcinoma. The interaction
between toenail selenium and smoking was tested using likelihood ratio tests. To
evaluate the potential influence of preclinical disease on toenail selenium levels,
analyses were also conducted after excluding cases occurring in the first year of follow-
up. Finally, we analyzed the relationship between toenail selenium and lung cancer with
regard to the dietary intake of retinol, beta-carotene and vitamin C (in the subset of
people with complete dietary data), to study the potential effect modification by these
vitamins. Two-sided p-values are used throughout this report
Results
Table 1 provides information on the distribution of gender, age, smoking habits and
highest attained level of education among lung cancer cases and subcohort members for
whom the toenail selenium level was known. As expected, large differences in the
relative frequencies of gender, age and smoking habits were observed between the case
and subcohort groups, while smaller differences were found with respect to highest
attained level of education. For both men and women, the average toenail selenium
concentration was lower among lung cancer cases than among the subcohort members.
For men, the mean (± SD) toenail selenium levels in cases and subcohort were 0.529
(± 0.206) ug/g and 0.547 (± 0.126) ug/g, respectively, while for women values of 0.537
(± 0.080) and 0.575 (± 0.109) ug/g, respectively, were observed.
When toenail selenium levels of cases according to histological subtype were
compared, cases with adenocarcinoma showed the lowest toenail selenium levels while
the highest levels were observed among cases with squamous cell carcinoma (table 2).
For all four types of carcinoma, male cases showed somewhat lower values than female
cases. When cases were categorized with respect to the year of follow-up in which they
were diagnosed, there was no trend towards lower toenail selenium levels in cases
occurring early in both men and women, indicating no effect of preclinical disease on
toenail selenium levels (table 2).
The results of the stratified analysis of toenail selenium and lung cancer risk are
shown in table 3. Toenail selenium was inversely associated with the risk of lung cancer
in this analysis (test for trend p<0.001). The relative rate of lung cancer in the highest
quintile of toenail selenium compared to the lowest quintile was 0.40 (95% confidence
interval (CI) 0.27-0.59).
In the multivariate analyses we additionally adjusted for smoking and level of
education; the additional information on packyears of smoking and level of education
was available for 317 lung cancer cases and 2311 subcohort members. The results,
shown in table 4, indicate an inverse association between toenail selenium and lung
cancer risk among the total group of subjects (trend-p=0.006), with a relative rate of
lung cancer for those in the highest quintile compared to the lowest quintile of toenail
selenium of 0.50 (95% CI 0.30-0.81).
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Table 1. Distribution of lung cancer cases and subcohort members with complete toenail selenium data
according to various characteristics.
Characteristic
Total
Gender
Men
Women
Age (years)
55-59
60-64
65-69
Smoking habits
Never smoked
Ex-smoker
Current smoker
Highest level of education
Primary school
Lower vocational education
Secondary school/medium vocational
University/higher vocational
Toenail selenium (|ig/g)
Men (mean ± SD)
Women (mean ± SD)
Cases
••
370
335
35
100
134
136
6
109
253
117
102
108
35
0.529 ±
0.537 ±
(%)
(90-5)
(9 .5)
(27.0)
(36.2)
(36.8)
( 1-6)
(29.6)
(68.8)
(323)
(28.2)
(29.8)
( 9.7)
0.206
0.080
Subcohort
n»
2459
1211
1248
941
855
663
863
852
740
745
542
833
310
0.547
0375
(*)
(49-2)
(50.8)
(38.3)
(34.8)
(26.9)
(35.2)
(34.7)
(30.1)
(30.7)
(22.3)
(34.3)
(12.8)
± 0.126
±0.109
* Due to missing questionnaire data, numbers may not add up to 370 and 2459, respectively.
Table 2. Toenail selenium levels (jig/g) in male and female lung cancer cases according lo histological
subtype and year of follow-up.
Group
Histological subtype
Squamous cell care.
Small cell care.
Adenocarcinoma
Large cell, other care
Year of follow-up
1
2
3
4
Men
n
161
56
65
53
93
104
113
25
Mean ± SD
0.541 ± 0.278
0.520 ± 0.099
0.518 ± 0.100
0317 ±0.113
0340 ± 0348
0330 ± 0.123
0316 ± 0.092
0348 ±0.146
Women
n
9
8
10
8
7
13
11
4
Mean ± SD
0347 ± 0.101
0331 ± 0.079
0327 ± 0.063
0344 ± 0.089
0372 ± 0.045
0330 ± 0.089
0351 ± 0.079
0458 ± 0.066
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Table 3. Mantel-itacMzei relative rate of lung cancer according to loeoail selenium level in gender-age-
stratificd analysis.
Toenaii selenium level
(quintile boundaries in (ig/g)
1 (S 0.483)
2 (S 0-530)
3 (S 0373)
4 (S 0.630)
5 (> 0.630)
Test for ircnd: j * (p-value)
No. of
cases
134
75
«9
S3
39
Person years
in subcohort
1598
1597
1593
1587
1609
!.00*
0.64
0.66
0.56
0.40
23.159
(95% CI)
(0.47-0.89)
(0.47-0.92)
(039-0.80)
(027-0.59)
( < 0.001)
* Reference category.
Because of the high proportion of male Sung cancer cases, the association with toenaii
selenium among men strongly resembles that in the total group. Nevertheless, also
among women an inverse relationship was observed, with a relative rate of lung cancer
of 0.40 (95% CI 0.13-1.24; trcnd-p=0.101) for those in the highest quartile compared to
the lowest quartile. After excluding cases occurring in the first year of follow-up, the
inverse association between toenaii selenium and lung cancer persisted (trend-p=0.036),
with a relative rate of 0.52 (95% CI 0.30-0.91) for those in the highest versus the lowest
quintile (table 4). We also evaluated whether the association with toenaii selenium was
different among smoking categories (never, ex-, current smokers) by testing for
interaction between smoking and toenaii selenium. No significant interaction was noted,
however (likelihood ratio x'=4.10, df=8; p=0.849).
Table 4. Relative rate of lung cancer according to toenaii selenium level in multtvariate analysis*.
Group No. of
cases
Quantile of toenaii selenium level (boundaries in jig/g) Test for trend
It 2 3 4 5 x* (p-value)
(SO.483) (SO.530) (SO.573) (SO.630) (>0.630)
All cases
(95% CT)
Men
(95% CI)
Womcnt
(95% CI)
317
285
Excluding cases
from first yr of
follow-up 228
(95% CI)
1.00
1.00
32 1.00
1.00
0.71 0.79 0.82 0.50 7.697 (0.006)
(0.49-1.04) (0-53-1.18) (0.53-1.26) (030-0.81)
0.69 0.81 0.83 0.50 6.415 (0.011)
(0.46-1.02) (0.54-1.21) (0.54-1.29) (030-0.82)
0.58 0.61 0.40
(020-1.66) (022-1.75) (0.13-1.24)
2.688 (0.101)
0.78 0.80 0.89 0-52 4380 (0.036)
(0.51-1.19) (0-50-1.26) (0-55-1.45) (030-0.91)
* The model included terms for age, (gender), packyears of past smokers, packyears of current smokers,
level of education.
t Reference category.
$ Because of the small number of cases, use was made of quartilcs instead of quinlilcs; quartile
boundaries were: SO.497, sO.551, SO.612, >0.612 >ig/g.
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As can be seen from table S, the inverse association with toenail selenium is not
restricted to a particular histological subtype of lung cancer. Because of the relatively
small numbers, relative rates of lung cancer are presented here by quartile of toenail
selenium. The relative rates (95% CI in parentheses) for those in the highest toenail
selenium quartile compared to the lowest quartile were 0.55 (0.30-1.04) for squamous
cell carcinoma, 0.19 (0.04-0.87) for small cell carcinoma. 0.59 (0.25-1.40) for
adenocarcinoma, and 0.70 (0.31-1.58) for large cell carcinoma and other types of lung
carcinoma.
Table 5. Relative rale of lung cancer according to quartile of loenail selenium level in multivariale
analysis', by histological subtype.
Histology
Squamous cell care.
(95% CI)
Small cell care.
(95% CI)
Adenocarcinoma
(95% CI)
Large cell, other
(95% CI)
No. of
cases
143
55
62
57
Quartile of toenail selenium level
(boundaries in iig/g)
It
(SO.497)
1.00
1.00
1.00
1.00
2
(S0.551)
0.95
(0.60-1.50)
0.71
(032-1.56)
0.76
(038-1.52)
0.58
(0.28-1.18)
3
(S 0.612)
0.84
(0.50-1.42)
1-59
(0.76-3.30)
0.95
(0.47-1.90)
0.47
(0.20-1.07)
4
(>0.612)
0.55
(0.30-1.04)
0.19
(0.04-0.87)
0-59
(0.25-1.40)
0.70
(0.31-1.58)
Test for
3.899
0.868
0.987
2.046
trend
(p-valuc)
(0.048)
(0351)
(0320)
(0.153)
* The model included terms for age, gender, packyears of past smokers, packyears of current smokers,
level of education,
t Reference category.
In additional models we also adjusted for the intake of retinol, beta-carotene and
vitamin C in the subset of 293 cases and 2204 subcohort members who had both
complete dietary and toenail data. This adjustment resulted in similar effect estimates
(table 6, first line) as the model without adjustment for dietary variables. We also
examined the association between toenait selenium and lung cancer by category of
intake of these vitamins. Table 6 shows the relative rates, 95% confidence intervals and
tests for trend for quintiles of toenail selenium in those who are in the lowest two
quintiles and those who are in the highest two quintiles of intake of these three
vitamins, respectively. The association between toenail selenium and lung cancer risk
did not differ appreciably between those with a low or high retinol intake. In contrast,
for beta-carotene and particularly for vitamin C, the protective effect of selenium seems
to be concentrated in those with a relatively low intake of these vitamins (trend-
p=0.028 and <0.001 for the low beta-carotene and vitamin C groups, respectively). The
relative rates (95% CI in parentheses) of lung cancer for those in the highest quintiles
of toenail selenium were 0.45 (0.22-0.92) and 0.36 (0.17-0.75) in the subjects with a low
intake of beta-carotene and vitamin C, respectively. Tests for interaction indicated that
the differences in estimates per selenium quintile between the low and high vitamin
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intake groups were not significant for beta-carotene (likelihood ratio test p=0.662) or
vitamin C (p=0.439), but the compared groups are rather small.
Table 6. Relative rate of lung cancer according to toenail selenium level by category of intake of
retinol, beta-carotene and vitamin C.
Oroup
Allt
(95% CI)
Rctinol intake*
I/OW
(95% CI)
High
(95% CI)
No. of
caici
293
89
148
llcta-carotenc intake*
IAIW 143
(95% CI)
High
(95% CI)
99
Vitamin C intake*
Low 143
(95 % CI)
High
(95% CI)
98
Quinlile
1'
(SO.483)
1.00
1.00
1.00
1.00
1.00
1.00
1.00
of toenail selenium level (boundaries in
2
(SO.530)
0.68
(0.46-1.02)
0.86
(0.42-1.79)
0.71
(0.41-1.23)
0.54
(031-0.94)
1.06
(0.54-2.06)
0.59
(0.34-1.03)
0.93
(0.47-1.83)
3
(SO.573)
0.75
(0.49-1.15)
0.79
(035-1.76)
0.93
(0.51-1.70)
0.64
(034-1.18)
0.77
(034-1.77)
0.49
(0.27-0.90)
1.20
(0.57-2.51)
4
(SO.630)
0.78
(0.49-1.24)
1.00
(0.44-2.31)
0.89
(0.46-1.70)
0.73
(038-1.41)
1.44
(0.67-3.07)
0.51
(0.26-0.99)
1.02
(0.47-2.18)
fg/S)
5
(> 0.630)
0.49
(0.30-0.82)
0.58
(0.24-1.38)
0.63
(031-1.28)
0.45
(0.22-0.92)
0.68
(0.28-1.64)
036
(0.17-0.75)
0.63
(027-1.49)
Test for
7.514
1.135
1.175
4.826
0.021
13.777
0.463
trend
(p-value)
(0.006)
(0287)
(0278)
(0.028)
(0.885)
(<0.001)
(0.496)
• Reference category.
t Model adjusted for age, gender, packycars of past smokers, packyears of current smokers, level of
education, intake of rctinol, beta-carotene and vitamin C.
* Low and high are defined as the two lowest quintiles and the two highest quintiles of intake,
respectively.
Discussion
In this prospective cohort study, a statistically significant inverse trend was found
between the toenail selenium level and the risk of lung cancer. A number of prospective
studies on selenium in serum and lung cancer risk have been published, all using the
nested case-control approach (22,32). In the first prospective study that showed a
significant inverse association of selenium with total cancer, Willett et al. (22) found
nonsignificantry lower serum selenium levels among lung cancer cases compared to
controls. However, the difference between cases and controls was in fact greater for
lung cancer than for all cancers combined. Because there were only 18 lung cancer
cases invoked, the association did not reach statistical significance. Salonen et al. did
observe a significant inverse association between serum selenium and respiratory cancer
risk (15 cases) in a Finnish cohort (26), whereas a nonsignificant inverse association
with respiratory cancer (23 cases) was found in another Finnish cohort (27).
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Nonsignificantry lower serum selenium levels among lung cancer cases compared to
controls have also been reported in four other studies (24,28-30), but these nested case-
control studies only included a small number of lung cancer cases. The largest nested
case-control study on serum selenium and lung cancer to date was published by Knckt
et al. (23). This Finnish cohort yielded 198 lung cancer cases and a strong, significant
inverse association between serum selenium and lung cancer risk; the relative risk for
men in the highest compared to the lowest quintile of serum selenium was estimated at
0.3. In three other studies nonsignificantry positive associations between serum selenium
and lung cancer have been observed (25,31,32). The study by Menkes et al. (31) was the
largest, involving 99 lung cancer cases. In that study, a positive association was also
observed for the various histological subtypes of lung cancer.
Thus, in the majority of the studies an inverse association between serum selenium
and lung cancer is observed, albeit mostly nonsignificant. It should be kept in mind that
most of these studies were focused primarily on overall cancer risk and even then the
number of cases was often rather small. The limited number of respiratory cancer cases
in virtually all studies precludes the possibility to draw conclusions from the inconsistent
findings, but in a number of these studies the association with selenium was stronger for
respiratory cancer than for all cancers combined (22-24,26,28,30). As has been noted
before (2,24), a possible explanation for the discrepant findings might be the difference
in the range of selenium levels that has been investigated in the various countries. In
the US, generally high serum selenium levels are reported, whereas low values occur in
New Zealand and Finland. Indeed, most of the studies that show an inverse association
originate from Finland where selenium intake used to be low (23). Selenium intake is
moderate in the Netherlands and blood selenium levels are intermediate between those
reported from New Zealand and the United States as is true for toenail selenium levels
(33).
The inverse association between toenail selenium and lung cancer in our study was
not restricted to men. This seems in apparent contrast with an earlier suggestion that
the protective effect of selenium might be specific for men only (17). However, the size
of most studies was not sufficient to allow site-specific analyses by gender. Gender-
specific information is usually only reported for breast cancer; most studies have shown
that there is no association between selenium and this type of cancer (13,14,22-25,33).
Because lung cancer often represents a substantial part of the male cases (in contrast to
female cases) and breast cancer is the most important female cancer site, the suggested
gender-specific effect of selenium might reflect site-specific effects. Indeed, as Coates et
al. (24) have suggested, the differences in cancer site distributions between the various
studies might also explain the inconsistent results of the published prospective studies.
As in other studies (11,12), smoking was inversely related with toenail selenium
levels in our population (34) and might therefore be an important confounder of the
relationship between selenium and lung cancer. It is unlikely that there is major
residual confounding by smoking in our analyses, however, because the inverse
association persisted after presumably close control of smoking by using packyears of
smoking. In addition, we found no clear indication that the selenium effect is restricted
to specific subtypes of lung carcinoma that are associated more strongly with smoking
such as squamous cell and small cell carcinoma (15).
Confounding by dietary variables was not observed after evaluating models that
included terms for retinol, beta-carotene and vitamin C intake. (Because the Dutch
food table does not contain information on the vitamin E content of foods, we could
not evaluate the influence of this vitamin.) Some evidence, however, was found for
effect modification by the level of vitamin intake. While for beta-carotene and vitamin
C the effect of a high toenail selenium level was concentrated in those with a relatively
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low intake of these vitamins, there was no clear effect modification by retinol intake,
which is in line with the lower antioxidative capacity of retinol (35). Others have
evaluated the interaction with antioxidant vitamins by studying serum levels of retinol,
beta-carotene and a-tocopherol; the interactions were only assessed with regard to
overall cancer risk. While the effect modification by beta-carotene is supported by other
studies (23,32), the observations on interaction with retinol levels are inconsistent
(17,22-24,27,32). No other cohort studies on this subject have evaluated the effect
modification by vitamin C. Nevertheless, since this vitamin can also protect against
oxidativc damage, the observed interaction between selenium and vitamin C fits within
the antioxidant hypothesis (36). It would be interesting to find out if a similar effect
modification by vitamin C exists in the cohort studies that have been published. Vitamin
C is, however, degraded rapidly in frozen serum (10), which is the probable reason why
it has not been investigated in these cohort studies with nested case-control analyses.
Therefore, the assessment of interaction will necessarily have to involve dietary vitamin
C intake.
As in most serum studies regarding overall cancer risk (22-24,27,30,31), although
not all (29), we found no influence of preclinical lung cancer on the toenail selenium
levels. This was indicated by the persistence of the inverse association after excluding
cases detected in the first year of follow-up. Also, no increasing trend in the average
toenail selenium levels was observed when cases were categorized by year of follow-up.
This was to be expected since the toenail selenium level is assumed to be a long-term
marker of selenium status, while the selenium level in serum is regarded as a short-term
marker.
In conclusion, we observed an inverse association between toenail selenium and
lung cancer risk. The association was not restricted to a particular gender, smoking
category or histological subtype of lung cancer. The possible effect modification by
beta-carotene and particularly vitamin C warrants further study.
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Abstract
The association between toenail selenium and the risk of stomach and colorectal
cancer was investigated in a prospective cohort study on diet and cancer, that started
in the Netherlands in 1986 among 120,852 men and women aged 55-69 years. After 3.3
years of follow-up, 155, 313 and 166 microscopically confirmed incident cases of
stomach, colon and rectum cancer were detected, respectively. Toenail selenium data
were available for 104 stomach cancer, 234 colon cancer, 113 rectum cancer cases and
2459 members of a randomly selected subcohort. In a multivariate analysis, the relative
rates of stomach cancer for subjects in increasing quintiles of toenail selenium level
were 1.00, 0.44, 0.59, 0.84 and 0.64 (trend-p=0.491). For men, there was more evidence
for an inverse association between toenail selenium and stomach cancer the relative
rate for those in the highest compared to the lowest quintile of toenail selenium was
0.40 (95% confidence interval, 0.17 to 0.96), albeit that the test for trend was not
significant (p=0.136). For stomach cancer among women, there was no negative
association with toenail selenium. The negative association between toenail selenium
and stomach cancer was concentrated in subjects with a relatively low vitamin C
intake. For beta-carotene, there was no evidence for such an effect modification.
Toenail selenium was not associated with the risk of colon or rectum cancer. After
excluding cases diagnosed in the first year of follow-up, the relative rates of colon
cancer for increasing quintiles of toenail selenium were 1.00, 1.27, 1.17, 0.75 and 1.07
(trend-p=0.554); for rectum cancer these relative rates were estimated at 1.00, 1.73,
0.83, 1.58 and 1.12 (trend-p=0.890). These data support a suggestive, but Inconsistent
inverse association between selenium status and the risk of stomach cancer but not of
colorectal cancer.
* Accepted in revised form by the Journal of the National Cancer Insitute
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Introduction
Animal studies (1) and ecologie studies among human populations (2-4) suggest
that a low dietary selenium intake is associated with an increased risk of various types
of cancer. Because the assessment of dietary selenium intake is unreliable (5), case-
control and cohort studies on selenium and cancer have frequently used biologic
markers of selenium status such as serum or toenai) selenium levels. Case-control
studies on serum selenium and cancer are difficult to interpret because serum levels
might be reduced due to sequestration of selenium by tumor cells (6,7). In patients with
advanced upper gastrointestinal cancer serum selenium levels were also found to be
progressively decreased (8). Prospective serum studies, in which this interpretation
problem can be avoided, were mostly limited to overall cancer risk as the primary goal
of the analysis (9-19). In all of these studies, a nested case-control approach was used.
Although cases had significantly lower prediagnostic selenium levels than controls in
various prospective studies (9-11,13,16,19), the results are inconsistent. In a number of
studies, however, the difference between cases and controls was greater for
gastrointestinal cancer sites than for all cancer sites combined (9,10,14,15,19). Apart
from the study by Knekt et al. (19), the numbers of gastrointestinal cancer cases were
usually too small to permit detailed analyses of these sites in the mentioned studies.
In recent years, toenail selenium has gained popularity as biomarker of selenium
status, following observations that this marker is an indicator of long-term selenium
status (20,21) and reflects differences in selenium intake (22,23). With regard to
gastrointestinal cancer, one prospective study using toenail selenium has been reported.
In this study among women, toenail selenium was not associated with colon cancer risk
(24). The purpose of our study was to investigate the relationship between prediagnostic
toenail selenium levels and the risk of stomach and colorectal cancer in a large-scale
prospective cohort study among men and women in the Netherlands.
Materials and methods
The cohort
In September 1986, a prospective cohort study on diet and cancer of the breast,
colon, rectum, stomach and lung has been initiated in the Netherlands. The study
design has been described in detail (25). The cohort included 58,279 men and 62,573
women aged 55-69 years at the start of the study. The study population originated from
204 municipal population registries throughout the country. At baseline, the cohort
members completed a self-administered questionnaire on usual diet and potential
confounding variables and also provided toenail clippings. The semi-quantitative food
frequency questionnaire was specifically designed for, and pretested among men and
women of the cohort age range and was validated against a 9-day dietary record
method (Goldbohm et al., submitted for publication). For data processing and analysis
the case-cohort approach is used: the cases are enumerated for the entire cohort
(numerator information of incidence rates), while the accumulated person years of the
entire cohort are estimated using a subcohort sample (providing the denominator
information). Following this approach, a random subcohort of 3,500 subjects (1688 men,
1812 women) was sampled from the cohort after the baseline exposure measurement
The subcohort has been followed up for vital status information in order to estimate the
accumulated persontime in the cohort. Until December 31. 1989 (the end of the present
follow-up period), there were no subcohort members lost to follow-up.
Selenium and gastrointestinal cancer 167
Cancer follow-up
Follow-up for incident cancer was accomplished by a computerized record linkage
with all nine regional cancer registries in the Netherlands and with PALGA, the Dutch
national data base of pathology reports. The method of record linkage has been
published previously (26). Record linkage has been conducted annually with PALGA
and the cancer registries. The lag time between diagnosis of cancer and definitive
registration in the cancer registries is usually less than three months, but may
occasionally extend to 1.5 years. Considering this lag time, the linkage performed in
1991 thus accounted for presumably all cancers diagnosed until the end of 1989. The
analysis in this report is restricted to the cancer incidence in the period from September
17, 1986 (cohort baseline measurement) until December 31, 1989, i.e. a follow-up
period of 3.3 years. In this period a total of 1882 cases of breast, colorectal, stomach or
lung cancer were detected in the cohort of 120,852 subjects. The cancer follow-up was
estimated to be 95% complete after comparing observed and expected numbers of
incident cases in this follow-up period (27).
Population for analysis
Among the 1882 cases, there were 176 stomach, 351 colon and 185 rectum cancer
cases. After excluding cases reporting a history of cancer other than skin cancer in the
baseline questionnaire (18 stomach, 39 colorectal cancer cases), cases with in situ
carcinoma (2 stomach, 16 colorectal cancer cases) and cases without a microscopically
confirmed diagnosis (0 stomach, 2 colorectal cancer cases), 155 incident stomach cancer
and 479 colorectal cancer cases were available for analysis. After excluding prevalent
cancer cases other than skin cancer from the subcohort of 3500 as well, 3346 subjects
remained in this group. Toenail clippings had been provided by 107 stomach cancer
cases, 361 colorectal cancer cases and 2569 subcohort members. Problems with the
detection of toenail selenium (interference by other elements such as calcium) occurred
in 1, 5 and 16 of these 107, 361 and 2569 specimens, respectively. Another 2, 9 and 94
specimens were excluded from the stomach cancer, colorectal cancer and subcohort
groups, respectively, because the specimens weighed less than 10 mg, which would yield
unreliable selenium measurements. Thus, toenail selenium data on 104 stomach cancer
(84 men, 20 women), 234 colon cancer (121 men, 113 women), 113 rectum cancer (77
men, 36 women), and 2459 subcohort members (1211 men, 1248 women) were available
for analysis.
Determination of toenail selenium levels
The toenail selenium analyses were carried out by the Interfaculty Reactor Institute
(IRI) at Delft University, the Netherlands. Each analytical batch contained toenail
specimens of cases and subcohort members, and specimens were analyzed in a manner
blinded with respect to case/subcohort status. Toenails were first cleared by scratching
off any debris with a quartz knife. After ultrasonic cleaning with acetone for 15
minutes, distilled water for 10 minutes and acetone for 15 minutes, respectively, the
specimens were freeze-dried during 15 hours to eliminate any humidity variations
between runs. The selenium content of the toenails was measured by instrumental
neutron activation analysis of the metastable-selenium-77 isotope. The specimens were
irradiated for 17 seconds in a thermal flux of 1.2x10" neutrons, s'.cm'*. After a decay
time of 20 seconds, gamma radiation of ^™Se was measured for 60 seconds. The
accuracy of the method was checked by analysis of a certified Bovine liver standard
(Standard Reference Material 1577a of the US National Bureau of Standards). For 26
determinations, a mean value (± SD) of 0.70 ± 0.04 ^g/g selenium was observed
against a certified value of 0.71 ± 0.04 jig/g. The precision of the method was evaluated
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by duplicate selenium measurements of specimens from 27 randomly selected subjects;
the coefficient of variation was 6.6 percent.
Data analysis
The relationship between toenail selenium level and its various potential predictors
has been analyzed before (28). For each of the three sites (stomach, colon, rectum
cancer) the gender-specific mean toenail selenium levels of the cases were compared
with those of the subcohort. To evaluate the potential influence of prediagnostic cancer
on toenail selenium levels, the cases were categorized according to the year of follow-up
in which the diagnosis was made. For each site, the mean toenail selenium
concentrations of the case groups defined by year of follow-up were then compared
with each other.
Next, case-cohort analyses (29) were conducted, based on the assumption that
survival times were exponentially distributed in this follow-up period (Volovics et al., in
preparation). For these analyses, toenail selenium levels were categorized into quartiles
or quintiles (depending on the available number of cases) according to the distribution
in the subcohort. In the gender-age-stratified analyses, we computed Mantel-Haenszel
relative rates of stomach, colon and rectum cancer for each of the quantiles, 95%
confidence intervals, and tests for trend in the relative rates (which were corrected for
the additional variance introduced by the subcohort sampling). In the multivariate case-
cohort analyses, relative rates (with corrected 95% confidence intervals) of cancer were
computed after adjustment for the effects of several factors simultaneously. For
stomach cancer, these included gender, age, smoking (expressed as packyears for past
and current smokers), highest level of education (categorized as low/medium/high) and
intake of vitamin C and beta-carotene. For colon and rectum cancer, adjustment was
made for gender, age, family history of intestinal cancer, Quetelet index, level of
education and alcohol use. In addition to these factors, we also fitted models with
additional adjustment for the intake of calories, fat, protein, carbohydrate, fiber, beta-
carotene and vitamin C; since this additional adjustment did not yield materially
different results, we only present the former, simpler models. Similarly, for the stomach
cancer analyses the additional adjustment for family history of stomach cancer did not
affect the relative rate estimates regarding selenium. For each analysis, tests for trend
were computed based on likelihood ratio tests with scores of 1-5 assigned to increasing
quintiles of toenail selenium, as in the stratified analysis. Apart from analyses for the
total group, analyses were also conducted for men and women separately, and after
excluding cases occurring in the first year of follow-up. Two-sided p-values are used
throughout this report. The analyses were carried out using the GLIM statistical
package (30,31).
Results
In table 1 the average toenail selenium levels among men and women in each of
the case groups are presented. For the subcohort the mean (±SD) toenail selenium
concentrations were 0.547 (± 0.126) ug/g in men and 0.575 (± 0.109) u.g/g in women.
Male stomach cancer cases showed lower selenium levels than men in the subcohort
while female stomach cancer cases showed higher levels than female subcohort
members. For colon cancer these differences had the same directions but were less
marked. Rectum cancer cases showed higher toenail selenium levels than subcohort
members in men and women. When cases were categorized with respect to the year of
follow-up in which they were diagnosed, there was no trend towards lower toenail
selenium levels in cases occurring closer to baseline in the stomach and rectum cancer
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group, indicating no effect of prediagnostic cancer on toenail selenium levels for these
sites. For colon cancer, however, the lower selenium levels among cases occurring in the
first year of follow-up suggest the presence of such an effect for this site (table 1).
Table 1. Toenail selenium levels (iig/g) in cases according to gender and year of follow-up.
Group'
Gender
Men
Women
Stomach cancer
n
84
20
Year of follow-up
1
2
3
4
30
31
31
12
Mean ± SD
0.528 ± 0.081
0.647 ± 0.184
0.566 ± 0.142
0.543 ± 0.127
0.548 ± 0.088
0.543 ± 0.099
Colon
n
121
113
69
69
80
16
cancer
Mean
0.536
0.561
0.519
0.559
0.563
0.546
±
±
±
±
±
+
SD
0.092
0.104
0.945
0.108
0.092
0.082
Rectum
n
77
36
31
39
31
12
cancer
Mean ±
0-5% ±
0.580 ±
0.561 ±
0.632 ±
0391 ±
0334 ±
SD
0.410
0.089
0.115
0.542
0.190
0.131
' Mean (±SD) selenium levels in the subcohort were 0347 (±0.126) for men (n-1211) and 0375
(+0.109) (ig/g for women (n=1248).
The results of the gender-age-stratified analyses are presented in table 2, for each
of the three sites. This table shows, per quintile of toenail selenium, the number of
cases observed in the cohort and the person years that were accumulated by the
subcohort members.
Table 2. Manlel-Haenszcl relative rate of stomach, colon and rectum cancer according to toenail
selenium level in gendcr-age-slralified analysis.
Tumor site
Stomach
No. of cases
(Person years
in subcohort)
(95%'ci)
Colon
No. of cases
(Person years
in subcohort)
(95% CI)
Rectum
No. of cases
(Person years
in subcohort)
(95%"ci)
Quintile
1*
(£0.483)
32
(1599)
1.00
54
(1599)
1.00
25
(1598)
1.00
of toenail selenium level (boundaries in |
2
(£0.530)
19
(1596)
0.69
(038-1.25)
53
(1590)
0.98
(0.65-1.48)
28
(1595)
1.20
(0.68-2.12)
3
(£0.573)
17
(1593)
0.64
(035-1.17)
48
(1592)
0.89
(038-1.36)
13
(1591)
0.61
(030-1.23)
4
(£0.630)
19
(1588)
0.83
(0.45-1.53)
36
(1588)
0.68
(0.43-1.08)
25
(1588)
1.20
(0.67-2.14)
'g/g)
5
(> 0.630)
17
(1610)
0.61
(033-1.11)
43
(1607)
0.77
(0.49-1.19)
22
(1610)
1.01
(0.55-1.84)
Test for
1.272
2.713
•cO.001
trend
(p-value)
(0.259)
(0.100)
(0.991)
* Reference category.
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In the calculation of the person years at risk, it was assumed that subjects who develop
a certain cancer are still at risk for cancer at a different site. It can be seen from table 2
that the Mantel-Haenszel relative rates of stomach and colon cancer are
nonsignificantry decreased for subjects in the upper quintiles of toenail selenium (p-
values for trend-test for stomach and colon were 0.259 and 0.100, respectively). For
rectum cancer there was no association with toenail selenium in the gender-age-
stratified analysis (trend-p=0.991).
In the multivariate analysis regarding stomach cancer we adjusted for gender, age,
smoking, education and the intake of vitamin C and beta-carotene. When all the 92
cases with complete data on the variables in the model were used in the analysis, there
was some evidence for a decreased risk of stomach cancer, with relative rates of 1.00,
0.44, 0.59, 0.84 and 0.64 for increasing quintiles of toenail selenium, but the test for
trend was not significant (p=0.491). Only for those in the second quintile the relative
rate was significantly different from unity. (A model in which vitamin C and beta-
carotene were replaced by the intake of vegetables and fruits yielded essentially similar
results.) The negative association between stomach cancer and toenail selenium was
only seen in men, where the relative rates for increasing quintiles of toenail selenium
were 1.00, 0.49, 0.50, 0.92 and 0.40, respectively. Although the relative rates for those in
the second and fifth quintiles compared to the lowest quintile were significantly
different from one, the test for trend was not significant (trend-p=0.136). In women, no
evidence for a negative association was found. A more definitive evaluation of a
possible modest positive association in women requires more cases than the 20 who
were available now. The relative rate estimates were not materially affected after
exclusion of the cases occurring in the first year of follow-up, indicating no effect of
prediagnostic stomach cancer on toenail selenium levels (table 3).
Table 3. Relative rate of stomach cancer according to toenail selenium level in multivariate analysis*.
Tumor site No. of
cases
Quantilc of toenail selenium level (boundaries in u.g/g) Test for trend
It 2 3 4 5 x* (p-value)
(sO.483) (SO.530) (SO.573) (sO.630) (>0.630)
All cases
(95% CI)
Men
(95% CI)
Women!
(95% CI)
Including cases
from first yr of
follow-up
(95% CI)
92
72
20
67
1.00
1.00
1.00
1.00
0.44 0.59 0.84 0.64 0.474 (0.491)
(0.22-0.88) (031-1.15) (0.44-1.61) (033-1.27)
0.49 0.50 0.92 0.40 2.225 (0.136)
(0.24-0.99) (0.24-1.06) (0.46-1.82) (0.17-0.%)
0.73 136 1.68
(0.14-3.71) (033-5.60) (0.43-6.54)
1305 (0.253)
0.47 0.56 0.91 0.60 0.440 (0.507)
(0.21-1.02) (0.26-1.22) (0.43-1.91) (027-1.34)
• The model included terms for age, (gender), packyears of past smokers, packycars of current smokers,
level of education, intake of beta-carotene and vitamin C.
t Reference category.
$ Because of the small number of cases, use was made of quartiles instead of quinliks; quarlile
boundaries were: SO.497, S0.551, SO.612, >0.612 ug/g.
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The results for colon cancer and rectum cancer are presented in a similar way in
tables 4 and 5, respectively. There seems to be some evidence for a negative
relationship between toenail selenium and the risk of colon cancer in the analysis
among all 216 cases with complete data (trend-p=0.067); this association is seen in both
men and women. However, (as already expected from the results in table 1) the
negative association disappeared when cases occurring in the first year of follow-up are
excluded: the relative rates of colon cancer in that model were 1.00, 1.27, 1.17, 0.75 and
1.07 for increasing quintiles (trend-p=0.554) (table 4). With regard to rectum cancer,
no association was observed with toenail selenium concentration when all cases were
considered; the relative rates for increasing quintiles of toenail selenium were 1.00, 1.13,
0.58, 1.19 and 1.05, respectively (trend-p=0.829). There was also no evidence for an
association in gender-specific analyses or when cases from the first year of follow-up
were excluded.
Table 4. Relative rate of colon cancer according to locnail selenium level in niultivariatc analysis*.
Quintile of toenail selenium level (boundaries in ug/g) Test for trend
Tumor site No. of
cases
It 2 3 4 5 x' (p-value)
(S0.48J) (SO.530) (sO.573) (SO.630) (>0.630)
All cases
(95% CI)
Men
(95% CI)
Women
(95% CI)
216 1.00 1.08 0.89 0.67 0.80 3.353 (0.067)
(0.71-1.63) (0.56-1.40) (0.40-1.12) (0.50-1.29)
116 1.00 1.20 1.06 0.85 0.82 0.965 (0.326)
(0.70-2.05) (0.59-1.90) (0.45-1.60) (0.43-1.58)
100
Excluding cases
from first yr of
follow-up 150
(95% CI)
1.00 0.94 0.71 0.51 0.77 2.287 (0.131)
(0.49-1.81) (037-1.38) (0.25-1.04) (0.41-1.45)
1.00 1.27 1.17 0.75 1.07 0.350 (0.554)
(0.76-2.12) (0.67-2.02) (0.40-1.43) (0.61-1.88)
* The model included terms for age, (gender), familial intestinal cancer, level of education, Quctclct
index, alcohol use.
t Reference category.
Because we have observed a modification of the effect of selenium by the level of
intake of vitamin C and beta-carotene in a previous study on toenail selenium and lung
cancer (Van den Brandt et al., submitted for publication), we evaluated this possibility
in the current study also for stomach cancer. The results are given in table 6 where the
relative rates of stomach cancer per quartile (because of the small number of cases) of
toenail selenium are presented for subjects with relatively low and high intake of each
of the two vitamins, respectively. Only for vitamin C, there was some evidence of effect
modification: the negative association between selenium and stomach cancer was
concentrated in the low vitamin C group, no statistical significance was reached. Among
subjects with a relatively high vitamin C intake the association between selenium and
stomach cancer was inconsistent For beta-carotene no indication for effect modification
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was found, although the effect estimates were somewhat lower in the low than in the
high beta-carotene group.
Table 5. Relative rate of rectum cancer according to tocnail selenium level in mullivahate analysis*.
Quantile of toenail selenium level (boundaries in |ig/g) Test for trend
It 2 3 4 5 x* (p-value)
(SO.483) (S0.53O) (SO.573) (sO.630) (>0.630)
Tumor site
All CMC*
(95% CI)
Men
(95% CI)
Women t
(95% CI)
Including case*
from first yr of
follow-up
(95% CI)
No. of
cases
102
70
32
76
1.00
1.00
1.00
1.00
1.13 0.58 1.19 1.05 0.047
(0.61-2.07) (0.27-1.25) (0.60-2.35) (0.54-2.03)
130 0.66 1.16
(0.66-2.56) (0.28-1.57) (0.55-2.45)
0.82 0.44 1.58
(0.27-2.51) (0.12-1.61) (0.59-4.22)
0.91 0.116
(0.41-2.00)
1.204
(0.829)
(0.733)
(0.273)
1.73 0.83 1J58 1.12 0.019 (0.890)
(0.85-3.51) (0.34-2.01) (0.71-3.51) (0.49-2.55)
* 'lite model included terms for age, (gender), familial intestinal cancer, level of education, Quetclct
index, alcohol use.
t Reference category.
$ Because of the small number of cases, use was made of quarliles instead of quinliles; quartile
boundaries were: SO.497, SO.551, SO.612, >0.612 ug/g.
Table 6. Relative rate of stomach cancer according to tocnail selenium level by category of intake of
beta-carotene and vitamin ('.
Group
Heta-carotenct
Lowt
(95% CI)
High*
(95% CI)
Vitamin C intake§
Low*
(95%CI)
High*
(95% CO
No. of
cases
38
37
41
34
Quartile
1*
(SO.497)
1.00
1.00
1.00
1.00
of tocnail selenium level (boundaries in ug/g)
2
(S0.551)
0.57
(0.22-1.47)
0.70
(0.26-1.89)
0.63
(0.28-1.45)
0.65
(0.20-2.01)
3
(SO.612)
0.87
(034-2.25)
0.98
(038-2.54)
0.56
(0.21-1.48)
1.21
(0.43-338)
4
(>0.612)
0.81
(0.31-2.10)
0.%
(035-2.59)
0.66
(0.26-1.68)
1.46
(0.54-3.92)
Test for trend
X* (p-value)
0.041 (0.839)
<0.001 (0.987)
1.135 (0.287)
1.113 (0.291)
• Reference category.
t Model adjusted for age, gender, packycars of past snwkcrs, packycars of current smokers, level of
education, vitamin C intake.
£ Low and high arc defined as the two lowest quinliles and the two highest quintfles of intake,
respectively.
§ Model adjusted for age, gender, packycars of past smokers, packycars of current smokers, level of
education, beta-carotene intake.
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Discussion
In this prospective study we found suggestive, but inconsistent evidence for a
negative association between toenail selenium and the risk of stomach cancer, but not
for colon (after excluding cases from the first year of follow-up) or rectum cancer. The
negative association between toenail selenium and stomach cancer was only observed in
men. The number of female cases was too small to reach a more definitive conclusion
about the possible relationship.
Few prospective studies have been carried out on selenium status and the risk of
cancer of gastrointestinal sites. With regard to toenail selenium, only one other study
has been reported. In that prospective study among over 14,000 Dutch women, 36 cases
of colorectal cancer were observed after a mean follow-up of 5.8 years (24). As in our
study, there was no evidence of an association with colorectal cancer in that study. With
regard to serum selenium, a number of nested case-control studies have yielded results
specifically for gastrointestinal cancers, albeit mostly for all cancers of the digestive tract
combined (9-12,14,15,17-19,32-34). Unfortunately, most of these studies only present
information on the overall difference in mean selenium levels between cases and
controls, and no information on relative risks per quantile of serum selenium (due to
the small number of cases). Based on the differences in mean serum selenium level
between cases and controls, in several studies the association with selenium was
stronger for gastrointestinal cancer than for total cancer (9,10,14,15,19). In three other
studies, the association with selenium was less strong for gastrointestinal sites than for
all cancers combined (11,12,18). In six reports (14,15,19,32-34) information is presented
for specific sites within the digestive tract. A negative association with serum selenium
was found for pancreatic cancer (19,34), stomach cancer (19,32) and oesophageal and
stomach cancer combined (32), while no (significant) association was found for
colorectal cancer in four studies (14,19,32,33). The reports by Knekt et al. (19,32)
represent the largest prospective study to date on serum selenium and the risk of
gastrointestinal cancer. In that Finnish cohort, a significant association between serum
selenium and stomach cancer was found among men, with a relative risk for men in the
upper four quintiles compared to the lowest quintile of serum selenium of 0.14, after a
median 8-year follow-up. For women, a nonsignificant negative association was found,
with a corresponding relative risk of 0.28. Thus, while our observation of a negative
association between toenail selenium and stomach cancer among men is supported by
the study of Knekt et al. (19), the findings among women seem to be in contrast with
that report. However, our result among women is based on only 20 cases; a larger
number of cases is needed for a more definitive conclusion. For both colon and rectum
cancer, our observations of no effect are in agreement with the earlier studies using
serum selenium (14,19,32,33) and toenail selenium (24).
Whereas the toenail selenium levels seemed to be decreased by prediagnostic colon
cancer in our study, this was not observed for stomach cancer. Although absence of an
effect of prediagnostic cancer has been reported often in the serum studies with regard
to overall cancer (9,10,17-19), there are very few studies reporting site-specific analyses
in this respect. Nevertheless, our findings with regard to effects of prediagnostic
stomach and colon cancer are supported by the results of the serum studies by Knekt et
al. (19) and the toenail study by Van Noord (24). Thus, case-control studies on
selenium status and colon cancer need to be interpreted with caution.
Following the observation that smoking is negatively associated with toenail
selenium levels (Van den Brandt et al., submitted for publication), we cannot exclude a
possible confounding effect of smoking on the association between toenail selenium and
stomach cancer. However, we have attempted to control for smoking in our analysis by
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using packyears of smoking instead of a crude categorization into never/ex/current
smokers; the negative association persisted after this tighter control for smoking.
In our previous study we observed that the negative association between toenail
selenium and lung cancer was modified by the level of intake of the antioxidants (35)
beta-carotene and particularly vitamin C (Van den Brandt et al., submitted for
publication). For stomach cancer, we also found some evidence for an effect
modification by vitamin C intake but it is less strong than for lung cancer. Because of
the differences in etiology of stomach cancer and lung cancer, it is difficult to
extrapolate from one site to the other. The discrepancies between the current finding
with regard to selenium may be partly explained by the fact that smoking is a less
important risk factor for stomach cancer than for lung cancer. Since smoking induces
oxidative stress (36,37), the effects of antioxidants and the interaction between them
(e.g., selenium and vitamin C) may be more evident for lung cancer than for stomach
cancer. For stomach cancer, the interaction between selenium and vitamin C may also
be of a different nature since the protective effect of vitamin C against this cancer may
have to do with its role in blocking the formation of N-nitroso compounds in gastric
conditions (38-40), which is independent of its antioxidative capacity.
In conclusion, we found a suggestive, but inconsistent negative association between
toenail selenium level and the risk of stomach cancer. The effect seemed only to be
present in men and there was some evidence for an effect modification by vitamin C.
However, the number of cases is still rather small; a more definitive evaluation would
require a longer follow-up period. As in other studies, no association was found
between selenium status and colorectal cancer risk.
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Chapter 17
Toenail selenium levels and the subsequent risk of breast
cancer*
Piet A. van den Brandt', R. Alexandra GoldbohmH Pieter van 't Veer*, Peter Bode',
Elisabeth Dorant', Rudolph JJ . Hermus-, Ferd Sturmans'.
Abstract
The association between toenail selenium levels and subsequent breast cancer risk wai
studied In a prospective cohort study on diet and cancer among 62,573 women aged 55-
69 years. Baseline exposure measurement included collection of toenail clippings,
assessment of dietary habits and potential confounders. After 3.3 years of follow-up,
471 microscopically confirmed incident breast cancer cases were detected. Toenail
selenium data were available for 355 cases and 1248 members of a randomly selected
subcohort of women. The relative rates of breast cancer In increasing quintiles of
toenail selenium were 1.00, 0.72, 0.62, 0.68 and 0.84 (test for trend p=0.307), while
adjusting for traditional breast cancer risk factors, alcohol and energy intake.
Selenium levels were significantly lower among cases diagnosed eariy during follow-up,
suggesting an influence of prediagnostic breast cancer. After excluding cases occurring
in the first year of follow-up, the relative rates of breast cancer in increasing quintiles
of toenail selenium were 1.00, 0.90, 0.76, 0.86, 0.91 (trend-p=0.618). It is concluded
that selenium status, as measured by toenail selenium, is not associated with breast
cancer risk.
* Submitted for publication
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Introduction
Studies among rodents have indicated a possible protective effect of selenium on
virally or chemically induced mammary tumours. In these studies, both the addition of
inorganic selenium (selenite, selenate) and organic selenium (yeast) in the diet have
shown a reduction in tumour yield (1-6). In ecological studies among humans, an
inverse association between per capita selenium consumption, blood selenium levels or
forage crop selenium content and breast cancer mortality has been reported (7,8).
However, case-control studies have yielded inconclusive results. While in some
studies serum selenium, a short-term marker of selenium intake, was significantly lower
in breast cancer cases compared to controls (9-11), this was not true in another study
(12). Selenium in long-term markers, such as erythrocytes (12,13) or toenails (12) was
not significantly associated with breast cancer. In prospective cohort studies where
prediagnostic selenium status can be measured and thus information bias can be
avoided, the majority of studies indicates no association of breast cancer risk with
serum or toenail selenium levels (14-20). This latter marker has been suggested as an
indicator of long-term selenium status (21,22) and it reflects differences in selenium
intake (23,24). We studied the relationship between toenail selenium levels and the risk
of breast cancer in a prospective cohort study in the Netherlands, a country with a high
incidence of breast cancer (25) and a moderate selenium intake (26).
Methods
The cohort characteristics and the method of cancer follow-up have been described
before (27,28). Briefly, the cohort study started in 1986 when 58,279 Dutch men and
62,573 women aged 55-69 years were enrolled in the cohort. At baseline, cohort
members completed a self-administered questionnaire on usual dietary intake and
potential confounders and also provided toenail clippings. Following the case-cohort
approach for analysis of the data, a subcohort of 3,500 subjects (1688 men, 1812
women) was randomly sampled from the cohort after the baseline exposure
measurement. The subcohort has been followed up biennially for vital status
information in order to estimate the accumulated persontime in the cohort. Incident
cancer cases occurring in the cohort have been identified by record linkage to cancer
registries and a pathology register. The analysis in this report is restricted to the cancer
incidence in the recently completed 3.3 year follow-up period from September 1986 to
December 1989. The completeness of cancer follow-up was estimated to be 95% (29).
In these 3.3 years of follow-up, a total of 553 breast cancer cases were detected among
the cohort of 62,573 women. After excluding incident cases reporting a history of cancer
other than skin cancer in the baseline questionnaire (n = 67) and cases with in situ
carcinoma of the breast (n=15), 471 microscopically confirmed incident breast cancer
cases were available for analysis. After excluding prevalent cases with cancer other than
skin cancer from the female subcohort of 1812 as well, 1716 subjects remained in this
group. Toenail clippings had been provided by 374 breast cancer cases and 1322 female
subcohort members. Problems with the detection of toenail selenium (interference by
other elements such as calcium) occurred in 7 and 9 of these 374 and 1322 specimens,
respectively. Another 12 and 65 specimens were excluded from the breast cancer and
subcohort groups, respectively, because the specimens weighed less than 10 mg, which
would yield unreliable selenium measurements. Thus, toenail selenium data on 355
breast cancer cases and 1248 female subcohort members were available for analysis.
Toenail selenium analyses were carried out by the Interfaculty Reactor Institute
(IRI) at Delft University, the Netherlands. Each analytical batch contained toenail
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specimens of cases and subcohort members, and the laboratory personnel conducting
the analysis was unaware of case or subcohort status. After cleaning and freeze-drying
of the specimens, the selenium content of the toenails was measured by instrumental
neutron activation analysis of the metastable-selenium-77 isotope. The specimens were
irradiated for 17 seconds in a thermal flux of 1.2x10" neutrons, s'.cm"^. After a decay
time of 20 seconds, gamma radiation of Se was measured for 60 seconds. The
accuracy of the method was checked by analysis of a certified Bovine liver standard
(Standard Reference Material 1577a of the US National Bureau of Standards). For 26
determinations, a mean value (± SD) of 0.70 ± 0.04 ug/g selenium was observed
against a certified value of 0.71 ± 0.04 |ig/g. The precision of the method was evaluated
by duplicate selenium measurements of specimens from 27 randomly selected subjects;
the coefficient of variation was 6.6 percent.
Data analysis
Mean toenail selenium levels of breast cancer cases and subcohort were compared, as
well as the mean levels of case groups, after categorizing the cases according to year of
follow-up. In addition to the factors studied in a previously conducted study on
predictors of toenail selenium (30), we also evaluated a possible association between
toenail selenium level and traditional breast cancer risk factors. This was followed by
case-cohort analyses (31), based on the assumption that survival times were
exponentially distributed in this follow-up period. For these analyses, toenail selenium
levels were categorized into quintiles according to the distribution in the female
subcohort. In the age-stratified analyses, we computed Mantel-Haenszel relative rates of
breast cancer for each of the quintiles, 95% confidence intervals, and tests for trend in
the relative rates (which were corrected for the additional variance introduced by the
subcohort sampling). Similar analyses were conducted for traditional risk factors for
breast cancer in the groups of subjects with complete toenail data. In the multivariate
case-cohort analyses, relative rates (with corrected 95% confidence intervals and tests
for trend) of breast cancer were computed for each toenail selenium quintile, after
adjustment for the effects of traditional breast cancer risk factors and intake of energy
and alcohol. To evaluate the potential influence of prediagnostic breast cancer on
toenail selenium levels, analyses were also conducted after excluding cases occurring in
the first year of follow-up. The analyses were carried out using the GLIM statistical
package (32,33). Two-sided p-values are used throughout this report.
Results
The mean (±SD) toenail selenium level in breast cancer cases was 0.569 (±0.104)
ug/g, while in the female subcohort members this value was 0.575 (±0.109) ug/g (table
1). When cases were categorized with respect to the year of follow-up in which they
were diagnosed, mean toenail selenium levels were increased towards later years of
follow-up. Cases in the first and second year of follow-up had significantly lower toenail
selenium levels than cases diagnosed in subsequent years (table 1). This suggests a
possible modifying influence of prediagnostic breast cancer on toenail selenium level.
Toenail selenium levels were not significantly associated with traditional risk factors
for breast cancer (results not shown), apart from smoking status, which had already
been shown to be predictive of toenail selenium levels (29). When an age-stratified
analysis of toenail selenium and breast cancer was conducted, the Mantel-Haenszel
relative rates were somewhat decreased in the upper four quintiles compared to the
lowest quintile, but only the relative rate of 0.64 in the third quintile was significantly
different from one. Also, the test for trend was not significant (table 2).
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Table 1. Toenail selenium leveb (ug/g) in breast cancer cases according to year of foUow-up.
Group* No. of cases Toenail selenium level (u.g/g)
Mean
0.569
0.558
0.557
0.583
0.593
± SD
±0.104
±0.116
±0.091
±0.108
±0.073
1
j
p-valuet
0.031
0.022
-t
All cases
Year of foUow-up
1
2
3
4
355
89
117
126
23
• Mean (± SD) selenium level in female subenhort members was 0.575 (± 0.109) ug/g (n = 1248).
t T-lcst between strata, based on In-transformed toenail selenium levels.
$ Reference category.
Table 2. Relative rate of breast cancer according to toenail selenium level in stratified and multivariate
analyses.
Quintile of toenail selenium level (boundaries in yg/g) Test for trend
Type of
adjustment
1» 2 3 4 5 x* (p-value)
(SO.499) (sO.544) (sO.585) (SO.645) (>0.645)
Age-stratified
No. of cases 87
(Person years (811)
in subcohort)
RRM, , 1.00
(95% (T)
Mullrvariati- modclt
No. of cases 67
(Person years (631)
in subcohort)
RR 1.00
(95% CI)
Excluding cases from
first year of follow-upt
No. of cases 44
(Person years (437)
in subcohort)
RR 1.00
(95% CI)
66
(813)
57
(816)
66
(813)
79
(804)
0.76 0.64 0.77 0.93 0.198 (0.656)
(0.53-1.09) (0.44-0.94) (0.53-1.10) (0.65-1.33)
48
(628)
46
(670)
49
(643)
60
(634)
0.72 0.62 0.68 0.84 1.044 (0.307)
(0.47-1.11) (0.40-0.%) (0.44-1.05) (0.55-1.27)
39
(436)
37
(465)
40
(444)
42
(438)
0.90 0.76 0.86 0.91 0248 (0.618)
(0.55-1.46) (0.47-1.23) (0.53-1.39) (0.56-1.46)
• Reference category.
t The nKHlel included terms for age, history of benign breast disease, maternal breast cancer, breast
cancer in sislcr(s), age at menarche, age at menopause, oral contraceptive use, parity, age at first birth,
Quctclct index, education, current cigarette snuiking, intake of alcohol and energy.
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In the group of subjects with complete toenail data, the effects of the established breast
cancer risk factors were in the anticipated direction. After stratification by age, an
elevated risk was observed for those with a history of benign breast disease (Mantel-
Haenszel relative rate, RR = 1.87; 95% confidence interval, CI, 1.27 to 2.74), history of
breast cancer in mother (RR=1.68; 95% CI, 0.99 to 2.86) and history of breast cancer
among one or more sisters (RR = 1.76; 95% CI, 1.12 to 2.77). Parity showed a
significantly inverse association with breast cancer risk (chi for trend = -2.58; p=0.010).
Age at first birth was significantly positively associated with the risk of breast cancer
(chi for trend = 2.11; p=0.035, among parous only). Age at menarche was inversely
associated with breast cancer risk, although not significantly (chi for trend = -1.32;
p=0.187), whereas age at menopause showed a borderline significant positive
association (chi for trend =1.90; p=0.057). No significant associations were observed
with menopause induced by hormones or surgically (RR=0.96; 95% CI, 0.69 to 1.32),
use of oral contraceptives (RR=1.02; 95% CI, 0.76 to 1.37), level of education (chi for
trend=0.365; p=0.715), current cigarette smoking (RR=0.98; 95% CI, 0.73 to 1.32) or
Quetelet index (chi for trend = -0.68; p=0.497).
When the association between toenail selenium and breast cancer risk was tested in
a multivariate model containing terms for the mentioned established and potential
breast cancer risk factors, energy intake and alcohol use, the relative rates for
increasing quintiles of toenail selenium were estimated at 1.00, 0.72, 0.62, 0.68 and 0.84,
respectively (table 2). Again, the relative rate in the third quintile was significantly
below the null value, but the trend was not significant (trend-p=0.307). When a similar
model was fitted after excluding cases diagnosed in the first year of follow-up, the
relative rates in the upper four quintiles were closer to the null value and the relative
rate in the third quintile no longer significant (table 2). Additional exclusion of cases
occurring in the second year of follow-up again yielded no association between selenium
and breast cancer (trend-p=0.577).
Discussion
We did not find a significant inverse association between toenail selenium level and
breast cancer risk in this prospective study among postmenopausal women, after
excluding cases occurring in the first year of follow-up. Our findings on lowered toenail
selenium levels in cases occurring early in the follow-up period are in contrast with
those of Hunter et al. (20), who reported no influence of prediagnostic breast cancer on
toenail selenium levels. However, in another cohort study, prevalent breast cancer cases
showed slightly lower toenail selenium concentrations than incident cases (19). The
possible influence of prediagnostic breast cancer on lowering selenium status is also in
accordance with observations on normal and tumour tissue of breast cancer patients,
indicating a sequestration of selenium by the tumour tissue (34). Furthermore, it has
been found in case-control studies that plasma and erythrocyte selenium levels were
lowered only in cases with large tumours (12) and that selenium levels were inversely
associated with breast cancer stage (10). Given the possible modulation of selenium
status by prediagnostic breast cancer, the results of case-control studies are difficult to
interpret. Case-control studies on serum selenium showed varying results (9-12); a
possible explanation for this might be a dissimilarity in the stage distribution of breast
cancer patients between the various studies. Case-control studies that have measured
erythrocyte selenium showed no association with breast cancer (12,13). Toenail
selenium was modestly inversely related to breast cancer in a recent case-control study
(12). Indeed, if we would limit our analysis to the first year of follow-up only, the
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relative rate estimate for increasing quintiles of toenail selenium would be 1.00, 0.37,
0.39, 0.43, 0.73, with the middle three estimates being significantly different from unity.
Two prospective studies on toenail selenium and breast cancer have been published,
both using a nested case-control analysis. Hunter et al. (20) found no association
between toenail selenium and breast cancer in their study, encompassing 434 incident
breast cancer cases originating from a cohort of 62,641 US nurses after a follow-up of
4.4 years; there was also no association when pre- and postmenopausal women were
analyzed separately. The study by Van Noord et al. (19) among 8760 premenopausal
women (27 incident cases after two years of follow-up) also showed no association with
selenium levels. Apart from these toenail studies, a number of prospectively nested
case-control studies using serum selenium have been conducted, from which specific
results on breast cancer risk have been reported (14-18). The follow-up periods covered
in these studies ranged from five (14) to over 10 years (15,18). None of these serum
studies showed a significant association between serum selenium and breast cancer risk,
but it should be mentioned that the number of breast cancer cases in most of these
studies was too small to perform statistically meaningful analyses specifically for this site
(14-17).
In conclusion, we found no evidence for an inverse association between selenium
itatus, as measured by toenail selenium levels, and the risk of breast cancer. The
relatively low toenail levels observed among cases occurring early during follow-up
illustrate the need to interpret case-control studies on selenium and breast cancer with
caution.
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Epilogue
Instead of elaborating on all results described in the various chapters, the primary
objective of this epilogue is to evaluate the choice to conduct a prospective cohort study
rather than conducting several case-control studies. In addition, we will discuss the
results on selenium and cancer now that the analyses of the relation between selenium
status and cancer sites of initial interest (stomach, colon, rectum, breast and lung) have
been completed.
Choice of study design
Textbooks on epidemiology state that prospective cohort (follow-up) studies may
provide a better basis for inference than other types of epidemiologie research, except
experiments (1). The reason for this is that case-control studies may suffer from
je/ecfi<?n a/w/ wi/omuittor» or reca// War, which are avoided in a prospective design.
Potential drawbacks of prospective studies - most of them related to the large scale
required for such studies - include ri'cn«/men/ <?ƒ a co/iort o/ suflfciWif .vtr<*, /o//r>w-j</) O/
<Aaf co/zort /or f/ie end-po/nU o/ interest, fne jxw.«7>/y few flcc«ra/«r I U O H I K M «ƒ <u/>avnre,
and last but not least, the pre.vumaMv HJ/?/I cratt. Did the advantages outweigh the
disadvantages in the present prospective study as compared to a case-control study? We
will attempt to formulate a (preliminary) answer by reviewing the points successively.
Selection bias
Selection bias may operate in case-control studies if enrollment of cases or controls
is associated with exposure, either direct or mediated by some other factor. Known as
well as unknown factors may introduce this type of bias. If these factors are known,
selection bias can be controlled by proper selection of case and control groups (2,3). In
prospective studies selection bias does not play a role, since cases originate from the
cohort. Substantial non-response of either cases or controls in case-control studies may
also result in selection bias, since response may be related to the exposure of interest,
but differentially so for cases and controls. For example, in a recent case-control study
on oral contraceptives and breast cancer the non-responders among the control subjects
appeared to have used less oral contraceptives than the responders, resulting in a lower
relative risk estimate (4). In prospective cohort studies, bias due to non-response is
presumed to be absent, since there are no cases yet at the time of the baseline exposure
measurement. Thus, although non-response may introduce selection that is related to
exposure, this is likely to be independent of the (future) case status of the cohort
members and will, therefore, not introduce bias. In cohort studies, however, the
counterpart of selection bias due to non-response is exposure-related loss to follow-up;
this will be discussed later.
Information bias
Information bias is considered to be a more serious problem than selection bias in
some case-control studies, in particular in studies that assess dietary habits. Information
bias can arise as a result of altered dietary habits in cases due to the disease under
study (e.g., cancers of the digestive tract). Even if the participant is asked to recall his
habits before the development of symptoms, recall bias may play a role since studies
have consistently shown that recall from the past is influenced by current habits (5,6,7).
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Studies on diseases that do not directly affect dietary habits (e.g., breast cancer) may
also suffer from recall bias, since cases may be more aware of their dietary habits and
more motivated to recall them. Although empirical evidence for the existence of
information bias in case-control studies on diet and cancer is limited, the plausibility of
its existence has been one of the main reasons to launch prospective cohort studies (8).
Available evidence comes from two cohort studies. In the Nurses' Health Study, 398
breast cancer cases, who had completed a baseline questionnaire, again completed the
questionnaire after diagnosis of the disease. The relative risk for the highest versus the
lowest quintile of fat consumption was 0.97 in the prospective analysis compared to 1.43
in the case-control analysis (9). A similar study did not provide evidence for recall bias
in a case-control study on breast cancer (10).
Prospective cohort studies, however, may also suffer from information bias, albeit
only bias due to a change in dietary habits caused by symptoms of prediagnostic
disease. In our data there was some evidence for this type of bias. For example, alcohol
and energy intake in men with colorectal cancer as well as toenail selenium in subjects
with breast and colon cancer appeared to be lower in cases diagnosed in the first year
of follow-up. However, this bias can be corrected by excluding cases with a short period
between baseline exposure measurement and diagnosis as we have done.
Choice of the study population and recruitment of the cohort
One of the attractive options in cohort studies compared to case-control studies is
that the investigator can choose the study population. Of course, the choice may also
depend on practical aspects of cohort recruitment and follow-up. Given the existing
opportunities in the Netherlands, we were able to assemble a cohort originating from
the general population. Several well-known cohort studies from other countries have
made use of professional groups because sampling from the general population was not
feasible (e.g., Nurses' Health Study (11) or Health Professionals' Follow-up Study (12)).
Studying such groups, particularly those occupied in health-related fields, may have
several advantages as compared to a general population cohort. Besides the availability
of professional listings for recruitment, and the ability of these subjects to complete
detailed questionnaires, a very important point is the access to diagnostic information
that the investigators can obtain through cohort members (who can be both patients
and treating physicians). This enables the investigators to study a range of different
diseases (e.g., cancer, heart disease, osteoporosis, gallstones, hypertension (12-15)). A
final point is the lack of confounding by occupation which is imposed by the restriction
to the occupational group in the design.
However, studying the general population has several important advantages as well
which, conversely, can be viewed as disadvantages of studying an occupational group.
First, the results may be more easily extrapolated to the population for which all the
research is meant. This may be important when translating the results into cancer
prevention programs for the general public and when use is made of population
attributable risks. Second, by studying the general population, one may provide a
greater contrast in the exposures of interest since diet is related to socioeconomic
status. Furthermore, it enables the investigator to study interaction between diet and,
for example, occupation in relation to cancer. Surprisingly, the fields of occupational
cancer research (i.e., dealing with occupation as possible cause) and dietary cancer
research are almost totally separated, while it is not unlikely that these two exposures
may modify each others' effects on cancer risk. By studying our general population
cohort, we were also able to assess effects of dietary exposures on cancer in men and
women simultaneously (e.g., selenium and various cancers, alcohol and colorectal
cancer). When cohort studies are conducted in certain professional groups these are
often restricted to one gender. Subsequent comparisons of results from separate male
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and female cohort studies may be more difficult to interpret, because different results
may be attributable to variations in design, exposure measurement techniques, quality
of follow-up information, and so on.
A third option is to recruit a cohort from an ongoing screening program (e.g.,
16,17). With regard to pros and cons this can be viewed as a mixture of the two
previous options. The screening program is usually offered to the general population,
but by the very nature of the screening it is often limited to a particular gender. A
distinct advantage of this approach is that biomarkers of exposure or susceptibility can
be obtained during the screening visit(s). These personal contacts also facilitate follow-
up of the cohort members. However, because screening programs are gradually
introduced into the population, more time is needed to assemble the total cohort. In
the first years of a study this may be a disadvantage since it takes longer until a
sufficient number of cases has emerged. Also, the staggered entry and inclusion of
expensive biomarker measurements often results in somewhat smaller cohorts.
Some cohort studies have created a greater contrast in dietary exposure by
including vegetarians (18). We have also made an attempt to overreprcsent vegetarians
in the cohort. Since the population registries do not contain such data, we had to call
for participation in magazines, and in leaflets displayed in health food stores and
packaged in vegetarian products. Although vegetarians could potentially be
overrepresented by a factor five at most, as was deducted from the observation that
20% of the vegetarians who applied for participation were also present in the random
sample from the general population, the specially recruited vegetarians increased the
proportion of vegetarians in the cohort from 1.0 to 1.2% only. Nevertheless, this implies
that in a cohort of 120,000 people a substantial number is vegetarian; after a longer
follow-up period it will be interesting to study cancer incidence in this particular group.
The unsuccessful attempt to overrepresent vegetarians does illustrate, however, how
inefficient such recruitment procedures are: (a) response to the call for participation
was extremely low in comparison with the population sampled from the population
registries, who received a personal invitation letter; (b) although the calls for
participation included criteria, such as age and residence, one third of the applicants
did not meet the criteria; (c) the names, birth dates and addresses provided by the
applicants were often incomplete, illegible or incorrect, resulting in decreased sensitivity
of record linkage with the cancer registries. Thus, the yield of this recruitment
procedure (larger contrast in dietary habits) relative to the amount of work involved
was very low. In contrast, sampling of the general population from the population
registries appeared to be extremely efficient, even when we take into account the
relatively high costs of sampling and the rather low response (36%). The advantages,
i.e. selection of the required age group, complete and correct identifying information
not requiring computer entry, outweighed the disadvantages (costs) by far. In 1985, it
appeared to be relatively easy to get permission from the municipalities to draw a large
sample, since only 7% of the municipalities refused. Since then, however, privacy
regulations have become more riged, resulting in less efficient procedures or even the
impossibility of sampling. For epidemiologie research this is a very unfortunate
development, which can only be diverted when researchers and administrators would
agree on guidelines for handling privacy-sensitive (identifying) information.
Follow-up
Completeness of follow-up is important in prospective studies for two reasons: (1)
loss to follow-up may introduce (positive or negative) bias into the results, if this loss is
related to the exposure of interest and (2) loss to follow-up that is random, i.e. not
dependent on the exposure of interest leads to loss of efficiency (power), since less
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cases with the disease of interest are identified. In our cohort study, loss to follow-up
appeared to be very small as a result of a high degree of coverage by the cancer
registries and PALGA and high accuracy of the record linkage. We therefore conclude
that bias or decreased efficiency due to loss of follow-up is no issue in this study.
The follow-up procedures appeared to be very feasible, although time had to be
invested in the development of record linkage procedures. It appeared that in a
relatively short time period, the cancer registries have successfully organized the data
collection and in such a way that epidemiological studies like this cohort study are
greatly facilitated. In this respect, the patient-based cancer registry data require less
work for the investigators than the specimen-based PALGA data. In the PALGA data
base multiple pathology reports of one patient are stored as separate records without a
patient identification key, requiring extensive procedures using additional identifying
information to assign records belonging to a specific patient. The diagnostic information
of the aggregated records then has to be coded per tumor site into ICD-Oncology. The
efficiency of this procedure could be improved substantially if pathology laboratories
would label records as belonging to a particular patient. Nevertheless, the PALGA data
were of great importance for us, given our interest is in microscopically confirmed
cancers, because the cancer registries were not yet fully covering the whole country at
the start of the study. An additional advantage of PALGA is that the data are available
shortly after diagnosis.
The possibilities for follow-up through cancer registries and PALGA contrast
sharply with follow-up for causes of death. Although privacy considerations are likely to
be even more important for incident cancer data than for mortality data, privacy
regulations have been formulated such that they do not hamper use of the cancer
registries and PALGA for prospective studies. Unfortunately, record linkage of cohorts
to the national data base of causes of death, maintained by the Central Bureau of
Statistics, is hindered by privacy arguments (19).
Assessment of exposure
Large-scale cohort studies have to assess exposure using relatively inexpensive
methods that do not require involvement of personnel such as interviewers. For dietary
assessment, a self-administered food frequency questionnaire is then the method of
choice. Compared to case-control studies, in which a more elaborate, interviewer-
administered method of diet assessment can be used, the food frequency questionnaire
may be less accurate. Although many data are available on the validity of food
frequency questionnaires, such data are scarce for the more elaborate methods.
Pietinen et al. (20) used an extensive, interviewer-checked, questionnaire with picture
booklets. Its validity, as compared to a diet record method, however, is similar to the
food frequency questionnaire (FFQ) used in our study. Van Beresteijn et al. (21) used a
very comprehensive diet history method. Its reproducibility, which may give an
indication of the validity, is substantially higher than that of our FFQ. We may
conclude that a FFQ is less accurate than an extensive, interviewer-administered
method. The consequence is that the observed associations between diet and cancer are
somewhat more attenuated, requiring larger numbers of cases (22,23). For example,
Walker and Blettner (20) have calculated that in a cohort study 50% more cancer cases
are required to account for an assumed 0.10 decrease in correlation between the FFQ
and "true" intake as compared to the correlation between an elaborate method and
"true" intake. Although it is possible to correct relative risk estimates that are
attenuated by imperfect measurement methods, it is important in this respect that the
estimates should not biased by selection and information bias (23).
An advantage of case-control studies is that biomarkers of exposure (given that they
represent long-term status and are not influenced by disease) can sometimes be
Epilogue 189
included in the exposure assessment, whereas this is momentarily often too expensive
for large-scale cohort studies. An exception to this rule may be provided by cohorts
recruited from screening programs, for which exposure and biomarker assessment can
be combined with the screening. We also considered the possibility of including
biomarkers of exposure in our cohort study. In a pilot study we studied the feasibility of
including the following biochemical parameters: fecal pH. nitrite concentration of saliva
and selenium concentration in toenails. The pilot study showed that assessment of fecal
pH and salivary nitrite by the participants (using test strips) led to considerable
misclassification when comparing it with the laboratory analyses of the returned stools
and saliva specimens, respectively (24,25). Only toenail specimens appeared to be
feasible to collect on a large scale. This study has shown the potential usefulness of
toenails in epidemiologie research. There is clearly a need for developing more
exposure biomarkers that reflect the long-term status of particular nutrients or
metabolites and have an established feasibility in (large-scale) epidemiologie studies.
Likewise, there is a need for studying feasibility aspects, sources of variation and, in
particular, the predictive value of disease biomarkers (26,27).
Conclusion
Considering the points discussed above, we think that this cohort study has already
outweighed a case-control study on diet and cancer as far as the methodological aspects
are concerned. Furthermore, the conduct of the study appeared to be very feasible.
With respect to the costs, we have calculated that for the first five years of follow-up
the cost per case of breast, stomach, colorectal and lung cancer amounted to
approximately NLG 1000. Prolongation of follow-up of the cohort will further reduce
the cost invested per identified case. We had to devote much time to development and
validation of methods, e.g., the dietary questionnaire and its further processing and the
record linkage to the cancer registries and PALGA. It is to be expected that future
epidemiologie (cohort) studies may benefit from this work.
Selenium and cancer
Following observations on a possible protective effect of selenium in animal studies
and ecological studies among humans, a large number of prospective cohort studies
have been conducted in the 1980s on the hypothesized inverse association between
serum selenium and cancer risk. Although the cohorts studied were considered large,
the actual number of incident cancer cases was rather small. Therefore, in virtually all
of these cohort studies analyses focused on selenium and overall cancer risk. The site-
specific number of cases was usually too small to perform statistically meaningful
analyses, with the exception of the Finnish cohort study by Knekt et al. (28) and the
Washington County cohort (29). The informativeness of relationships with overall
cancer risk is limited, since it is unlikely that a single (nutritional) factor would be
protective against all or most types of cancer. Indeed, the etiology of most cancers
seems to be so variable that it would be very fortunate if a ubiquitous cancer-preventive
agent would exist. Differences in results between the conducted cohort studies on
selenium and cancer risk may therefore be partially explained by differences in
distribution of the tumor site. The sample size of serum selenium studies is usually
limited, because of the invasive sampling and logistic problems (collection, transport,
storage). Collecting toenail clippings is more attractive because sampling is noninvasive,
collection can be done by study subjects themselves, transport by mail poses no problem
and specimens can be stored at room temperature. Furthermore, they reflect long-term
selenium status and differences in selenium intake (8). A recent study among Finnish
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men also showed that toenails reflect selenium intake from diets rich in organic
selenium compounds (the predominant form in the human diet) but not from inorganic
selenium compounds such as selenite or selenate (30). The collection of toenails hence
enables investigators to assemble a larger cohort and consequently perform site-specific
analyses. Indeed, two prospective studies on breast cancer and toenail selenium have
been published previously (17,31).
When studying the association between selenium and cancer, this should preferably
be done in a setting in which sufficient variation in selenium levels exists between
individuals and where selenium intake may be limiting. In this respect, it has been
noted (32-34) that discrepancies in the findings from the cohort studies may partially be
explained by differences in the range of selenium levels that has been investigated in
the various countries. The lowest mean serum selenium levels have been reported from
Finland and New Zealand, whereas in North Americans the levels are two or three
times higher (35). Indeed, most of the studies that show a negative association originate
from Finland where selenium intake used to be low (28). Selenium levels in the Finnish
population have recently increased, following the use of selenium-enriched fertilizer to
increase the selenium content of the soil, and consequently of foods (36). Studying the
relationship between selenium and cancer was also interesting in the Netherlands,
because the estimated intake is moderate and serum selenium levels are intermediate
between those reported from New Zealand and those in the USA (37), as we found for
toenail selenium levels (38).
The postulated mechanisms by which selenium may exert a beneficial effect include
altered metabolism of carcinogens, reduction of the mutagenicity of carcinogens,
inhibition of cell proliferation, stimulation of the immune system and protection against
oxidative damage via the selenoenzyme glutathione peroxidase (34,39,40). The latter
mechanism has received most attention. If selenium indeed would be protective against
oxidative stress, studying smoking-related cancers might be informative since smoking
induces oxidative stress (41,42). Now that we have studied the association between
toenail selenium and the risk of several cancers simultaneously after 3.3 years of follow-
up and can compare these results, such a pattern indeed seems to emerge: the inverse
association with selenium is present in cancers of the lung and stomach, where smoking
plays a more important role in the etiology, whereas it is not seen in the other cancer
sites studied, i.e. breast, colon, rectum.
This pattern is in line with site-specific results from other studies. Knekt et al. (28)
observed the strongest association with serum selenium for lung, stomach and
pancreatic cancer in Finland, while in the Washington County cohort significant inverse
associations were found for pancreatic and bladder cancer but not for lung cancer (29).
In the majority of the other, smaller, cohort studies a nonsignificant inverse association
with lung cancer was seen which was often stronger than for total cancer. Finally, the
risk of oral cancer, another smoking-related cancer, was inversely related to toenail
selenium levels in a recent case-control study; this association was further modified by
the level of vitamin C intake (43). We also found evidence of a modification of the
effect of selenium by the antioxidant vitamins C and B-carotene, which lends additional
support to the antioxidant hypothesis regarding selenium and cancer. We could not
evaluate possible effect modification by vitamin E, since data on vitamin E content are
currently not available in the Dutch NEVO food table. This is unfortunate, since an
interaction between this antioxidant vitamin and selenium has been described in several
studies regarding overall cancer risk (28,44-46). Extending the food table to vitamin E,
other antioxidants and (yet) nonnutritive elements is warranted, as is further study of
the interactions between antioxidants such as vitamin C, vitamin E and selenium with
regard to cancer risk.
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Of course, a disadvantage of our study is that no definitive conclusion can be drawn
about a true independent inverse association of toenail selenium with lung and stomach
cancer. Although we have controlled for smoking in our analyses fairly rigorously using
pack-years of current and past smokers, residual confounding by smoking cannot be
excluded, given the observation that smoking is inversely related to toenail and other
selenium status parameters (8,38,47). Therefore, it may be that a low toenail selenium
level is only a consequence of smoking and that it has no independent contribution to
the occurrence of these tumors. We did find an inverse association between toenail
selenium and lung cancer within categories of smoking (never/ex/current), but it is then
still possible that heavy smokers have both the lowest selenium levels and the highest
cancer risk. A randomized controlled trial would be needed to solve this issue more
definitively; several trials have been considered (34,48-51).
Finally, a criticism of our selenium analyses may be the relatively short follow-up
time of 3.3 years. This potential problem was addressed by evaluating mean toenail
selenium levels of cases occurring in each of the years of follow-up, as well as by
excluding cases diagnosed in the first year of follow-up from the relative risk analyses.
Only for breast and colon cancer toenail selenium levels appeared to be decreased by
prediagnostic cancer, which may be due to lowered selenium intake, altered absorption
and excretion or sequestration by the tumors (33,52,53). Because we did not find an
effect of prediagnostic stomach cancer on toenail selenium levels, the first possibility
seems less likely for breast and colon cancer. Nevertheless, the lowered selenium levels
of breast and colon cancer cases occurring early during follow-up indicate the need to
interpret case-control studies on this issue with caution. The number of stomach cancer
cases after 3.3 years of follow-up was still rather low for analyzing the association with
toenail selenium. For this site, as well as for other, less frequent sites a longer follow-up
period is warranted to study the relationship with selenium status in a more definitive
way.
Also, when more cases are available, it will be possible to evaluate more fully effect
modification by other antioxidants. The size of most epidemiological studies precludes
an investigation of interaction between several exposures. The size of our cohort is such
that, with a sufficiently long follow-up, effect modification can be studied with regard to
the occurrence of cancer. What becomes more important then is information on the
reproducibility of toenail selenium levels over time (31). Included in our dietary
reproducibility study was a collection of toenail clippings. Due to a lack of funds we
have not yet been able to assess the reproducibility using these five repeated
measurements. Information on intraindividual variation (of exposure and covariates)
can be used to correct relative rates for attenuation. This requires further development
and use of statistical methods that take into account random errors in both exposure
and covariates (54,55). Irrespective of whether selenium will be shown to be protective
against (smoking-related) cancers such as lung cancer, it is important to note that the
magnitude of the smoking-lung cancer association is much stronger than that between
selenium and lung cancer. Cancer prevention through smoking reduction therefore
remains substantially more important.
Concluding remarks
Many epidemiologists and textbooks commonly recommend prospective
investigators to use a prospective study design to avoid several biases and to conduct
pilot studies to develop the methods of data collection. Fewer recommend their
colleagues also to document the validity and reproducibility of these methods, as
applied in the actual epidemiological study. This latter point is clearly appreciated by
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methodological investigators but much less so by funding agencies. Furthermore, the
general rule of funding research projects for four years is hardly compatible with
conducting a truly prospective study with sufficient follow-up time. This then usually
leads to carrying out a case-control study or may lead to a prospective study with an
unrealistically short follow-up with low power and, depending on type of exposure,
interpretation problems similar to case-control studies.
We have conducted a prospective cohort study on diet and cancer that would both
yield a number of answers to diet-cancer questions in a relatively short period of time
and satisfy methodological interests. Conducting such a study in four years is
impossible, certainly after incorporating a number of methodological substudies.
Fortunately, the Dutch Cancer Society has been supporting not only a two-year pilot
study but also two four-year periods during which the actual cohort study was initiated
and carried out so far. The methodological substudies, some of which have been
financed by our own institutes, included testing the feasibility of a cohort study in the
Netherlands, developing and testing the dietary questionnaire both in terms of validity
and reproducibility, development of the record linkage for cancer follow-up and
development of methods for statistical analysis of case-cohort studies. Conducting such
methodological investigations has several advantages for the cohort study itself. They
can be viewed as prerequisites for the interpretation of the results of the main study,
because they give information on the quality of the various aspects of the study. This
information can also be useful when the data from the cohort study are being used
together with those of other studies in pooling or meta-analyses. We are currently
participating in a pooling project on diet and various cancers in which data from five
North American cohorts, one Swedish cohort and our cohort are analyzed in a
collaborative effort. Particularly with regard to less frequent tumor sites, such an
approach can, in addition to the individual studies, yield more definitive information on
the relationship between diet and human cancer.
This thesis contains the first results of analyses of a number of diet-cancer
relationships, conducted after 3.3 years of follow-up. With continued follow-up of the
cohort, the study can be extended to the analyses of various other associations between
diet (nutrients, non-nutritive factors, foods, dietary patterns) and the risk of common as
well as rare cancers. Also, interactions between dietary factors or between diet and
other factors (e.g., smoking, occupation) in relation to cancer risk can be investigated in
more detail.
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Summary
Various types of cancer are thought to be related to dietary habits, but the
epidemiologie evidence (mostly from case-control studies) is not always consistent. A
prospective cohort study avoids at least one of the possible sources of inconsistency,
namely retrospective assessment of dietary habits, which may introduce recall or
information bias. However, required budget and time or feasibility considerations often
preclude the conduct of such a study. In the Netherlands, the opportunity existed to
efficiently recruit a cohort from the general population and, more importantly, to use
the newly established cancer registries and PALGA (a computerized database of
pathology reports) for follow-up. This thesis describes a prospective cohort study on
dietary habits and the risk of cancer, conducted in the Netherlands since 1986 among
more than 120,000 men and women. Methodological issues, such as the design of the
study and the development and validation of methods used, form a substantial part of
the thesis. First results after 3.3 years of follow-up are also presented.
The design of the prospective cohort study is presented in Chapter 2. In September
1986, a cohort of 58,279 men and 62,573 women, aged 55-69, was recruited from 204
municipal population registries. The participants completed a self-administered
questionnaire on dietary habits and potential confounders (e.g., smoking, occupation,
education, reproductive variables); about two-thirds of them also provided toenail
clippings, which were used to assess their selenium status. The initial interest was in
stomach, colorectal, breast and lung tumors. To reduce costs, a case-cohort approach
was applied in which a subcohort of 3500 subjects (1688 men, 1812 women) was
randomly sampled from the cohort and followed up for vital status biennially to
estimate the person-time accumulated in the entire cohort. The 204 municipalities were
selected on the basis of two criteria: (a) availability of a computerized population
registry - for practical reasons - and (b) sufficient coverage by cancer registries and/or
PALGA to minimize loss to follow-up. The estimation of the coverage of the
municipalities by these registries using hospital discharge data is being described in
Chapter 3. It was estimated that the mean coverage degree of the cohort sample was
98.5% at the start of the study and was 100% complete in 1988.
Chapter 4 describes the development of a protocol, in collaboration with the IKL-
cancer registry, to link the cohort to the cancer data contained in the cancer registries
and PALGA. The optimal procedure starts with a computerized linkage using a key
consisting of encrypted information on the first four characters of the family name, date
of birth and gender to match a cohort member to a cancer patient. Subsequent visual
verification with additional identifying information (place of birth, migration, first
initial) is used to separate computer matches into true and false positive matches. In
the pilot linkage with this protocol, a sensitivity of 98% was achieved, whereas the
predictive value of (definitely) accepted matches was 100%. The protocol has
subsequently been adopted by all cancer registries and PALGA which have performed
record linkages periodically.
An important aspect of this study was the assessment of usual dietary intake. In a
pilot study in 1984-85 detailed dietary history interviews had been conducted among 169
men and women in the age range of the cohort. Regression analysis was employed to
select from the data set those food items that contributed most to interindividual
variation in intake of the 15 nutrients of primary interest. A total of 150 selected food
items were incorporated in a semi-quantitative food frequency questionnaire, which was
pretested twice. The validity and the reproducibility of the self-administered food
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frequency questionnaire (FFQ) are described in Chapters 5 and 6, respectively. The
validity was investigated in a subgroup of the cohort (59 men and 50 women) two years
after the baseline questionnaire was completed. A dietary record, kept over three 3-day
periods, four to five months apart, served as reference method. Pearson correlation
coefficients between nutrient intakes assessed by the record and the FFQ completed
afterwards ranged from 0.40 for vitamin B-l to 0.86 for alcohol intake, with correlations
for most nutrients between 0.6 and 0.8. Adjustment for energy intake and sex did not
materially affect these correlations, except that for fat intake, which changed from 0.72
to 0.52. To evaluate the representativeness of the validation study population for the
entire cohort, their baseline questionnaires were compared to those of a random sample
of the cohort. Correlation coefficients were only slightly modified when the results were
extrapolated to the cohort at large.
The reproducibility of the FFQ was determined from five annually repeated
questionnaire administrations in independent random samples from the cohort. Pearson
correlation coefficients between the baseline and the repeated measurement of nutrient
intake were calculated for each time interval, i.e. ranging from one to five year. Linear
regression of the correlation coefficients on time interval provided estimates of the test-
retest correlation of the FFQ (intercept of the regression line) and of the decline in
correlation over time (slope). The test-retest correlation averaged over all nutrients was
0.66. The decline in correlation amounted on average to 0.07 after five years. It was
concluded that the food frequency questionnaire is able to rank subjects according to
intake of food groups and nutrients and that this capacity was maintained over time.
Thus, a single baseline measurement with the FFQ is a good indicator of dietary habits
over a period of at least five years.
Besides exposure information obtained by questionnaire, we also collected toenail
clippings as a biomarker of the nutritional status of certain trace elements, in particular
selenium. Toenail selenium levels and questionnaire data of subcohort members were
used to identify potential determinants of toenail selenium in men and women, which
may act as potential confounders in subsequent analyses of selenium and cancer risk
(Chapter 7). Toenail selenium data were available for 2459 subcohort members. This
analysis revealed that smoking, gender and selenium intake were independently
associated with toenail selenium levels, whereas age, alcohol intake and Quetelet index
were not. Current smokers showed lower selenium levels than non-smokers or past
smokers; men showed lower levels than women. Selenium intake was weakly positively
associated with toenail selenium levels.
When collection of biomarkers on a large scale is not feasible, biomarkers may be
used to validate other exposure measurements. In this respect, nitrate levels from two
overnight urine specimens were compared with nitrate intake information obtained by a
semiquantitative food frequency questionnaire in a comparable cohort study on diet and
cancer in the United States (Chapter 8). After correction for within-person variation in
urinary excretion, the partial coefficient between dietary and urinary nitrate was 0.59.
These data suggested that a self-administered questionnaire may provide useful
information on usual nitrate intake. In addition, these results were used in the
construction of the Dutch cohort questionnaire.
In case-control studies, cancer cases may recall previous dietary habits (i.e., before
diagnosis) differently from control subjects without cancer, leading to information bias.
One of the reasons this might occur is that dietary habits were altered due to the
disease. To test this assumption, we compared a cross-sectional analysis of the
association between meat consumption and the prevalence of breast or colorectal
cancer (both at the time of baseline measurement in the cohort) with a longitudinal
analysis taking timing of a change in meat consumption frequency in relation to the
Summary 197
date of cancer diagnosis into account (Chapter 9). These analyses revealed that meat
consumption decreased substantially after cancer is diagnosed, which complicates the
interpretation of cross-sectional and possibly case-control studies, since the recall of
past dietary habits is influenced by current habits.
The method of statistical analysis of case-cohort studies is presented in Chapter 10.
The chapter concentrates on methods for stratified analysis and regression analysis. The
proposed methods were illustrated with the analysis of a well-known association in
cancer epidemiology, namely that between smoking habits and lung cancer. The case-
cohort analysis of our cohort data confirmed the strong positive dose-response
relationship between smoking and lung cancer. Compared to never smokers, the
incidence rate of lung cancer was estimated to be 3.6 and 9.8 times higher for past and
current smokers, respectively.
In Chapters 11-17, analyses of diet and cancer relationships are presented. For this
thesis cancer follow-up data are used from the period September 1986-December 1989.
In this 3.3 year period, the following numbers of microscopically confirmed incident
cancer cases were detected in the cohort: 155 stomach, 313 colon, 166 rectal. 471 breast
and 552 lung cancer cases. Regarding person-time, there were no subcohort members
lost to follow-up in these 3.3 years.
Chapter 11 deals with the association between dietary fat and breast cancer. For
this analysis dietary data were available for 437 incident breast cancer cases. No
significant associations with breast cancer risk were detected for total fat,
monounsaturated or polyunsaturated fat. For saturated fat, there was some evidence for
a weak positive association but its statistical significance was inconsistent. While this
analysis did not support a major role of dietary fat in the etiology of breast cancer, it
confirmed previously reported associations with nondietary breast cancer risk factors.
Elevated risks were found for women with a family history of breast cancer, a history of
benign breast disease, an early menarche and a late menopause, while decreased risks
were observed for those with an early first pregnancy and high parity.
Chapters 12 and 13 describe the relationship between colorectal cancer risk and the
consumption of alcohol and meat respectively. After exclusion of cases diagnosed in the
first year of follow-up, the analysis of alcohol consumption was based on 217 incident
cases of colon cancer and 113 cases of rectal cancer. For colon cancer, no association
with intake of alcohol nor with the consumption of beer or wine could be
demonstrated; for liquor a statistically significant decreasing risk with increasing
consumption was observed. For rectal cancer in men, positive trends were observed for
alcohol, beer and liquor. Multivariate models including alcohol intake and one beverage
type at a time showed that the increased risk was mainly restricted to consumption of
beer; the relative rate (RR) of beer drinkers compared to non-beer drinkers was 1.9.
Results for rectal cancer in women were consistent with those in men, but data were
too scarce to provide stable estimates. It was concluded that only consumption of beer
appeared to increase risk of rectal cancer, but not colon cancer. It was speculated
whether the high nitrosamine content of beer in the past has caused the increased risk.
The association between the consumption of meat and cancer of the colon was
based on 215 incident cases, excluding those diagnosed in the first year of follow-up. No
trends in relative rates were detected for intake of energy nor for energy-adjusted
intake of fats, protein, fat from meat and protein from meat. Consumption of (fresh)
meat, beef, pork, minced meat, chicken and fish was not associated with risk of colon
cancer either. Meat products, however, were shown to increase risk in men and women
(RR = 1.17 per 15 g/day).
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Risk of colorectal carcinoma after previous gallbladder surgery was investigated in
478 incident cases of colorectal cancer, 64 of whom reported at baseline to have
undergone previous gallbladder surgery (Chapter 14). The relative rate for colorectal
cancer in subjects who had undergone cholecystectomy compared to subjects who had
not resulted in an RR of 1.8 in men and l.S in women. In women, the highest RR (1.9)
was detected in the right colon, whereas in men, no site within the large bowel
accounted specifically for the increased relative rate. In both men and women, the
relative rate appeared to increase from approximately six years after cholecystectomy
onward. According to the TNM stage of the disease, cholecystectomized patients were
not detected in an earlier stage than the other patients. It was concluded that the
positive association between colorectal cancer and cholecystectomy could not be
explained by detection bias or ascertainment bias and was not confounded by risk
factors for gallstone disease or by dietary factors.
In Chapters 15-17 results are presented on the association between toenail selenium
and the risk of lung, stomach, colon, rectal and breast cancer. Toenail selenium data
were available for 370 incident lung, 104 stomach, 234 colon, 113 rectal and 355 breast
cancer cases. After controlling for smoking and various other factors, a significant
inverse association was observed between toenail selenium levels and lung cancer risk
(Chapter 15), with a RR of 0.50 for those in the highest selenium quintile compared to
those in the lowest quintile. The inverse association was found in both men and women
and persisted after excluding cases diagnosed in the first year of follow-up. The
protective effect of selenium was concentrated in subjects with a low intake of B-
carotene and, in particular, vitamin C. This effect modification by vitamins with
antioxidnnt properties supports the hypothesized anticarcinogenic effect of selenium
based on its role in the cellular antioxidant system. For stomach cancer, suggestive, but
inconsistent, evidence was found for an inverse relationship with toenail selenium
(RR=0.6 for highest vs. lowest selenium category). The effect was only seen in men
(RR=0.4), but the number of female cases was too small to draw more definitive
conclusions about a possible gender specificity of the effect (Chapter 16). Although
there was some evidence for modification of the effect of selenium on stomach cancer
risk by the level of vitamin C intake, this was less clear than for lung cancer. This may
be related to differences in etiology of lung and stomach cancer and in the importance
of smoking as a risk factor. For colon and rectal cancer, no association was found
between toenail selenium status and cancer risk. As for colon cancer (but not for lung,
stomach and rectal cancer), breast cancer cases diagnosed in the first year of follow-up
showed lower toenail selenium levels than cases diagnosed in subsequent years,
suggesting an influence of prediagnostic disease (Chapter 17). After taking this into
account, there was no association between toenail selenium and breast cancer risk. The
observations on the tumors studied are in line with those of other reports and suggest
that selenium status is inversely related to cancers of the upper digestive tract, as well
as to lung cancer, which are associated with smoking. Our observations on the possible
influence of prediagnostic disease also illustrate the need to interpret case-con trol
studies on selenium and certain tumors with caution because of the likelihood of
information bias.
While this thesis is limited to results of several diet-cancer analyses after 3.3 years
of follow-up, continued follow-up of the cohort will enable the investigation of various
other associations between diet (nutrients, non-nutritive factors, foods, dietary patterns)
and the risk of common as well as rare cancers. Also, interactions between dietary
factors or between diet and other factors (e.g., smoking, occupation) in relation to
cancer risk can be investigated in more detail.
Samenvatting 199
Samenvatting
Een aantal soorten kanker wordt in verband gebracht met voedingsgewoonten,
maar resultaten van epidemiologisch onderzoek (meestal patiënt-controle onderzoeken)
zijn niet altijd consistent. Een prospectief cohortonderzoek vermijdt tenminste één van
de mogelijke bronnen van inconsistentie, namelijk het vaststellen van iemands
voedingsgewoonten in het verleden dat tot vertekening van het onderzoeksresultaat kan
leiden (informatiebias). De kosten, de tijdsduur en de praktische uitvoerbaarheid
verhinderen echter meestal dat zo'n onderzoek wordt opgezet. In Nederland bestond
gelegenheid om op een efficiënte wijze een cohort uit de algemene bevolking samen te
stellen en - van nog groter belang - voor het vaststellen van kanker gebruik te maken
van de pas opgezette kankerregistraties en PALGA (een computerbestand van p.a.-
rapporten). Dit proefschrift beschrijft een prospectief cohortonderzoek naar de relatie
tussen voedingsgewoonten en het risico voor het krijgen van kanker, dat sinds 1986
wordt uitgevoerd onder meer dan 120.000 Nederlandse mannen en vrouwen.
Methodologische onderwerpen, zoals de onderzoeksopzet en de ontwikkeling en
validering van methoden die in het onderzoek worden gebruikt, vormen een belangrijk
onderdeel van het proefschrift. Tevens worden de eerste resultaten na een follow-up
periode van 3,3 jaar gepresenteerd.
De opzet van het prospectief cohortonderzoek staat weergegeven in hoofdstuk 2.
Het cohort omvat 58.279 mannen en 62.573 vrouwen van 55-69 jaar, afkomstig uit 204
gemeentelijke bevolkingsregisters. De cohortdeelnemers hebben in september 1986 een
schriftelijke vragenlijst ingevuld over hun gewoonlijke voedselconsumptie en potentiële
confounders (bijv. rookgewoonten, beroep, opleiding, medische informatie); circa
tweederde van hen stuurde ook teennagelknipsels in, waarmee de seleniumstatus in het
lichaam gemeten kan worden. In eerste instantie gaat de aandacht uit naar
maligniteiten van de maag, colon en rectum, borst en long. Om kosten te besparen is
een case-cohort benadering gebruikt waartoe aselect een subcohort van 3500 mensen
(1688 mannen, 1812 vrouwen) is getrokken uit het cohort; door dit subcohort elke twee
jaar aan te schrijven wordt ingeschat hoeveel persoonsjaren 'at risk' in het totale cohort
worden opgebouwd. De 204 deelnemende gemeenten werden doelbewust gekozen op
grond van twee criteria: (a) de aanwezigheid van een geautomatiseerd
bevolkingsregister - om praktische redenen - en (b) voldoende dekking van de gemeente
door de kankerregistraties en/of PALGA om een zo compleet mogelijke follow-up te
bewerkstelligen. In hoofdstuk 3 wordt beschreven hoe de dekkingsgraad van de
gemeenten door deze registraties is geschat met behulp van gegevens over
ontslagdiagnoses uit ziekenhuizen. De gemiddelde dekkingsgraad van het cohort werd
geschat op 98.5% bij de start van het onderzoek en op 100% in 1988.
In hoofdstuk 4 wordt de ontwikkeling (i.s.m. het Integraal Kankercentrum Limburg)
beschreven van een protocol voor de koppeling van de cohortgegevens met de gegevens
van de kankerregistraties en PALGA. De optimale procedure gaat uit van een
geautomatiseerde koppeling met een koppelingssleutel bestaande uit geëncrypteerde
informatie over de eerste 4 letters van de geboortenaam, de geboortedatum en het
geslacht, waarmee cohortleden gekoppeld kunnen worden aan kankerpatiënten.
Vervolgens vindt handmatige verificatie hiervan plaats met additionele identificerende
gegevens (geboorteplaats, migratie, eerste voorletter), waardoor de computer-
koppelingen gescheiden kunnen worden in terecht en fout-positieve koppelingen. In een
proefkoppeling werd met dit protocol een sensitiviteit van 98% bereikt, terwijl de
predictieve waarde van (definitief) geaccepteerde koppelingen 100% bedroeg. Dit
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protocol is vervolgens overgenomen door alle regionale kankerregistraties en PALGA,
die daarna periodiek koppelingen hebben uitgevoerd.
Een belangrijk onderdeel van het onderzoek was het vaststellen van de
gebruikelijke voedingsgewoonten bij de leden van het cohort. Tijdens een
vooronderzoek in 1984 en 198S werden uitgebreide mondelinge voedingsenquêtes
afgenomen bij 169 mannen en vrouwen in de leeftijd van het cohort. Met behulp van
regressieanalyse werden uit het resulterende gegevensbestand die (groepen van)
voedingsmiddelen geselecteerd die het meest bijdroegen aan de variantie in inneming
van 15 nutriënten die van mogelijk belang geacht werden voor kanker. De 150
geselecteerde voedingsmiddelen werden verwerkt in een schriftelijke zogenaamde
voedselfrcquentielijst (food frequency questionnaire, FFQ), die tweemaal werd
uitgetest.
De validiteit en de reproduceerbaarheid van de FFQ zijn respectievelijk beschreven
in hoofdstukken 5 en 6. De validiteit is onderzocht in een subgroep uit het cohort (59
mannen en 50 vrouwen) twee jaar na de afname van de lijst bij de start van het
cohortonderzoek. Gedurende drie perioden van drie opeenvolgende dagen, met
tussenpozen van vier tot vijf maanden, werd door de deelnemers een gedetailleerd
voedingsdagboek bijgehouden. De hieruit verkregen gegevens werden gebruikt als
referentie voor de voedselfrequentielijst, die twee maanden na de laatste
opschrijfperiode nogmaals werd ingevuld. De Pearson correlatiecoëfficiënten tussen de
opschrijfmethode en de FFQ varieerden van 0,40 voor de inneming van vitamine B-l
tot 0,86 voor de alcoholinneming; de meeste correlaties lagen tussen 0,6 en 0,8.
Correctie voor energieinncming en geslacht hadden weinig invloed op de correlatie,
behalve voor vet, waarvan de correlatie daalde van 0,72 naar 0,52. Om de
representativiteit van de deelnemers aan het valideringsonderzoek ten opzichte van het
gehele cohort te beoordelen, werden hun oorspronkelijke ("baseline") vragenlijsten
vergeleken met die van een aselecte steekproef uit het cohort. De
correlatiecocfficiënten veranderden slechts weinig bij extrapolatie van de resultaten uit
het valideringsonderzoek naar het gehele cohort.
De reproduceerbaarheid van de FFQ werd gemeten via vijf jaarlijkse herhalingen
van de vragenlijst bij aselecte, onafhankelijke steekproeven uit het cohort. Pearson
correlatiecoëfficiënten tussen de eerste en de herhaalde meting van de
nutriëntinneming werden berekend voor ieder tijdsinterval variërend van een tot vijf
jaar. Lineaire regressie van de correlatiecoëfficiënten op tijdsinterval leverden
schattingen op van de test/hertest correlatie van de FFQ (intercept van de regressielijn)
en van de afname van de correlatie in de tijd (helling van de lijn). De test/hertest
correlatie bedroeg gemiddeld 0,66. De gemiddelde afname in correlatie bedroeg 0,07 na
vijf jaar. De conclusie is dat de voedselfrequentielijst in staat is personen te
rangschikken volgens hun voedingsmiddelengebruik en nutriëntinneming en dat blijft
over een periode van tenminste vijf jaar. Een enkele meting met behulp van de FFQ
geeft dus een goede indicatie van de voedingsgewoonten gedurende langere tijd.
Behalve vragenlijstinformatie over de blootstelling zijn ook teennagelknipsels
verzameld als "biomerker" van de lichaamsstatus van een aantal sporenelementen, met
name selenium. Seleniumgehalten in teennagels en vragenlijstgegevens van de mensen
uit het subcohort zijn gebruikt om potentiële determinanten van
teennagelseleniumgehalten in mannen en vrouwen op te sporen, die als mogelijke
confounders op kunnen treden in de analyse van selenium en kankerrisico (hoofdstuk
7). In totaal waren van 2459 subcohortleden seleniumgehalten in nagels beschikbaar.
Deze analyse liet zien dat roken, geslacht en seleniumconsumptie onafhankelijk van
elkaar waren gerelateerd aan seleniumwaarden van de nagels; dat gold niet voor
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leeftijd, alcohol en Quetelet index. Rokers vertoonden lagere seleniumgehalten dan ex-
rokers of personen die nooit gerookt hadden: mannen lieten lagere seleniumwaarden
zien dan vrouwen.
Als biomerkers niet op grote schaal verzameld kunnen worden, kunnen ze
eventueel wel dienen om andere blootstellingmetingen te valideren. Als illustratie
hiervan werden nitraatgehalten van 2 urinemonsters, telkens verzameld gedurende de
avond en nacht, vergeleken met de nitraatconsumptie zoals gemeten met een
semikwantitatieve voedselfrequentievragenlijst in een gerelateerd Amerikaans
cohortonderzoek naar voeding en kanker (hoofdstuk 8). Na correctie voor
binnenpersoons-variatie in de urineuitscheiding bedroeg de partiële correlatiecoëfficiënt
tussen nitraat uit de voeding en urine 0,59. Uit deze bevindingen was af te leiden dat
met een schriftelijke vragenlijst bruikbare informatie over de gewoonlijke
nitraatconsumptie is te verkrijgen. Tevens konden deze resultaten gebruikt worden bij
de constructie van de Nederlandse cohortvragenlijst.
In patiënt-controleonderzoek kan informatiebias ontstaan wanneer kankerpatiënten
zich vroegere voedingsgewoonten (van vóór de diagnose) anders herinneren dan
controlepersonen zonder kanker. Dit kan onder andere gebeuren doordat
voedingsgewoonten gewijzigd kunnen zijn als gevolg van de ziekte. Om deze aanname
te verifiëren vergeleken we een cross-sectionele analyse van het verband tussen
vleesconsumptie en de prevalentie van borst of darmkanker (beide ten tijde van de
baselinemeting in het cohort) met een longitudinale analyse waarin het tijdstip van
verandering in vleesconsumptie in relatie tot het tijdstip van kankerdiagnose
verdisconteerd werd (hoofdstuk 9). Uit deze analyses bleek dat de frequentie van
vleesconsumptie in kankerpatiënten substantieel gedaald is na de kankerdiagnose. Dit
bemoeilijkt de interpretatie van dwarsdoorsnede- en mogelijk ook patiënt-
controleonderzoek, aangezien de herinnering van vroegere gewoonten beïnvloed wordt
door de huidige eetgewoonten.
In hoofdstuk 10 is de methode gepresenteerd om case-cohortonderzoeken statistisch
te analyseren. Daarbij wordt aandacht geschonken aan methoden voor gestratificeerde
analyse en regressieanalyse. De voorgestelde methoden werden geïllustreerd met een
analyse van een bekende relatie in de kankerepidemiologie, namelijk die tussen
rookgewoonten en longkanker. Onze case-cohortanalyse bevestigde de sterk positieve
dosis-responsrelatie tussen roken en longkanker. Ten opzichte van nooit-rokers werd
het relatief risico (in feite: relatieve rate, RR) op longkanker voor vroegere en huidige
rokers geschat op respectievelijk 3,6 en 9,8.
In de hoofdstukken 11-17 wordt ingegaan op resultaten uit analyses van enkele
verbanden tussen voeding en kanker. Hierbij zijn follow-up gegevens gebruikt uit de
periode van september 1986 tot en met december 1989. Gedurende deze 3,3 jaren van
follow-up werden de volgende aantallen microscopisch bevestigde incidente
kankerpatiënten gedetecteerd in het cohort: 155 maag-, 313 colon-, 166 rectum-, 471
borst- en 552 longkankerpatiënten. De follow-up van subcohortleden (persoonsjaren)
was compleet.
In hoofdstuk 11 wordt de analyse van het verband tussen voedingsvet en
borstkanker gepresenteerd. Voor deze analyse waren voedingsgegevens beschikbaar van
437 incidente borstkankerpatiënten. Er werden geen significante verbanden gevonden
tussen het risico op borstkanker en de consumptie van totaal vet, enkelvoudig- en
meervoudig onverzadigd vet. Verzadigd vet leek zwak positief geassocieerd te zijn met
borstkanker maar de statistische significantie van deze bevinding was niet consistent.
Terwijl deze analyse geen ondersteuning bood voor de hypothese dat vet sterk
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gerelateerd is aan borstkanker, bleken een aantal traditionele risicofactoren ook in ons
onderzoek gerelateerd te zijn aan het borstkankerrisico. Verhoogde risico's werden
waargenomen voor vrouwen met een positieve familieanamnese voor borstkanker, een
goedaardig borstgezwel in de voorgeschiedenis, een vroege me narene en een late
menopauze; verlaagde risico's werden gevonden voor vrouwen met een vroege eerste
zwangerschap en een hoge pariteit.
Hoofdstukken 12 en 13 beschrijven het verband tussen het risico op dikke darm
kanker enerzijds en het gebruik van respectievelijk alcohol en vlees anderzijds. De
analyse van alcoholgebruik was, na uitsluiting van patiënten die gediagnostiseerd
werden in het eerste jaar na de start van het onderzoek, gebaseerd op respectievelijk
217 en 113 incidente colon- en rectumkankerpatiënten. Voor colonkanker werd geen
verband gevonden met alcoholgebruik, noch met de consumptie van bier en wijn; voor
jenever werd een met de gebruikte hoeveelheid afnemend risico geconstateerd. Voor
rectumkanker bij mannen werd een positief verband met alcohol, bier en jenevergebniik
gevonden. Multivariate modellen, waarin alcohol en één soort drank steeds tegelijk
opgenomen werden, maakten aannemelijk dat het verhoogde risico voornamelijk
beperkt is tot biergebruik; het relatieve risico (RR) voor bierdrinkers vergeleken met
niet-bierdrinkers was 1,9. De resultaten voor rectumkanker bij vrouwen kwamen
overeen met die bij mannen, maar er waren te weinig bierdrinkende patiëntes om
betrouwbare schattingen te maken. Mogelijk, doch onbewezen, heeft het hoge gehalte
aan nitrosaminen dat vroeger in bier voorkwam bijgedragen aan het verhoogde risico.
De analyse van het verband tussen vleesconsumptie en colonkanker was gebaseerd
op 215 incidente patiënten na uitsluiting van patiënten gediagnostiseerd in het eerste
jaar. Er werd geen verband aangetoond met de inneming van energie en voor energie
gecorrigeerde inneming van vetten, eiwit en van vlees afkomstig vet en eiwit. Ook de
consumptie van (vers) vlees, rundvlees, varkensvlees, gehakt, kip en vis bleek niet
geassocieerd te zijn met het risico op colonkanker. Vleeswaren gaven echter een
verhoogd risico te zien, zowel bij mannen als bij vrouwen (RR = 1,17 per 15 g/dag).
Het risico op dikke darmkanker na een galblaasoperatie is onderzocht bij 478
patiënten, waarvan 64 in de vragenlijst hadden aangegeven die operatie ondergaan te
hebben (hoofdstuk 14). Bij mannen en vrouwen kwam respectievelijk 1,8 en 1,5 maal zo
vaak darmkanker voor na een galblaasoperatie. Bij vrouwen werd het hoogste relatieve
risico (1,9) gevonden voor het proximate deel van het colon, terwijl bij mannen geen
verschil tussen localisaties kon worden aangetoond. Zowel bij mannen als bij vrouwen
deed de stijging van het relatieve risico zich pas voor ongeveer zes jaar na de operatie.
Darmkankerpatiënten die eerder aan de galblaas waren geopereerd werden niet in een
vroeger stadium gediagnostiseerd dan de overige patiënten. De conclusie luidt dat het
waargenomen positieve verband tussen cholecystectomie en darmkanker niet verklaard
wordt door een aantal bekende bronnen van vertekening noch door samenhang met
risicofactoren voor galstenen of met voedingsvariabelen.
In de hoofdstukken 15-17 zijn de resultaten gepresenteerd van het verband russen
seleniumgehalten in teennagels en het risico op long-, maag-, colon-, rectum- en
borstkanker. Voor deze analyses waren seleniumwaarden beschikbaar van 370 incidente
longkankerpatiënten, 104 maag, 234 colon, 113 rectum en 335 borstkankerpatiënten.
Deze analyses lieten, na controle voor roken en enkele andere factoren, een significant
negatief verband zien tussen teennagelselenium en het risico op longkanker (hoofdstuk
15); het relatieve risico voor degenen uit het hoogste quintiel van selenium ten opzichte
van het laagste quintiel bedroeg 0,5. De negatieve associatie werd zowel bij mannen als
bij vrouwen waargenomen en bleef bestaan nadat patiënten waren uitgesloten die in het
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eerste jaar van follow-up waren gediagnostiseerd. Het beschermende effect van
selenium werd vooral aangetroffen bij mensen met een lage inneming van beta-caroteen
en met name vitamine C. Deze effectmodificatie door vitaminen met antioxidant-
eigenschappen ondersteunen de hypothese dat selenium anticarcinogeen kan werken via
zijn rol in het cellulaire verdedigingssysteem tegen oxydatieve schade. Voor maagkanker
werd ook een negatieve associatie met selenium gevonden maar de bevindingen waren
minder consistent (RR=0.6 voor hoogste versus laagste selenium categorie). Met effect
werd alleen bij mannen waargenomen (RR=0,4), maar het aantal vrouwelijke
maagkankerpatiënten was te gering om meer definitieve conclusies te trekken over een
mogelijke geslachtsspecifiek effect (hoofdstuk 16). Hoewel er bij maagkanker ook enige
aanwijzing was voor een effectmodificatie van het seleniumeffect door de vitamine C
consumptie, was dit minder duidelijk dan voor longkanker. Mogelijk heeft dit te maken
met verschillen qua etiologie tussen long- en maagkanker en het belang van roken
daarin. Voor colon- en rectumkanker werd geen verband gevonden tussen
seleniumconcentratie in teennagels en het kankerrisico. Evenals voor colonkanker
(maar niet voor long-, maag- en rectumkanker) vertoonden borstkankerpatiënten die in
het eerste jaar van follow-up gediagnostiseerd werden, lagere seleniumwaarden in de
nagels dan patiënten uit latere follow-up jaren, hetgeen op een invloed van preklinische
ziekte wijst (hoofdstuk 17). Wanneer hiermee rekening werd gehouden bleek er geen
verband te bestaan tussen seleniumwaarden en het risico op borstkanker. De
waarnemingen ten aanzien van deze kankervormen komen overeen met bevindingen uit
andere onderzoeken en suggereren dat selenium negatief gerelateerd is aan kanker van
het bovenste deel van de tractus digestivus, alsmede aan longkanker, kankervormen die
geassocieerd zijn met roken. Onze bevindingen ten aanzien van de mogelijke invloed
van preklinische kanker illustreren tevens dat patiënt-controleonderzoeken naar
selenium en bepaalde kankervormen voorzichtig moeten worden geïnterpreteerd
vanwege de mogelijke aanwezigheid van informatiebias.
Terwijl dit proefschrift zich beperkt tot de eerste resultaten van een follow-up
periode van 3,3 jaar, zullen na continuering van de follow-up ook andere associaties
tussen voeding (voedingsstoffen, andere bestanddelen van de voeding,
voedingsmiddelen, voedingspatronen) en het risico op zowel frequente als zeldzame
kankervormen onderzocht kunnen worden. Ook kunnen dan interacties tussen
voedingsfactoren of tussen voeding en andere factoren (bijvoorbeeld roken, beroep)
met betrekking tot kankerrisico meer in detail worden bestudeerd.
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Het zal duidelijk zijn dat ook dit proefschrift niet alleen het werk is van de
promovendi. Op de eerste plaats willen we hierbij alle deelnemers aan het
cohortonderzoek hartelijk danken voor het invullen van de vragenlijst en insturen van
teennagels in 1986. Hoewel we uit vooronderzoek hadden geschat dat het invullen
ongeveer één uur in beslag zou nemen, hebben we later nog vaak kunnen vernemen dat
het ook veel langer kan duren. Ook heeft 2/3 van de deelnemers zelf voor postzegels
voor de retourzending gezorgd en daarmee ƒ 120.000,- bespaard aan onderzoeksgeld.
Hierbij willen we vooral ook de leden van het subcohort danken voor hun inzet om
regelmatig een vervolgvragenlijst in te vullen, waarmee cruciale informatie werd
verkregen voor het onderzoek. We hopen dat we dit ook in de toekomst nog voort
mogen zetten.
Ten tweede willen we onze promotoren danken voor hun bijdragen. Ferd, jij hebt
ons steeds en op diverse wijzen gesteund bij het uitvoeren van onze ideeën. Vooral in
het begin van 1986 was jouw hulp en daarmee die van de RU Limburg van groot
belang voor het daadwerkelijk starten van het onderzoek toen niet voor iedereen
duidelijk was dat ook postzegels een essentieel onderdeel uit kunnen maken van
wetenschappelijk onderzoek. We hopen tevens dat we je voldoende gecompenseerd
hebben. Ook jouw steun, Ruud, is altijd van groot belang geweest om het project te
continueren. Iedere wetenschapper weet dat de beginjaren van een prospectief
onderzoek moeizaam kunnen verlopen. Het duurt lang voordat er 'resultaten' komen en
er moet zeer veel moeite gestoken worden in de opzet en uitvoering, zeker wanneer het
op deze schaal wordt aangepakt. We stellen het erg op prijs dat jullie altijd vertrouwen
in ons en de goede afloop hebben gehad, want het was toch wel een riskante
onderneming.
We owe very special thanks to professor Walter Willett of the Harvard School of
Public Health. You infected us with your enthusiasm for nutritional epidemiology and
convinced us that conducting a prospective cohort study on diet and cancer was not a
mad idea. Your example and transatlantic support has been very important to us, in
particular at times when other people were sceptic. We enjoy collaborating with you in
the Pooling Project of seven prospective studies and look forward to the intellectually
very stimulating discussions on the first analyses this summer. We also want to thank
you very much for taking the time to come to Maastricht as a member of the
Committee.
Vervolgens willen we graag Pieter van 't Veer en Elisabeth Dorant bijzonder
bedanken voor hun inzet in de diverse fasen van het onderzoek. Pieter, jij was vanaf het
begin bij de opzet van dit project betrokken. De eerste ideeën voor een
cohortonderzoek in Nederland zijn geboren in Shattuck House in Boston en namen
daar, na vele lekkere door Matthea gekookte maaltijden, steeds reëler vormen aan.
Aangezien je patiënt-controleonderzoek een steeds groter deel van je tijd ging opeisen,
heb je je daar op toegelegd. Echter ook in de analysefase heb je ons gevraagde en
ongevraagde adviezen kunnen geven die goed van pas kwamen. We hopen dat we deze
samenwerking kunnen continueren nu je in Wageningen werkt. Elisabeth, ook jij
vervulde een cruciale rol in het onderzoek, met name bij de follow-up via de
kankerregistraties en PALGA. Jij weet als geen ander dat het uitvoeren van dergelijke
koppelingen mooi klinkt maar desalniettemin nog zeer veel input vergt bij de
interpretatie van hieruit voortkomende informatie. Daarnaast speelde je een belangrijke
rol bij de vele ad hoc vragen tijdens de invoer en bij het opzetten van de database. Net
als wij zag jij in dat het uitvoeren van cohortonderzoek gewoon erg veel inzet vergt
vooraleer er resultaten geboekt kunnen worden. Je moet er dan ook niet aan beginnen
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als je op korte termijn-successen uit bent. We zijn erg verheugd dat je in de komende
tijd de gelegenheid krijgt ook jouw resultaten te boeken.
Henny Brants, jij kwam in 1984 voor het eerst als uitzendkracht voor ons project op
TNO werken. Daar deed je, samen met Anneke Huldij, het veldwerk voor de pilot
study. Nadat je een paar jaar de interviews voor het patiënt-controleonderzoek naar
borstkanker had gedaan, heb je je ervaring ingezet voor supervisie en training van de
diëtisten die het valideringsonderzoek uitvoerden. Daarna was (en is nog steeds) jouw
voedingskundige inbreng bij het invoeren en het verwerken van de voedingsvragenlijst
van groot belang. Je gedegen werkwijze, de manier waarop je alles tot in details
documenteert, je vermogen om alle kleine en grote problemen te overzien zijn
belangrijke schakels geweest in het succes van het voedingskundige deel van het
ondcr/ock. Tot slot bleek je ook nog in staat je aan te passen bij onze kronkels, die wel
eens van de bestaande paden afweken.
Zeer veel mensen waren in de afgelopen negen jaar voor kortere of langere tijd bij
dit onderzoek betrokken als medewerker, uitzendkracht of student, in Maastricht en
Zeist. We noemen hierbij in de eerste plaats de administratieve assistenten (in
chronologische volgorde): Hans Smit, Judith Knipsael, Dave van Gelder, Mariëlle
Bethlehem, Gemma Snijders, Patricia Florax, Arthur van Aken, Judith van den Brink,
Jolanda Nelissen, Willy van Dijk en Annemie Pisters. Desirée van de Cappellen en
Jenny Goes hebben in recordtempo een record aantal vragenlijsten ingevoerd. Het
zoeken van de vragenlijsten en (nog erger) teennagels in die enge kelder vol
spinncwebben, het invoeren van duizenden vragenlijsten, en het versturen van talloze
mailings, jullie deden het allemaal. Zonder jullie inzet was er niets van het hele project
terechtgekomen. Jullie hebben soms heel wat van ons en onze ideeën te verduren
gehad. Sacha van de Crommert, door jouw inzet in de verschillende fasen van het
onderzoek werd de invoer in goede banen geleid en door jouw consequente manier van
werken werd het datamanagement verder verbeterd. Arthur Schiphorst, van jou hebben
wij kneepjes van het publiciteitsvak geleerd toen het onderzoek van start ging. De
automatisering in het cohortonderzoek was natuurlijk geen sinecure. Gelukkig konden
we hierbij gebruik maken van de diensten van het Medisch en Maatschappelijk
Informatiecentrum van de RL en de rekencentra van beide instellingen. We willen hier
graag Harry van Montfort, Ruud Schmeitz, Gregor Franssen, Mariene Kruijen en Tony
van Montfort danken voor hun betrokkenheid bij dit onderzoek. Door belangrijke steun
van professor Riet Drop (Medische Sociologie) werd het mogelijk om de
gegevensinvoer via een personal computer daadwerkelijk gestalte te geven. Ook waren
je adviezen met betrekking tot de meting van alcoholconsumptie waardevol. Cor
Kistemaker, jouw VEVES programma is zeer plezierig voor het laatste onderdeel van
de vragenlijstverwerking, namelijk de berekening van nutriënten en
voedingsmiddelengebruik.
Van de vele studenten en uitzendkrachten noemen we Carla van Deursen en
Hannelore Hofhuis, die de vragenlijst uittestte en de contacten met de drukker
onderhield toen Sandra met zwangerschapsverlof was. Monique Al, Ingeborg van den
Heuvel, Anita Langeveld, Renée Boogerd, Dian Drenth, Marieke Rouwhorst, Ellen van
Vliet en Jacqueline Neijenhuis hebben tijdens het veldwerk voor het
valideringsonderzoek heel wat fiets-, bus- en autokilometers afgelegd. Jeanne van Loon,
het was een plezierige ervaring om met jou de analyses van de respons en vlees en
kanker te verrichten; je tegenwoordige rol in het cohortonderzoek stellen we ook zeer
op prijs. Hanneke den Breeijen, jij hebt, na je doctoraarvak, de spits afgebeten bij het
verwerken van de voedingsvragenlijst, waarbij je bleek aan te voelen waarom mensen
bepaalde invulfouten maakten. Stagiaires van de Hogere Informaticaopleiding in
Heerlen (Jacqueline Vliegen, Helma van der Linden, Anky Gense, Michiel van Kessel
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Marc Houben, Luc Crousen en Michel Koken) hebben allerlei nuttige programmatuur
geschreven.
Lex Volovics en Marion de Leeuw willen we hartelijk danken voor hun bijdragen
bij de opzet en de statistische analyse van het onderzoek. Martin van 't Hof, dankzij de
uit de KRIS periode stammende contacten met jou hebben wij niet één maar wel vijf
herhaalde metingen in het design geïncorporeerd en geanalyseerd. Ook zijn we Jet Smit
en Svenneke van de Heuvel van het NIPG dankbaar voor de verwerking van
beroepsgegevens. Voor het uitvoeren van de seleniumanalyses in circa 4000 nagels zijn
we Peter Bode, Anneke Ammerlaan en Frank van Paassen van het Interuniversitair
Reactor Instituut in Delft veel dank verschuldigd. Wat het aantal nagelanalyses betreft,
zijn jullie momenteel vast en zeker wereldrecordhouders.
Vervolgens willen we natuurlijk stilstaan bij de zeer belangrijke rol die de
kankerregistraties en PALGA hebben gespeeld in het tot stand komen van dit
onderzoek. De (combinatie van) gegevens van beide soorten instellingen vormden voor
ons precies datgene wat een groot cohortonderzoek mogelijk maakt in Nederland.
PALGA vormt met zijn geautomatiseerde landelijke databank van pathologisch-
anatomische gegevens een unieke gegevensverzameling. Wij zijn PALGA, tegenwoordig
SIG-Amsterdam, zeer erkentelijk voor de bereidwilligheid om deze gegevens te
gebruiken voor het cohortonderzoek en willen hierbij m.n. Rcnso Camps, Hnrmen
Schut, Ben van den Bergh, Han Hol en Lodewijk Otto danken voor hun medewerking
en adviezen.
De Integrale Kankercentra zijn erin geslaagd om in relatief korte tijd een complete,
landelijk dekkende kankerregistratie (de landelijke als som van de regionale
registraties) op te zetten. Dit mag gezien de eerdere ervaringen in de jaren vijftig en
zestig gerust een prestatie genoemd worden. Het is daarbij mogelijk gebleven - ook in
deze tijd van privacydiscussies - de gegevens te gebruiken voor o.a. epidemiologisch
onderzoek. Wij willen alle regionale kankerregistraties van de verschillende Integrale
Kankercentra (IKA, IKL, IKMN, IKN, IKO, IKR, IKST, IKW, IKZ), alsmede het
Landelijk Overlegorgaan Kankercentra hartelijk danken voor hun bereidwilligheid mee
te werken aan dit onderzoek.
Een zeer speciaal woord van dank gaat uit naar Leo Schouten van het Integraal
Kankercentrum Limburg. Leo zag al erg vroeg het belang in van dit onderzoek, ook
voor de kankerregistratie. Door de intensivering van onze contacten (via het IKL-
consulentschap van één van ons) gaf hij ons een duidelijker inzicht in de werkwijze en
ontwikkelingen in de registraties. Vooral door het gezamenlijk ontwikkelen van het
koppelingsprotocol werd de follow-up veel concreter en beter uitvoerbaar. Daarnaast
heeft Leo een belangrijke rol gespeeld bij het adopteren van het protocol door de
andere IKCs. Leo, het is helaas niet gelukt onze samenwerking verder formeel uit te
bouwen, maar we hopen die in de toekomst toch voort te zetten. Daarnaast mag ook de
rol van de andere Hoofden en automatiseringsdeskundigen van de kankerregistraties uit
de verschillende IKCs niet onvermeld blijven. We willen hierbij met name noemen:
Tiny Benraadt en Otto Visser (IKA/IKST); Perry Hünen en Loek Smeets (IKL); Hans
Berkel, Charles Gimbrère en Frits Bosman (IKMN); Renée Otter, Joyce Span en Jos
Schakenraad (IKN); Bart Kiemeney en Herman Ament (IKO); Mary-Ann Fijn van
Draat, Ronald Damhuis en Marja Tolsma (IKR); Hajo Kruijff, Roei van Westering en
Harry Verschuur (IKW); Marijke Verhagen-Teulings en Louis van der Heijden (IKZ).
De Nederlandse Vegetariërsbond, de VNR, Theo van Rooy van Smiths Reform en
Frans van der Reep van Natufood willen wij bedanken voor hun hulp bij het recruteren
van vegetariërs. Aan hen heeft het zeker niet gelegen dat dit onderdeel niet zo'n succes
werd. Ook willen we op deze plaats onze dank betuigen aan de leden van de
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Begeleidingscommissie en de Stuurgroep, de deelnemende gemeenten, de Stuurgroep
Epidemiologie in de Basisgezondheidsdiensten, de Vereniging van Directeuren
Basisgezondheidsdiensten, het Bureau Kwaliteitsaangelegenheden van TNO
(J. Remmerswaal, M. Gruisen) en de gemeente Maastricht (met name J. Kikken) voor
hun medewerking aan het onderzoek.
Verder willen we de (ex-)collega's van de vakgroep Epidemiologie en de afdeling
Voeding danken voor de plezierige werksfeer en de hulp in voorkomende gevallen. Met
name willen we hierbij noemen Ad Vissers, de stille kracht die door zijn bufferende
werking het project in goede banen hielp leiden; Diny van Faassen voor haar rol in de
pilot-fase van het onderzoek en adviezen ten aanzien van biomarkers in het algemeen
en teennagels in het bijzonder; Frans Kok voor je steun en goede adviezen. Naast
Thum 'Thesis' Aarts, die je over lay-out niets hoeft uit te leggen, zoals men kan zien,
willen we ook Willy en Patricia speciaal bedanken voor hun bijdragen aan dit
proefschrift en het ontcijferen van de manuscripten. Zoals jullie gemerkt hebben, was
het goed voor je Grieks! Dirk van der Heij was daarentegen goed voor ons Engels en
werd veel vaker dan "biennially" te hulp geroepen.
En, last but surely not least, zijn we Geja en Edward zeer dankbaar voor hun
enorme steun vóór, tijdens en na dit onderzoek. Alleen jullie weten echt wat dit project
aan tijdsinvestering heeft gekost, waardoor veel andere dingen erbij inschoten. Door
jullie motivatie - en kennis van zaken - tijdens de moeilijker fasen bleven we in de
goede afloop geloven. Jullie bijdragen waren ons het meest dierbaar. Bep van Vlooten
en Ankic Gcrrits, jullie waren onovertroffen "kunstmoeders" voor Sandra's kinderen.
Dankzij jullie liefde en huishoudcapaciteiten heeft de hele familie de afgelopen acht
jnar uitstekend doorstaan.
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1 Here your dale of birth is printed, aa given by you or your municipality: 1
Is this date correct? c=i yes igo on to question 2) o no
It nol. are you the the person whose name and address are printed on the envelope?
ca yes-> If so. what is your correct date of birth? I I I • I I I 191 I I
• no - > K M , could you give this letter to the addressee?
2 In what municipality were you bom? (country).
3 What is your marital status? a never marned ca divorced
ca marned ca widowed
4 Do (or did) you have twin brother? ca no ca yea
If so. Is his first initial the same as yours? ca no
Do you smoke currently? a no. I ve never smoked ca no, but formerly I did a yes
What do (or did) you smoke? (more than one answer possible) •=> cigarettes =a cigars
ca hand-rolled cigarette» ca pipe
6 Do you have any special eating habtts?
ca no ca macrobiotic ca vegetarian ca anthroposophic ca vegan
ca 7th day adventist ca other, namely (don't mention dicta)
If so, since when? Since 19 I I I
How many days on average per week do you eat meat?
ca 0 days ca t day ca 2 days ca 3 days ca 4 days ca 5 days ca e day* ca 7 days per week
In case you never eat meat or only eat it once a week, since when heve you been doing this? Since 19| I I
8 Do (or did) you have any type of cancer? 1=3 no (go on to question 10) ca yes
If so, what type(s)? ca stomach ca bladder c=> kidney ca lung
ca esophagus ca skin 1=1 leukemia ca oral cavity
ca large bowel ca brains ca Hodgkin's disease ca non-Hodgkin lymphoma
ca prostate ca testis ca bone ca liver
ca other, namely
9 When was this discovered for the first time? ca 1986 ca 1984 ca 1982
ca 1985 ca 1983 ca before 1982, namely in 19
10 Has a physician ever diagnosed one of the following conditions and what was your age at that time?
(Put a mark in front of the condition and mark your age behind it)
CONDITION younger than 30 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69
ca asthma ca ca ca ca ca ca ca ca ca
ca chronic bronchitis ca ca ca ca ca ca ca ca ca
ca diabetes ca c a c a c a c a c a c a c a c a
ca high blood pressure ca c a i = > c a c a c a c a c a c a
ca heart attack ca ca ca ca ca ca ca ca ca
ca angina pectons ca ca ca ca ca ca ca ca ca
ca gall-stones ca ca ca ca ca ca ca ca ca
ca kidney stones ca c a c a c a c a c a c a c a c a
ca thrombosis (in the leg) ca ca ca ca ca ca ca ca ca
ca stroke ca ca ca ca ca ca ca ca ca
ca tuberculosis ca c a c a c a c a c a c a c a c a
ca gastric ulcer/bleeding ca c a c a c a c a c a c a c a c a
ca chronic bowel irritation ca ca ca ca ca ca ca ca ca
ca polyps in bowel ca ca ca ca ca ca ca ca ca
ca hepatitis ca c a c a c a c a c a c a c a c a
ca rheumatoid arthritis •=> c a c a c a c a c a c a c a c a
Have you ever had surgery on your gall-bladder or for a gastric ulcer, what was your age at that time?
ca gall-bladder ca ca ca ca ca ca ca ca ca
ca stomach ca ca ca ca ca ca ca ca ca
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ara your data ol birth Is prlntad, as given by you or your municipality: i1 H e   l i  I  l ,  i      i i lit :
Is this data correct? ca yes (go on to question 2) ca no
If not are you tha tha parson whose name and address are printed on tha envelope?
ca yes - > If so, what Is your correct data of birth? I I I - I I I -191 I I
ca no - > If so, could you give this latter to the addrassaa?
I 2 In what municipality ware you born? (country).
3 What Is your marital status? ca never married
ca married
ca divorced
ca widowed
4 Do (or did) you hava twin brother? ca no ca yes
II so, Is his flrat Initial tha sama as yours? ca no yea
Do you smoke currently? ca no. I've never smoked
What do (or did) you smoke? (more than one answer possible)
no. but iormerly I did
cigarettes
hand-rolled cigarettes
i=> yes
a cigars
ca pipe
6 Do you hava any special eating habits?
• i» ca macrobiotic c=i vegetarian
a 7th day adventlst ca other, namely
H so, slnca whan? Since 19 | | I
anthroposophic vegan
(don't mention diets)
7 How many days on avaraga par waak do you aat meat?
ca U iluys ca 1 day ca 2 (lays i=i 3 days a 4 days a 5 days i=> 6 days a 7 days per week
In case you never aal maat or only aat It onca a weak, slnca whan have you bean doing this? Since 191 I I
Do (or did) you have any type ol cancer?
If so, what type(s)? <=> stomach
ca esophagus
= large bowel
•=3 breast
ca uterus
no (go on to question 10) yes
bladder
skin
brains
ovary
cervix
kidney
leukemia
Hodgkins disease
bone
other, namely
lung
oral cavity
non-Hodgkin lymphoma
liver
9 When was this discovered for the first tlma? 1986 ca 1984 a 1982
1985 ca 1983 t=i before 1982, namely in 191 I I
10 Has a physician avar dlagnoaad one ol tha following conditions and what was your aga at that tlma?
(Put a maik in Iron! ol the condition and mark your age behind it)
CONDITION younger than 30 30-34 35-39 40-44 45-49 50-54 55-59
i—i asthma ca ca ca ca ca ca ca
ca chronic bronchitis ca • — • • — • • — • • — • • — i i — i
i—i diabetes ca ca ca ca ca ca ca
i—i high blood pressure ca ca ca ca ca ca ca
ca heart attack ca c a c a c a c a c a c a
ca angina pectons ca c a c a c a c a c a c a
ca gall-stones ca c a c a c a c a c a c a
ca kidney stones ca c a c a c a c a c a c a
ca thrombosis (in the lag) ca c a c a c a c a c a c a
ca stroke ca c a c a c a c a c a c a
ca tuberculosis ca c a c a c a c a c a c a
ca gastric ulcer/bleeding ca c a c a c a c a c a c a
ca chronic bowel irritation ca c a c a c a c a c a c a
ca polyps in bowel ca ca ca ca ca ca ca
ca hepatitis ca c a c a c a c a c a c a
ca rheumatoid arthritis ca c a c a c a c a c a c a
ca benign breast disease ca c a c a c a c a c a c a
Hava you avar had surgary on your gall-bladdar or tor a gastric ulcar. what was your aga at that tlma?
ca gall-bladder ca c a c a c a c a c a c a
ca stomach ca c a c a c a c a c a c a
60-64
ca
ca
65-69
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The tofcwnnQ questions concern your EATING AND M l — M M Iwtlfai el <»PMt W » . In C—WMdent know an answei because
you don't prepare meate yourseH ptaaee ask the one who does. ls»i>embei lhat the qmrtont oonoem the things you eat
and drink. If you don't understand some question*, ptease ask your partner, tnends or chiMeren to help you.
Sometimes your are requested to spealy a certam brand. The reason lor this is that diflerent brands may dWer In
composton: the information t$ not used for commercial purposes. When the distinction "m summer" and "in winter" is used,
approximate penods are meant not strictly periods of three months.
11 How many eggs do you eat per week?
Do you drink coffee?
Do you take sugar in your coffee?
Do you take milk in your coffee?
Do you drink tea?
Do you take sugar In your tea?
'—*—' eggs per week
r=)
no™ no
*= no
<=no
= no
12 How many times per week do you use a hot meal?
Do you prepare the hot meals yourself?
How often did you have these products
for your hot meel during the past year?
bread instead of a hot meal
Chinese or Indonesian food
Italian food (e.g. pasta. 0122a)
soup as main course
fish
egg instead ot meat
cheese instead of meat
meat or chicken
. pulses (e.g. white or kidney beans,
lentils, marrowfats)
. soybean products (e.g. tolu, tempen)
. white rice (not in Chinese food)
. brown rice
. millet, buckwheat, wheat, barley.
oats and other cereals
. french tried potatoes
. mayonnaise
. potatoes (boiled, fried, mashed or
in a mixed dish)
. raw vegetables and boiled
vegetables: in winter
in summer
. only raw vegetables without boiled
vegetables: in winter
in summer
. only boiled vegetables: in winter
in summer
° y «
~yes
= yes.
<=yes
= yes
1 1 1
1 cup» per day
1—I—" teaspoons/lumps per cup
usually
j " " j j cup» per day
1 1 1 teaspoons/lumps per cup
times per week ^_^^
2
(type of milk please)
•=> no. seldom or never •=> yes 1—'—• times per week
never or
less than
1 x, month
=
1 =
C 3
ca
=
1 = 1
C 3
1 = 1
C = l
•=•
C D
1=3
1»
per
mo.
=>
«=
•=•
a
ca
C 3
C D
1 =
C 3
=
=
a
C 3
C = l
t = 3
2-3» 1i 2-0» 4-Sx »-7>
per per pet per per
•fc» jfc ^ajafe^sklf ^uaft^a^Lr ^ajaB^a^b ^B^AK^B^LY
*lf\J' I f ü W Wr^^H IfVvVl WI^ W^W
es ca ca ca ca
ca ca ca ca a
= = «= = "=
E3 = 1=3 CJ O
C=> C3 1=3 C3 C=3
e=» 1=3 c=i e= ca
C3 1=3 t=3 C3 <=3
1=3 1=3 1=3 C3 C=3
(=3 (=1 C3 ^ C=l
C=J 1=1 1=3 C3 CD
C3 C3 C=3 C=3 C=3
^=4 C3 C3 ^ 3 C=-
C=l C=- C3 1=1 1=1
C3 C3 C3 t = l (=1
S C3 (=1 1=3 1=1
1=1 1=1 1=1 (=3 c= l
C3 Q C3 1=1 t=l
t = l 1=3 (=3 C=l C=3
1=3 1=3 t=3 (=3 1=1
C=l C=3 C=J 1=} C=3
1=3 1=3 1=3 C 3 C 3
CD C=3 C=3 (=1 1=3
how much did you eat?
m mces
1 1 1 serving spoons
1 1 1 serving spoons
1 1 1 serving spoons
1 1 1 serving spoons
1 1 1 tablespoons
1 1 1 serving spoons
1 1 1 serving spoons
1 1 1 serving spoons
1 1 1 tablespoons
1 1 1 pieces the size
ol an egg
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38 Hava you «var chawed tobacco? ™ no ™ yes. during L-J—J yea's
Have you avar antffad tobacco? " n o " yes, during I—I—I years
39 Did your father or mother smoke when you were living with them? •=> no ~* mother only
• = both •=• fattier only
Does or did your partner smoke In your company?" no " yes " he/she used to. but not anymore since 19 I I I
What does or did your partner smoke in your company? ™ cigarettes " cigars ™ pipe
Are or were you exposed to cigarette smoke at work? " never •=> occasionally •=• usually •=• always
How many hours a day on average are you exposed to cigarette smoke? I I I hours
(remember home, car, work, canteens etc.)
EDUCATION AND OCCUPATION
40 Which of the following schools did you attend and which did your partner attend?
ma partner
a a primary school
a —i lower vocational education (e.g. technical, domestic science school)
i=i ea junior high school
<=> c— senior high school
e=a ea higher vocational education
es ca university
«=> other, e g specific part-time education, namely
a other, e. a. specific part-time education, namelv
41 Have you ever had paid employment? = y e s , wage-earning "=> no. but did have an unpaid job
• = yes, self-employed •=• no (go on to question 43)
What have been your occupat ions In your lifetime? At what companies or Institutions did you work, what w a s being
produced? What was your |ob and for how long did you work there? Fill in this information in the space below, as in
the example on the first line. If you are/were self-employed, fill in the type of company and your exact job only.
name ol company type of company what was being produced your exact what period did
or institution? or institution? at your department job? you work there?
./U/HMUII / /»'. rumuftiiiy firm tqfai i'/r. lyj/iofofmv from 1 9 I n I 7 I to 19 I 7 In I
from 191 I I to 19 j j j
from19J I ] to 191 I I
from 191 I I to 191 I I
from 191 I I to 19 I I I
from 19l—I—I to 19 I—I—I
42 Are you currently employed? <=• no •=• yes
If not, which situation applies to you?
<=> temporarily unemployed •=• disabled
= retired •=• exclusively homemaker (on/y /nc/ucted in questionnaire tor mmen;
" other, namely
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MEDICAL INFORMATION
43 How do you consider your health in general? •= encalant = good ™ reasonable *^ poor
H w matT>hc<ir» of s leepy you usually oet per day? (in me dav-hme and »t~or<t) L J - J hour»
bad
44 What surgical operations have you had and at what age? (name the last ITWM)
at age ( H H
at age D U
at age
45 Have you ever had an X-ray photograph taken of your:
stomach D no a y e s If so. how often? I I I times
bowels n n o a yes If so. how often? I I I time*
lung/chest a no i=> yes If so. how often? I 1 I time*
neck or shoulder o no ca yes If so. how often? 1 I I time*
back ca no <= y«s It so, how often? I I I rimes
other, namely
Have you ever had radiotherapy? •=• no " yes ft so, for what d t ta—T
If so, how often? I I 1 times
list below what medlclne(s) you have used longer than sli months, for what condltlon(s) and In what periods)?
«medicine for what condition ir~n m
Please
name of 
fromteCH)
from 191 I I
from ml I 1 loig
tnial"~n
47 What Is your blood type? <=> don t know = 0 e
What is your rhesus factor? •=• don't know = positive
B =
negative
48 Did any of your parents, brothers or sisters have cancer? •=• no
If so. please fill this in in the space below, as in the example.
what relation type of cancer
5I.VW
yes
age at diagnosis if alive, give
current age
at age I s I ? I Is Iv I years old
at age I I I
at age I I I
at age C I I
How many brothers and sisters do (did) you have? 1—1—I brothers and I I I sisters
In what year were your father and mother born?
In case they have died, in what years did they die, and what was the cause of death?
lather: born in 19 J=Jz=j (died in 19 L ^ J , cause of death:
I I I years old
j | | years old
I I I years old
if dead, give
age at death
at age I I I
at age I I I
at age I I I
at age I I I
mother: born in 1 I (died in 19 I 1 I cause of death:
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49 How often do you usually hava a bowal movamant?
*=• more than 2 limes per day ^ t -2 limes per day " 1 time per day " 1 time per 2 days ™ 2 times per week or less
Do you avar sutfar from obstipation? " never " seldom *=* sometimes " often " very often
OTHER QUESTIONS
50 How tall ara you? 1 I I centimeters _ ^ _ ^ _
How much do you walgh? d Z ) kilogram» What was your weight at aga 20? I I I I kilograms
What alia do you waar? shirt: I—1—1 pants: I—1—1
51 Pleas» fill In below the last four residences where you hava lived.
residence province from |—|—. to |—|—.
trom19b=j=d to 19
from 19'—'—' 10 19'—'—'
residence province (country)
What was your residence during the winter from 1944-1948?
52 Was your father employed during the crisis <1»32-1»40)?___
• no ca yes. he was employed in that period from 19 '—'—' to 19
53 How many minutes do you spend on avaraga per day walking or cycling to your work, to go shopping or to taka out your dog?
I I 1 1 minuten per day
How many hours of your leisure time do you spend on average per week on the following aclvrties?
yaritanmu •=> I never do this <=• less than 1 hour <=> 1 -2 hours ™ more than 2 hours
cycling, walking ™ I never do this ™ less than 1 hour ™ 1-2 hours ™ more than 2 hours
sports, gymnastics ™ / never do this ™ less than t flour = t-2 hours ^ more than 2 hours
In caae you play sports, what sports do you play?
54 In case you formerly played sports, please Indicate In the table below: what sport(s), was It in a competition system,
how many hours par week did you spand on aach sport (exercise included) and in what pariod?
type ot sport competition how many hours per week Irom to
<=> no •=• yes I 1 I hours per week trom 191 I I to 19 I I I
•=• no = yes I I I hours perweek from 19CZEZI m iq I I J
•=> no ™ yes I I I hours per week from 191 I I to 19 I I I
55 This question concerns leisure interests you have (had), e.g. fishing, woodcarving. dark room activities, painting.
On what leisure Interests do you spend a fair amount of time?
56 Do you keep pets Inside your home? (eg birds, hamster, dog) •=• no •=• yes
If so, what animals?
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MEDICAL INFORMATION
43 How do you consider your health in general? •=• exceaent = good ™ leasonable ™ poor ™ bad
How many hours ol sleep do you usually get per day? (m the day-time and at rnoht) I I I hour»
44 What surgical operations have you had and at what aga? (name the last three)
«age C D
at age C D
45 Have you ever had an X-ray photograph taken ol your: __
stomach • no e=> yes II so, how often? I I I time*
bowels o no CD yes It so, how often? I 1 1 times
. lung/cheat D no es yes II so, how often? I I I time»
neck or shoulder n no ra yes H so, how often? I I I time*
back o no = yes If so. how often? | I I time*
breasts o no <= yes II so, how often? I 1 I time*
other, namely ^ ^ _ _ _ _ _ _ _ _ ^ ^ ^ ^ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ ^ ^ ^ ^ ^ _ II *o, how often? | | | times
Have you ever had radiotherapy? ° no " yes H so, lor what dtsaata?
46. Please list below what medtcine(s) you have used longer than six months, tor what condition!,») and In what periods)?
name ot medicine loc what condition trom In
t romtoQI] to 19 j j j
trom 191—LJ lot9l—LJ
from 19J—1-3 to IP 1—1 I
from 19 C D to 19 C O
47 At what age did you have your first menstrual period? at age I I I
Have you ever used oral contraceptives? •=• no •=• yes
II so, at what age did you start using oral contraceptives? at age '—'—'
Are you still using oral contraceptives? "^ yes ™ no It not, when did you stop? at a q e L J Z j
How many years have you used oral contraceptives, excluding the years you stopped? I I I years
At what age did your menopause start off? at age I I I
How did your menopause start off? •=• naturally =• after surgery ^a with medication
Have you ever used hormones because of a discomfort during/after the menopause? ^ no ™ yes ^ don't know
If so, for how long did you use these hormones? Irom 19l I I to I—I—J
48 Have you ever had a Pap smear? = no •=• yes II so, when was the last time? in 19 I—I—I
Were you ever screened for breast cancer? "^ no "^ yes
If so. when was the last time? in 19 I—I—I
49 In case you are (or were) married, in what year were you married for the first time? in 191—I—I
Did you have childeren? ^ no ^ yes if so, how many L_LJ (also mention stillbirths, don't mention miscarriages)
If so. in what year was your first child born? in 191—I—I
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50 Did any of your parents, brothers or sisters have cancer? a no •=• yes
If so, please fill this In In the space below, as in the example.
what relation type of cancer age at diagnosis if alive, give if dead, give
current age age at death
tM/fr ftfi-mf at age I 5 17 I I 5 19 I years old at age I I I
at age I I I j I I years old at age I I I
at age I I I 1 I I years old at age I I I
at age I — O I I I years old at age I I I
How many brothers and sisters do (did) you have? I I I brothers and I I I sisters
In what year were your father and mother born?
In case they have died, In what years did they die, and what was the cause of death?
lathor: born in 191 I (died in 19 I I , cause ol death: )
mother: born In 191—LJ (died in 191 I I ; cause of death: )
OTHER QUESTIONS
61 How tall are you? I j I centimeters
How much do you weigh? I I I kilograms What was your weight at age 20? I I I I kilograms
What size do you wear? blouse: Q J skirl: I I I
52 Please fill In below the last four residences where you have lived.
residence province from to
from 19JHJHI to 19 j j I
from 191 j ] to 19 I I I
from 19IZZIZZI to 19 I I I
f r o m i 9 n z ] to 19 c u m
residence province (country)
What was your residence during the winter from 1944-1945?
53 Was your father employed during the crisis (1932-1940)? ____,
1=3 no <=> yes, he was employed in that period from 19 I I I to 19 L H ]
54 How many minutes do you spend on average per day walking or cycling to your work, to go shopping or to take out your dog?
I I I I minutes per day
How many hours of your leisure time do you spend on average per week on the following acivities?
gardening •=• I never do this •=• less than 1 hour •=• 1-2 hours •=• more than 2 hours
.cycling, walking •=* I never do this ca less than 1 hour •=• 1-2 hours •=• more than 2 hours
.sports, gymaslics •=* I never do this •=> less than 1 hour •=• 1-2 hours •=• more than 2 hours
In case you play sports, what sports do you play?
55 In case you formerly played sports, please Indicate in the table below: what sport(s), was it in a competition system,
how many hours per week did you spend on each sport (exercise included) and in what period?
type of sport competition how many hours per week from to
c=i no en yes I I I hours per week from 19 f I I to 19 I I I
. i=3 no •=" yes I I I hours per week from 19 f I I to 19 I I I
c=i no c=> yes I I I hours per week from 19 f I I to 19 I I I
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